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Abstract	
	
Background.	 Former	 socialist	 countries’	 transitions	 to	 market	 economies	 have	 had	
significant	 implications	 for	 health	 service	 policy	 and	 delivery.	 This	 study	 uses	 the	
transition	in	Macedonia	as	a	case	study	setting	to	explore	how	such	changes	and	related	
policies	 have	 been	 perceived	 to	 impact	 upon	 an	 important	 area,	 the	 prescribing	 and	
supply	 of	 medicines.	 This	 study	 focuses	 on	 the	 key	 primary	 care	 policies	 relating	 to	
limitations	to	prescribing	volume	and	dispensing	policy	enforcement.	
Study	 aims	 were	 to	 explore	 experiences	 and	 perceptions	 of	 how	 privatisation	 and	
regulation	 policies	 influenced	 the	 prescribing	 and	 dispensing	 of	 medicines	 from	 the	
perspectives	 of	 primary	 care	 physicians,	 pharmacists,	 patients	 and	 elite	 group	
stakeholders.	
Methods.	 A	 qualitative	 design	 was	 used	 utilising	 semi-structured	 interviews	 with	 a	
purposive	and	snowball	sample	of	17	doctors,	12	pharmacists,	14	patients	and	13	elites.	
Interviews	 were	 conducted	 face-to-face	 and	 fully	 recorded	 and	 transcribed	 and	 then	
analysed	using	a	thematic	analysis	approach.	
Findings.	Differing	but	often	negative	perspectives	emerged,	with	primary	care	provider	
physicians	 and	 pharmacists	 feeling	 pressure	 from	 both	 regulatory	 and	 governmental	
bodies	 and	 patients	 qua	 their	 expectations	 and	 medicines	 demands.	 Physicians	 and	
pharmacists	 felt	 detached	 from	 policies	 and	 that	 guidance	 was	 lacking.	
Disempowerment	 and	 threats	 to	 professional	 autonomy	 resulted,	 with	 unethical	
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implications	 for	 irrational	 prescribing	 and	 supplying	 medicines	 without	 prescriptions.	
Elites	 considered	 recent	 policy	 changes	 as	 necessary	 although	 they,	 and	 other	
participants,	 made	 comparisons	 to	 the	 previous	 system	 which	 was	 viewed	 with	
nostalgia,	 as	 being	 fairer.	 Mandatory	 prescription	 enforcement	 appeared	 ineffective	
with	patients	being	able	to	obtain	medicines,	although	patients	reported	new	pressures	
in	negotiating	medicine	supply	and	justifying	self-medication	practices.	Lack	of	coherent	
policy	implementation	was	a	recurring	theme.	
Discussion	 and	 Conclusions.	 Increasing	 regulation,	 marginalised	 professionals	 and	
patients	led	to	numerous	negative	experiences.	Using	a	Habermasian	perspective,	policy	
changes	within	Macedonia	 reflect	 a	 system	 that	 threatens	 individuals'	 lifeworlds;	 new	
policies	 represent	 juridification	 and	 professionals’	 perception	 of	 being	 isolated,	
uninvolved	 and	 unsupported,	 reflecting	 disruption	 of	 communicative	 acts	 and	 justice.	
This	study	suggests	the	need	to	improve	communication	between	different	stakeholders	
and	 involve	 practitioners	 and	 patients	 to	 ensure	 policy	 change	is	 sensitive,	 and	 not	 a	
threat,	to	individuals'	autonomy.	
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Glossary	of	Terms	
	
The	 Glossary	 of	 terms	 was	 prepared	 based	 on	 the	materials	 used	 in	 this	 thesis,	 with	
intention	to	clarify	meanings	and	uses	of	particular	terms	in	the	context	of	this	research.	
Anatomical	 Therapeutic	 Chemical	 (ATC)	 Classification	 System	 -	 system	 used	 for	 the	
classification	of	medicines.	First	published	in	1976,	the	system	divides	medicines	into	
different	 groups	 according	 to	 the	 organ	 or	 system	 on	which	 they	 act	 and/or	 their	
therapeutic	and	chemical	characteristics.	
Appropriate	 prescribing	 -	 defined	 with	 various	 terms	 referring	 to	 the	 result	 or	 what	
should	result	as	outcome	of	prescribed	medicine	or	treatment	(Buetow	et	al	1997).	
Although	suggested	by	some	scholars	that	for	specific	purposes	can	be	synonymized	
with	 ‘rational	 prescribing’,	 the	 term	 ‘appropriate	 prescribing’	 refers	 to	 a	 different	
concept	explaining	what	results,	or	should	result	as	the	outcome	of	the	prescribing,	
for	 which	 purpose	 ‘rational	 prescribing’	 is	 not	 always	 ‘appropriate’	 (Buetow	 et	 al	
1997).	 As	 will	 be	 explained	 later	 in	 this	 thesis,	 the	 ‘rational	 prescribing’	 and	
‘appropriate	prescribing’	are	distinguished,	but	mainly	 for	 the	purpose	of	providing	
theoretical	 understanding	 of	 the	 two	 concepts;	 otherwise,	 the	 thesis	 is	 not	
concerned	 with	 doing	 particular	 research	 on	 their	 distinctions,	 and	 therefore,	
commonly	used	in	the	research	is	the	term	‘rational	prescribing’.	
Culture	 -	 Culture	 in	 its	 wider	 definition	 presents	 ‘that	 complex	 whole	 which	 includes	
knowledge,	 belief,	 art,	 morals,	 law,	 custom	 and	 any	 other	 capabilities	 and	 habits	
acquired	 by	man	 as	 a	member	 of	 society’	 (Taylor	 1871).	 Culture	 is	 also	 defined	 as	
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cultivated	 behaviour	 representing	 the	 totality	 of	 a	 person's	 learned,	 accumulated	
experience,	which	is	socially	transmitted	through	communication.	
Essential	Medicines	 List	 (EML)	 -	 also	 called	 ‘list	 of	 essential	medicines’	 and	 ‘essential	
drug	 list’,	 as	 defined	 by	 the	World	 Health	 Organisation	 consists	 of	 medicines	 that	
‘satisfy	 the	 health	 care	 needs	 of	 the	 majority	 of	 the	 population;	 they	 should	
therefore	be	available	at	 all	 times	 in	adequate	amounts	and	 in	appropriate	dosage	
forms,	at	a	price	the	community	can	afford.’	(WHO	2016).		
Fee-for-service	 -	 model	 of	 payment	 in	 the	 health	 systems,	 used	 both	 in	 primary	 or	
hospital	care	 in	which	services	are	unbundled	and	paid	for	separately.	The	model	 is	
based	 on	 payment	 dependent	 on	 the	 quantity	 of	 care,	 rather	 than	 quality	 of	 care	
(Berenson	and	Rich	2010).	
Medicine	 (drug)	 -	 also	 referred	 to	 as	 drug,	 pharmaceutical	 drug,	 pharmaceutical,	
medication	 or	 medicament,	 is	 commonly	 defined	 as	 any	 chemical	 substance	
intended	for	use	in	the	medical	diagnosis,	cure,	treatment,	or	prevention	of	disease.	
For	 the	 purposes	 of	 this	 research,	 the	 terms	 the	 above	 terms	 will	 be	 used	
interchangeably	as	synonyms.	
Patient-based	capitation	model	–	a	model	for	healthcare	services	payment,	in	which	a	
physician	receives	a	payment	that	is	dependent	on	the	number	and	type	of	patients	
registered	with	the	physician’s	practice	(Chaix-Couturier	et	al	2000).	
Positive	medicines	list	(PML)	–	List	of	medicines	that	are	recognized	by	the	government	
as	 reimbursable	under	health	 insurance.	Some	of	 the	medicines	on	 the	positive	 list	
can	 be	 obtained	with	 certain	 co-payment,	 defined	 based	 on	 separate	 criteria.	 The	
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positive	medicines	list	is	based	on	the	Essential	Medicines	List	(EML).	In	this	paper,	it	
is	used	synonymously	with	the	term	‘positive	list’.	
Prescribing	 –	 term	 referring	 to	 recommending	 substance	 or	 action	 as	 something	
beneficial.	In	medical	terms,	prescribing	(of	a	health	practitioner)	refers	to	advice	and	
authorization	for	use	of	a	medicine	or	treatment	for	someone,	especially	provided	to	
the	patient	in	writing.	For	the	purposes	of	this	research,	the	term	‘prescribing’	will	be	
generally	used	for	prescribing	of	medicines.	
Prescribing	 culture	 –	 literature	 defines	 this	 term	 as	 decision	 making,	 including	
prescribing	 based	 on	 different	 influences	 (Maddox	 2011;	 Hall	 et	 al	 2003)	 from	 the	
society,	 including	 others’	 prescribing	 behaviour	 and	 patients,	 guided	 by	 informal	
rules	 (Bishop	 et	 al	 2011;	 Cavazos	 et	 al	 2008),	 and	 not	 necessarily	 evidence	 based	
(Ljungberg	 et	 al.	 2007),	 and	 sometimes	 stretching	 beyond	 clinical	 appropriateness	
(e.g.	Fontana	et	al	2000;	Wood	et	al	2007).	
Prescribing	 of	 medicines	 -	 one	 of	 the	 most	 frequent	 therapeutic	 decisions	 made	 by	
general	 practitioners	 (Bakker	 et	 al	 2007),	 representing	 a	 focal	 point	 of	 contact	
between	 physicians	 and	 patients	 and	 being	 used	 as	 one	 of	 the	 indicators	 of	 the	
quality	of	medical	care	(Harding	et	al	1985).	
Primary	healthcare	 -	often	used	for	describing	a	narrow	concept	of	family	doctor-type	
services	delivered	to	individual	patients	or	first	point	of	contact	with	the	healthcare	
system.	 Primary	 Health	 Care	 is	 otherwise	 a	 broader	 concept,	 which	 in	 addition	 to	
primary	 care	 services	 includes	 health	 promotion	 and	 disease	 prevention,	 and	 also	
population-level	public	health	functions,	reflecting	the	approach	to	service	provision	
for	a	community	proposed	in	the	WHO	1978	Alma	Ata	Declaration	(WHO	1979).	For	
the	purposes	of	this	research,	the	term	‘primary	healthcare’	will	mostly	be	used	in	its	
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narrow	definition	 of	 provision	 of	 services	 by	 primary	 healthcare	 providers	 (general	
practitioners,	family	physicians,	pharmacists)	to	patients.	
Privatization	 -	a	process	of	transferring	ownership	of	a	business,	enterprise,	agency	or	
public	 service	 from	the	public	 sector	 (government)	 to	 the	private	 sector	 (business).	
Privatization	 has	 different	 forms,	 one	 of	 which	 is	 concession,	 i.e.	 an	 exclusivity	
contract	between	private	and	public	sector	for	operation	of	public	utility	or	delivery	
of	public	service	for	an	agreed	number	of	years.	In	the	case	of	Macedonia,	although	
called	privatization,	the	reform	of	primary	healthcare	by	all	characteristics	is	more	a	
concession	type	of	transformation.	
Public	policy	-	principled	guide	to	action	taken	by	the	administrative	executive	branches	
of	 the	 state	 with	 regard	 to	 a	 class	 of	 issues	 in	 a	 manner	 consistent	 with	 law	 and	
institutional	 customs.	 The	 foundation	 of	 public	 policy	 is	 composed	 of	 national	
constitutional	laws	and	regulations.	Public	policy	is	considered	strong	when	it	solves	
problems	 efficiently	 and	 effectively,	 serves	 justice,	 supports	 governmental	
institutions	 and	 policies,	 and	 encourages	 active	 citizenship	 (Norwich	 University	
2016).	
Public	policy	analysis	-	problem-solving	discipline	that	draws	on	theories,	methods	and	
substantive	 findings	 of	 the	 behavioural	 and	 social	 sciences,	 social	 professions	 and	
social	and	political	philosophy.	Process-wise,	public	policy	analysis	is	multidisciplinary	
inquiry	 designed	 to	 create,	 critically	 assess	 and	 communicate	 information	 that	 is	
useful	in	understanding	and	improving	public	policies	(Dunn	2004).	For	the	purposes	
of	this	research,	public	policy	analysis	is	used	to	define	the	discipline	and	the	process	
referring	to	public	policies	relating	to	health,	health	systems	and	health	policies.	
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Rational	 prescribing	 -	 described	 in	 various	 terms	 referring	 to	 the	 process	 whereby	
prescribing	 decisions	 are	 made,	 based	 on	 the	 medical	 indication,	 necessity	 and	
known	effectiveness	of	the	prescribed	medicine	or	treatment.	Although	suggested	by	
some	 scholars	 that	 for	 specific	 purposes	 can	 be	 synonymized	 with	 ‘appropriate	
prescribing’,	 the	 term	 ‘appropriate	 prescribing’	 refers	 to	 a	 different	 concept	
explaining	what	results,	or	should	result	as	the	outcome	of	the	prescribing,	for	which	
purpose	‘rational	prescribing’	is	not	always	‘appropriate’	(Buetow	et	al	1997).	As	will	
be	 explained	 later	 in	 this	 thesis,	 ‘rational	 prescribing’	 and	 ‘appropriate	 prescribing’	
are	distinguished,	but	mainly	for	the	purpose	of	providing	theoretical	understanding	
of	 the	 two	 concepts;	 otherwise,	 the	 thesis	 is	 not	 concerned	 with	 doing	 particular	
research	on	their	distinctions,	and	therefore,	commonly	used	 in	 the	research	 is	 the	
term	‘rational	prescribing’.	
Transition	countries	(transition	economies)	–	countries	(and	their	economies)	changing	
from	 a	 centrally	 planned	 command	 economy	 to	 a	 market	 economy.	 Transition	
economies	undergo	a	set	of	structural	transformations	intended	to	develop	market-
based	 institutions	 (Leave	 2010;	 Kornai	 and	 Eggleston	 2001).	 According	 to	 the	
literature,	 the	 transition	 countries	 comprise	 29	 economies	 of	 Central	 and	 Eastern	
Europe	 and	 the	 Former	 Soviet	 Union,	 divided	 into	 three	 groups:	 i)	 Central	 Eastern	
Europe	and	Baltic	States:	Croatia,	Estonia,	Hungary,	Latvia,	Lithuania,	Poland,	Slovak	
Republic	 and	 Slovenia;	 ii)	 South-Eastern	 Europe:	 Albania,	 Bosnia	 and	 Herzegovina,	
Bulgaria,	Macedonia,	Montenegro,	 Serbia,	 and	Romania;	 and	 iii)	 Commonwealth	of	
Independent	States:	Armenia,	Azerbaijan,	Belarus,	Georgia,	Kazakhstan,	Kyrgyzstan,	
Moldova,	Russia,	Tajikistan,	Turkmenistan,	Ukraine	and	Uzbekistan.	 In	addition,	 the	
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European	Bank	of	Reconstruction	and	Development	 (EBRD)	also	 categorises	Turkey	
and	Mongolia	in	this	group	(Carvalho	et	al	2013).		
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CHAPTER	1:	Introduction	
	
1.1. Overview	
	
This	first	chapter	sets	out	the	reasons	for	studying	prescribing	and	dispensing	practices	
and	 attitudes	 during	 a	 period	 of	 significant	 changes	 within	 a	 healthcare	 system,	 my	
relationship	to	the	topic	and	an	overview	of	the	structure	of	the	thesis.		
This	 research	 explores	 the	 subjective	 effects	 of	 healthcare	 reforms	 in	 transition	
countries,	 namely	 those	 that	 have	 experienced	 a	 shift	 from	 command	 to	 market	
economy.	Through	the	use	of	qualitative	research	it	provides	a	greater	understanding	of	
the	 effect	 of	 this	 transition	 on	healthcare	 services	 provision,	 and	 especially	medicines	
supply	at	the	level	of	prescribing	and	dispensing,	as	viewed	by	a	range	of	stakeholders.	
Specifically,	 this	 research	explores	 the	effects	of	policy	 changes	 relating	 to	prescribing	
and	dispensing	of	medicines	in	primary	care	in	Macedonia	on	the	practices	and	attitudes	
of	policy	makers,	physicians,	pharmacists	and	patients	 in	terms	of	medicines	provision.	
Particular	 focus	 is	 chosen	 for	 two	 reasons:	 i)	 as	 a	 country,	Macedonia	 has	 undergone	
major	 privatization	 reform,	 explained	 in	 detail	 further	 in	 this	 thesis,	 and	 ii)	 as	 a	 sub-
setting,	 a	 significant	 proportion	 of	 prescribing	 and	 dispensing	 happens	 at	 the	 primary	
healthcare	 level.	 I	 have	 undertaken	 the	 research	 using	 semi-structured	 interviews.	 I	
hope	that	this	knowledge	will	inform	better	design	and	implementation	of	future	policy	
changes	in	Macedonia	as	well	as	in	other	countries	undergoing	healthcare	reform.	
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1.2. Rationale	for	studying	prescribing	and	dispensing	of	medicines	in	
transition	economies	
	
Healthcare	 reforms	 and	 privatization	 in	 transition	 economies	 have	 been	 the	 focus	 of	
previous	 research	 (Kornai	 and	 McHale	 2000;	 Leive	 2010).	 These	 have	 been	 analysed	
mostly	from	a	financial	perspective	or	 in	relation	to	health	outcomes	(Janssen	and	van	
der	Made	 1990;	Querciolli	 et	 al	 2013).	 However,	 there	 is	 little	 published	 evidence	 on	
effects	 of	 privatisation	 on	 social	 and	 behavioural	 aspects	 such	 as	 the	 attitudes	 of	
primary	care	providers	(i.e.	physicians	and	pharmacists)	and	patients	(Butler	et	al	1998;	
Ong	 et	 al	 1995;	 Emanuel	 and	 Emanuel	 1992).	 This	 research	 seeks	 to	 address	 this	
omission	and	does	so	using	a	further	specific	focus,	which	is	argued	to	have	been	absent	
in	transition	country	policy	change	research,	namely	the	supply	of	medicines.	Medicines	
represent	 an	 important,	 tangible	 aspect	 of	 all	 health	 systems	 and	 several	 aspects	 of	
their	 control	 and	 supply	 have	 been	 argued	 to	 have	 considerable	 significance	 for	
different	stakeholders	(Whyte,	van	der	Geest	and	Hardon	2002;	Britten	2008).	Involving	
prescribing	 doctors,	 dispensing	 pharmacists	 and	 consuming	 patients,	 the	 supply	 of	
medicines	will	be	argued	to	be	an	important	trajectory	for	framing	the	impact	of	policy	
reform	and	is	worthy	of	empirical	investigation.		
Undertaking	such	 research,	 is	 innovative	and	can	directly	 inform	the	on-going	debates	
about	the	significant	changes	to	healthcare	systems	aimed	at	improving	effectiveness	of	
the	 use	 of	 limited	 resources	 to	 address	 increasing	 demands	 for	 healthcare	 (Maarse	
2006;	Higgs	and	Jones	2001,	p.144).	Such	issues	have	been	rarely	subject	to	qualitative	
research	 in	 transition	 economies,	 resulting	 in	 very	 limited	 existing	 literature	 exploring	
transition	economies.	Further	research	using	qualitative	methods	allows	for	an	in-depth	
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cultural	 and	 sociological	 exploration	 of	 the	 policies	 and	 policy	 responses	 within	 the	
unique	contextual	circumstances	of	these	countries.	
	
1.3. My	background	and	research	interests	
	
My	interest	in	studying	prescription	practices	within	primary	healthcare	stems	from	my	
background	 as	 a	 pharmacist	 and	my	 experience	 in	 researching	 healthcare	 reforms	 in	
Macedonia	 since	 its	 independence.	 In	 the	 past	 years	 of	 my	 work,	 I	 have	 explored	 a	
number	of	cases	when	policies	were	adopted	based	on	other	countries’	best	practices	or	
on	 international	 experts’	 advice,	 without	 prior	 thorough	 assessment	 of	 their	 likely	
effects	 on	 society	 or	 on	 the	 individual.	 Most	 often	 the	 response	 was	 either	 partial	
compliance	 or	 continuation	 of	 previous	 practices,	 leading	 to	 recurrent	 failure	 of	
implementation.	The	prescribing	and	dispensing	policies	are	one	such	example,	where	
sequential	changes	made	to	address	failure	have	not	produced	the	desired	results,	with	
continuing	 high	 levels	 of	 antibiotic	 use	 (Radoshevic	 et	 al	 2009;	 Ivanovska	 et	 al	 2013).	
This	 is	 particularly	 observable	 within	 prescribing	 and	 dispensing	 of	 antibiotics,	 for	
example,	 which	 in	 Macedonia	 continues	 to	 be	 an	 issue;	 the	 extremely	 high	 levels	 of	
antibiotic	 prescribing	 and	 self-medication	 are	 contributing	 to	 the	 global	 concern	 of	
increasing	antimicrobial	resistance	(Angelovska	et	al	2016).	
In	 trying	 to	 understand	 these	 failures	 of	 policy	 implementation	 in	 general,	 and	 the	
effects	 of	 primary	 care	 reform	 in	 particular,	 my	 research	 interest	 is	 focused	 on	
understanding	the	practices	and	attitudes	of	policymakers,	physicians,	pharmacists	and	
patients	relating	to	policy	changes	covering	prescribing	and	dispensing	of	medicines.	In	
addition,	 I	 would	 like	 to	 explore	 whether	 taking	 these	 practices	 and	 attitudes	 into	
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consideration	could	contribute	positively	 towards	policy	design	and	 implementation	 in	
Macedonia	and	other	similar	countries.		
	
1.4. Thesis	outline	
	
Beyond	 this	 introductory	 chapter,	 the	 thesis	 is	 logically	 structured	 and	 divided	 into	
several	parts.	The	following	section	provides	an	overview	of	the	thesis.	
The	second	chapter	provides	an	overview	of	the	health	reforms	in	transition	countries,	
followed	 by	 a	 description	 of	 the	 reforms,	 and	 particularly	 prescribing	 and	 dispensing	
policy	changes,	in	Macedonia.	
The	 third	 chapter,	 Literature	 Review,	 outlines	 the	 existing	 body	 of	 literature	 on	
prescribing	 and	 dispensing	 of	medicines,	models	 of	 prescribing	 and	 issues	 concerning	
prescribing	 and	 dispensing	 in	 primary	 healthcare.	 An	 overview	 of	 the	 literature	 on	
prescribing	 and	 dispensing	 in	 the	 specific	 context	 of	 transition	 countries	 is	 then	
provided.		
The	fourth	chapter,	Methodology,	gives	a	critical	overview	of	existing	methodology	and	
provides	justification	for	choosing	a	qualitative	research	methodology	and	also	the	use	
of	semi-structured	 interview	methods	 in	 this	 research.	This	chapter	provides	details	of	
all	 stages	 of	 the	 research	 process,	 including	 the	 rationale	 for	 choosing	 the	 groups	 of	
interest,	sampling,	 interviewing,	transcribing	and	translation.	 It	describes	how	the	data	
were	 interpreted	and	analysed	using	thematic	analysis,	 followed	by	a	critical	reflection	
of	quality	and	credibility	in	relation	to	this	study	and	a	consideration	of	research	ethics	
issues	that	arose	as	part	of	this	research.	
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The	 fifth	 chapter,	 Findings,	 provides	 an	 account	 of	 the	 discerned	 themes	 from	 the	
research,	 which	 were	 summarized	 as:	 i)	 reflections	 on	 past	 and	 present	 policies;	 ii)	
issues	 arising	 from	 implementation;	 and	 iii)	 pressures	 in	 prescribing	 and	 dispensing	
practice.	 As	 will	 be	 shown	 in	 this	 chapter,	 there	 is	 general	 understanding	 of	 the	
necessity	for	change,	but	different	opinions	and	perceptions	regarding	the	development	
and	implementation	of	policies	for	prescribing	and	dispensing	in	primary	care;	nostalgia	
for	the	past	system	plays	a	key	role	in	shaping	these	perceptions	and	the	practice.	There	
is	also	acknowledgement	of	lack	of	effective	policy	implementation,	but	reluctance	from	
various	 groups	 to	 accept	 responsibility.	 Perceived	 disempowerment	 and	 reduced	
autonomy	was	articulated	by	providers	as	detachment	 from	the	system	and	 increased	
pressures	 in	 practice,	 whereas	 for	 patients	 it	 provided	 justification	 for	 negotiating	
medicine	supply	and	continuing	self-medication	practices.		
Chapter	 Six,	Discussion,	 contextualises	 the	 findings.	 Firstly,	 it	 compares	 and	 contrasts	
the	findings	with	the	literature	identified	in	chapter	three	and	it	is	argued	that	there	are	
similarities	 to	 themes	 previously	 identified	 in	 other	 research	 and	 health	 systems.	 A	
second	 aim	 is	 to	 argue	 that	 an	 existing	 theory,	 namely	 Habermas’s	 social	 theory	 of	
system	and	lifeworld,	is	an	important	way	in	which	the	findings	can	be	interpreted.	The	
chapter	 then	 goes	 on	 to	 consider	 the	 implications	 of	 the	 findings,	 not	 only	 for	
Macedonia,	but	other	transition	countries	too.		
The	 seventh	 and	 final	 chapter,	 Conclusions	 and	 Recommendations,	 summarises	 the	
research	and	offers	several	recommendations	based	on	the	emerging	research	findings	
of	this	study,	at	both	policymaking	and	implementation	levels.	In	terms	of	policymaking	
process,	 a	 recommendation	 is	 made	 to	 consider	 better	 involvement	 of	 providers	 in	
policymaking	and	providing	them	with	more	information	on	policy	changes.	In	terms	of	
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implementation,	 the	 key	 recommendations	 relate	 to:	 encouraging	 feedback	 about	
practice	experiences	 from	both	providers	and	patients	that	would	 inform	future	policy	
formulation,	 providing	 additional	 education	 of	 providers	 in	 communication	 with	
patients,	 alongside	 continuing	 efforts	 for	 awareness	 raising	 and	 improving	 health	
literacy	of	patients.		
Following	the	main	body	of	the	thesis,	various	supporting	materials	and	information	are	
provided	 in	 the	Appendices	 A	 to	 G,	 including	 ethical	 approvals,	 research	 instruments,	
and	 information	 sheets	 provided	 to	 participants,	 as	well	 as	 the	 consent	 form	 used	 to	
provide	 their	 participation	 under	 the	 principles	 of	 research	 ethics	 and	 guaranteed	
confidentiality.	 	
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CHAPTER	2:	 Health	system	reforms,	prescribing	and	
dispensing	medicines	in	Macedonia	
	
2.1. Overview	of	health	reform	and	privatization	in	transition	
countries	
	
Transition	from	planned	to	market	economy	has	inevitably	brought	a	new	paradigm	of	
system	structure,	operation,	functions,	reallocation	of	resources	and	thinking	within	the	
post-socialist	 societies	 (Krelle	 2000).	 Countries	 deciding	 to	 make	 this	 shift	 have	
embarked	on	a	process	of	massive	 reforms	 in	 the	economy	and	virtually	all	 sectors	of	
the	 society.	 For	 some	 sectors,	 this	 transition	 was	 blueprinted	 with	 a	 relatively	 well-
designed	roadmap	for	the	required	reforms	towards	the	desired	deliberative	democracy	
with	 equality	 and	 equity	 as	 main	 values.	 For	 example,	 market	 economy	 principles	
dictated	 liberalisation	 of	 production	 and	 markets,	 enabling	 competition	 and	
engagement	of	private	capital	(Kornai	and	McHale	2000).	Accordingly,	with	more	or	less	
success,	 the	 transition	 countries	 have	 completed	 this	 process,	 at	 least	 from	 its	
regulatory	and	normative	standpoint.		
The	 health	 and	 social	 sectors,	 as	 dominant	 accomplishments	 of	 a	 welfare	 state	 in	
developed	 democracies,	 exhibit	 a	 variety	 of	 approaches	 in	 reaching	 the	 same	 goals,	
partly	due	to	the	nuances	of	economic	and	social	contexts	and	partly	as	a	result	of	the	
specific	cultural	fabric	of	particular	states.	While	based	on	the	same	principles	of	equity	
and	equality,	individual	societies	value	health	differently,	as	illustrated	by	the	fraction	of	
resources	 they	 allocate	 for	 healthcare	 (Leive	 2010).	 For	 example,	 in	 the	 EU	 average	
health	expenditure	in	2015	accounted	for	nearly	10%	of	GDP,	but	ranges	between	7%	of	
GDP	 in	 Luxembourg	 to	 around	 11%	 in	 Germany,	 Sweden	 and	 France	 (OECD	 2016).	
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Therefore,	 the	 advice	 and	 guidance	 on	 restructuring	 the	 healthcare	 systems	 was	 far	
more	 ambiguous	 and	 much	 less	 determined	 in	 terms	 of	 how	 these	 transformations	
should	 proceed	 (Kornai	 and	 McHale	 2000).	 In	 transition	 countries,	 in	 2014	 the	
investment	in	health	ranged	from	little	over	5%	of	GDP	in	Albania,	Latvia	and	Romania	
to	over	10%	in	Serbia;	 in	the	same	year,	Macedonia	was	dedicating	6.5%	of	 its	GDP	to	
health	expenditures	(WHO	2017).	
Prior	to	1990,	systems	in	most	of	these	countries	were	financed	from	general	revenues,	
using	historically	determined	line-budgets	for	hospitals	and	fixed	salaries	for	physicians.	
Healthcare	 was	 virtually	 free	 to	 the	 population	 and	 was	 largely	 accessible	 through	
unnecessarily	 extensive	 health	 infrastructure.	 With	 the	 reforms,	 healthcare	 financing	
was	 channelled	 through	 newly	 introduced	 social	 insurance	 schemes	 and	 its	 execution	
transformed	to	a	more	performance-based	system,	mostly	as	a	combination	of	some	of	
the	 well-established	 payment	mechanisms	 of	 fee-for-service,	 capitation	 (payment	 per	
patient)	 and	 pharmaceutical	 price	 regulation	 (Leive	 2010).	 At	 the	 same	 time,	 the	
economic	restructuring	and	decline	of	the	production	sector	snowballed	a	reduction	in	
government	 expenditures	 for	 health.	 This	 affected	 access	 to	 healthcare,	 especially	 in	
terms	 of:	 lapses	 in	 availability	 of	 care,	 reductions	 in	 supplies	 of	 medicines	 and	 other	
materials,	lower	salaries	for	healthcare	providers	and	decrease	in	their	motivation,	and	
lowering	of	patients’	confidence	and	trust	in	the	quality	of	care	(Shkolnikov,	2001;	Atun	
et	 al	 2005;	 Kunitz	 2004;	 Bartlett	 et	 al	 2012,	 pg.4-5).	 The	 first	 in	 line	 for	 reforms	was	
primary	 care,	 as	 the	 gatekeeper	 of	 the	 system	 authorising	 access	 to	 specialist	 and	
hospital	care	(Franks	et	al	1992).		
The	goals	 for	 reforming	primary	care	were	 relatively	similar	 in	all	 countries:	 improving	
efficiency	 and	 introducing	 a	 stronger	 gatekeeping	 role,	while	 ensuring	 availability	 and	
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accessibility	 as	 an	 entry	 point	 to	 the	 health	 system	 (Cernis-Istenic	 1998;	Nordyke	 and	
Peabody	2002).	To	improve	the	efficiency	of	primary	care,	some	countries,	as	a	result	of	
donor-driven	 initiatives	 and	 examples	 from	 developed	 countries	 (Anell	 2011),	 have	
opened	 the	 market	 to	 private	 initiative	 (Nordyke	 and	 Peabody	 2002;	 Cernic-Istenic	
1998)	 and	 implemented	 the	 privatization	 model,	 for	 example	 Croatia	 (Hebrang	 et	 al	
2003;	 Dzakula	 et	 al	 2014),	 Slovenia	 (Albrecht	 and	 Klazinga	 2009;	 Albrecht	 2009)	 and	
Macedonia	(Nordyke	2000;	Milevska	Kostova	et	al	2017).	
	
2.2. Health	reform	and	primary	care	privatization	in	Macedonia	
	
2.2.1	Health	reform	in	Macedonia	
Prior	 to	 gaining	 independence	 in	 1991,	Macedonia	 had	 a	 centrally	 planned	 command	
economy	 and	 a	 well-distributed	 health	 care	 system,	 free	 to	 all	 at	 all	 levels	 of	 care	
(Ivanovska	and	Ljuma	1999).	Similar	to	other	transition	economies,	Macedonia	initiated	
economic	and	political	changes	triggering	market-oriented	reforms	in	all	(Carvalho	et	al	
2013),	including	the	health	sector	(Lazarevik	et	al	2012).	The	reforms	have	changed	the	
whole	 economic	 and	 societal	 fabric,	with	 implications	 for	 the	 health	 and	wellbeing	 of	
the	population	(Ivanovska	and	Ljuma	1999).	
Under	 the	 pressure	 of	 decreasing	 resources,	 the	 government	 initiated	 health	 sector	
reforms	 (Menon	 2006).	 The	 first	 decade	 of	 reforms	 was	 marked	 with	 health	 market	
liberalization	enabling	private	service	provision	during	the	1990s	(Nordyke	and	Peabody	
2002),	followed	by	establishment	of	a	third-party	payer	system,	through	establishment	
of	a	Health	Insurance	Fund	in	2000	and	reintroduction	of	a	social	insurance	model	based	
on	mandatory	salary	contributions	for	health	insurance	(Gjorgev	et	al	2006;	Leive	2010).	
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In	continuation	of	these	reforms,	government	considered	improvement	of	resource	use	
efficiency,	 part	 of	 which	 was	 primary	 healthcare	 privatization,	 initiated	 in	 2005	
(Milevska-Kostova	2010).	
	
2.2.2	Privatization	of	primary	healthcare	in	Macedonia	
In	2005,	the	Macedonian	government	commenced	a	process	of	privatization	of	primary	
healthcare	 (PHC),	 seeking	 to	 improve	 its	 efficiency	 and	 quality,	 and	 to	 strengthen	 its	
gatekeeper	role	 in	 the	system	(Figure	1)	 (Nordyke	and	Peabody	2002).	The	attempt	to	
capitalize	on	private	investment	in	the	public	domain	began	with	the	transfer	of	primary	
healthcare	 providers	 from	 public	 to	 private	 sector;	 they	 then	 needed	 to	 open	 private	
practice	 and	 set	 up	 contracts	 with	 the	 Health	 Insurance	 Fund	 (HIF)	 for	 provision	 of	
primary	 care	 services.	 This	 privatisation	 involved	 general	 practitioners,	 paediatricians,	
gynaecologists	and	pharmacists	(Gjorgjev	et	al	2006;	Milevska	Kostova	et	al	2017).	
Various	models	of	primary	care	funding	were	assessed,	 including	fee-for-service,	salary	
and	 mixed	 systems	 (Nordyke	 2002).	 For	 general	 practitioners,	 paediatricians	 and	
gynaecologists,	 the	 model	 applied	 was	 the	 blended	 capitation	 model,	 consisting	 of:	
payment	of	a	 fixed	amount	 for	each	patient	 registered	 in	 the	physician’s	 roster,	and	a	
variable	amount	for	delivery	of	preventive	care,	i.e.	fulfilment	of	pre-defined	preventive	
goals	 (Chaix-Couturier	 et	 al	 2000;	 Tulevska	 and	 Dimkovski	 2015),	 elaborated	 in	 more	
detail	in	the	following	paragraphs.	
By	 the	 end	 of	 2008,	 a	 total	 of	 2176	 primary	 care	 providers	 were	 contracted	 by	 the	
Health	 Insurance	 Fund	 (HIF	 2009),	 constituting	 95%	 of	 all	 licensed	 primary	 care	
providers	 (LKM	 2009).	 Within	 the	 taxonomy	 of	 privatization	 models,	 the	 process	 of	
transformation	of	primary	healthcare	in	Macedonia	is	closest	to	the	model	of	franchising	
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(Savas	 1989),	 as	 it	 is	mainly	 concerned	with	 provision	of	 services	 by	 private	 providers	
through	public	 funding,	and	does	not	 involve	any	 transfer	of	assets	 from	the	public	 to	
the	private	domain	(Poole	Jr.	2008).		
	
Figure	1.	Development	of	primary	healthcare	in	Macedonia		
(Adapted	from:	Nordyke	and	Peabody	2002)	
	
	
	
2.2.3	Capitation	payment	in	primary	healthcare	in	Macedonia	
The	 introduced	 payment	 model	 in	 primary	 healthcare	 is	 a	 patient-based	 blended	
capitation	model;	contracted	physicians	receive	a	defined	amount	per	registered	patient	
(Chaix-Couturier	 et	 al	 2000;	 Glazier	 et	 al	 2009),	 as	 well	 as	 incentives	 for	 rational	
prescribing	 and	 preventive	 services	 delivery.	 In	 practice,	 the	 contract	 consists	 of	 two	
major	 payment	 categories:	 70%	 fixed	 amount,	 and	 30%	 conditional	 amount	 based	 on	
fulfilment	of	the	so-called	preventive	goals	of	the	PHC	(Table	1),	which	are	revised	each	
trimester	 by	 the	 Health	 Insurance	 Fund.	 When	 the	 system	 was	 introduced,	 the	
preventive	goals	and	weighted	percentage	for	their	fulfilment	were:	rational	prescribing	
by	 limiting	 the	 number	 of	 prescriptions	 per	 registered	 patient	 (7%	 of	 capitation	 fee),	
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rational	 referrals	 and	 sick-leaves	 (4%),	 and	 preventive	 services	 for	 early	 detection	 of	
malignancies	 in	adults	and	health	conditions	 in	children	(combined	19%)	(HIF	2010).	 In	
2009,	rational	prescribing	was	defined	through	a	budget	ceiling	for	prescribing.	
	
Table	1.	Preventive	goals	in	primary	healthcare	in	Macedonia	(2009	and	2014)	
	 2009	 2014	
Goal	 Description	of	
activities	
%	of	capitation	
fee	
Description	of	
activities	
%	of	
capitation	
fee	
Prescriptions	 Rational	prescribing	
based	on	number	of	
prescriptions	per	
patient	
7%	 Rational	prescribing	
Prescribing	within	
budget	ceiling	
6%	
Continuous	
Medical	
Education	
-	 -	 Undertaking	training	 2%	
Sick	leaves	
and	Referrals	
Rational	referral	to	
higher	levels	of	
healthcare	
2%	 Rational	and	justified	
sick	leaves	and	referrals	
(max.	15	days	sick	
leave)	
2%	
Rational	and	justified	
referral	for	sick	leave	
2%	
Preventive	
services	
Adults:	Preventive	
activities	for	early	
detection	of	cancers	
and	cardiovascular	
diseases	
Children:	Preventive	
activities	for	various	
conditions,	including	
deformities	
19%	total	 Adults:	Preventive	
activities	for	
cardiovascular	diseases,	
diabetes	mellitus	and	
kidney	diseases	
20%	
(Source:	adapted	from	Preventive	Goals	in	PHC	(2010)	and	Tulevska	and	Dimkovski	(2015))	
	
	
The	 initial	 preventive	 goals	 were	 later	 adjusted	 in	 accordance	 with	 the	 increasing	
understanding	 of	 population	 needs	 and	 the	 accumulated	 experience	 of	 purchasing	
health	 services	 from	 private	 providers.	 As	 shown	 in	 Table	 1,	 in	 2014,	 the	 preventive	
goals	were	reformulated	to:	 rational	prescribing	based	on	defined	budget	ceiling	 (6%),	
rational	 referrals	and	sick	 leaves	 (2%),	undertaking	 training	 (2%),	and	other	preventive	
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services	now	also	including	prevention	of	major	non-communicable	diseases	in	the	age	
group	14-65	and	deformities	in	children	(20%)	(Tulevska	and	Dimkovski	2015).	Based	on	
experience,	 instead	of	number	of	issued	prescriptions,	rational	prescribing	was	defined	
and	 monitored	 through	 prescribing	 budget	 ceilings.	 The	 newly	 introduced	 budget	
ceilings	for	prescribing	were	defined	for	each	physician	weighted	on	the	characteristics	
of	their	patients,	in	particular	age	and	gender	(HIF	2014).	
	
2.3. Prescribing	and	dispensing	in	primary	healthcare	in	Macedonia	
	
2.3.1	Overview	of	prescribing	and	dispensing	policies	
Prescribing	 and	 dispensing	 policies	 in	 primary	 healthcare	were	 gradually	 changed	 and	
adapted	 to	 address	 the	 main	 issues	 of:	 i)	 rational	 prescribing	 and	 dispensing,	 i.e.	
prescribing	 and	 dispensing	 based	 on	 medical	 indication,	 necessity	 and	 known	
effectiveness	 of	 the	 prescribed	 medicine	 or	 treatment;	 and	 ii)	 cost	 containment,	 i.e.	
reducing	costs	incurred	as	a	result	of	excessive	and	unnecessary	prescribing.	This	section	
is	 intended	 to	 provide	 a	 structured	 overview	 of	 these	 changes.	 Table	 2	 and	 Figure	 2	
below	 summarize	 the	 policy	 changes	 relating	 to	 rational	 prescribing	 and	 dispensing	
reflected	through	the	following	policy	changes	(PCs):	
- PC1:	 Limiting	 prescriptions	 per	 patient	 per	 trimester	 (part	 of	 the	 preventive	
goals	defined	for	primary	care	physicians);	
- PC2:	 Budget	 ceiling	 for	 prescribing	 (part	 of	 the	 preventive	 goals	 defined	 for	
primary	care	physicians);	
- PC3:	 Dispensing	 only	 upon	 presentation	 of	 valid	 prescription,	 and	 within	
medicine	quotas	(part	of	the	enforcement	of	dispensing	in	pharmacies).	
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Table	2.	Summary	of	policy	changes	in	prescribing	and	dispensing	in	primary	care	in	Macedonia	
Policy	change	 Year	 Mechanism	 Indicator	 Incentive/	Penalty	
Prescribing	policy	changes	
PC1	 2005	
(Upon	
initiation	of	
privatisation)	
Part	of	preventive	
goals	for	physicians,	
measured	as	number	
of	prescriptions	
2	prescriptions	per	
patient	per	
trimester	
7%	of	variable	
capitation	lost/gained	
PC2	 2009	 Part	of	preventive	
goals	for	physicians,	
measured	as	number	
of	prescriptions	
Part	of	preventive	
goals	for	physicians,	
measured	as	budget	
spent	on	
prescriptions	
	
	
	
	
Budget	ceiling,	
adjusted	to	number	
and	age/gender	of	
registered	patients	
	
7%	of	variable	
capitation	lost/gained	
	 	
	
2014	
	
	
	
6%	of	variable	
capitation	lost/gained	
Dispensing	policy	changes	
PC3	 2009	
	
Enforcement	of	
dispensing	policy	in	
pharmacies	
Dispensing	only	
upon	presentation	
of	valid	prescription	
Fines	in	accordance	
with	penal	stipulations	
in	the	law	
	 	
2011	
	
	
Budget	ceilings	
(quotas)	for	
dispensing	under	
health	insurance	
	
Ceiling	defined	per	
population	
coverage	and	
historical	records	
	
None	
Legend:	PC=policy	change	
	
Figure	2.	Policy	changes	for	rational	prescribing	in	primary	healthcare	in	Macedonia		
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As	 can	 be	 seen	 from	 the	 above,	 prescribing	 and	 dispensing	 were	 among	 the	 areas	
reformed	as	part	of	the	primary	healthcare	reform,	and	thus,	the	next	sections	provide	
an	overview	of	policies	pertaining	to	this	process	and	relevant	to	this	research.	
	
2.3.2	Prescribing	policy	changes	
With	 the	 health	 system	 reforms	 and	 the	 aforementioned	 liberalisation	 of	 service	
delivery	and	medicine	supply	markets,	a	key	priority	 for	 the	governments	of	 transition	
economies	was	 the	 regulation	 of	 private	 providers	 (Petrova	 2001;	 Bartlett	 et	 al	 2012,	
p.3).	 Under	 the	 pressure	 of	 decreasing	 resources	 and	 with	 the	 international	
community’s	 guidance,	 the	 government	 of	 Macedonia	 continued	 the	 reform	 of	
increasing	efficiency,	as	in	other	transition	economies.	The	resources	did	not	match	the	
needs	 and	 the	 demand	 for	 healthcare	 (Nordyke	 2001);	 this	 was	 particularly	 true	 for	
pharmaceutical	 expenditures,	 as	 the	 pre-independence	 policies	 enabled	 health	
insurance	coverage	of	all	medicines	and	medical	preparations,	including	vitamin/mineral	
supplements.	 Thus,	 citizens	were	used	 to	obtaining	 their	medical	 supply	 at	no	 charge,	
and	 providers	 were	 not	 bound	 by	 any	 limitation	 in	 their	 prescribing	 decision-making.	
Also,	there	were	no	policies	regulating	rational	prescribing	(Petrova	2002),	such	as,	 for	
example	clinical	guidelines.		
One	of	the	first	changes	in	the	early	1990s	was	removal	of	over-the-counter	medicines	
from	 the	 health	 insurance	 package.	 The	 next	 policy	 action	 was	 development	 of	 the	
Positive	 Medicines	 List	 (PML),	 encompassing	 essential	 medicines	 covered	 by	 health	
insurance.	 However,	 there	 was	 still	 no	 regulation	 on	 the	 quantity	 of	 medicines	 that	
providers	 could	 prescribe	 or	 dispense.	 The	 overall	 pharmaceutical	 expenditure	 was	
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controlled	 through	centralized	decisions	on	 the	procured	and	distributed	quantities	of	
medicines.		
It	was	not	until	2005	that	the	first	tangible	policy	changes	for	efficiency	improvement	in	
prescribing	and	dispensing	were	conceptualized	and	implemented	(Lazarevik	et	al	2012).	
As	 explained	 earlier	 in	 this	 chapter,	 a	 transfer	 of	 primary	 care	 providers	 (physicians,	
dentists	 and	 pharmacists)	 from	 the	 public	 to	 the	 private	 domain	 occurred	 between	
2005-2009	 (LKM	 2009).	 Primary	 care	 providers	 were	 paid	 for	 their	 services	 via	 a	
combined	 capitation	 model,	 where	 70%	 of	 the	 capitation	 amount	 was	 fixed	 (fee	 per	
patient)	 and	 the	 remaining	 30%	 was	 conditioned	 by	 implementation	 and	 delivery	 on	
pre-defined	preventive	goals,	including	‘rational	prescribing’	(HIF	2007;	HIF	2014).	
The	 first	 policy	 on	 ‘rational	 prescribing’	 (Policy	 Change	 PC1)	 involved	 measuring	 the	
appropriateness	of	prescribing	as	adherence	to	an	assigned	number	of	prescriptions	per	
patient,	 unadjusted	 by	 any	 parameter.	 Physicians	 were	 allowed	 to	 prescribe	 a	 total	
number	of	prescriptions	calculated	as	2	prescriptions	per	patient	quarterly.	At	this	stage,	
each	prescription	could	be	used	for	any	medicine	on	the	PML,	 irrespective	of	the	cost.	
Thus,	 this	policy	change	regulated	the	habit	of	prescribing	and	not	the	pharmaceutical	
expenditure.	 As	 such,	 it	 could	 not	 have	 been	 expected	 to	 contribute	 much	 to	 cost-
containment,	 as	 it	 was	 based	 on	 counting	 (prescriptions)	 and	 not	 on	 accounting	 (for	
their	 value).	 It	 was	 rather	 intended	 to	 introduce	 ‘discipline’	 and	 awareness	 that	
medicines	are	a	limited	commodity	and	can	come	with	a	‘price	tag’	(Ernst	et	al	2000).	
Further	evolving	from	this,	in	2009,	the	policy	was	changed	(to	PC2)	to	introduce	budget	
ceiling	 for	 prescribing	 (this	 time	 irrespective	 of	 the	 number	 of	 prescriptions),	 with	
amounts	 adjusted	 to	 reflect	 the	 demographic	 structure	 of	 the	 registered	 population	
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with	 the	physician’s	 practice	 (i.e.	 age,	 gender	 and	 rural/urban	 location)	 (HIF	 2010).	At	
first,	this	still	constituted	7%	of	the	variable	capitation	amount,	and	was	reduced	to	6%	
in	2014	(see	Table	2	above).	Later	on,	with	the	introduction	of	information	technology	in	
the	 health	 sector,	 an	 e-prescription	 system	 was	 introduced	 in	 2015,	 as	 an	 additional	
control	 over	 pharmaceutical	 spending	 in	 real	 time	 (Milevska	 Kostova	 et	 al	 2017).	 This	
latest	policy	change	 is	mentioned	to	 illustrate	the	ever-changing	context	of	prescribing	
in	Macedonia,	but	it	was	not	analysed	within	this	research,	since	it	was	introduced	after	
the	data	collection	for	this	research	was	already	completed.		
While	 the	main	 focus	 of	 the	 research	 is	 on	 analysing	 the	 demand	 side	measures,	 the	
interconnectedness	with	 the	 supply	 side	measures	 imposes	 the	need	 to	briefly	 review	
these,	 as	 they	 potentially	 correlate	with	 prescribing	 behaviour	 and	 patients’	 influence	
on	 this	behaviour.	Within	 the	 cost-containment	 strategies,	 supply	 side	measures	were	
also	 introduced,	 such	 as	 reference	 pricing,	 through	 capping	 of	 medicines’	 prices	 to	 a	
maximum	 level	 of	 reimbursement	 by	 health	 insurance	 (Mossialos	 et	 al	 2004)	 and	
promotion	 of	 generic	 substitution,	 through	 measures	 encouraging	 use	 of	 generic	
medicines	 (Godman	 et	 al	 2014;	 Dauti	 et	 al	 2015).	 This	 triggered	 expansion	 of	 the	
Positive	Medicines	List	especially	for	medicines	with	minimum	or	no	co-payments,	which	
were	 introduced	 earlier	 (in	 2003)	 as	 a	 demand	 side	measure	 for	 containing	 costs	 on	
medicines	 covered	 by	 health	 insurance.	 According	 to	 the	 Health	 Insurance	 Fund,	 by	
2013,	76.5%	of	the	medicines	on	the	positive	 list	could	be	obtained	with	no	additional	
charge	to	patients,	a	major	change	compared	to	2009	when	this	share	was	only	around	
20%	(Dauti	et	al	2015).	The	effects	of	this	change	can	be	viewed	from	the	perspectives	
of	 the	 two	main	 stakeholders	within	 this	 research:	physicians	 and	patients.	 Physicians	
still	needed	to	comply	with	the	prescribing	budget	ceilings;	thus	it	appears	unlikely	that	
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this	 policy	 intervention	 would	 influence	 physicians’	 decision	 to	 prescribe	 more	 than	
before	 or	 more	 than	 they	 would	 consider	 necessary.	 To	 patients,	 the	 removal	 of	 co-
payments	 for	 a	 larger	 share	 of	 medicines	 might	 resemble	 the	 conditions	 of	 the	 past	
system,	and	thus	encourage	increased	pressure	on	physicians	for	prescription	medicines	
(Leive	2010).		
	
2.3.3	Dispensing	policy	changes	
With	regards	to	medicine	dispensing,	the	situation	was	slightly	different,	but	consistent	
with	 the	 rational	 prescribing	 efforts	 of	 the	 government.	 Privatization	 of	 public	
pharmacies	 was	 completed	 by	 2005	 and	 constituted	 complete	 transfer	 to	 private	
ownership,	including	premises.	This	was	accompanied	by	an	obligation	for	both	private	
and	newly	privatized	pharmacies	to	sign	a	contract	with	the	Health	Insurance	Fund	for	
dispensing	medicine	under	 the	health	 insurance	 scheme.	Based	on	 this	obligation,	 the	
pharmacies	 were	 only	 allowed	 to	 dispense	 medicines	 upon	 receipt	 of	 a	 valid	
prescription	(HIF	2004).	However,	 this	rule	was	often	not	adhered	to,	with	pharmacies	
regularly	 selling	 prescription-only	medicines	 in	 the	 absence	 of	 a	 prescription	 (Rietveld	
2006).	Starting	in	2009,	with	the	third	important	policy	change	(PC3),	a	requirement	for	
a	valid	prescription	was	enforced	more	rigorously	(MoH	2008),	with	on-site	inspections	
and	controls	over	the	dispensing	of	prescription-only	medicines.		
Further	 to	 the	 above,	 in	 2011	 the	 Health	 Insurance	 Fund	 introduced	 budget	 ceilings	
(quotas)	 to	 pharmacies	 for	 prescription	 medicines	 covered	 by	 health	 insurance.	 The	
budget	 ceilings	were	determined	based	on	population	 coverage	 and	historical	 data	 of	
dispensing	of	particular	medicines.	This	policy	was	intended	to	contribute	to	the	rational	
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prescribing	and	containment	of	costs	on	pharmaceuticals	under	health	insurance.	This	is	
categorised	within	this	thesis	as	part	of	Policy	Change	3	(PC3).	
The	 policy	 changes	 described	 in	 Table	 2	 and	 Figure	 2	 (section	 2.3.1	 above)	 have	
influenced	 the	 regulation	 of	 the	 pharmaceutical	 market	 in	 Macedonia,	 particularly	
prescribing	 and	 dispensing	 (shown	 in	 Figure	 3	 below);	 namely,	 the	 primary	 care	
providers,	 represented	by	physicians	 and	pharmacists,	were	put	under	more	 stringent	
regulatory	control	at	both	the	point	of	prescribing	and	of	dispensing.		
	
Figure	3.	Simplified	flowchart	of	prescribing	and	dispensing	in	Macedonia	
	
*Legend:	solid	line	=	referral;	dotted	line	=	back-referral:	prescribing;	dashed	line	=	reporting	
(Source:	own	compilation)	
	
This	new	policy	setting	inevitably	influenced	and	continues	to	influence	the	prescribing	
and	dispensing	of	medicines	as	the	system	of	incentives	has	changed	for	both	physicians	
and	pharmacists	 in	primary	care.	The	next	section	provides	an	overview	of	prescribing	
and	dispensing	levels	in	privatized	primary	healthcare	in	Macedonia.	
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2.3.4	Prescribing	and	dispensing	levels	in	privatized	primary	health	care	
In	 theory,	 the	 above	 elaborated	 policy	 changes	 were	 expected	 to	 have	 the	 following	
effects:	
1) Move	from	PC1	(limitation	of	number	of	prescriptions)	to	PC2	(budget	ceiling	for	
prescribing)	from	2009:		
a. Physicians	in	primary	healthcare	have	to:	(1)	monitor	the	budget	ceiling	
instead	of	number	of	prescriptions;	(2)	negotiate	with	patients	if	there	is	
no	 obvious	 need	 for	 the	 prescription	medicine;	 (3)	 negotiate	with	 the	
policy	makers	for	the	increase	of	budget	ceilings;	
b. Patients	 need	 to:	 negotiate	 with	 the	 physician	 the	 necessity	 of	 the	
prescription	medicine,	if	there	is	no	obvious	medical	indication	for	it;	
2) Amending	 PC2	 (budget	 ceiling	 for	 prescribing)	with	 PC3	 (dispensing	 only	 upon	
presentation	 of	 valid	 prescription	 from	 2009,	 within	 defined	medicine	 quotas	
from	2014):		
a. Pharmacists	 have	 to:	 (1)	 expect	 reduced	profits	 from	 the	prescription-
only	medicines	that	are	dispensed	without	prescription;	(2)	engage	with	
patients	 in	 explaining	why	 the	medicine	 cannot	 be	 dispensed	without	
prescription;	(3)	handle	the	dispensing	within	the	defined	quotas.	
b. Patients	 need	 to:	 (1)	 visit	 a	 primary	 healthcare	 physician	 to	 obtain	 a	
valid	 prescription	 in	 order	 to	 obtain	 prescription-only	 medicines;	 (2)	
obtain	medicines	from	the	pharmacies	where	the	quota	is	available.	
	
While	most	 of	 the	 above	 theories	 require	 testing	 via	 a	 qualitative	 approach,	 it	 is	 also	
useful	 to	 examine	 quantitative	 data	 from	 this	 time	 period.	 Table	 3	 and	 Figure	 4	
represent	 the	 trends	 in	prescribing	 in	primary	healthcare,	both	 in	 terms	of	 amount	of	
funding	 and	 number	 of	 prescriptions	 during	 the	 period	 for	 which	 data	 was	 available	
(2008	to	2014).		
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Table	3.	Prescribed	and	dispensed	medicines	covered	by	the	Health	Insurance	Fund,	
2008-2014	
Year		
Number	of	
prescriptions	
%	increase	compared	to	
previous	year	
Amount	spent	
on	prescribed	
medicines		
(million	MKD)	
%	increase	compared	
to	previous	year	
2008	 10,283,273	 -	 1,318.9	 -	
2009	 14,959,878	 45.5%	 1,828.7	 38.7%	
2010	 15,277,792	 2.1%	 1,778.0	 -2.8%	
2011	 16,332,551	 6.9%	 1,902.8	 7.0%	
2012	 17,485,146	 7.1%	 1,993.2	 4.8%	
2013	 17,822,132	 1.9%	 2,124.0	 6.6%	
2014	 19,385,458	 8.8%	 2,235.8	 5.3%	
(Source:	own	compilation	from	HIF	Annual	reports	2008	to	2014)	
	
Figure	4.	Prescribed	and	dispensed	medicines	by	ATC	groups	covered	by	the	Health	
Insurance	Fund	
	
Anatomical	Therapeutic	Chemical	classification	(ATC)	codes	legend:	A	-	alimentary	tract	and	metabolism;	B	-	
blood	and	blood	forming	organs;	C	-	cardiovascular	system;	D	-	dermatologicals;	G	-	genito-urinary	system	
and	 sex	 hormones;	 H	 -	 systemic	 hormonal	 preparations,	 excluding	 sex	 hormones	 and	 insulins;	 J	 -	
antiinfectives	 for	 systemic	 use;	 L	 -	 antineoplastic	 and	 immunomodulating	 agents;	 M	 -	 musculo-skeletal	
system;	N	-	nervous	system;	P	-	antiparasitic	products,	insecticides	and	repellents;	R	-	respiratory	system;	S	-	
sensory	organs;	V	-	various		
(Source:	own	compilation	from	HIF	Annual	reports	2010	to	2014)	
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From	the	above	data,	it	can	be	concluded	that	medicine	prescribing	and	dispensing	have	
generally	 showed	 an	 upward	 trend,	 despite	 the	 introduced	 policy	 changes.	 It	may	 be	
argued	 to	be	a	 result	of	other	policy	 changes,	which	might	act	as	 confounding	 factors	
(e.g.	 the	 reduction	of	medicines’	prices	 in	2013).	However,	 these	 trends	 in	prescribing	
and	dispensing	call	for	additional	research,	in	terms	of	attitudes,	opinions	and	practices	
in	primary	care,	which	is	the	main	aim	of	this	thesis.		
It	 is	 noteworthy,	 that	 the	 above	 data	 does	 not	 represent	 the	 totality	 of	 medicines	
consumption	 in	 the	 country.	 Namely,	 within	 the	 current	 system,	 there	 are	 two	 key	
agencies	 responsible	 for	pharmaceutical	policies	and	maintaining	 records	of	medicines	
on	 the	pharmaceutical	market.	The	 first	one	 is	 the	Health	 Insurance	Fund,	 responsible	
for	purchasing	health	services	(e.g.	physicians,	pharmacies)	under	the	health	 insurance	
scheme,	including	insurance-covered	medicines.	The	second	is	the	Agency	for	Medicines	
and	Medical	Devices,	 responsible	 for	 registration	of	medicines	 and	 issuing	permits	 for	
putting	medicines	 into	 use,	 and	 thus	 responsible	 for	 keeping	 records	 of	 all	medicines	
placed	on	the	market,	i.e.	including	the	share	of	medicines	dispensed	with	prescription	
issued	 outside	 of	 health	 insurance	 or	 medicines	 dispensed	 without	 prescription.	
However,	 no	 data	 could	 be	 retrieved	 from	 the	 Agency	 for	 Medicines	 and	 Medical	
Devices.	 At	 the	 time	 of	 data	 collection	 for	 this	 research,	 this	 agency	 had	 non-
systematized	data	only	in	paper	format,	and	was	not	equipped	to	analyse	the	data	or	to	
provide	any	data	for	this	analysis.	
In	 addition,	 only	 partial	 records	 could	 be	 gathered	 from	 the	 Health	 Insurance	 Fund,	
presented	 above.	 Due	 to	 changes	 in	 the	methodology	 of	 data	 collection	 and	 analysis,	
detailed	 information	on	 the	number	of	prescriptions	and	pharmaceutical	expenditures	
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was	also	not	available	from	the	HIF	records	prior	to	2008.	Thus,	the	picture	of	medicine	
consumption	as	presented	is	incomplete.	
Although	 incomplete,	 as	 mentioned	 above,	 the	 presented	 data	 shows	 a	 steadily	
increasing	 trend	 in	 prescribing	 between	 the	 analysed	 policy	 changes	 described	 in	 the	
earlier	sections.	The	data	presented	in	Table	3	and	Figure	4	show	that	the	policy	change	
from	limitations	of	prescriptions	(PC1,	2005	until	2009)	to	budget	ceiling	(PC2,	2009	until	
present	 time)	 did	 not	 produce	 the	 desired	 results	 of	 reducing	 prescribing	 levels,	
although	its	predominant	aim	was	to	reduce	pharmaceutical	expenditure	(HIF	2009;	HIF	
2010;	HIF	2011).		
It	has	to	be	noted	as	well,	that	the	increased	number	of	prescriptions	might	 in	part	be	
due	 to	 enforcement	 of	 the	 policy	 for	 dispensing	 of	 prescription-only	 medicines	 with	
prescription	only,	towards	the	end	of	2009.	Since	there	are	no	comprehensive	analyses	
and	records	of	the	actual	enforcement	of	this	policy,	this	is	only	a	hypothesis.	
Due	 to	 the	 limited	 quantitative	 data	 available,	 a	 qualitative	 method	 was	 chosen	 to	
further	 explore	 the	 impact	 of	 policy	 changes	 relating	 to	 prescribing	 and	 dispensing	 in	
primary	health	care	in	Macedonia.		
	
2.4. 	Summary	of	chapter	
	
During	 the	 1990s,	 transition	 economies	 including	 Macedonia	 initiated	 economic	 and	
political	transformations,	including	the	health	sector,	primarily	for	cost	containment	and	
increasing	 resource	 use	 efficiency.	 In	 Macedonia,	 prior	 to	 the	 primary	 healthcare	
reform,	prescription	policies	were	rather	liberal	and	not	cost-efficient	and	new	policies	
were	introduced	to	regulate	medicine	supply	and	demand,	through	rational	prescribing	
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and	 dispensing	 in	 primary	 care	 in	 particular.	 In	 prescribing,	 measures	 included	 firstly	
limitation	 on	 number	 of	 prescriptions,	 followed	 by	 prescribing	 budget	 ceilings.	 In	
dispensing,	these	included	reinforcement	of	the	existing	policies	of	dispensing	with	valid	
prescription,	alongside	new	policy	on	dispensing	quotas.	
Both	 the	 reinforcement	 of	 the	 existing	 and	 the	 introduction	 of	 the	 new	 policies	were	
expected	to	have	relevant	influence	on	prescribing	and	dispensing,	and	will	be	explored	
in	this	research.	The	next	chapter	provides	a	review	of	relevant	literature,	identifying	the	
gaps	in	knowledge	to	be	addressed	with	this	research.	
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CHAPTER	3:	Literature	review	
	
3.1. Introduction	
	
This	chapter	provides	an	overview	of	the	existing	knowledge	on	prescribing	medicines,	
regulation	of	prescribing	and	dispensing,	 and	 factors	 influencing	 them,	 in	particular	 at	
primary	care	level.	Further,	the	literature	review	touches	upon	the	theories	of	behaviour	
that	 may	 explain	 the	 attitudes	 and	 practices	 and	 potentially	 behaviour	 changes	 of	
primary	 healthcare	 providers	with	 respect	 to	 prescribing	 and	 dispensing.	 This	 chapter	
also	 provides	 an	 introduction	 to	 the	 main	 theoretical	 framework	 for	 the	 research,	
drawing	upon	Habermas’	 theory	of	 social	 life,	 and	 in	particular	 the	 interactions	of	 the	
system	 and	 the	 lifeworld	 pertaining	 to	 decision-making	 around	 prescribing.	 Further	 in	
the	 chapter,	 the	 literature	 on	 prescribing	 and	 dispensing	 in	 transition	 countries	 is	
reviewed,	with	the	aim	of	providing	understanding	to	the	reader	of	the	context	in	which	
prescribing	and	dispensing	is	researched	–	namely	the	primary	health	care	reforms	and	
changes	 in	 the	 pharmaceutical	 policies	 in	Macedonia,	which	 belongs	 to	 this	 cluster	 of	
countries.	The	chapter	concludes	by	summarising	the	gaps	in	the	literature	and	the	aims	
of	this	research	in	contributing	to	the	existing	body	of	knowledge.	
	
3.2. Literature	search	strategy	
	
The	aim	of	the	literature	review	was	to	identify	relevant	and	up-to-date	literature	on	the	
following	key	topic	areas:	
• Regulation	of	 prescribing	 and	dispensing,	 challenges	 to	 regulation,	 and	 factors	
influencing	prescribing	and	dispensing;	
• Theories	of	behaviour	which	may	affect	prescribing	and	dispensing,	particularly	
Habermas’	theory;	
• Prescribing	 and	 dispensing	 in	 transition	 countries,	 particularly	 following	
privatisation	and	reform	of	primary	healthcare.	
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3.2.1	Search	methods	
Within	 the	 literature	 search,	 systematic	 principles	 were	 used	 to	 identify	 relevant	
literature	on	 the	 topic	areas	above,	 though	not	as	a	 full	 systematic	 review	on	a	 single	
topic.	 The	 initial	 literature	 search	 was	 conducted	 between	 July-December	 2014	 and	
updated	for	new	references	in	March-April	2017.	In	the	process,	the	following	electronic	
databases	 were	 used:	 PubMed,	 PubMed	 Central,	 Medline,	 Google	 Scholar	 and	 the	
Cochrane	Database	of	Systematic	Reviews	(CDSR).		
The	literature	search	used	a	combination	of	the	following	methods:	
• Searching	of	bibliographic	databases	–	as	listed	above;	
• Expert	knowledge	of	the	subject	area	–	my	expertise	and	that	of	my	supervisors	
in	different	areas	of	the	above	topics	was	used	as	a	source	of	key	articles;	
• Reference	tracking	from	key	articles	–	relevant	articles	to	the	 literature	review	
and	research	questions	cited	in	the	key	articles;	and	
• Iterative	searching	–	further	searches	of	the	literature	following	development	of	
understanding	of	the	wider	topic.	
	
3.2.2	Database	search	strategy	
Due	to	the	broad	nature	of	the	topic	and	the	different	themes	covered	by	the	literature	
review,	 the	databases	 listed	above	were	searched	using	combinations	of	 the	 following	
terms,	 which	 were	 adapted	 in	 further	 iterative	 searches	 as	 additional	 useful	 articles	
were	identified:	
• Topic	 area	 1	 (regulation	 of	 prescribing	 and	 dispensing):	 Terms	 around	 the	
following	were	used:	prescribing,	dispensing,	regulation,	challenges,	 influences,	
factors,	combined	with	terms	for	primary	healthcare.	
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• Topic	area	2	 (theories	of	behaviour	and	Habermas’	 theory):	 Terms	around	 the	
following	were	used:	theory/theories	+	behavio(u)r	+	prescribing,	or	“Habermas’	
theory”	
• Topic	area	3	(prescribing	and	dispensing	 in	transition	countries):	Terms	around	
the	 following	 were	 used:	 prescribing,	 dispensing,	 regulation,	 transition	
country/ies,	transition	economy/ies,	privatis(z)ation.	
	
The	specific	terms	and	their	combination	used	in	the	search	strategy	are	shown	in	Table	
4	below.	Free	text	 terminology	was	based	on	the	main	concepts	and	the	key	 issues	of	
research	interest	to	this	thesis.	
	
	
Table	4.	Key	words	used	in	electronic	databases	search	
Topic	area	and	topics	 Search	terms	
Topic	area	1:	Prescribing	and	dispensing	
Prescribing	 prescr*;	prescription	medicines;	prescribers;	
prescribing	AND		
practices;	attitudes;	behaviour;	challenges;	influences;	factors;	
AND	review	
AND	primary	healthcare;	primary	care	
Dispensing	 dispens*;	dispensing	of	prescription	medicines	AND		
practices;	attitudes;	behaviour;	challenges;	influences;	factors;	
AND	review	
AND	primary	healthcare;	primary	care	
Regulation	 regulation	AND	
prescription	medicines;	prescribing;	pharmaceutical	policies;	
pharmaceutical	market;	challenges;	influences;	factors;	
AND	review	
AND	primary	healthcare;	primary	care	
Topic	area	2:	Theories	of	behaviour	and	Habermas’	theory	
Theories	of	behaviour	 Behaviour	AND	
medicine	use;	prescribing;	dispensing	
AND	review	
Habermas’	theory	 Habermas’	theory		
Habermas’	theory	AND	
medic*;	medicines;	physician-patient	relationship;	prescribing;	health	
decision	making	
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Topic	area	and	topics	 Search	terms	
Topics	area	3:	Prescribing	and	dispensing	in	transition	countries	
Prescribing	in	
transition	countries	
Transition	country/ies;	Transition	economy/ies	AND	
prescribing	AND	
privatis(z)ation;	policies;	practices;	attitudes;	qualitative;	influences;	
factors;	
AND	review	
AND	primary	healthcare;	primary	care	
Dispensing	in	
transition	countries	
Transition	country/ies;	Transition	economy/ies	AND	
dispensing	AND	
policies;	pharmaceutical	policies;	practices;	attitudes;	qualitative;	
challenges;	influences;	factors;	
AND	review	
AND	primary	healthcare;	primary	care	
	
	
3.2.3	Inclusion	and	exclusion	criteria	
Inclusion	criteria	
The	following	types	of	articles	were	included:	
• Key	 theory	 articles	 outlining	 the	 main	 topic	 areas,	 including	 theories	 around	
regulation	of	prescribing	and	theories	of	behaviour	such	as	Habermas’	theory;	
• Review	articles	on	prescribing	and	dispensing;	
• Key	 empirical	 studies	 reporting	on	 the	main	 topic	 areas,	 such	 as	 regulation	of	
prescribing,	challenges	to	regulation,	and	factors	influencing	prescribing,	both	in	
primary	healthcare	generally	and	within	transition	countries;	
• Key	qualitative	studies	on	attitudes	and	practices	in	prescribing	and	dispensing,	
including	physician-patient	relationship	and	patients’	expectations;	
• Articles	 published	 in	 English,	 or	 any	 of	 the	 Slavic	 languages	 spoken	 in	 the	
countries	 in	 South-Eastern	 Europe	 (Bosnian,	 Bulgarian,	 Croatian,	Macedonian,	
Montenegrin,	and	Serbian).	
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Exclusion	criteria	
Articles	related	to	the	following	topics	were	excluded:	
• Prescribing	 in	 inpatient	 facilities	 (secondary	 and	 tertiary	 care,	 surgery	 practice	
and	emergency	wards);	
• Prescribing	 associated	with	 specific	 population	 groups,	 such	 as	 elderly	 in	 care	
homes,	prisoners	in	prisons	and	so	forth;	
• Developing	countries	that	were	not	classified	as	transition	countries.	
	
3.2.4	Results	of	literature	search		
Since	the	literature	search	consisted	of	a	series	of	iterative	searches	on	different	topics,	
plus	 references	 identified	 via	 expert	 knowledge	 and	 reference	 tracking	 from	 relevant	
articles,	it	was	not	possible	to	provide	a	precise	figure	for	the	total	number	of	included	
articles.	 For	 the	 search	 in	 the	 first	 topic	 area	 on	 prescribing	 and	 dispensing,	 large	
number	 of	 articles	 were	 retrieved,	 which	 were	 filtered	 using	 the	 [AND]	 function	 for	
different	 combinations	 of	 two	 or	 three	 search	words.	 The	 search	 in	 the	 second	 topic	
area	also	retrieved	a	number	of	articles	and	book	chapters	on	theories	of	behaviour	and	
Habermas’	 theory	 in	 relation	 to	 medicine	 supply.	 The	 situation	 was	 different	 with	
regards	 to	 the	 third	 topic	 area,	 relating	 to	 prescribing	 and	 dispensing	 in	 transition	
countries.	Namely,	the	search	on	prescribing	or	dispensing	in	primary	care	in	transition	
countries	 generated	 very	 few	 articles;	 the	 results	 were	 similar	 for	 the	 search	 on	
privatisation	and	prescribing	or	dispensing,	and	for	the	use	of	qualitative	methodologies	
for	 researching	prescribing	 and	dispensing	 in	 transition	 countries.	After	 assessment	of	
their	 relevance,	 these	articles	were	analysed	and	where	appropriate	were	used	 in	 the	
literature	review.	
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3.3. Medicines:	An	overview	
	
Medicines	play	a	significant	role	in	the	curing,	management	and	prevention	of	diseases	
(Britten,	 2008,	 p.4)	 and	 represent	 a	 core	 element	 of	 many	 healthcare	 treatments	
(Harding	et	al	1985).	It	is	argued	that	millions	of	lives	have	been	saved	due	to	the	use	of	
medicines	(WHO	2002;	WHO	2009;	Podolsky	2010),	and	that	longer	life	expectancy	can	
in	part	be	attributed	to	medicine	use	(Van	Raay	2011).		
However,	for	as	long	as	there	have	been	medicines,	alongside	benefits,	there	has	been	a	
threat	of	 their	harmful	 and	even	deadly	effects.	 In	 the	16th	 century,	Paracelsus	 (1538)	
formulated	this	observation	as:	“the	dosage	makes	it	[the	medicine]	either	a	poison	or	a	
remedy”,	 explaining	 the	 need	 for	 knowledge-founded	 and	 experience-driven	medicine	
administration,	understanding	and	control	of	 the	positive	and	 the	adverse	effects,	 the	
appropriate	 time	 to	 begin	 and	 discontinue	 the	 administration,	 the	 type	 of	
administration	 route	 and	 the	 appropriate	 dosages.	 In	 a	 broader	 sense,	 Paracelsus’	
observation	 can	 be	 seen	 as	 a	 precursor	 of	 measured	 and	 monitored	 medicine	 use.	
Therefore,	 prescribing	 was	 introduced	 in	 an	 attempt	 to	 balance	 the	 need	 to	 provide	
medicines	for	 improving	quality	of	 life	while	working	to	prevent	the	diversion	of	those	
substances	to	their	overuse,	misuse	and	abuse	(Greene	and	Watkins	2012,	p.5).		
As	medicines	represent	a	significant	element	of	treatment	pathways	for	many	diseases,	
their	 common	 availability	 and	 the	 potential	 absence	 of	 professional	 supervision	 raise	
concerns	 regarding	 potential	 inappropriate	 use	 (Oster	 et	 al.,	 1990;	 Barber,	 1993;	
Blenkinsopp	and	Bradley,	1996;	O’Mahony	et	al	2015).	This	has	been	argued	to	result	in	
potential	 iatrogenic	 harm,	 misdiagnosis,	 the	 masking	 of	 more	 serious	 conditions	 and	
harmful	 interactions	 with	 other	 medicines	 taken	 concurrently	 (Bissell	 et	 al	 2001;	
O’Connor	 et	 al	 2012;	 Patterson	 et	 al	 2012).	 Thus,	 providing	 professional	 support	 and	
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expert	knowledge	in	therapeutic	decisions	on	medicines	becomes	an	intrinsic	part	of	the	
healthcare	system.	Prescribing	 represents	one	of	 the	core	activities	 for	measuring	and	
monitoring	the	treatments	of	many	medical	 interventions	 (Bradley	1991;	Britten	2008,	
p.5).	With	this	in	mind,	the	investigated	literature	shows	that	prescribing	was	of	interest	
to	 research	 from	many	 aspects,	 including	 clinical,	 economic	 and	 social	 (Mosiallos	 and	
Mrazek	2002).	In	particular,	such	interest	arises	from	the	complex	settings	of	prescribing	
itself,	taking	place	at	different	levels	(Cribb	and	Barber	1997;	Opondo	et	al	2012;	Davey	
et	 al	 2017),	 and	 making	 a	 decision	 that	 involves	 or	 is	 influenced	 by	 a	 wide	 array	 of	
stakeholders,	 including	 health	 professionals,	 patients	 (Ryan	 et	 al	 2014),	 professional	
groups,	 industry	 and	 suppliers	 (Lieb	 and	 Scheurich	 2014)	 and	 the	 regulatory	 and	
payment	authorities	(Carone	et	al	2012).	In	addition,	as	a	result	of	what	is	argued	to	be	
the	asymmetry	of	information	between	providers	(such	as	doctors	and	pharmacists)	and	
patients	 (Carone	 et	 al	 2012)	 additional	 processes	 are	 needed	 to	 prevent	 harm	 and	
manage	 these	 different	 perspectives.	 The	 regulation	 of	 prescribing	 and	 dispensing	
represent	key	examples	of	such	processes	and	will	be	further	elaborated	in	subsequent	
sections	of	this	thesis.	
In	 most	 countries,	 access	 to	 and	 supply	 of	 medicines	 is	 governed	 by	 regulatory	
frameworks	and	clinical	evidence	based	on	knowledge	of	benefits	and	risks	of	medicines	
to	 the	population	 (Barber	1993;	Bond	2008;	Carone	et	al	2012).	Based	on	 the	 level	of	
deregulation,	literature	suggests	that	access	to	medicines	in	general	can	be	divided	into	
three	 submarkets:	 over-the-counter	 (OTC),	 hospital	 submarket	 and	 prescription	
submarket	 (Britten,	2008,	p.3).	Each	of	 these	has	been	subject	 to	 research	 in	 terms	of	
effectiveness,	risks	and	so	forth	(Barber	1993,	Bissell	et	al	2001).	While	OTC	medicines	
(also	 referred	 to	 as	 non-prescription	 medicines	 or	 pharmacy	 medicines)	 are	 more	
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loosely	 regulated	 and	 can	 be	 obtained	 and	 administered	 by	 the	 general	 population	
without	 physician’s	 prescription,	 the	 other	 two	 submarkets	 exhibit	 different	 levels	 of	
control	 and	 management	 mechanisms,	 for	 a	 number	 of	 reasons,	 including	 cost	
containment,	 but	 also	 appropriateness	 of	 administration,	 dosage	 and	 duration	 of	
treatment	 (Buetow	et	al	1997,	Spinewine	et	al	2007,	Davey	et	al	2013,	Rashidian	et	al	
2015).	 In	 most	 developed	 and	 transition	 countries	 medicines	 at	 both	 hospital	 and	
primary	 care	 level	 are	 subject	 to	 administration	 and	 dispensing	 based	 on	 clinical	
indication,	embedded	in	evidence-based	clinical	practice	guidelines	(Grol	and	Grimshaw	
2003;	Carlsen	et	al	2007;	Francke	et	al	2008;	Tonkin-Crine	2012).		
Whilst	 the	hospital	 submarket	 shares	 some	of	 the	 same	concerns	and	challenges	with	
the	 prescription	market	 (also	 referred	 to	 as	 primary	 care	 level	 prescribing),	 the	 latter	
involves	 an	 additional	 layer	 of	 direct	 involvement	 of	 patients	 in	 consultation	 and	
therapeutic	 decision-making,	 and	 their	 knowledge,	 attitude,	 and	 demand	 in	 particular	
influences	prescribing	practices	 (Chretien	et	al	1975;	Bauchner	et	al	1999;	Palmer	and	
Bauchner	 1997;	 Vanden	 Eng	 et	 al	 2003;	 Ryan	 et	 al	 2014;	 Ofori-Asenso	 and	 Agyeman	
2016).	 As	 will	 be	 reviewed	 later	 in	 this	 chapter,	 there	 is	 an	 ample	 body	 of	 literature	
suggesting	 that	 diverse	 factors	 influence	 providers’	 prescribing	 behaviour	 (Butler	 et	 al	
1998;	Macfarlane	et	al	1997;	Mangione-Smith	et	al	1999;	Tonkin-Crane	2012).		
In	 addition	 to	 the	 above,	 and	 bearing	 in	 mind	 that	 the	 prescription	 market	 in	 most	
developed	countries	represents	75-85%	of	total	pharmaceuticals	expenditures	(Tele	and	
Groot	2009),	prescribing	at	primary	care	level	is	of	particular	interest	to	this	thesis,	and	
is	 elaborated	 in	 detail	 in	 further	 sections,	 from	 the	 aspect	 of	 regulation	 and	 factors	
influencing	decision-making	in	prescribing.	Towards	the	end	of	the	chapter,	prescribing	
51	
and	dispensing	in	transition	countries	is	reviewed,	with	the	aim	of	framing	the	research	
questions	within	the	wider	available	literature.	
	
3.4. Regulating	medicines	supply	and	demand	
	
Pharmaceuticals	are	one	of	the	areas	enjoying	great	attention	of	governments	and	their	
political	 agendas,	 in	 an	 attempt	 to	 secure	 health	 policy	 objectives:	 protecting	 public	
health;	 guaranteeing	 patient	 access	 to	 safe	 and	 effective	 medicines;	 improving	 the	
quality	 of	 care;	 and	 ensuring	 that	 pharmaceutical	 expenditure	 does	 not	 overrun	 and	
undermine	these	and	other	government	objectives	(Mossialos	et	al	2004).	As	such,	one	
of	governments’	roles	in	pharmaceutical	policy	is	to	provide	the	funding	and	framework	
that	allows	the	highest	attainable	quality	of	care	within	the	available	 limited	resources	
(Mossialos	et	al	2004;	Carone	et	al	2012).	
Regulation	of	the	pharmaceutical	market	is	a	complex	process,	involving	multiple	actors,	
such	 as	 government	 and	 third-party	 payers	 (insurance),	 prescribing	 physicians,	
dispensing	 pharmacists,	 patients	 and	 patient	 advocacy	 groups,	 manufacturers	 and	
wholesale	 suppliers,	 and	 research-based	 industries	 (Mossialos	 et	 al	 2004).	 And,	 while	
the	main	aims	of	some	groups	such	as	 industry	and	wholesalers	are	to	maximise	sales	
and	 profits,	 conversely,	 the	 interests	 of	 providers	 and	 patients	 are	 mostly	 aimed	 at	
achieving	the	best	attainable	care	with	little	if	any	consideration	of	costs	and	economic	
efficiency.	In	trying	to	balance	these	interests	and	achieve	effective	and	efficient	use	of	
resources,	 governments	 apply	 different	 mechanisms	 in	 regulating	 pharmaceutical	
spending	 adjusted	 to	 their	 context	 and	 circumstances	 (Permanand	 et	 al	 2004).	 In	
general,	 these	 can	 be	 divided	 into	 regulating	 the	 two	 sides:	 the	 supply	 side	 and	 the	
demand	side.		
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3.4.1	Regulating	medicines	supply	
Governments	 tend	 to	 focus	 on	 regulatory	 measures	 on	 the	 supply	 side,	 namely	 the	
pharmaceutical	 industry	 and	 wholesale	 providers.	 The	 supply-side	 strategies	 for	
optimising	 pharmaceutical	 expenditure	 are	 often	 implemented	 through	 regulating	
pharmaceutical	 prices	 and	 reimbursement	 levels	 (Mrazek	 et	 al	 2004).	 These	 so-called	
cost-containment	policies	on	the	supply	side	are	usually	implemented	through	measures	
such	as:	direct	fixed	price	controls,	profit	controls	and	reference	pricing	(Mossialos	et	al	
2004).	 Fixed	 pricing	 is	 aimed	 at	 securing	 pharmaceutical	 prices	 that	 are	 considered	
reasonable	 for	 a	 given	health	 system	 (Mrazek	et	 al	 2004),	or	 as	defined	by	 the	World	
Health	Organisation	 ‘at	a	price	 the	community	can	afford.’	 (WHO	2016).	Profit	 control	
(currently	unique	to	the	UK)	is	aimed	at	ensuring	that	pharmaceutical	producers	are	not	
making	 excessive	 profits	 on	 patent-protected	 products	 (Department	 of	 Health	 UK,	
1999).	Reference	pricing	is	a	system	of	setting	maximum	medicine	reimbursement	levels	
per	drug	 that	will	be	paid	by	 the	government	or	health	 insurance,	based	on	groups	of	
drugs	 with	 a	 similar	 function	 (Mrazek	 et	 al	 2004;	 Kanavos	 and	 Taylor	 2007).	 Yet,	 the	
success	–	or	failure	–	of	these	policies	 is	discussed	in	the	literature	as	being	difficult	to	
measure	 as	 societies	 are	 faced	 with	 continuing	 trends	 of	 increase	 in	 pharmaceutical	
expenditures	 (Mossialos	 et	 al	 2004).	 The	 literature	 notes	 that	 in	 part,	 this	 increase	 in	
pharmaceutical	expenditure	is	due	to	growing	demand,	which	is	increasingly	addressed	
through	 demand	 side	 measures	 (Mrazek	 2002;	 Mossialos	 et	 al	 2004).	 The	 following	
section	 gives	 a	 brief	 overview	 of	 demand-side	 instruments	 for	 regulating	 the	
pharmaceutical	market.	
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3.4.2	Regulating	medicines	demand	
Another	 method	 of	 controlling	 pharmaceutical	 spending	 and	 consumption	 is	 through	
influencing	 behaviour	 of	 groups	 that	 generate	 the	 demand,	 namely	 physicians,	
pharmacists	 and	 patients	 (Hutton	 et	 al	 1994).	 According	 to	 the	 literature,	 no	 single	
strategy	 could	 be	 identified	 as	 a	 ‘magic	 bullet’	 (Oxman	 1995;	 Tonkin-Crine	 2012)	 and	
different	policy	approaches	have	been	designed	and	implemented	to	address	this	issue.	
Demand	side	measures	are	usually	aimed	at	 influencing	medicine	consumption.	This	 is	
frequently	 done	 through	 monitoring	 and	 influencing	 physician	 decision-making	 and	
changing	 the	physician-patient	 relationship	 (Mossialos	et	 al	 2004;	Godman	et	al	 2010;	
Godman	 et	 al	 2014).	 One	 of	 the	 most	 common	 approaches	 is	 standardization	 of	
physician	decision-making,	through	enforcement	of	clinical	guidelines.	Clinical	guidelines	
have	become	a	 common	 tool	 for	promoting	quality	 and	equity	of	 services,	 and	at	 the	
same	 time	 controlling	 costs	 (Carlsen,	 Glenton	 and	 Pope	 2007).	 These	 evidence-based	
protocols	are	intended	to	improve	the	standard	and	consistency	of	healthcare	(Tonkin-
Crine	2012,	p.8),	and	to	ensure	availability	of	state-of-art	knowledge	in	decision-making.	
In	 addition	 to	 guidelines,	 physicians	 are	 exposed	 to	 the	 latest	 scientific	 developments	
and	 practice	 through	 their	 continuous	 professional	 development,	 which	 in	 many	
countries	is	obligatory.	Both	of	these	mechanisms	for	ensuring	standardisation	in	health	
care	 are	 then	 monitored	 by	 relevant	 authorities,	 either	 from	 health	 outcome	 or	
expenditure	perspectives	(Goossens	et	al	2005;	WHO	2009;	Zwar	et	al	1999;	Mossialos	
et	al	2004;	Godman	et	al	2014).		
Clinical	guidelines	are	also	used	to	standardize	decision-making	in	prescribing,	especially	
since	 there	 is	 a	 documented	 trend	 of	 overmedicalisation	 of	 healthcare	 (e.g.	 Chand	
2014),	 stemming	 from,	 among	 other	 things,	 inadequate	 management	 of	 diagnostic	
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uncertainty	 (Whaley	 et	 al	 2013),	 lack	 of	 commitment	 of	 physicians	 and	 patients	 in	
shared	 decision-making	 (Arnold	 and	 Strauss	 2005),	 expressed	 or	 perceived	 patients’	
expectations	(Little	et	al	2004;	Britten	and	Ukoumunne	1997)	and	permanent	expansion	
of	 treatments	 (Hanslik	 and	 Flahault	 2016).	 The	 next	 section	 elaborates	 more	 on	 the	
literature	related	to	rational	prescribing	in	general,	and	at	the	primary	level	in	particular,	
since	as	explained	earlier,	 the	dominant	proportion	of	prescribing	happens	at	primary	
care	level	as	in	most	healthcare	systems	primary	care	providers	are	gatekeepers	(Willcox	
et	al	2011)	and	the	first	contact	of	patients	with	the	healthcare	system	(Shi	2012).		
	
3.5. Prescribing	of	medicines	
	
Although	 it	 has	 been	 recognized	 for	 some	 time	 that	 prescribing	 should	 be	 necessary,	
safe	 and	 effective	 (Parish	 1973),	 prescribing	 approaches	 are	 not	 always	 standardized	
(Bateman	et	al	1996;	Buusman	et	al	2007)	or	adherent	to	the	relevant	clinical	guidelines	
(Metge	et	al	2004;	Carlsen	et	al	2007;	Tonkin-Crine	2012).	In	support	of	this	statement	
are	 studies	 showing	 an	 overall	 increase	 in	 prescribing	 and	 antibiotic	 prescribing	 in	
primary	 care	 in	 particular	 (Butler	 et	 al	 1998;	 Holloway	 et	 al	 2013),	 despite	 the	 global	
trend	 of	 gradual	 epidemiological	 shift	 from	 communicable	 to	 noncommunicable	
diseases	 in	 the	 past	 forty	 years	 (Omran	 2005).	 The	 following	 section	 provides	 an	
overview	of	what	constitutes	good	and	therefore	rational	prescribing.	
3.5.1	Rational	prescribing	
In	 order	 to	 discuss	 the	 factors	 influencing	prescribing	 and	 the	mechanisms	of	 rational	
prescribing	in	the	subsequent	sections,	it	is	necessary	to	examine	the	literature	on	what	
constitutes	rational	prescribing.		
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Rational	 prescribing	 is	 widely	 described	 in	 the	 literature	 as	 cost-effective	 prescribing	
based	on	 clinical	 indication,	 for	which	 evidence	 shows	 that	 the	prescribed	medication	
will	 produce	 benefit	 or	 prevent	 further	 complications	 of	 patients’	 health	 conditions.	
According	 to	 the	 World	 Health	 Organisation	 (WHO),	 rational	 use	 of	 medicines	 is	 a	
process	 in	 which	 ‘patients	 receive	 medications	 appropriate	 to	 their	 clinical	 needs,	 in	
doses	that	meet	their	own	individual	requirements,	for	an	adequate	period	of	time,	and	
at	the	lowest	cost	to	them	and	their	community’	(WHO	1985;	WHO	2016).	A	2011	report	
commissioned	by	the	King’s	Fund,	states	that	within	the	UK,	rational	prescribing	is	cost-
efficient	 therapy	 proven	 to	 be	most	 effective	 according	 to	 evidence-based	 guidelines	
(Kings	 Fund	 2011).	 Clinical	 guidelines	 often	 describe	 the	 treatment	 in	 full,	 including	
medicines	to	be	administered,	and	any	prescribing	that	does	not	fit	into	these	guidelines	
or	 recommendations	 is	 considered	 inappropriate,	 irrational	 or	 unnecessary	 (Tonkin-
Crine	 2012,	 p.7).	 This	 unnecessary	 prescribing	 has	 been	 extensively	 researched	 (e.g.	
Gallagher	 et	 al	 2007;	 Garfield	 et	 al	 2009;	 Holloway	 et	 al	 2013;	 Ofori-Asenso	 and	
Agyeman	2016),	identifying	for	example,	wide	practice	of	prescribing	antibiotics	for	viral	
and	 self-limiting	 conditions	where	 antibiotics	would	 contribute	 either	 nothing	 or	 very	
little	in	terms	of	alleviating	the	symptoms	or	improving	the	health	condition	(Little	et	al	
2005;	Llor	and	Bjerrum	2014).	In	a	similar	way,	literature	shows	that	trends	in	treatment	
of	 depression	 in	 primary	 healthcare	 shifted	 from	 under-treatment	 due	 to	 lack	 of	
recognition	 of	 depressive	 conditions	 (Davidson	 and	Meltzer-Brody	 1999;	 Moore	 et	 al	
2009),	 toward	a	concern	with	over-treatment	and	over-prescription	of	antidepressants	
(Heath	1999;	Sirdifield	et	al	2015)	and	medicalization	of	patients	with	problems	of	living	
(Hyde	 et	 al	 2005,	 NICE	 2004);	 this	 resulted	 in	 dramatic	 increase	 of	 antidepressants’	
prescribing	 over	 the	 last	 three	 decades	 although	 the	 number	 of	 clinical	 cases	 of	
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depression	did	not	follow	such	a	rising	trend	(Middleton	et	al	2001).	The	WHO	estimated	
that	 globally	 more	 than	 50%	 of	 all	 medicines	 are	 prescribed,	 dispensed,	 or	 sold	
inappropriately	(WHO	2002).		
The	research	 interest	on	prescribing	and	prescribing	behaviours	dates	 from	the	1950s,	
when	Dunlop	et	al	 (1952)	conducted	a	survey	of	prescribing	of	general	practitioners	 in	
England	(Dunlop	et	al	1952).	One	of	the	major	findings	of	most	studies	conducted	since	
suggests	 tremendous	 variations	 in	 volume	 and	 cost	 of	 prescribing	 between	 countries	
(Goossens	et	al	2005;	Ferech	et	al	2006)	and	between	individual	prescribers	(Denig	et	al	
1988;	Bradley	1991;	McGuire	et	al	1994;	Carlsen	et	al	2007;	Buusman	et	al	2007;	Glinz	et	
al	 2017).	 Variations	 in	 prescribing	 have	 been	 analysed	 against	 both	 clinical	 and	 non-
clinical	 variables	 (Wilkin	 1987;	 Webb	 and	 Lloyd	 1994;	 Bradley	 1992;	 Lewis	 and	 Tully	
2011)	 and	 results	 show	 that	 non-clinical	 variables,	 such	 as	 the	 physician’s	 personal	
characteristics/experience	 and	 patients’	 expectations	 also	 play	 an	 important	 role	 in	
prescription	 behaviour	 (Bradley	 1992;	Webb	 and	 Lloyd	 1994;	Wilson,	 1996;	 Cockburn	
and	 Pit	 1997;	 Lewis	 and	 Tully	 2011).	 These	 will	 be	 considered	 in	 more	 detail	 in	
subsequent	sections.	
According	 to	 Aronson	 (2006),	 good	 prescribing	 is	 one	 that	 ‘recommends	 a	 medicine	
appropriate	 to	 the	 patient’s	 condition	 and	minimizes	 the	 risk	 of	 undue	 harm	 from	 it’	
(Aronson	 2006).	 In	 his	 discussion	 on	 good	 prescribing,	 Barber	 (1993)	 argued	 that	 the	
older	definition	of	 rational	 prescribing	defined	by	Parish	 (1973)	 as	 ‘appropriate’	 instils	
ambiguity	and	therefore	needs	to	be	revisited	to	reflect	the	safety	and	effectiveness	of	
medicine	treatment.	Barber	(1993)	argued	that	rather	than	defining	the	outcome	of	the	
prescribing,	 it	 is	worthwhile	 to	consider	 the	process	elements	 that	 lead	 to	 the	desired	
outcome,	i.e.	defining	what	prescribers	should	consider	in	their	prescribing	decision.	In	
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his	 view,	 prescribers’	 decisions	 should	 be	 based	 on	 the	 key	 aspects	 of	 safety,	
effectiveness,	economic	consideration	and	 respect	 for	patients’	 choices	 (Barber	1993).	
According	to	this,	 the	complexity	of	 the	prescribing	decision	should	allow	for	a	certain	
level	 of	 autonomy	 of	 the	 providers	 in	 order	 to	 be	 able	 to	 address	 what	 constitutes	
rational	prescribing.		
In	 this	 sense,	over	 the	past	 two	decades,	 irrational	prescribing	as	a	 result	of	 failure	 to	
prescribe	 in	 accordance	 with	 clinical	 guidelines	 has	 been	 challenged	 by	 the	 ‘patient-
centred’	approach	 in	which	an	alternative	autonomy	of	doctors	 for	 individualization	of	
prescribing	 therapy	 emerges	 (Armstrong	 2002).	 The	 following	 section	 reviews	 the	
literature	 dealing	 with	 prescribing	 from	 the	 perspective	 of	 professional	 autonomy	 of	
providers.	
3.5.2	Autonomy	and	prescribing	
Autonomy	 of	 the	 medical	 profession	 has	 been	 subject	 to	 research	 from	 different	
perspectives,	 including	 economic,	 political	 and	 clinical	 (Elston	 1991).	 While	 economic	
and	political	autonomy	are	concerned	with	doctors’	rights	to	participate	in	policy	making	
and	 defining	 their	 remuneration,	 clinical	 autonomy	 addresses	 the	 professionals’	
discretion	in	medical	and	treatment	decision-making	(Armstrong	2002).		
Prescribing	 has	 been	 of	 particular	 interest	 to	 clinical	 autonomy,	 given	 that,	 as	
mentioned	 earlier,	 it	 represents	 one	 of	 the	 key	 elements	 of	 treatment	 pathways	
(O’Mahony	et	al	2015)	and	most	frequent	decisions	taken	by	physicians	at	primary	care	
level	 (Bakker	 et	 al	 2007).	 According	 to	 Davis	 (1997),	 the	 right	 to	 prescribe	 is	 a	 key	
component	of	 clinical	 freedom,	 representing	one	of	 the	core	activities	 that	demarcate	
the	 medical	 profession	 from	 other	 groups	 (Britten	 2001).	 In	 the	 1990s,	 the	 share	 of	
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patients	 attending	 primary	 care	 who	 received	 prescriptions	 was	 estimated	 at	 68%	 in	
Germany	 (Himmel	 et	 al	 1997)	 and	 50%	 in	 Australia	 (Cockburn	 and	 Pit	 1997),	 with	
growing	 trends	 in	 recent	years	 (Cadieux	et	al	2007).	 Literature	 links	 such	outcomes	 to	
the	 considerable	 autonomy	 of	 the	 medical	 profession	 over	 prescribing	 (Ensor	 and	
Duran-Moreno	 2004)	 citing	 it	 as	 an	 opportunity	 for	 increasing	 the	 consumption	 of	
medicines	beyond	their	‘appropriate	use’	(Scott	and	Shiell	1997)	or	levels	of	demand	of	a	
well-informed	consumer	 (McGuire	et	al	1994).	Thus,	beginning	 in	 the	1990s,	extensive	
literature	 emerged	 on	 clinical	 autonomy	 and	 prescribing,	 reviewed	 briefly	 in	 the	
subsequent	paragraphs.	
According	to	the	literature,	since	the	1990s,	autonomy	of	prescribing	has	been	a	focus	of	
governments’	 attempts	 to	 regulate	 overprescribing	 and	 excessive	 associated	 costs.	
Beyond	 the	 standardization	 of	 decision-making	 discussed	 earlier,	 many	 governments	
deregulated	the	classes	of	medicines	not	associated	with	abuse	(Britten	2001),	with	the	
aim	of	 reducing	 the	 power	 of	 doctors	 and	 increasing	 choice	 for	 patients	 (Blenkinsopp	
and	Bradley	1996;	Branstad	et	al.	1994).		
Clinical	 autonomy	 in	 prescribing	 was	 examined	 by	 Freidson	 (1985)	 and	 Elston	 (1991)	
from	 the	 perspective	 of	 the	 two	 dominant	 theses	 of	 proletarianisation	 and	
deprofessionalisation.	 The	 proleterianisation	 thesis	 argues	 that	 economic	 forces	 are	
increasingly	 influencing	 clinical	 pathways,	 allowing	 for	 dominance	 of	 bureaucratic	
criteria	over	autonomy	(Armstrong	2002;	McKinlay	ad	Arches	1985;	McKinlay	&	Stoeckle	
1988).	The	deprofessionalisation	thesis,	on	the	other	hand,	considers	the	diminishing	of	
dominance	 of	 health	 professionals	 through	 changing	 relations	 between	 doctors	 and	
patients,	emergence	of	well-informed	patients	and	rise	of	consumerism	(Scambler	and	
Britten	 2001).	 These	 and	 other	 authors	 (Gabe	 et	 al	 1994)	 concluded	 that	 both	 theses	
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were	not	particularly	applicable	to	clinical	autonomy,	given	the	increasing	formalisation	
through	 which	 professions	 control	 their	 own	 members	 (Freidson	 1985),	 such	 as	 via	
clinical	guidelines	discussed	earlier.		
In	 the	 context	 of	 transition	 economies,	 clinical	 autonomy	 has	 been	 affected	 by	 both	
bureaucratic	 criteria	 and	 changing	 relationships	 between	 providers	 and	 patients.	
Britten’s	 (2001)	 arguments	 on	 clinical	 freedom	 in	 prescribing	being	under	 threat	 from	
both	regulatory	and	patient	pressures	are	valid	and	applicable	in	the	transition	context,	
and	will	be	reviewed	under	appropriate	sections	later	in	this	chapter.		
Irrational	dispensing	also	occurs	 as	 a	phenomenon	 (Ofori-Asenso	and	Agyeman	2016),	
mostly	 as	 a	 practice	 of	 non-compliance	 with	 the	 policies	 regulating	 dispensing	 of	
prescription	medicines.	The	 following	 section	 reviews	 the	 literature	 related	 to	 rational	
dispensing.	
3.5.3	Rational	prescribing	and	relationship	to	changes	in	behaviour	
As	 discussed	 earlier,	 trends	 for	 increasing	 pharmaceutical	 expenditure	 are	 largely	
related	to	prescribing	levels,	which	might	not	always	be	directly	associated	with	clinical	
conditions	 and	 necessity	 for	 therapy.	 As	 already	 mentioned,	 the	 main	 approach	 in	
promoting	 rational	 prescribing	 on	 the	 demand	 side	 is	 through	 influencing	 medicine	
consumption.	In	this	respect,	and	of	particular	interest	to	this	thesis,	is	the	influence	of	
policy	changes	on	change	of	behaviour	in	prescribing	and	dispensing.		
Policies	and	mechanisms	for	promoting	rational	prescribing	at	the	least	assume	change	
of	 behaviour,	 which	 has	 been	 described	 also	 in	 the	 literature	 as	 the	 most	 difficult	
intervention	 especially	 at	 the	 level	 of	 individual	 interaction	 (Butler	 et	 al	 1998;	 Arnold	
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and	Strauss	2005).	So,	 to	be	able	 to	 influence	behaviour	 it	 is	 important	 to	understand	
the	behaviour	and	its	theoretical	underpinnings.		
Theories	 of	 human	 behaviour	 emanate	 from	 all	 disciplines	 of	 social	 sciences,	
conceptualising	 behaviour	 in	 several	 ways.	 The	 largest	 number	 of	 theories	 comes	
primarily	 from	within	 the	psychology	 field,	and	 these	 focus	either	on	 the	 individual	as	
the	 locus	 of	 behaviour	 or	 on	 behaviour	 itself,	 relationships	 between	 behaviour,	
individuals	and	the	social	and	physical	environments	 in	which	they	occur	(Tonkin-Crine	
2012).		
Physicians’	 behaviour	 in	 decision-making,	 and	 in	 particular	 in	 prescribing,	 has	 been	
analysed	from	the	perspective	of	different	theories	(Grol	et	al	2007;	Tonkin-Crine	2012),	
including:	social	cognitive	theory	(Bandura	1998);	theory	of	reasoned	action	and	theory	
of	 planned	 behaviour	 (Ajzen	 1991;	 Ajzen	 1998);	 self-determination	 theory	 (Ryan	 and	
Deci	2000);	operant	 learning	theory	(Blackman	1974);	self-regulation	theory	(Leventhal	
et	 al	 1998)	 and	 so	 forth.	 The	 aim	 of	 such	 analysis	 was	 to	 understand	 physicians’	
behaviours	and	identify	attitudes	and	beliefs	that	have	an	effect	on	their	motivation	to	
prescribe,	which	would	potentially	be	used	for	formulating	policies	and	interventions	to	
change	these	behaviours	(Walker	et	al	2001).	Conclusions	emerging	from	these	studies	
show	 that,	 empirical	 evidence	 of	 the	 effectiveness	 and	 feasibility	 of	 most	 theoretical	
approaches	promoting	behaviour	 change	 is	 limited	 (Grol	 et	 al	 2007).	 This	 implies	 that	
drawing	 conclusions	 and	 proposing	 specific	 interventions	 needs	 to	 be	 based	 on	 the	
specificities	of	the	different	economic,	political,	and	organizational	contexts	(Godin	et	al	
2008;	Goodwin	2012),	bearing	in	mind	their	complexities	and	the	behaviour	intended	to	
be	changed	(Walker	et	al	2007;	Goossens	et	al	2005;	Ferech	et	al	2006).	An	illustrative	
example	 is	 an	 international	 comparative	 study	 in	 13	 countries	 showing	 major	
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differences	 between	 physicians	 in	 the	 decision	 of	 whether	 or	 not	 to	 prescribe,	 from	
twice	as	likely	to	four	times	less	likely,	compared	to	the	overall	mean	(Butler	et	al	2009).	
Bearing	 in	 mind	 the	 above,	 policies	 have	 been	 designed	 to	 embed	 different	
contextualized	mechanisms	 to	 address	prescribing	behaviour	 among	physicians.	 These	
mechanisms	 in	medicolegal	 terms	 can	 be	 divided	 into	 preventive	 and	 curative,	where	
preventive	 implies	that	physicians	are	educated	 in	theory	and	advised	 in	their	place	of	
practice	on	good	prescribing	based	on	clinical	guidelines	and	prescribing	protocols,	and	
curative	is	based	on	incentive	and	punishment	systems.	In	most	cases,	a	combination	of	
the	two	types	of	mechanisms	 is	used.	 In	the	UK	and	most	EU	countries	there	are	both	
interventions	for	providing	information	through	guidelines	and	continuous	professional	
development,	 as	 well	 as	 through	 audit	 and	 feedback	 -	 based	 on	 the	 monitoring	 of	
prescribing	 at	 the	 primary	 care	 practice	 level	 over	 a	 certain	 period	 of	 time,	 and	
providing	 feedback	 that	 potentially	 would	 initiate	 behaviour	 change	 (Tonkin-Crine	
2012).	In	addition	to	these	preventive	mechanisms,	as	mentioned	above,	countries	have	
also	 established	 curative	 actions;	 most	 EU	 countries	 are	 monitoring	 physicians'	
prescription	patterns,	and	in	cases	of	large	divergence	from	the	predefined	benchmark,	
the	physicians	are	advised,	asked	to	explain	and	may	be	fined	or	undergo	 legal	action,	
including	waiving	of	their	prescribing	right	 if	no	explanation	is	provided	(Carone	2012).	
These	 interventions	 have	 been	 shown	 to	 have	 positive	 effect	 on	 changing	 behaviour	
towards	reducing	unnecessary	prescribing	and	on	higher	adherence	to	clinical	guidelines	
(Zwar	et	al	1999;	Munck	et	al	1999;	Davey	et	al	2013).	An	elaborate	review	of	all	studies	
published	 during	 1990-2006,	 produced	 by	 the	 World	 Health	 Organisation	 (WHO),	
showed	 trends	 of	 some	 improvement	 in	 rational	 prescribing	 over	 the	 25-year	 period	
based	 on	 the	 interventions	 assessed	 in	 these	 studies.	 The	 review	 concludes	 that	 the	
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most	frequent	types	of	interventions	used	for	improving	appropriateness	of	prescribing	
have	been	educational	programmes	 for	health	providers	alone	or	 in	 combination	with	
educational	 programmes	 and	 health	 information	 for	 patients	 (WHO	 2009);	 however,	
increasing	 numbers	 of	 interventions	 consisting	 of	 enhanced	 supervision	 and	 routine	
monitoring	 of	 prescribing	 have	 also	 been	 observed.	 The	 review	 concludes	 that	multi-
faceted	 interventions	directed	at	both	providers	and	patients	have	tended	to	be	more	
effective	than	those	that	employ	one	strategy	only	(WHO	2009).	
Thus,	 interventions	 aimed	 at	 change	 in	 behaviour	 can	 have	 significant	 influence	 on	
appropriate	 prescribing	 and	 rational	 use	of	medicines.	However,	 at	 the	 same	 time,	 as	
argued	 by	 Britten	 (2001),	 ‘the	 acts	 of	 prescribing	 and	 dispensing	 define	 social	
relationships	between	patients,	doctors,	nurses,	pharmacists	and	others’	(Britten	2001),	
and	 behaviour	 is	 determined	 by	 these	 interactions,	which	 are	 in	 turn	 influenced	 by	 a	
number	 of	 factors.	 The	 next	 section	 provides	 an	 overview	 of	 factors	 influencing	
prescribing	 with	 a	 focus	 on	 primary	 healthcare,	 representing	 a	 focal	 point	 of	 contact	
between	physicians	and	patients.	
	
3.6. Overview	of	factors	influencing	prescribing	in	primary	healthcare		
	
As	 already	 described,	 prescribing	 medicines	 is	 one	 of	 the	 most	 frequent	 therapeutic	
decisions	 made	 in	 primary	 healthcare	 (Bakker	 et	 al	 2007)	 and	 is	 used	 as	 one	 of	 the	
indicators	of	quality	of	 care	 (Glinz	et	al	2017).	As	elaborated	earlier,	one	of	 the	major	
findings	 of	 most	 studies	 on	 factors	 influencing	 prescribing	 suggests	 considerable	
variations,	identifying	both	clinical	and	non-clinical	reasons	(Goossens	et	al	2005;	Ferech	
et	 al	 2006;	 Denig	 et	 al	 1988;	 Bradley	 1991;	 McGuire	 et	 al	 1994;	 Carlsen	 et	 al	 2007;	
Buusman	 et	 al	 2007;	 Teixeira	 et	 al	 2013;	 Glinz	 et	 al	 2017).	 In	 this	 sense,	 there	 is	 a	
63	
continuous	 research	 interest	 in	 factors	 influencing	 prescribing.	 A	 recent	 review	 of	
qualitative	 studies	 on	 physician	 prescribing	 behaviour	 divided	 the	 influencing	 factors	
into	two	main	groups:	intrinsic	and	extrinsic	(Rodrigues	et	al	2013).	Among	the	intrinsic	
factors	conclusive	evidence	is	drawn	on	the	physicians’	experience	(Paredes	et	al	1996;	
Schouten	et	al	2007;	Paluck	et	al	2001;	Kumar	et	al	2003;	Denig	and	Haaijer-Ruskamp	
1995)	 and	 level	 of	 education	 (Liabsuetrakul	 et	 al	 2003;	Paluck	et	 al	 2001;	Kumar	et	 al	
2003).	Among	the	extrinsic	 factors	 found	to	 influence	prescribing,	 the	most	prominent	
are	those	pertaining	to	the	regulatory	mechanisms	and	patients	(Björnsdóttir	et	al	2010;	
Kotwani	et	al	2010;	Rodrigues	et	al	2013).		
All	of	the	above	reflect	the	complexity	of	the	prescribing	process	and	highlight	the	need	
to	understand	the	 influence	of	 these	 factors	 (Rodrigues	et	al	2013)	on	prescribing	and	
dispensing.	 These	 are	 elaborated	 in	detail	 in	 the	 following	 sections,	 reviewed	 through	
three	 perspectives:	 providers’	 experience,	 regulatory	 mechanisms,	 and	 social	 factors	
pertaining	to	the	patients	and	physician-patient	interaction.	
3.6.1.	Providers’	experience	factors	
With	 regards	 to	 providers’	 experience,	 several	 dimensions	 have	 been	 explored	 in	 the	
literature.	 The	 majority	 of	 studies	 highlight	 professional	 and	 personal	 experience	 of	
physicians	 as	 the	 most	 influential	 factor	 that	 dictates	 prescribing	 decisions	 (Wood-
Mitchell	 et	 al	 2008;	 Schwartz	 et	 al.	 1989;	 Tichelaar	 et	 al.	 2010;	 Vallano	 2004).	 The	
predominance	 of	 this	 factor	 is	 reported	 to	 even	 influence	 prescribing	 when	 scientific	
evidence	contradicts	the	professional	experience	of	the	physicians	(Schwartz	et	al	1989).		
The	 influence	 of	 others’	 prescribing	 on	 the	 physician’s	 decision-making	 has	 been	
assessed	 in	 the	 literature,	 and	 there	 is	 evidence	 that	 such	 influence	 is	 recognized	and	
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acknowledged	 in	 the	 physicians’	 perceptions.	 Research	 on	 the	 attitudes	 of	 physicians	
regarding	the	influence	of	other	physicians	shows	that	further	to	their	own	experience,	
physicians	 value	 the	 experience	 of	 colleagues	 and	 peers,	 even	 though	 this	 is	 more	
widely	researched	and	established	as	a	finding	among	clinicians	at	hospital	level.	A	few	
studies	 have	 found	 physicians’	 decisions	 on	 prescribing	 in	 primary	 healthcare	 to	 be	
influenced	 by	 specialists	 or	 the	 physicians	 in	 higher	 levels	 of	 care,	 i.e.	 hospitals	
(Buusman	et	 al	 2007;	 Eccles	 et	 al	 1996).	 For	 example,	 several	 studies	 have	 concluded	
that	physicians	at	primary	care	level	feel	reluctant	to	discontinue	the	prescription	from	a	
higher	 level	 of	 care,	 i.e.	 specialist	 or	 hospital	 clinicians	 (Armstrong	 and	 Ogden	 2006;	
Buusman	et	al.	2007;	Cantrill	et	al.	2000).	
The	research	on	attitudes	of	physicians	towards	influence	of	peers	on	their	prescribing	
shows	 that	 physicians	 in	 primary	 care	 also	 value	 the	 experience	 and	 opinion	 of	 their	
peers,	but	due	to	lack	of	possibilities	to	interact	(physically	per	se)	on	a	daily	basis,	they	
exchange	their	expertise	mainly	 in	scientific	meetings	(Prosser	et	al.	2003;	Wood	et	al.	
2007).	Yet,	other	studies	depict	that	such	 interaction	 is	not	valued	or	practiced	among	
general	 practitioners,	 due	 to	 confidence	 in	 their	 own	 prescribing	 ability	 and	 fear	 of	
criticism	(Carthy	et	al	2000).		
Related	to	the	confidence	in	their	own	prescribing,	physicians	disclosed	it	as	sometimes	
being	subject	to	the	influence	of	informal	rules	(Bishop	et	al	2011;	Cavazos	et	al	2008),	
which	are	not	always	evidence-based	(Ljungberg	et	al.	2007;	Fontana	et	al	2000;	Wood	
et	 al	 2007).	 Kumar	 et	 al	 (2003)	 found	 that	 physicians	 sometimes	 prescribed	 without	
medical	 indication	 to	 prevent	 complications,	 and	 felt	 comfortable	with	 such	 decisions	
(Kumar	et	al	2003).	Further	 literature	suggests	that	doctors’	decision	making	 is	altered	
by	 patient,	 time	 and	 workload	 pressures	 (Petursson	 2005;	 Greenhalgh	 and	 Gill	 1997;	
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Miller	et	al	1999;	Welschen	et	al	2004)	-	all	influenced	by	the	policies	regulating	health	
systems.	The	regulatory	factors	influencing	prescribing	are	elaborated	in	further	detail	in	
the	next	section.		
3.6.2.	Regulatory	factors	and	system’s	influence	on	prescribing	
There	 is	 a	 long	 list	 of	 regulatory	 factors	 influencing	 prescribing	 that	 have	 been	
researched	 in	 the	 literature.	 This	 review	 provides	 insights	 into	 those	 that	 are	 of	
relevance	to	the	research	questions,	and	to	the	situation	in	the	analysed	context.		
Cost	as	a	factor	for	decision-making	in	prescribing	has	not	been	extensively	researched,	
although	 it	 was	 considered	 in	 part	 in	 several	 studies.	 The	 examined	 literature	
distinguishes	the	costs	as	those	arising	for	the	system,	and	the	costs	that	are	born	by	the	
patient.	When	 it	comes	to	costs	of	prescribing,	physicians	are	rarely	aware	(Ernst	et	al	
2000;	Coenen	et	al	2006)	or	concerned	 (Coenen	et	al	2006),	although	 in	 some	studies	
costs	to	the	system	were	considered	in	decision	making	(Greenfield	et	al.	2005;	Jacoby	
et	 al	 2003;	 Little	 and	Williamson	 1995),	 as	 well	 as	 costs	 to	 the	 patients	 (Hassel	 et	 al	
2003).	 However,	 other	 factors	 are	 sometimes	 viewed	 as	 more	 important	 than	 costs	
(Ljungberg	et	al	2007;	Prosser	and	Willey	2006;	Coenen	et	al	2006),	and	while	taken	into	
consideration,	 physicians	 are	 not	 ready	 to	 accept	 or	 make	 entirely	 cost-oriented	
decisions	in	prescribing	(Maddox	2011).		
One	 of	 the	most	 researched	 topics	 on	 regulatory	 factors	 is	 the	 relationship	 between	
prescribing	 and	 attitudes	 and	 practices	 related	 to	 clinical	 guideline	 existence	 and	
adherence	 (e.g.	 Sun	 et	 al	 2015;	 Grol	 and	Grimshaw	 2003).	 It	 can	 be	 argued	 from	 the	
literature	 that	 guidelines	 have	 significant	 influence	 on	 the	 prescribing	 decisions	 of	
physicians	at	both	primary	(Wood	et	al	2005)	and	other	levels	of	care	(Higgins	and	Tully	
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2005;	 Ljungberg	et	 al	 2007).	 Furthermore,	 targeted	educational	 efforts	 at	 the	practice	
level	 (Coenen	 et	 al	 2005)	 and	 monitoring	 of	 prescribing	 (Tonkin-Crine	 2013)	 have	
significant	 influence	 in	 changing	 prescribing	 behaviour.	 However,	 there	 are	 studies	
showing	 that	 guidelines	might	 not	 always	 have	 predominance	 in	 influencing	 decision-
making	(Wathen	and	Dean	2004;	Butler	et	al	1998;	Coenen	et	al	2006),	and	that	other	
factors	can	override	the	‘written	rules’	when	they	differ	from	the	experience	(Schwartz	
et	al	1989),	from	other	guidelines	(Wathen	and	Dean	2004)	or	from	the	best	interest	of	
the	patient	 (Wood	et	al.	2007).	These	other	 factors	 include	professional	experience	as	
mentioned	earlier	(Wood-Mitchell	et	al	2008;	Schwartz	et	al.	1989;	Tichelaar	et	al.	2010;	
Vallano	 2004),	 maintaining	 a	 good	 relationship	 with	 the	 patient	 (Butler	 et	 al	 1998;	
Coenen	et	al	2006),	patient	satisfaction	(Himmel	et	al	1997)	and	so	forth.		
In	this	respect,	influencing	factors	related	to	patients	and	patient-physician	relationship	
are	elaborated	further	in	the	next	section.	
3.6.3.	Patients’	influence	and	physician-patient	relationship	
The	 third	 type	 of	 influence	 on	 prescribing	 considered	 in	 this	 research	 is	 the	 group	 of	
factors	pertaining	to	patients	and	the	physician-patient	relationship.		
Prescribing	 is	 inevitably	 influenced	 by	 patients	 and	 the	 physician-patient	 relationship,	
considered	by	physicians	as	one	of	the	main	elements	in	decision-making	for	prescribing	
(Mossialos	et	al	2004),	alongside	the	symptoms	and	condition	of	the	patient	(Butler	et	al	
1998;	Rodrigues	et	al	2013).		
The	past	 two	decades	have	 seen	continuous	attention	within	 the	 research	community	
on	 the	 role	 of	 patients	 in	 shaping	 prescribing	 behaviour	 and	 practices	 of	 healthcare	
providers	 (Cockburn	 and	 Pit	 1997;	 Davey	 2002;	 Vanden	 Eng	 2003;	 Ashworth	 2016).	 A	
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number	of	studies	have	found	that	physicians	tend	to	prescribe	under	patient	pressure,	
despite	 the	 imbalance	 of	 professional	 expertise	 and	 information	 between	 the	 two	
parties.	With	the	expansion	of	the	Internet	and	easier	access	to	information	outlets	and	
educational	 resources,	 this	 pressure	 is	 likely	 to	 become	 even	 greater	 in	 the	 future	
(Gardiner	 2008).	 Literature	 shows	 that	 patients	 come	 to	 the	 physician	 with	 certain	
expectations,	 stemming	 from	 their	 somatic	 symptoms,	 previous	 experience,	 perceived	
vulnerability,	 and	 so	 forth	 (Kravitz	 et	 al	 1996);	 but	 also	 that	 physicians	 are	 to	 some	
extent	 aware	 of	 the	 patients’	 expectations	 (Rao	 et	 al	 2000;	 Butler	 et	 al	 1998).	 The	
literature	 review	 by	 Rao	 et	 al	 (2000)	 on	 the	 visit-specific	 expectations	 of	 patients	
underlines	 that,	 while	 there	 are	 studies	 showing	 no	 significant	 influence	 or	 that	 are	
inconclusive	on	such	influences,	there	are	studies	concluding	that	unmet	expectations	of	
patients	 –	 for	 prescription	 in	 particular	 -	 led	 to	 either	 repeated	 visits	 for	 the	 same	
symptoms	 (Mcfarlane	 et	 al	 1997)	 or	 obtaining	 the	 medicine	 without	 prescription	
(Rapoport	1979).	These	expectations,	from	a	theoretical	perspective,	play	an	important	
role	in	physician-patient	interactions,	as	will	be	reviewed	in	more	detail	in	the	following	
paragraphs.	
There	 is	ample	evidence	 in	 the	 literature	 that	 the	physician-patient	 interaction	plays	a	
significant	role	 in	decision-making	(Britten	2008,	Ch.	3)	and	has	a	 large	contribution	to	
excessive	and	unnecessary	prescribing	(Cribb	and	Barber	1997;	Butler	et	al	1998;	Arnold	
and	 Strauss	 2005;	 Rodrigues	 2013).	 While	 describing	 it	 as	 the	 most	 uncomfortable	
decision	 about	 prescribing	 that	 they	 make	 (Bradley	 1991;	 Bradley	 1992),	 physicians	
often	 incline	towards	clinically	 inappropriate	prescribing	for	reasons	 involving	patients’	
expectations	or	perceived	expectations	to	have	medicines	prescribed	(Arnold	and	Straus	
2005;	Kotwani	et	al	2010;	Hornberger	et	al	1997;	Himmel	et	al	1997).		
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As	 described	 by	 Butler	 et	 al	 (1998),	 for	 example,	 ‘general	 practitioners	 attempted	 to	
sense	patients’	flexibility	and	prescribe	antibiotics	as	soon	as	they	perceived	resistance	
to	a	non-antibiotic	approach’	(Butler	et	al	1998).	When	patients	expect	antibiotics	they	
are	more	 likely	 to	 be	 prescribed	 (Vinson	 and	 Lutz	 1993;	 Kravitz	 et	 al	 2002)	 and	when	
physicians	perceive	that	patients	expect	antibiotics	they	are	10	times	more	likely	to	be	
prescribed	(Cockburn	and	Pit	1997;	Little	et	al	2004;	Toiviainen	et	al	2005).	In	this	sense,	
irrespective	of	 the	potential	non-adherence	 to	 the	clinical	 guidelines	or	 rationalization	
policies,	 studies	 have	 shown	 that	 physicians’	 decisions	 on	 prescribing	 can	 often	 be	
driven	by	the	motivation	of	preserving	a	good	physician-patient	relationship	(Carlsen	et	
al	2007)	even	if	 it	means	fulfilling	patients’	wishes	without	evidence-based	justification	
(Miller	 et	 al	 1999).	 Maintaining	 a	 good	 physician-patient	 relationship	 (Coenen	 et	 al	
2006)	and	impact	on	the	therapeutic	power	of	the	physician-patient	relationship	(Butler	
et	al	1998)	were	seen	by	some	physicians	as	more	important	than	prescribing	based	on	
medical	indication.	It	can	thus	be	concluded	that	the	physician-patient	relationship	and	
interaction	during	a	patient’s	visit	contribute	to	the	prescribing	decision.		
	
3.7. 	Rational	dispensing	and	challenges	to	legal	supply	
	
The	previous	sections	provided	an	overview	of	prescribing	and	associated	influences	and	
also	 how	 policy	 has	 been	 used	 to	 regulate	 the	 supply	 of	 medicines	 but	 there	 is	 an	
emerging	 literature	 that	 indicates	such	regulation	 is	not	always	effective.	 In	particular,	
there	 have	 been	 several	 studies	 -	 drawing	 on	 ethnographic	 methods	 in	 transition	
countries	 -	 that	 have	 explored	 the	 supply	 of	 prescription	medicines	 through	 practices	
and	 settings	 that	 are	 not	 considered	 either	 legal	 or	 authorised.	 These	 have	 been	
helpfully	summarised	by	Whyte,	Van	der	Geest	and	Hardon	(2002)	who	have	identified	a	
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phenomenon	 of	 ‘pharmacists	 as	 doctors’	 wherein	 pharmacists	 provided	 an	 extensive	
range	 of	 medicines	 without	 the	 need	 for	 patients	 to	 consult	 a	 physician.	 Although	
stressing	 the	 socio-cultural	 significance	 of	 such	 research,	 they	 identified	 studies	
particularly	 in	 Latin	 America	 where	 pharmacists	 were	 engaged	 in	 ‘quasi-legal	 and	
shadowy	practices’	 (Whyte,	Van	der	Geest	and	Hardon,	2002).	For	some	communities,	
this	 has	 been	 argued	 to	 arise	 due	 to	 logistical	 problems	 in	 seeking	 medical	 advice	
(Ferguson	 1988).	 In	 others,	 however,	 there	 appeared	 to	 be	 a	more	 overt	 intention	 to	
subvert	recognised	laws	and,	 indeed,	some	health	professionals	appeared	to	recognise	
the	problematic	nature	of	such	supplies	 (Wolffers	1987).	Van	der	Geest	 (1982)	 framed	
this	 phenomenon	 in	 terms	of	 two	 key	questions:	 how	are	 such	practices	possible	 and	
why	do	patients	use	such	sources	of	medicines.	He	argued	that	there	are	economic	and	
commercial	drivers	which	can	influence	pharmacists	to	make	such	supplies	and	further	
questioned	 if	 this	 is	 a	 consequence	 of	 laisse	 fair	 capitalist	 economies	 and	whether	 it	
would	happen	in	socialist	countries	(Van	der	Geest	1982	p.211).	The	desire	for	patients	
to	make	such	purchases	is	argued	to	arise	for	complex	reasons	relating	not	only	to	more	
obvious	economic	factors,	but	also	complex	social	factors.	
Such	issues	are	not	restricted	only	to	Latin	America	and	Smith	(2009)	provided	a	review	
of	pharmacy	 services	and	highlighted	many	 such	practices	 in	 settings	 such	as	Vietnam	
(Duong	et	al	1997),	Nepal	(Wachter	et	al	1999),	Nigeria	(Oladipo	and	Lamikanra	2002),	
Brazil	(Volpato	et	al	2005),	Zimbabwe	(Nyazema	et	al	2007),	Thailand	(Apisarnthanarak	
et	al	2008),	 and	Zambia	 (Kalungia	et	al	2016).	Most	of	 these	 studies	pointed	 to	 socio-
cultural	 factors	 dominating	 the	 decision	 to	 dispense	 and	 obtain	 medicines	 without	
prescription,	justified	as	lack	of	access	to	physicians’	prescription,	but	also	as	perceived	
sufficient	professional	knowledge	of	pharmacists	to	prescribe.	
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Literature	 shows	 that	 such	 practices	 are	 present	 in	 Europe	 as	well;	 studies	 describing	
self-medication	and	home	keeping	of	medicines	-	antimicrobial	medicines	in	particular	-	
in	Spain	(Orero	et	al	1997;	Gonzalez	Nunez	et	al	1998),	Greece	(Contopoulos-Ioannidis	et	
al	2001;	Mitsi	et	al	2005),	Russia	(Stratchounski	et	al	2003),	and	Malta	(Borg	and	Scicluna	
2002)	 also	 suggested	 considerable	 use	 of	 these	 medicines	 without	 consulting	 a	
physician.	Obtaining	medicines	 from	pharmacies	without	prescription	 is	also	described	
in	 the	 literature	 as	 a	 frequent	 practice	 in	 eastern	 European	 countries	 (Grigoryan	 et	 al	
2006;	 Versporten	 et	 al	 2014).	 Recent	 research	 findings	 regarding	 the	 association	
between	 inappropriate	 use	 of	medicines	 and	 antimicrobial	 resistance	 (Goossens	 et	 al	
2005)	continue	to	keep	rational	prescribing	(Aronson	2004;	Aronson	2006;	Wallerstedt	
et	 al	 2014;	 Reeve	 et	 al	 2015)	 and	 legal	medicine	 supply	 high	 on	 the	 research	 agenda	
(Goff	et	al	2002,	Iruka	et	al	2005).	
Other	 studies	 found	 that	 not	 only	 antimicrobials,	 but	 other	 classes	 of	 medicines	 are	
dispensed	without	prescription.	A	study	in	northwest	Spain	found	that	nearly	two	thirds	
of	 pharmacist	 respondents	 admitted	 to	 dispensing	 medicines	 without	 prescription,	
including	 angiotensin-converting	 enzyme	 inhibitors,	 benzodiazepines	 and	 oral	
contraceptives	(Caamano	et	al	2005);	Guinovart	et	al	(2015)	confirmed	this	finding	and	
discovered	that	the	practice	continued	with	upward	trend	for	antibiotics.	Several	studies	
were	 looking	 into	 determinants	 of	 quality	 of	 dispensing,	 indicating	 a	 wide	 range	 of	
influences,	 such	 as	 social	 and	 demographic	 factors,	 educational	 background	 and	
workload	 (Caamano	 et	 al	 2004),	 as	 well	 as	 pharmacists’	 opinions	 about	 their	 role,	
especially	pertaining	to	underestimation	of	physicians	qualifications	and	overestimation	
of	their	own	qualifications	to	prescribe	(Caamano	et	al	2005;	Beney	et	al	2000).		
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This	 section	 provided	 a	 brief	 overview	 of	 a	 relatively	 neglected	 aspect	 of	 medicine	
supply	 (Van	 der	 Geest	 1982).	 Lack	 of	 existing	 literature	 and	 scarce	 emphasis	 put	 on	
dispensing	and	rational	dispensing	by	scholars	who	have	researched	medicine	supply	in	
extenso,	further	confirms	the	necessity	for	additional	research	in	the	area.	For	example,	
Britten	 in	 her	 book	 Medicines	 and	 Society	 (2008)	 looks	 into	 dispensing	 but	 is	 not	
dedicating	substantive	attention	as	part	of	the	medicine	supply.	
So	far,	the	literature	surrounding	the	supply	of	medicines	has	been	presented	in	terms	
of	 mainly	 empirical	 research	 relating	 to	 various	 influences	 upon	 prescribing	 and	
dispensing	and	associated	rationality	and	autonomy.	In	the	remainder	of	this	chapter,	a	
theoretical	 approach	 to	 considering	not	only	 the	 supply	of	medicines	will	 be	provided	
(Britten	2008),	but	also	how	this	relates	uniquely	to	transition	countries.	
	
3.8. Medicine	supply	and	Habermas’	System	and	Lifeworld	
	
Several	 attempts	 have	 been	 made	 to	 offer	 a	 more	 sociological	 account	 of	 medicine	
supply.	 Whyte,	 Van	 der	 Geest	 and	 Hardon	 (2002)	 argued	 that	 there	 was	 a	 socially	
grounded	nature	of	medicines	and	what	 they	 termed	 the	 ‘social	 lives	of	medicines’	 as	
evidenced	 through	 numerous	 ethnographic	 accounts.	 In	 addition,	 Britten	 (2001)	 has	
argued	 that	 ‘the	acts	of	prescribing	and	dispensing	define	 social	 relationships	between	
patients,	 doctors,	 nurses,	 pharmacists	 and	 others’	 (Britten	 2001).	 Britten	 went	 on	 to	
explore	the	conceptualization	of	medicines	and	their	role	and	function	in	society	from	a	
more	specific	theoretical	perspective.	To	do	so,	she	argued	that	Habermas’	social	theory	
of	 system	 and	 lifeworld	 could	 be	 applied	 to	 different	 aspects	 of	medicines	 –	 in	 their	
development,	 prescribing	 and	 consumption	 –	 and	 that	 this	 theory	 offered	 an	
explanation	 for	 trends	 within	 medicine	 supply.	 In	 the	 following	 sections,	 Habermas’	
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theory	of	system	and	lifeworld	will	be	described	and	particularly	in	relation	to	medicine	
supply	and	the	respective	roles	of	prescribers	and	patients.		
3.8.1	Habermas’	theory	of	communicative	action	and	healthcare		
Before	considering	medicine	supply	specifically	 in	this	theoretical	sense,	 it	 is	necessary	
to	 describe	 the	 basic	 concepts	 of	 Habermas’	 theory	 of	 social	 life	 and	 communicative	
action	 (Habermas	 1987).	 In	 his	 theory,	 and	 of	 particular	 relevance	 to	 this	 thesis,	
Habermas	provided	arguments	for	the	two	distinct	spheres	of	social	life:	the	system	and	
the	lifeworld	(Barry	et	al,	2001;	Finlayson,	2005;	Britten,	2008),	with	each	of	these	two	
spheres	 governed	 by	 different	 rationality;	 the	 system	 being	 largely	 a	 subject	 of	
instrumental	 rationality	–	orientated	towards	structure,	systematisation	and	successful	
outputs;	 whilst	 the	 lifeworld	 is	 the	 depiction	 of	 the	 communicative	 rationality	 –	
orientated	 towards	 reasoning,	 interpretation,	 exchange	 and	 achieving	 mutual	
understanding	 (Stanford	 Encyclopaedia	 of	 Philosophy,	 2015).	 System	 and	 lifeworld	
represent	just	one	aspect,	however,	of	a	more	complex	and	broader	social	theory,	which	
focuses	 on	 the	 significance	 of	 communicative	 acts	 and	 rationality,	 and	 through	
important	mechanisms	such	as	discourse	ethics.	Although	a	more	detailed	discussion	of	
these	concepts	 is	beyond	 the	scope	of	 this	 thesis	–	particularly	 in	 terms	of	Habermas’	
political	 and	 philosophical	 aims	 –	 the	 enduring	 normativity	 of	 his	 work	 in	 relation	 to	
system	 and	 lifeworld	 are	 argued	 to	 be	 highly	 relevant	 to	 this	 thesis,	 and	 as	 will	 be	
shown,	 have	 been	 used	 by	 several	 writers	 to	 contextualise	 and	 understand	 different	
aspects	of	health	 (Mischler	1984;	Barry	et	al	2001;	Scambler	and	Britten	2001;	Britten	
2008;	Thompson	2009).	These	have	offered	 important	 insights	 into	 topics	as	varied	as	
doctor	and	patient	interactions,	the	role	of	medicines	in	society	and	the	involvement	of	
patients	in	research	networks.	
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Essentially,	the	lifeworld	as	explained	by	Habermas	refers	to	the	sphere	of	social	life	and	
through	its	‘communicative	action’	plays	an	essential	role	as	one	of	the	basic	interests	of	
modern	 society	 (Habermas	 1987),	 as	 central	 to	 human	 relationships	 (Cuff	 et	 al	 2006,	
p.292),	 and	 through	 which	 all	 cultural,	 experiential	 and	 knowledge	 exchanges	 occur	
(Britten,	 2008;	 Habermas,	 1987).	Within	 the	 lifeworld,	 communication	 and	 exchanges	
have	intrinsic	value	and	aim	to	achieve	common	understanding	without	any	dominance	
or	power	imbalance	between	individuals	(Barry	et	al	2001).	In	other	words:	
‘If	 communicative	action	 is	 taken	as	 the	most	basic	 form	of	human	action,	
then,	 it	 opens	 up	 the	 possibility	 of	 a	 society	 in	 which	 social	 relations	 are	
conducted	 on	 the	 basis	 of	mutual	 recognition	 of	 one	 another	 as	 free	 and	
independent	beings.’	Cuff	et	al	(2006,	p.292)	
	
Habermas’	system-world	stems	from	Marx’s	interpretations	of	society	and	the	Parsonian	
conception	of	the	social	system	(Cuff	et	al	2006,	p.	323).	It	is	concerned	predominantly	
with	 the	 material	 exchanges	 of	 the	 society	 and	 structuralism,	 whereby	 all	 means,	
including	human	beings	are	utilized	for	the	successful	production	of	actions	and	outputs	
(Finlayson,	 2005,	 Cuff	 et	 al	 2006,	 p.	 293).	 This	 uses	 rationality	 again,	 but	 instead	 of	
communicative	 rationality,	 it	 values	 scientific	 rationality	 and	 objective	 measurements	
(Britten	2008,	p.18).	 In	 the	context	of	healthcare	and	prescribing,	Britten	 (2008,	p.	19)	
explaining	this	divergence	as:		
‘…the	 lifeworld/system	 distinction	 points	 out	 the	 tension	 between	 the	
experiences,	needs	and	concerns	of	 lay	people,	patients	and	carers	on	one	
hand	 and,	 on	 the	 other,	 the	 need	 to	 make	 profit	 in	 a	 capitalist	 society	
(pharmaceutical	 companies)	 and	 the	 role	 in	 enacting	 government	 policies	
(health	professionals)…Individuals	who	become	 ill	 not	only	 find	 themselves	
as	 members	 of	 the	 familiar	 lifeworld	 but	 also	 members	 of	 an	 unfamiliar	
healthcare	 system	 with	 different	 rules	 and	 modes	 of	 behaviour’	 (Britten	
2008,	p.19)	
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A	further	 important	aspect	of	Habermas’	theory	 is	what	he	termed	the	colonisation	of	
the	 lifeworld	by	 the	system.	This	 is	argued	to	arise	 in	modern	societies	and	 it	 involves	
increasing	systematisation	of	particular	areas	of	the	lifeworld,	leading	to	deviation	from	
or	 stagnation	 of	 the	 original	 purpose	 of	 the	 lifeworld	 and	 its	 communicative	 action	
(Barry	 et	 al	 2001).	 In	 terms	 of	 the	 physician-patient	 encounter	 exemplifying	 the	
system/lifeworld	 interaction	 such	 systematisation	 and	 superimposition	 could	 be	
illustrated	 through,	 for	example,	pressure	of	 the	 system	on	 the	physician	 to	 see	more	
patients,	 manifest	 as	 increasingly	 limited	 times	 for	 consultation	 and	 thorough	
examination	(Butler	et	al	1998).	Physicians,	or	health	providers	in	general	are	expected	
to	 maximise	 their	 output	 in	 minimum	 time,	 as	 a	 prerequisite	 for	 being	 part	 of	 the	
system	 and	 its	 presupposed	 efficiency	 (Cuff	 et	 al	 2006).	 In	 turn,	 this	 leads	 to	 limited	
space	 for	 communicative	 rationality,	 producing	 patient	 dissatisfaction	 and	 unmet	
expectations	 (Kravitz	et	al	1996;	Rao	et	al	2000)	 that	 represents	a	 failure	 to	 reach	 the	
common	understanding.	
But	 however	 different	 the	 system	 and	 lifeworld	 rationalities	 are,	 they	 remain	
interdependent	and	in	continuous	interaction	(Habermas	1987;	Cuff	et	al	2006,	p.296).	
The	actual	 type	of	 interaction	between	 the	 two	spheres	–	 in	 this	 case	 the	patient	and	
the	 physician	 –	 is	what	 determines	 the	 product	 and	 the	 outcome	of	 such	 interaction.	
Barry	 et	 al	 (2001)	 in	 their	 research	 identify	 four	 types	 of	 interaction,	 summarized	 in	
Table	5	below.		
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Table	5.	The	four	types	of	engaged	interaction	between	system	and	lifeworld	and	the	
outcomes	summarized	by	Barry	et	al	(2001)	
Interaction	between	system	and	lifeworld	 Outcome	
When	doctor	and	patient	both	used	the	voice	of	medicine	exclusively	
(acute	physical	complaints)	this	worked	for	simple	unitary	problems		
Strictly	Medicine	
When	both	doctor	and	patient	engaged	with	the	lifeworld,	more	of	
the	agenda	was	voiced	and	patients	were	recognised	as	unique	
human	beings	
Mutual	Lifeworld	
Patients	use	the	voice	of	the	lifeworld	but	were	ignored	as	physicians	
use	the	voice	of	medicine		
Lifeworld	Ignored	
Patients	use	the	voice	of	lifeworld	but	are	blocked	as	physicians	use	
of	the	voice	of	medicine		
Lifeworld	Blocked	
	
	
Their	 analysis	 supports	 the	 premise	 that	 prioritising	 the	 lifeworld	would	 contribute	 to	
better	 outcomes	 and	 more	 humane	 treatment	 of	 patients	 as	 unique	 human	 beings	
(Barry	 et	 al	 2001),	 but	 would	 also	 contribute	 to	 higher	 compliance	 with	 the	
recommendations	and	medical	advice	given	to	them	(Roter	1977;	Kaplan	et	al	1989).	At	
the	same	time,	and	as	Britten	(2008)	noted,	this	emphasis	on	the	individualised	choice	
resonates	with	the	work	of	Giddens	 (1991)	and	the	work	on	 ‘individualisation’	of	Beck	
(2002)	who	 postulated	 that	 contemporary	 society	 can	 be	 characterised	 by	 the	way	 in	
which	 individuals	 choose	 the	 kind	 of	 life	 they	want	 to	 live,	with	 a	 reflexivity	 to	 every	
aspect	of	their	lives	so	as	to	increase	the	possibility	of	making	‘the	right’	choices.	
Following	the	above	theoretical	explanations	of	Habermas’	theory,	 it	can	be	concluded	
that	 the	 lifeworld	 has	 a	 significant	 role	 to	 play	 in	 prescribing,	 reviewed	 in	 the	 next	
section.	
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3.8.2	The	Lifeworld:	patients’	role	in	prescribing	and	dispensing	
The	 role	 of	 patients	 in	 medical	 decision	 making,	 and	 in	 particular	 in	 prescribing	 and	
dispensing,	 is	 not	 to	 be	 neglected	 and	 needs	 to	 be	 viewed	 through	 its	 perspective	 of	
complex,	 contextualized	and	meaningful	 interaction	with	 the	physician	and	 the	health	
system	in	general.	As	Scambler	and	Britten	(2001)	argue,	analysing	the	physician-patient	
relationship	as	‘an	autonomous	and	self-contained	unit	of	analysis’	raises	the	concern	of	
neglecting	 the	 broader	 sociological	 circumstances	 that	 influence	 it.	 The	 theoretical	
underpinning	 of	 this	 role	 has	 initially	 been	 reviewed	 by	 Mishler	 (1984)	 through	
Habermas’	 theory	 of	 communicative	 action	 applied	 to	 medical	 encounters,	 later	
researched	 and	 elaborated	 by	 other	 scholars	 (Frank	 1997,	 p.143;	 Barry	 et	 al	 2001;	
Britten	2008).		
Patients’	influence	on	decision-making	was	explained	by	Mishler	(1984)	through	medical	
encounters:	 ‘the	 voice	 of	 the	 lifeworld	 refers	 to	 the	 patient’s	 contextually-grounded	
experiences	 of	 events	 and	 problems	 in	 her	 life.’	 (Mishler	 1984,	 p.104).	 Stewart	 et	 al	
(2003)	 consider	 that	 the	 patient’s	 contribution	 to	 the	 healing	 process	 includes	 ‘the	
patient’s	 personal	 and	 subjective	 experience	 of	 sickness;	 the	 feelings,	 thoughts	 and	
altered	 behaviour	 of	 someone	 who	 feels	 sick’	 (Stewart	 et	 al	 2003,	 p.35).	 Therefore,	
behaviour	 and	 thus	 the	 influence	 of	 patients	 and	 their	 relationship	 with	 providers	 is	
inevitably	bound	 to	 the	 ‘complex	whole	which	 includes	knowledge,	belief,	art,	morals,	
law,	 custom	 and	 any	 other	 capabilities	 and	 habits	 acquired	 by	 man	 as	 a	 member	 of	
society’	(Taylor	1871).	Patients’	behaviour	represents	the	totality	of	a	person's	learned,	
accumulated	 experience,	which	 is	 socially	 transmitted	 through	 communication.	 In	 this	
sense,	the	personal	identity	as	conceived	by	Mead	(1972)	and	Durkheim	(1984)	arises	as	
a	 structure	 that	 results	 from	 taking	 over	 socially	 generalized	 expectations,	 and	 ‘an	
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organized	set	of	attitudes	that	one	takes	over	from	one’s	reference	persons’	(Habermas	
1989,	 p.58).	 Habermas	 refers	 to	 culture,	 society	 and	 personality	 as	 structural	
components	of	 the	 lifeworld,	where	 individuality	 is	 expressed	 through	 the	heightened	
claims	 to	 autonomy	 and	 self-realization	 (Habermas	 1989,	 p.107).	 Thus,	 beyond	 the	
specialised	 knowledge	 and	 system	 realities,	 individuality	 plays	 a	 significant	 role	 in	
shaping	 the	 communicative	 action	 and	 outcomes	 of	 a	 medical	 encounter,	 including	
modifying	prescribing	behaviour	(Britten	2008,	p.	50).	Habermas’s	communicative	action	
in	medical	encounters	was	described	by	Lazare	et	al	(1975)	as	a	process	of	negotiation	
between	the	physician	and	the	patient:	
‘Patients	are	conceived	of	as	appearing	with	one	or	more	requests...	It	is	the	
clinician's	 task	 to	 elicit	 the	 request,	 collect	 the	 relevant	 clinical	 data,	 and	
enter	into	a	negotiation	that	should	foster	a	relationship	of	mutual	influence	
between	patient	and	clinician.’	(Lazare	et	al	1975)	
	
Increasing	 access	 to	 information,	 reducing	 the	 knowledge	 gap	 between	 providers	 and	
patients	 and	 deprofessionalisation	 of	 medicine	 (Scambler	 and	 Britten	 2001)	 become	
enablers	for	the	empowered	patient’s	negotiation	and	influence	on	decision-making,	as	
part	of	the	resistance	to	the	colonization	of	the	lifeworld	by	either	the	state	or	market	
forces	 (Williams	 and	 Popay	 2002).	 Such	 influence	 is	 additionally	 induced	 by	 doctors’	
attempts	 to	 ‘balance	 between	 the	 task	 of	 understanding	 the	 disease	 (the	 'science	 of	
medicine')	and	that	of	understanding	the	patient	 (the	 'art	of	medicine')’	 (Butalid	2014,	
p.8).	 Physicians	 have	 a	 dual	 role	 to	 play,	 representing	 the	 system	 in	 the	 physician-
patient	interaction,	and	at	the	same	time	being	themselves	part	of	the	lifeworld;	thus	it	
is	 arguable	 that	 their	 behaviour	 is	 affected	 by	 the	 exchanges	 made	 through	 this	
interaction.	And,	indeed,	there	is	extensive	literature	not	only	on	such	interactions,	but	
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also	 on	 their	 impact	 on	 prescribing	 outcomes,	 describing	 a	 shift	 from	 the	 traditional	
supply-induced	care	into	a	more	demand-induced	care	(Brink-Muinen	et	al	2006).	
However,	 as	 already	 mentioned,	 these	 interactions	 do	 not	 happen	 in	 a	 vacuum,	 and	
have	 to	 be	 analysed	 also	 vis-à-vis	 the	 influences	 of	 a	 wider	 societal	 and	 economic	
context.	Cribb	and	Barber	(1997)	talk	about	the	context	of	choice	of	prescribing	as	being	
one	of	 the	key	 factors	 shaping	prescribing	decisions	 (Cribb	and	Barber	1997).	Britten’s	
(2008)	 further	 analysis	 confirmed	 that	 prescribing	 and	 dispensing	 is	 more	 than	 a	
technical	 issue,	 and	 is	 influenced	 by	 a	 range	 of	 social	 and	 contextual	 factors	 (Britten	
2008,	 p.115).	 As	 they	 are	 of	 particular	 interest	 to	 this	 thesis,	 the	 following	 sections	
review	the	literature	on	prescribing	and	dispensing	in	transition	countries.	
		
3.9. Prescribing	and	dispensing	in	transition	countries	
	
Since	primary	care	is	continuously	evolving,	the	doctor-patient	interaction	is	influenced	
by	 the	prevailing	 context	 of	 a	 particular	 point	 in	 time	 (Butalid	 2014,	 p.8).	 It	 is	 thus	of	
immense	 importance	 to	 provide	 an	 overview	 of	 primary	 care	 and	 its	 changes	 in	 the	
transition	countries,	as	the	context	in	which	prescribing	and	dispensing	is	of	interest	to	
this	thesis.	
3.9.1	Primary	care	and	system/lifeworld	interactions	
As	explained	earlier,	primary	care	represents	the	first	point	of	contact	with	patients,	and	
the	physician-patient	relationship	has	been	widely	researched	with	regards	to	it	(Bakker	
et	 al	 1997;	 Bradley	 1992).	 As	 the	 focus	 of	 this	 thesis	 is	 prescribing	 and	 dispensing	 at	
primary	 care	 level,	 in	 order	 to	 understand	 the	 transition	 economy	 context	 in	 which	
these	are	researched,	it	is	necessary	to	provide	background	information	on	the	context	
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in	which	primary	care	is	set,	functioning	and	evolving.	This	section	provides	an	overview	
of	 the	 different	 engagement	 mechanisms	 of	 providers	 in	 primary	 care	 through	 the	
perspective	of	the	Habermas’	theory.	
Salaried	 primary	 healthcare	 is	 closest	 to	 and	 most	 resembles	 financing	 in	 the	 health	
system	 under	 the	 socialist	 system	 of	 command	 economy	 (Mandel	 1986).	 Salaries	 in	
healthcare	 incentivise	 provision	 of	 care	 at	 the	 discretion	 of	 the	 provider	 that	 is	 not	
based	on	any	performance	indicators	and	encourages	referrals	and	prescribing,	as	these	
are	 often	 not	 financially	 confined.	 If	 viewing	 this	 through	 the	 perspective	 of	 the	
system/lifeworld,	 in	 the	 salaried	 model,	 physicians	 have	 more	 time	 and	 space	 for	
interaction	with	their	patients,	and	a	common	understanding	is	much	more	likely	to	be	
reached.	Such	a	common	understanding	 is	 likely	to	be	unfavourable	from	the	system’s	
perspective,	 as	 a	 result	 of	 disguised	 dissociation	 of	 doctors	 from	 the	 system,	 through	
lack	 of	 performance	 indicators	 (characteristic	 of	 purposive	 rationality)	 and	 enormous	
clinical	autonomy	(supportive	of	value	rationality).		
The	fee-for-service	(FFS)	model,	on	the	other	hand,	is	based	on	the	concept	of	efficient	
use	of	 allocated	 resources,	 incentivising	physicians	 to	provide	 fewer	unnecessary	 (and	
sometimes	necessary)	services.	It	can	be	argued	that	with	the	fee-for-service	model,	the	
time	 for	 the	 consultation,	 i.e.	 communicative	 rationality	 and	 reaching	 a	 common	
understanding	 are	 severely	 affected,	 as	 the	 system	 usually	 sets	 strict	 efficiency	
requirements	over	the	physician	for	obtaining	the	reward	for	the	work	delivered.	Thus,	
in	 this	 model,	 the	 system	 instrumentalizes	 providers	 in	 fulfilling	 its	 goals,	 explicitly	
superimposing	itself	onto	the	lifeworld.	
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The	 third	major	 reimbursement	method	 used	 in	 primary	 care,	 the	 capitation	model	 –	
and	 its	 modified	 alternatives,	 as	 already	 described	 in	 previous	 sections	 -	 is	 based	 on	
payment	of	a	set	amount	ex-ante	 for	each	registered	patient,	adding	a	proportionality	
dimension	to	the	income	relative	to	the	number	of	patients.	In	addition,	the	capitation	
model	also	addresses	some	of	the	issues	of	the	financing	of	additional	services,	such	as	
medicines.	 The	 capitation	 model	 thus	 encourages	 the	 communicative	 rationality	
between	 the	 system	 and	 the	 lifeworld,	 but	 still	 can	 arguably	 somewhat	 limit	 the	
possibilities	 for	 reaching	 a	 common	 understanding,	 especially	 with	 regards	 to	 the	
limitations	set	for	prescribing	or	referrals.	
Following	 this	 review	 of	 the	 main	 features	 of	 different	 models	 of	 primary	 care,	 the	
following	section	reviews	primary	care	in	the	context	of	the	transition	countries.	
3.9.2	Primary	care	in	transition	countries	
Although	there	were	some	experimentations	with	models,	by	the	mid-2000s	transition	
economies	 have	 almost	 all	 introduced	 capitation	models	 for	 payment	 among	 primary	
care	doctors	(e.g.	Albania,	Bulgaria,	Czech	Republic,	Hungary,	Macedonia),	or	capitation	
combined	with	 fee-for-service	 (Croatia,	 Poland,	 Romania)	 (Ciumas	 and	Vaidean	 2008),	
while	some	introduced	modified	versions	of	partial	or	full	reimbursement	through	fee-
for-service	 for	preventive	care	or	minor	surgery	 (Leive	2010).	Policies	and	mechanisms	
of	 capitation	 are	 similar	 in	 the	 broadest	 sense;	 capitation	 amount	 per	 patient	 is	 set	
based	on	varied	criteria,	generally	accounting	for	specific	adjustments	for	the	registered	
patients	in	terms	of	their	expected	health	needs,	dependent	on	age,	gender,	rural/urban	
location	and	so	forth	(Leive	2010).	Most	of	the	countries	adopting	the	capitation	model	
have	 a	 policy	 of	 limitation	 on	 the	 number	 of	 patients	 that	 can	 be	 registered	 under	 a	
single	provider	 (Kornai	 and	Eggleston	2001);	 however	 in	 some	 systems	 the	 limit	 set	 is	
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only	 to	 represent	 the	 cut-off	 point	 beyond	which,	 for	 additionally	 registered	 patients,	
physicians	would	receive	a	lower	capitation	amount	(Milevska-Kostova	et	al	2017,	p.24).	
This	 is	 aimed	 at	 dis-incentivising	 physicians	 to	 register	 more	 patients	 than	 optimally	
possible	 to	 interact	 with,	 and	 thus	 ensuring	 equality	 of	 access,	 through,	 for	 example,	
time	dedicated	to	each	patient.	In	other	words,	such	a	limitation	was	aiming	at	securing	
time	and	resources	for	communicative	action	and	reaching	mutual	understanding,	given	
that	 medical	 consultations	 are	 central	 to	 health	 care	 and	 primary	 care	 in	 particular	
(Butalid	2014,	p.9).	From	the	perspective	of	the	system/lifeworld,	this	can	be	argued	as	
somewhat	paradoxical,	since	it	means	that	the	system	is	diverging	itself	to	the	lifeworld,	
by	 attempting	 to	 enable	 sufficient	 time	 for	 communicative	 rationality,	 as	 opposed	 to	
confining	itself	to	efficiency	and	objective	measurements	of	the	outputs;	in	other	words	
stimulating	more	services	for	less	time	and	resources.		
As	described	at	the	beginning	of	this	section,	 the	previous	dominant	model	 in	socialist	
transition	countries	was	the	salary-based	one	(Mandel	1986).	Thus,	primary	care	reform	
was	a	major	change	in	the	health	systems	of	transition	countries,	which	have	previously	
focused	 their	 resource	 allocation	 and	 system	 development	 at	 the	 hospital	 level	 and	
secondary	 and	 tertiary	 care	 provision	 (Leive	 2010).	 Further	 to	 the	 change	 of	
reimbursement	model,	 some	countries	have	also	employed	more	 radical	measures	 for	
improving	efficiency	and	effectiveness	of	resource	use,	through	privatisation	of	primary	
care	 (Hebrang	 2003;	 Menon	 2006;	 Albrecht	 and	 Klazinga	 2009),	 mirroring	 the	
experience	 of	 some	 developed	 countries	 (Pollock	 2004;	 Anell	 2011).	 The	 following	
subsection	reviews	the	relevant	literature	on	privatisation	of	primary	care.	
	
82	
3.9.3	Privatisation	of	primary	care	in	transition	countries	
Following	the	principles	of	the	Alma	Ata	Declaration	(Alma	Ata	1978)	where	an	emphasis	
is	 put	 on	 prevention	 and	 basic	 care	 as	 an	 affordable	 and	much	 needed	 approach	 for	
developing	countries,	as	explained	earlier,	the	transition	economies	have	embraced	the	
idea	 of	 having	 a	 stronger	 role	 of	 primary	 healthcare.	 This,	 in	 conjunction	 with	 the	
already	 notorious	 perception	 of	 unresponsiveness	 and	 demotivated	 providers	 in	 the	
public	domain	that	deliver	poor	quality	of	care	(Lewis	et	al	2004),	led	to	privatisation	of	
primary	 healthcare	 in	 many	 transition	 countries.	 Alongside	 democratization	 and	
decentralisation,	it	was	considered	one	of	the	main	outcomes	of	the	overall	societal	and	
economic	 reform	 (Baillie	 et	 al	 1998).	 The	 expectations	 were	 a	 better	 line	 of	
responsibility	 and	 coordination,	 more	 effective	 use	 of	 resources	 and	 stronger	
accountability	 for	public	 spending	on	health	 (Golinowska	2007;	Wagstaff	and	Moreno-
Serra	 2009).	 As	 a	 result,	 many	 of	 the	 transition	 countries,	 gaining	 confidence	 from	
privatisation	in	the	other	economic	and	production	sectors	(Trupiano	1993;	Tirole	1991),	
have	embarked	on	the	process	of	privatisation	of	primary	care.	The	model,	with	various	
differences,	generally	consists	of	transfer	of	primary	care	providers	to	the	private	sector,	
while	 retaining	 their	 function	 of	 providing	 services	 for	 public	 funding,	 through	
contracting	either	with	the	local	and	regional	self-government	or	with	mandatory	health	
insurance	 institutions	 (Golinowska	 2007).	 This	 reform	 applied	 to	 all	 physicians,	
pharmacists	and	dentists	at	primary	care	level	(Kornai	and	Eggleston	2001).	The	model	
envisaged	establishment	of	their	own	practices	by	doctors	through	self-employment	or	
working	as	a	group	of	practices	of	several	physicians	(Croatia,	Macedonia).	Pharmacists	
opened	 private	 pharmacies	 that	 could	 operate	 freely	 on	 the	 market,	 but	 were	
contracted	by	 the	 respective	 insurance	 institutions	 for	 the	share	of	medicines	covered	
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by	the	mandatory	health	insurance	scheme	in	the	country.	By	2005,	the	transformation	
and	transfer	of	primary	care	to	the	private	sector	was	completed	or	near	completion	in	
most	countries;	Slovakia	reported	94%	of	primary	healthcare	‘privatized’	(Hlavacka	et	al	
2004;	 Szalay	 et	 al	 2011),	 the	 Czech	 Republic	 95%	 (Rokosova	 et	 al	 2005),	 and	 Poland,	
Hungary	 and	 the	 Baltic	 States	 around	 80%	 (Golinowska	 2007).	 In	 Croatia,	 the	 process	
began	 in	 1997	 when	 half	 of	 primary	 care	 was	 privatised	 and	 was	 completed	 several	
years	later	(Hebrang	et	al	2003).	With	a	slight	delay	to	the	above,	Macedonia	embarked	
on	the	process	in	2005,	and	by	2009	had	completed	the	privatisation	of	95%,	with	2010	
being	 the	year	of	 complete	 transfer	of	primary	 care	 into	private	ownership	 (Milevska-
Kostova	et	al	2017,	p.24).	In	some	countries,	like	Russia,	however,	privatisation	was	not	
considered	an	option	for	transformation	of	primary	care	(Sheiman	1991).		
To	what	 extent	 this	 transformation	 of	 primary	 care	 has	 achieved	 the	 desired	 goals	 of	
strengthening	its	gatekeeper	role	and	improving	efficiency	of	resource	use	has	been	the	
subject	 of	 a	 number	 of	 studies	 (e.g.	 Kornai	 and	 Eggleston	 2001;	 Hebrang	 et	 al	 2003;	
Golinowska	 2007).	 Existing	 literature	 points	 to,	 for	 example,	 increased	 levels	 of	
fragmentation	of	services	following	the	reform	(e.g.	Chernichovsky	and	Potapchik	1997)	
and	 changes	 in	 the	 number	 of	 referrals	 to	 higher	 levels	 of	 care	 (Leive	 2010).	
Responsiveness	and	adaptability	of	physicians	to	the	new	conditions	was	also	assessed	
(Hebrang	 et	 al	 2003),	 showing	 improved	 accountability	 and	 competition	 for	 ensuring	
improved	quality	of	care	(Leive	2010).	
However,	 a	 common	 theme	 concluded	 by	 all	 the	 studies	 reviewed	 is	 the	 apparent	
change	 of	 behaviour	 in	 one	 way	 or	 another,	 of	 both	 providers	 and	 patients.	 For	
example,	physicians	were	 triggered	by	 these	 reforms	 to	 further	 specialise	 (Golinowska	
2007),	or	provide	a	wider	range	of	services,	including,	for	example	some	minor	surgeries	
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and	telephone	counselling	after	working	hours	(Kornai	and	Eggleston	2001;	Hebrang	et	
al	2003).	On	the	other	hand,	findings	also	show	that	in	many	cases,	patients	continued	
to	visit	primary	care	physician	dominantly	for	obtaining	referral	to	higher	levels	of	care,	
bringing	into	question	the	actual	implementation	of	the	reform	with	regards	to	primary	
care’s	 gatekeeping	 role	 (Golinowska	 2007).	 In	 addition,	 these	 and	 other	 literature	
sources	(WHO	2009;	Kaae	et	al	2016)	note	the	lack	of	qualitative	research	in	this	area,	in	
particular	 pertaining	 to	 the	 changes	 in	 beliefs,	 attitudes	 and	 practices	 as	 a	 result	 of	
primary	care	 reform.	Furthermore,	no	studies	were	 identified	which	specifically	assess	
prescribing	and	dispensing	in	transition	countries	using	qualitative	methodology,	despite	
the	 wide	 behavioural	 research	 literature	 available	 for	 developed	 countries.	 The	 next	
section	provides	an	overview	of	prescribing	and	dispensing	in	transition	economies,	with	
the	 intention	 of	 explaining	 the	 social,	 economic	 and	 cultural	 contexts	 in	 which	 the	
research	questions	are	based.	
3.9.4	Prescribing	and	dispensing	in	primary	care	in	transition	countries:	
system	and	lifeworld	perspective	
The	 overall	 health	 reform	 and	 primary	 care	 transformation	 also	 affected	 medicine	
supply.	 Before	 the	 reform	 period,	 most	 transition	 countries	 had	 expanded	 limit-free	
pharmaceutical	 policies,	 without	 any	 limitations	 on	 prescribing	 or	 dispensing,	 which	
were	 available	 free	 of	 charge	 to	 all	 patients.	 The	 pharmaceutical	 list	 was	 one	 of	 a	
utopian	 health	 system,	 where	 everything,	 including	 vitamins	 and	 supplements,	 was	
prescribed	and	dispensed	free	of	charge	at	the	point	of	delivery,	within	the	possibilities	
of	the	rather	confined	reality	of	command	economies	(Joncheere	and	Paal	2002).	
Health	reform	also	changed	the	services	provision	landscape,	including	medicine	supply	
through	privatisation	of	domestic	and	penetration	of	foreign	pharmaceutical	production	
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and	 distribution	 companies.	 Countries	 liberalised	 markets	 for	 provision	 of	 services,	
including	 medicines	 (Nordyke	 and	 Peabody	 2002),	 as	 a	 complementary	 reform	 to	
privatisation	(Goodhue	et	al	1998).	The	liberalisation	was	quickly	embraced	by	both	the	
public	 and	 private	 sectors;	 for	 the	 former	 it	 was	 seen	 as	 a	 possibility	 to	 encourage	
competition	and	 lower	prices	while	expanding	medicines	availability	 for	 the	benefit	of	
the	citizens.	The	 latter	saw	 it	as	an	opportunity	 for	expanding	markets	and	generating	
welfare	 (Granville	and	Leonard	2003).	 In	 its	own	right,	 this	enabled	competition	 in	 the	
supply	side,	bringing	indeed	wider	availability	of	medicines,	which	consequently	affected	
the	demand	side	in	which	the	consumers,	i.e.	patients	became	empowered	to	recognize	
the	variations	in	the	scope	and	quality	of	services	and	medicines	provided	(Hebrang	et	al	
2003).	 The	 changes	 had	 drawbacks	 too;	 a	 study	 on	 access	 to	 medicines	 in	 Russia	 by	
Perlman	 and	Balabanova	 (2011)	 showed	 that	 between	 the	 early	 1990s	 and	 2000s	 the	
availability	of	prescription	medicines	in	pharmacies	improved,	but	at	the	same	time	the	
percentage	 of	 patients	 unable	 to	 obtain	 prescriptions	 rose	 sharply.	 Similar	 situations	
were	 reported	 in	 Armenia,	 Moldova,	 Ukraine	 and	 Kyrgyzstan	 (Falkingam	 et	 al	 2010;	
Jakab	 and	 Kutzin	 2009;	 Balabanova	 et	 al	 2012)	 where	 still	 in	 2010	 over	 half	 of	 the	
respondents	reported	lack	of	access	to	medicines	(Footman	et	al	2014).	
Returning	 to	 the	 issue	 of	 interest,	 models	 in	 which	 the	 transition	 economies	 have	
regulated	 the	 pharmaceutical	market	 did	 not	 differ	much	 from	 the	models	 explained	
earlier	 in	this	thesis;	countries	 introduced	both	supply	side	and	demand	side	measures	
adapted	 to	 the	 given	 health	 system.	 Without	 reiterating	 the	 details	 of	 the	
pharmaceutical	market	regulation	explained	earlier	 in	this	chapter,	 I	will	briefly	explain	
the	demand	side	measures	introduced,	as	these	are	of	particular	interest	to	the	research	
questions.		
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Regulation	of	the	pharmaceutical	market	did	not	necessarily	come	with	the	expertise	of	
the	public	sector	to	deal	with	the	new	public-private	 interaction.	 In	the	first	years,	the	
public	 sector,	 still	 under	 the	 old	 paradigm	 of	 health	 being	 ‘the	 most	 valuable	 public	
good’	that	needs	to	be	undisputedly	funded,	was	producing	policies	that	were	not	too	
successful	in	pharmaceutical	cost	containment.	Just	as	an	illustration,	in	the	late	1990s,	
the	 transition	 economies	 still	 spent	 between	 16-26%	 of	 health	 expenditures	 on	
medicines,	whereas	 in	the	EU	countries	this	share	was	between	7-11%	(Joncheere	and	
Paal	 2002).	 A	 further	 difficulty	 was	 posed	 by	 the	 necessity	 for	mind	 shift	 in	 terms	 of	
explaining	 to	voters	 that	 the	new	 ‘better’	 society	would	actually	provide	 ‘less’	of	what	
was	 available	 before.	 Thus,	 with	 predominantly	 political	 motivation,	 as	 well	 as	 to	
maintain	 social	 stability	 (Markota	 et	 al	 1999),	 governments	 considered	 introducing	
incremental	changes	in	cost	containment	policies.		
At	first,	 in	transition	countries	adopting	the	capitation	model	(e.g.	Croatia,	Macedonia)	
there	 was	 a	 limitation	 on	 the	 number	 of	 prescriptions	 (and	 referrals)	 that	 primary	
healthcare	 physicians	 could	 prescribe	 for	 their	 pool	 of	 registered	 patients.	 This	 policy	
intervention	 intended	 to	 ‘train’	 physicians	 to	 plan	 and	 rationalize	 their	 decisions	 for	
prescribing	 (Hebrang	et	 al	 2003).	At	 the	 same	 time,	 a	 health	 insurance-covered	 list	 of	
medicines	was	introduced,	as	another	measure	to	confine	the	previously	soaring	use	of	
medicines	and	high	pharmaceutical	spending	(Joncheere	and	Paal	2002).	In	parallel	with	
these	 policy	 interventions,	many	 transition	 countries	 have	 introduced	 evidence-based	
clinical	 guidelines	 for	 the	 recommended	 pathways	 of	 treatment,	most	 of	 them	 taking	
and	adapting	the	procedures	from	developed	countries,	mainly	the	UK	(Kanavos	1999).	
At	 this	 point,	 the	 policies	 still	 did	 not	 have	 a	 sufficient	 effect,	 keeping	 costs	 high	 and	
quality	 of	 care	 at	 ‘there	 is	 room	 for	 improvement’	 levels.	 Further	 policy	 changes	were	
87	
considered,	 and	 countries	 introduced	 fixed	 prescribing	 budgets	 in	 primary	 care	 (e.g.	
Croatia,	Macedonia)	or	 substitution	of	brand-name	with	generic	medicines	 (e.g.	Czech	
Republic,	 Romania,	 Slovakia).	 In	 addition,	 patients’	 co-payments	 for	 prescription	
medicines	with	 varying	 rates	 between	 10	 and	 50%	were	 introduced	 as	 a	measure	 for	
preventing	 overprescribing	 and	 overdispensing	 (e.g.	 Croatia,	 Czech	 Republic,	
Macedonia).	The	applied	combination	of	changes	depended	on	many	factors	(Hlavacka	
et	al	2004;	Rokosova	et	al	2005;	Golinowska	2007;	Gjorgjev	et	al	2006),	mainly	driven	by	
overall	 higher	 levels	 of	 prescribing	 compared	 to	 western	 countries.	 At	 this	 point,	
countries	also	introduced	reference	pricing	and	related	policies,	but	as	those	are	supply	
side	mechanisms,	for	clarity	of	the	text	these	are	not	elaborated	further	in	this	thesis.	
Yet,	 in	 some	 countries	 (e.g.	 Slovakia)	 even	 after	 pharmaceutical	 reform,	 the	 share	 of	
medicines	 remained	 as	 high	 as	 28%	 (in	 2008)	 of	 the	 total	 health	 expenditures	
(Golinowska	 2007).	 In	Macedonia,	 too,	 as	 already	 elaborated	 in	 the	 previous	 chapter,	
the	 number	 of	 prescriptions	 and	 pharmaceutical	 expenditure	 show	 a	 steady	 increase	
over	the	years,	despite	the	introduced	policy	changes.		
With	 the	 above	 in	 mind,	 it	 can	 be	 argued	 that	 other	 factors	 –	 stemming	 from	 and	
related	to	the	lifeworld	and	its	interactions	with	the	system	–	are	influencing	prescribing	
and	 dispensing	 levels.	 This	 is	 confirmed	 in	 the	 literature	 from	 the	 aspects	 already	
discussed	above.	However,	although	some	findings	might	be	universal	to	the	physician-
patient	relationship,	their	communication	and	outcomes	of	their	communicative	action,	
still	 their	 specific	 effects	 within	 the	 context	 of	 transition	 countries	 requires	 further	
attention.		
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3.10. Research	questions	
	
As	 shown	 throughout	 the	 literature	 review,	 there	 is	 a	 lack	 of	 qualitative	 research	 on	
prescribing	and	dispensing	in	transition	countries,	which	might	provide	insights	into	the	
possible	reasons	for	increasing	levels	of	medicine	use	despite	measures	to	contain	such	
trends.		
The	research	presented	in	this	thesis	is	concerned	with	two	major	issues:		
- What	 impact	do	policy	 changes	 for	 regulating	prescribing	and	dispensing	have	
on:	(1)	the	prescribing	practices	 in	primary	care	settings	and	(2)	the	dispensing	
practices	in	pharmacies? 
- What	 are	 the	 experiences,	 attitudes	 and	 opinions	 of	 patients,	 primary	 care	
physicians,	 pharmacists	 and	 other	 stakeholders	 (policy/decision	 makers,	
professional	 associations/chambers,	 academia)	 regarding	 the	 policy	 changes,	
relevant	to	their	practice	and	behaviour	in	the	new	circumstances?	
In	exploring	these	two	questions,	further	secondary	questions	also	arose,	concerning:	
a. What	are	the	issues	of	concern	with	the	policy	changes?	
b. What	are	the	benefits	and	barriers	arising	from	the	policy	changes?	
c. Are	 there	ethical	 issues	arising	 from	the	policy	changes	or	 from	efforts	
to	overcome	barriers?	
	
	
3.11. Summary	of	chapter		
	
The	 aim	 of	 this	 chapter	 was	 to	 review	 the	 available	 literature	 and	 identify	 gaps	 in	
knowledge	 leading	 to	 development	 of	 research	 questions	 on	 the	 impact	 of	 policy	
changes	 on	 attitudes	 and	 practices	 of	 prescribing	 and	 dispensing.	 In	 addition,	 its	
intention	was	to	provide	an	overview	of	the	research	context	by	summarising	the	past	
and	ongoing	changes	to	primary	health	care	organisation	in	transition	countries,	so	as	to	
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inform	 the	 reader	 of	 the	 societal	 context	 in	 which	 prescribing	 and	 dispensing	 of	
medicines	is	being	considered	and	studied	in	this	thesis.	
The	 literature	 review	 showed	 that	 prescribing	 and	 dispensing	 are	 not	 solely	 based	 on	
clinical	 indication	and	medical	knowledge.	Other	 factors	also	 influence	prescribing	and	
dispensing	 –	 such	 as	 regulatory	 factors	 (related	 to	 the	 system)	 and	 societal	 factors	
(related	 to	 patients	 and	 the	 lifeworld).	 Literature	 suggested	 that	 individual	 attitudes,	
beliefs	and	behaviour	have	significant	 impact	on	prescribing	and	dispensing.	Physicians	
have	 a	 dual	 role	 to	 play,	 representing	 the	 system	 in	 the	 physician-patient	 interaction,	
and	at	the	same	time	being	a	conduit	between	the	patient’s	lifeworld	and	system	world.	
The	 literature	additionally	highlights	the	fact	that	context-specific	circumstances	play	a	
key	 role	 in	 physician-patient	 interactions,	 prescribing	 behaviour	 and	 prescribing	 and	
dispensing	 outcomes.	 These	 findings	 have	 been	 confirmed	 across	 different	 contexts;	
however	the	 literature	on	transition	countries	 is	 rather	scarce.	Therefore,	 this	 thesis	 is	
aimed	at	reducing	these	gaps	in	knowledge.		
This	chapter	also	provided	an	overview	of	transition	countries’	intensive	health	reforms,	
where	pharmaceutical	expenditure	control	was	significantly	considered	in	an	attempt	to	
increase	efficiency	and	effectiveness	of	health	systems,	and	primary	care	 in	particular.	
(Nordyke	 and	 Peabody	 2002,	 Cernis-Istenic	 1998).	 Some	 countries	 have	 seen	 great	
improvements	 in	efficiency	 (Franco	et	al	2004),	while	others	have	not	been	subject	 to	
research	to	evaluate	the	economic	and	social	benefits	of	the	reforms.		
Despite	the	large	interest	 in	analysing	the	impact	of	health	policies	and	health	reforms	
in	 transition	 economies	 (Leive	 2010),	 a	 very	 small	 body	 of	 evidence	 exists	 from	 these	
countries	in	terms	of	qualitative	health	research.	The	WHO	review	of	medicines’	use	in	
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primary	care	in	developing	and	transitional	countries	noted	that	in	addition	to	the	small	
number	of	studies,	 the	research	topics	and	approaches	were	rather	fragmented	(WHO	
2009).	 The	 same	 review	 emphasised	 that	 many	 topics	 remain	 virtually	 unexplored,	
especially	using	qualitative	approaches.	
The	status	of	empirical	research	has	also	been	considered,	as	an	insight	into	the	current	
body	of	knowledge	on	the	researched	topic.	While	extensive	qualitative	 literature	was	
found	 relating	 to	 prescribing	 in	 general,	 very	 few	 studies	 have	 been	 identified	 on	
transition	economies	(e.g.	Petrusevska	et	al	2015;	Vucemilo	et	al	2013).	Of	the	available	
studies,	 some	 are	 concerned	with	 the	 attitudes	 and	 perceptions	 of	 particular	 groups,	
such	as	physicians	(Petrusevska	et	al	2015)	or	of	patients	and	their	carers	(Ilievska	2010).	
A	 significant	 gap	 in	 the	 literature	was	 identified	 regarding	 the	 perceptions,	 views	 and	
experiences	related	to	prescribing	or	dispensing	in	these	countries.	Furthermore,	a	gap	
was	also	 identified	 in	 terms	of	 theoretical	explanations;	neither	Habermas’	 theory	nor	
any	other	theories	of	behaviour	change	were	used	as	theoretical	underpinnings	in	any	of	
the	 identified	 empirical	 studies.	 Drawing	 in	 particular	 on	 Britten’s	 (2008)	 use	 of	
Habermas’	system	and	lifeworld	in	the	context	of	medicines	in	society	more	generally,	it	
is	 proposed	 to	 study	 Macedonian	 policy	 changes	 and	 regulation	 of	 prescribing	 and	
dispensing	in	primary	care	using	such	a	social	theory.	As	will	be	considered	in	the	next	
chapter,	 theory	 did	 not	 explicitly	 inform	 the	 analysis,	 as	 an	 inductive	 approach	 was	
sought,	but	the	discussion	chapter	will	seek	to	locate	the	findings	of	this	study	not	only	
in	the	extant	empirical	literature	described	in	this	chapter,	but	also	Habermas’	concepts	
of	system	and	lifeworld.		
From	a	research	point	of	view,	it	is	intriguing	to	explore	the	effects	of	policy	changes	in	
transition	 economies	 on	 the	 views	 and	 experiences	 of	 different	 actors	 involved	 in	
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prescribing	and	dispensing,	and	if,	why	and	how	these,	in	turn	have	affected	prescribing	
and	 dispensing	 practices	 in	 Macedonia,	 as	 a	 case	 study.	 Given	 the	 similarities	 of	
transition	societies	elaborated	earlier,	hopefully	 this	 research	would	also	contribute	to	
understanding	of	prescribing	and	dispensing	in	the	context	of	other	similar	countries.		
The	next	chapter,	Methodology,	elaborates	on	the	available	methods,	their	advantages	
and	 disadvantages,	 and	 justifies	 the	 choice	 of	 the	most	 appropriate	methods	 for	 this	
research,	alongside	instruments	used,	sampling	and	other	methodological	issues.	
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CHAPTER	4:	Methodology	
	
4.1. Introduction	
The	 aim	 of	 this	 chapter	 is	 to	 present	 and	 describe	 the	 research	 strategy	 and	 specific	
methods	 chosen	 to	 answer	 the	 questions	 that	 have	 emerged	 from	 the	 previous	
chapters,	 namely:	 what	 are	 the	 effects	 of	 prescription	 policy	 changes	 in	 primary	
healthcare	 on	 firstly,	 prescribing	 and	 dispensing	 practices	 and,	 secondly,	 the	 involved	
stakeholders’	 perceptions	 and	 attitudes	 towards	 changes	 in	 the	 prescribing	 and	
dispensing	policies.	As	will	be	elaborated	later	in	this	chapter,	in	this	thesis,	the	involved	
stakeholders	that	were	invited	to	share	their	opinions	and	attitudes	were	primary	care	
physicians	 and	 pharmacists,	 patients,	 and	 elites,	 including	 policy	 makers,	
representatives	of	professional	associations	and	academia.		
In	addition,	this	chapter	will	describe	in	detail	the	data	collection	methods	and	consider	
specific	 issues	 relating	 to	 sampling,	 data	 collection	 and	 analysis,	 as	 well	 as	 concerns	
relating	to	research	ethics,	and	practical	and	logistical	issues	of	conducting	the	research.	
A	reflexive	approach	to	the	research	 is	presented,	demonstrating	also	an	on-going	and	
active	understanding	of	my	role	in	the	research	process.	
The	next	sections	will	provide	the	rationale	for	the	appropriateness	of	the	methodology	
and	 methods	 chosen	 for	 this	 research.	 Further,	 a	 description	 of	 the	 actual	 research,	
including	 the	 above	 mentioned	 stages,	 as	 a	 common	 requirement	 of	 the	 scientific	
research	methodology	(Silverman	2005,	Seale	1999).	
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4.2. Choice	of	qualitative	methodology		
As	 summarised	 in	 previous	 chapters,	 the	 relevant	 healthcare	 reforms	 and	 the	 effects	
these	reforms	have	had	on	the	Macedonian	health	system	have	been	mainly	explored	
using	quantitative	research.	These	have	been	typified	by	the	use	of	dependent	variables	
such	 as	 the	 number	 of	 outpatient	 visits,	 or	 the	 volume	 of	 prescribed	 and	 dispensed	
medicines.	 These	 represent	 indicators	 of	 success	 as	 the	 most	 appropriate	 units	 of	
comparison	 and	 are	 arguably	 appropriate	 for	 a	 hypothetico-deductive	 epistemological	
perspective	on	policy	change	and	its	impact.	This	is	not	unexpected	and	it	is	recognised	
that	common	research	approaches	for	assessing	health	reforms	and	their	impact	utilise	
numerical	 and	measurable	 data,	 relating	 to	 resources	 (inputs)	 (Fox-Rushby	 and	Cairns	
2005,	 p.67),	 process	 and	 outputs	 (Olsen	 2009,	 p.	 18).	 Similarly,	 the	 policies	 are	 often	
changed	based	on	evidence	that	provides	causal	relationship	between	the	policy	change	
and	the	effects	of	that	change	(Dunn	2004,	p.34).	Such	approaches	are	predicated	on	a	
positivistic	 epistemology,	 privileging	 scientific	 knowledge	 about	 the	 social	world	 to	 be	
amenable	 to	 causal	 inference.	 The	 research	 questions	 argued	 to	 be	 relevant	 to	 this	
study	 seek	 to	 explore	 policy	 change	 from	 a	 very	 different	 perspective	 and	 value	 the	
subjective	 meaning	 attributed	 to	 such	 changes	 and	 their	 impact.	 Furthermore,	 they	
encourage	the	exploration	of	the	depth	and	potential	variety	of	experience	and	as	such,	
it	is	argued	that	qualitative	methodologies	are	appropriate.	
In	addition,	as	elaborated	 in	 the	previous	 chapter,	 the	prescribing	and	dispensing	acts	
are	complex	endeavours	of	system	and	lifeworld,	largely	influenced	by	the	interpersonal	
interaction	 between	 physician	 and	 patient.	 In	 this	 sense,	 research	 dealing	 with	 the	
underlying	causality	of	prescribing	and	dispensing	should	not	be	strictly	confined	to	the	
formal	properties	of	the	process,	such	as	examining	the	statistical	or	quantitative	data	to	
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identify	the	impact	of	policy	changes	on	the	outcomes.	This	may	neglect	the	more	subtle	
elements	of	 the	dynamics	of	 these	processes,	 including	an	understanding	of	 the	micro	
level	interactions	and	decision-making	taking	place	on	an	individual	level	that	inevitably	
influence	outcomes	on	the	macro	level.	
Qualitative	 research	methodologies	 vary	 but	 are	 broadly	 associated	 with	 attempts	 to	
gain	subjective	and	highly	situated	emic	(as	opposed	to	objective	etic)	accounts	of	social	
phenomena.	 In	 the	 context	 of	 these	 research	 questions,	 it	 is	 argued	 that	 such	
methodologies	 will	 value	 the	 subjective	 and	 variable	 nature	 of	 the	 impact	 of	 policy	
change	 for	 a	 range	 of	 stakeholders	 and,	 as	 will	 be	 shown,	 through	 specific	 methods	
associated	 with	 a	 qualitative	 methodology,	 permit	 the	 solicitation	 of	 rich,	 in-depth	
individual	accounts.	
	4.2.1	Epistemological	position	
In	this	research,	as	will	be	shown	in	later	sections,	different	methodological	approaches	
were	 considered.	 For	 addressing	 the	 research	 questions	 posed	 in	 this	 thesis,	 I	
considered	 the	 use	 of	 both	 quantitative	 and	 qualitative	 methodology.	 After	 doing	
thorough	reading	on	methodologies,	 I	 reasoned	that	quantitative	methodologies	could	
provide	 responses	 to	 questions	 involving	 association	 of	 policy	 changes	 with	 policy	
outcomes	 in	 terms	 of	 levels	 of	 prescribing	 and	 dispensing	 –	 which	 I	 covered	 as	
descriptive	analysis	in	chapter	two.	However,	I	further	considered	that	the	responses	to	
questions	 such	 as	 ‘what	 happened’	 would	 be	 beneficial	 in	 knowing	 the	 outcomes	 of	
policy	 changes	 and	 to	 assess	 if	 those	 outcomes	 are	 desirable	 or	 sufficient.	 But,	 those	
responses	 would	 not	 be	 sufficient	 to	 understand	 more	 in-depth	 ‘how’	 and	 ‘why’	 the	
policy	changes	arrived	at	 such	outcomes.	Further	methodological	 readings	 revealed	 to	
me	 that	 qualitative	 methods	 are	 more	 suited	 to	 responding	 to	 my	 chosen	 research	
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questions,	 which	 are	 substantially	 grounded	 in	 the	 social	 world	 and	 its	 interactions.	
Therefore,	 choosing	 qualitative	 methodology	 was	 considered	 valuable	 from	 the	
perspective	 of	 richness	 of	 data	 that	 it	 could	 provide,	 while	 bearing	 in	 mind	 that	 the	
accounts	 themselves	 do	 not	 necessarily	 represent	 ‘the	 truth’	 but	 rather	 the	 ‘subtle	
realism’	 of	 the	 respondents	 through	 their	 views,	 opinions,	 experience	 and	 attitudes.	
While	these	should	be	regarded	as	respondents’	interpretations	of	the	reality,	they	are	
also	my	interpretations	as	a	researcher,	of	what	their	views,	experiences	and	attitudes	
are.	
Thus,	I	further	reasoned	which	epistemological	approach	to	take.	Based	on	reading	and	
my	 further	 understanding	 of	 the	 research	 methodologies,	 I	 rejected	 the	 positivist	
approach	as	not	appropriate,	given	that	this	approach	is	grounded	on	the	postulates	of	
objectivity,	 which	 in	 qualitative	 research,	 as	 discussed	 in	 following	 paragraphs	 is	 not	
possible	to	achieve.	
The	epistemological	 foundation	of	 the	research	 is	based	on	assumptions	 that	 the	data	
collected	 are	 subject	 to	 various	 possible	 interpretations	 and	 these	 are	 dependent	 on	
myself	as	the	researcher.	Acknowledging	that	we	bring	to	research	ourselves	complete	
with	what	we	know	or	 think	highlights	 the	 impossibility	of	 separating	myself	 from	 the	
research.	 I	 inevitably,	 through	my	background	as	pharmacist	and	 role	of	 researcher	of	
health	policies	 and	health	 reform	 in	Macedonia	 in	 the	past	 fifteen	 years	 (described	 in	
more	detail	in	Chapter	One,	section	1.3	on	page	20),	brought	pre-understandings	to	the	
research	 process,	 as	my	 thoughts	 and	 ideas	were	 not	 something	 I	 considered	 I	 could	
abstract	 from,	 or	 according	 to	 Husserlian	 phenomenology,	 ‘bracket’	 (Gearing,	 2004).	
Freshwater	and	Avis	 (2004)	also	disputed	 the	concept	of	 findings	 just	 ‘emerging’	 from	
qualitative	 research.	 In	 a	 much	 earlier	 work,	 Gadamer	 (1976)	 considered	 pre-
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understandings	as	prejudices,	justifying	their	existence	and	arguing	that	they	should	not	
be	eliminated,	but	rather	properly	acknowledged	in	the	process	(Gadamer	1976,	p.9).		
In	other	words,	pre-understandings	are	not	necessarily	misperceptions	or	distortions	of	
truth	but	should	be	understood	and	accepted	as	conditions	by	which	we	encounter	the	
world	 as	 we	 experience	 something.	 We	 bring	 these	 pre-understandings	 into	 the	
research	 process	 and	 they	 influence	 how	we	 understand	 things	 or	 phenomena.	 Thus,	
pre-understandings	and	even	biases	are	something	we	cannot	simply	avoid	or	‘bracket’,	
which	is	reinforced	by	Finlay	(2003):	
“We	 should	 no	 longer	 work	 towards	 abolishing	 the	 presence	 of	 the	
researcher;	instead	subjectivity	in	research	is	transformed	from	a	problem	to	
an	opportunity”	(Finlay,	2003	p.5).		
	
It	is	therefore	understandable	that	the	epistemological	position	taken	in	this	research	is	
one	 where	 the	 research	 process	 is	 inextricably	 bound	 up	 in	 the	 researcher	 and	 that	
construction	 of	 knowledge	 occurs	 jointly	 with	 the	 participant	 (Freshwater	 and	 Avis	
2004).		
I	 also	 attempted	 to	 have	 a	 critical	 view	 of	 my	 professional	 background	 and	 previous	
knowledge	of	the	context,	alongside	that	of	the	respondents.	As	part	of	that	process,	 I	
attempted	to	reflect	on	my	role	in	the	interviews,	and	the	influence	my	own	experience	
had	 on	 the	 collected	 data.	 Inevitably,	 I	 had	 influence	 on	 the	 respondents,	 at	 least	 on	
those	 in	 the	elite	 stakeholders’	and	providers’	groups,	given	my	work	and	exposure	 in	
the	professional	community.	As	such,	and	upon	advice	from	the	supervisors,	I	decided	to	
use	the	method	of	keeping	a	reflexive	journal	(elaborated	in	details	under	section	4.3.6	
Reflecting	 on	 interviewing	 and	 data	 collection	 process)	 that	 helped	 me	 keep	 a	
continuous	reflection	process,	in	terms	of	both	my	feelings	and	experiences,	and	how	I	
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influenced	 the	 encounters	 in	 the	 interviews.	 As	 an	 important	 part	 of	 qualitative	
research,	 this	 process	 of	 reflexivity	 is	 elaborated	 in	 further	 detail	 under	 the	 section	
describing	the	data	collection	process,	later	in	this	chapter.	
Having	argued	that	a	qualitative	approach	would	be	most	appropriate	for	answering	the	
research	questions	posed,	in	the	next	section	I	elaborate	the	main	qualitative	methods	
available	for	doing	such	research,	the	choice	of	method	and	justification	for	such	choice.		
4.2.2	Rationale	for	choice	of	semi-structured	interview	method	
A	variety	of	qualitative	methods	are	available	(Silverman	2005;	Mason	2002),	 including	
observational	approaches,	focus	groups,	one-to-one	interviews	of	varying	types	and	also	
documentary	or	content	analysis.	In	this	section,	the	justification	for	the	use	of	a	single	
method	of	data	collection	–	semi-structured	one-to-one	interviews	–	will	be	presented.	
However,	in	order	to	demonstrate	a	transparent	and	reflexive	approach,	the	alternative	
methods	considered	are	described,	together	with	reasons	why	they	were	not	regarded	
as	appropriate	to	answer	the	research	questions.	
Focus	 group	 discussions	 were	 initially	 considered	 as	 a	 possible	 method	 as	 these	
represent	an	empirically	well-established	method	(Kitzinger	1995,	Morgan	1998;	Hedges	
1985)	and	have	been	used	 in	policy	 related	 research.	These	 involve	a	group	of	people	
being	asked	about	their	perceptions,	opinions,	beliefs	and	attitudes	towards	a	product,	
service,	 concept	 or	 idea	 (Henderson	 and	 Naomi	 2009).	 Focus	 groups	 are	 valuable	 for	
obtaining	data	 that	emerges	 from	group	discussions	and	debate,	 and	 this	 can	be	with	
similar	or	different	types	of	participants.	I	decided,	however,	that	focus	groups	were	not	
an	 appropriate	method	 for	 several	 reasons:	 firstly,	 the	 aim	was	 to	 consider	 individual	
experiences	in	depth	and	the	use	of	focus	groups	is	less	suited	to	this	than,	for	example,	
individual	 interviews;	 secondly,	 there	 was	 a	 concern	 that	 some	 participants	 such	 as	
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primary	care	providers	might	feel	unable	to	speak	openly	in	a	group	environment	about	
some	ethical	aspects	of	the	policy	changes	for	the	fear	of	repercussions;	finally	primary	
care	privatisation	imposed	competition	among	providers,	which	was	considered	another	
factor	that	could	influence	the	complete	honesty	and	openness	of	the	respondents.		
Also	considered	were	observational	methods,	which	represent	another	commonly	used	
approach	 in	 qualitative	 research	 (e.g.	 Smith	 1998b).	 Such	 methods	 involve	
systematically	 observing	 people	 and	 events	 to	 explore	 behaviours	 and	 interactions	 in	
natural	settings	(Mays	1995).	Related	to	this	study,	it	was	considered	whether	observing	
different	 participants	may	 be	 of	 value	 but	 as	with	 focus	 groups,	 this	was	 rejected	 for	
several	reasons.	The	choice	of	research	method	or	technique	may	vary	depending	upon	
the	nature	of	 the	 social	 phenomena	under	 investigation	and	upon	what	one	wants	 to	
understand	 about	 those	 phenomena	 (Cooper	 2006).	 Observational	 methods	 would	
arguably	 not	 provide	 insights	 into	 the	 second	 research	 question	 about	 the	 views	 and	
perceptions	 of	 stakeholders	 but	 could	 have	 offered	 insights	 into	 the	 first	 research	
question	concerning	the	impact	of	policy	change.	However,	a	key	concern	was	that	this	
research	 related	 to	 social	 phenomena	 relating	 to	 policy	 changes	 that	 occurred	 over	
some	time	and	as	such	observational	methods	would	not	be	able	to	capture	the	impact	
of	past	policy	 change	and	events.	A	 final	 concern	was	 that	 some	stakeholders	 such	as	
primary	 care	 providers	 for	 example,	 may	 have	 not	 given	 consent	 to	 have	 their	
professional	activities	observed;	as	will	become	apparent	 in	 the	 following	chapter,	 the	
identification	 of	 examples	 of	 un-professional	 practice	may	 have	 been	 easier	 to	 solicit	
from	interviews	as	retrospective	accounts,	than	to	have	directly	observed.		
	The	 chosen	method	of	 qualitative	data	 collection	 involved	 the	use	of	 semi-structured	
interviews.	 Interviews	 are	 considered	 a	 ‘conversation	with	 a	 purpose’	 (Erlandson	 et	 al	
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1993)	 allowing	 for	 reflection,	 introspection	 and	 in-depth	 discussion,	 and	 involving	
reasoning	 processes	 that	may	 not	 be	 apparent	 through	 observation	 (Bryman	 2008,	 p.	
329).	 Of	 the	 available	 approaches	 in	 interviewing,	 a	 semi-structured	 interview	 was	
chosen,	 as	 it	 allows	 both	 participant	 and	 researcher	 to	 influence	 the	 direction	 of	 the	
conversation,	whilst	permitting	the	former	the	opportunity	to	express	their	reasoning	in	
their	 own	 language	 and	 in	 a	 way	 that	 they	 find	 most	 appropriate.	 I	 considered	 this	
method	the	most	appropriate	since	it	would	allow	me	to	explore	the	research	questions	
in	depth,	encouraging	detailed	responses	and	also	enabling	me	to	probe	and	challenge	
responses	where	appropriate.	Further	 to	 that,	 this	method	allows	 for	 issues	and	 ideas	
arising	out	of	early	interviews	to	be	used	to	inform	subsequent	interviews.	By	adopting	
such	an	interpretative	approach,	interviews	would	also	allow	the	respondents	to	reflect	
upon	issues	or	to	raise	new	ones	themselves	that	they	encountered	in	their	practice,	but	
which	 I	 have	 not	 anticipated	 in	 the	 questionnaire	 guide,	 and	 so	 could	 be	 asked	 of	
subsequent	respondents.	The	use	of	unstructured	or	narrative	interviews	(Squire	2008)	
was	 also	 considered	 but	 given	 the	 aim	 of	 capturing	 accounts	 from	 a	 potentially	wide	
range	of	stakeholders,	it	was	felt	that	a	balance	was	needed	-	between	the	depth	of	data	
and	 the	 need	 to	 capture	 diverse	 accounts.	 The	 free	 association	 narrative	 interviews	
(Holloway	 and	 Jefferson	 2000),	 based	 on	 free	 associations	 made	 by	 the	 interviewee,	
were	 also	 considered	 but	 rejected	 for	 the	 same	 reasons.	 The	 next	 section	 provides	 a	
more	detailed	account	of	the	data	collection	and	in	particular	the	choice	and	methods	of	
recruiting	different	participant	stakeholders.	
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4.3. Data	collection	
4.3.1	Sampling	
After	 choosing	 semi-structured	 interviews	 as	 the	most	 suitable	method	 to	 inform	 the	
research	questions,	the	next	step	in	my	research	approach	was	to	identify	respondents	
for	each	of	the	groups	of	interest	as	described	above	and	begin	the	recruitment	process	
for	the	fieldwork.	The	aim	was	to	use	a	range	of	different	stakeholders	based	on	their	
relationship	 to	 the	 various	 policy	 changes:	 physicians	 (as	 prescribers	 of	 medicines),	
pharmacists	(as	suppliers	of	medicines),	patients	(as	consumers	and	users	of	medicines)	
and	various	elite	stakeholders	(selected	due	to	their	involvement	in	or	analysis	of	policy	
itself).	 Although	 sampling	 for	 these	 groups	 was	 ultimately	 the	 same	 and	 involved	
purposive	sampling,	the	identification	and	recruitment	process	varied.		
	
Elite	stakeholders	
This	participant	group	was	identified	based	on	the	literature	review	and	also	through	my	
experiences	and	networks.	As	a	researcher	in	the	health	sector	for	over	a	decade,	I	had	
attended	 different	meetings	 and	 events,	 and	 participated	 in	 a	 number	 of	 studies	 and	
research	 projects	 involving	 many	 professionals	 belonging	 to	 the	 groups	 of	 research	
interest.	 Through	 these	 endeavours,	 I	 had	 the	 chance	 to	 hear	 their	 elaborations	 and	
expertise	on	a	variety	of	 issues	related	to	health	and	the	health	system	in	the	country,	
which	 I	 considered	appropriate	 to	use	 for	 the	purposive	 sampling	approach	 that	 I	had	
chosen	to	apply.	Firstly,	 for	 sampling	within	 the	group	of	elites,	as	will	be	shown	 later	
on,	I	considered	those	involved	in	health	policy	formulation,	including	health	authorities,	
academia	and	professional	associations	and	chambers	to	be	particularly	relevant.	Given	
the	size	of	the	country,	all	of	these	institutions	are	represented	with	headquarters	in	the	
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capital,	and	some	(not	all)	have	executive	branches,	which	are	not	involved	in	the	policy	
planning	 or	 formulation	 happening	 at	 central	 level.	 Having	 identified	 these	 key	
associations	 or	 bodies,	 the	 next	 stage	 was	 to	 identify	 individuals	 or	 representatives.	
Although	I	personally	know	some	of	them,	I	used	formal	invitation	and	introduction	for	
all	recruited	participants	in	this	group.		
	
Physicians	and	Pharmacists	
In	 the	 initial	 stages,	 I	 considered	 a	 sampling	 strategy	 to	 identify	 the	 participants	 for	
these	 two	 professional	 subgroups,	 by	 using	 the	 list	 of	 registered	 physicians	 and	
pharmacies	 publicly	 available	 onn	 the	 Health	 Insurance	 Fund’s	 official	 website.	 There	
were	 a	 number	 of	 issues	 identified	with	 this	 approach;	 firstly,	 the	 list	 did	 not	 always	
contain	 the	 contact	 data	 for	 the	 registered	 entries,	 and	 secondly	 the	 lists	 comprised	
names	of	registered	offices,	in	which	one	or	more	physicians	or	pharmacists	worked.	In	
this	 context,	 given	 that	 qualitative	 research	 does	 not	 require	 for	 the	 sample	 to	 be	
random	or	quantitatively	representative	of	 the	population	because	 ‘representativeness	
is	not	a	prime	requirement	when	the	objective	 is	to	understand	social	processes’	 (Mays	
and	 Pope	 1995),	 I	 have	 undertaken	 a	 purposive	 sampling	 approach	 with	 these	 two	
groups,	using	relevant	categories	such	as	different	ages,	to	allow	different	generational	
perspectives	on	the	policy	changes;	administratively	and	geographically	different	places	
were	 also	 used	 to	 inform	 the	 sample,	 as	 I	 anticipated	 there	 might	 be	 differences	 in	
attitudes	 and	 practices	 between	 larger	 and	 smaller	 communities,	 i.e.	 between	 urban	
and	 rural	 areas.	 Reflexively,	 this	 approach	 to	 identifying	 and	 sampling	 also	 required	
consideration	particularly	with	regards	to	my	prior	knowledge	of	the	context	and	some	
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people	 from	both	 groups;	 however,	 I	 felt	 that	 the	benefits	 such	 insights	 offered	were	
ultimately	an	advantage	for	the	sampling.		
	
Patients	
For	the	final	participant	group	–	the	patients	–	I	undertook	a	slightly	different	purposive	
sampling	 approach,	 by	 selecting	 from	 the	 patients	 who	 visited	 the	 office	 of	 the	
interviewed	physician	or	pharmacist.	The	purposefulness	of	this	sampling	approach	can	
be	argued	in	the	sense	that	patients	who	visit	the	particular	physician	or	pharmacy	are	
more	 likely	 to	 have	 similar	 attitudes,	 as	 they	 are	 not	 assigned	 to	 the	 practice	 or	
pharmacy	by	 some	specific	 criteria,	other	 than	 the	choice	of	 the	patient.	A	concern	 in	
utilising	this	kind	of	sampling	was	seen	in	the	possibility	that	some	dimensions	of	their	
interaction	might	not	be	available	to	capture,	 for	example,	 radically	different	attitudes	
within	the	group.	However,	at	this	stage,	I	hoped	that	within	the	sampled	patients	there	
would	be	some	with	experience	of	changing	their	chosen	physician,	and	certainly	those	
that	obtain	medicines	in	different	pharmacies,	that	would	allow	for	exploring	this	aspect	
as	well.	A	purposive	 approach	was	used,	 however,	 in	 selecting	patients	based	also	on	
factors	such	as	different	gender,	age	and	geographical	 location.	This	 included,	as	much	
as	 applicable	 in	 the	 given	 circumstances,	 choosing	 patients	 from	 both	 genders	 and	
different	ages	across	all	visited	physicians’	offices	and	pharmacies.	Once	 I	had	decided	
on	the	sampling	strategy,	the	next	stage	involved	defining	the	sample	size.	
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4.3.2	Sample	size	
Sample	 size	 calculations	 are	 not	 very	 commonly	 used	 in	 qualitative	 research	
(Sandelowski	1995)	and	it	can	often	be	difficult	to	predict	how	many	interviews	will	be	
undertaken.	 Theoretical	 saturation	 was	 used	 as	 a	 criterion	 to	 define	 the	 sample	 size	
which	was	understood	as	being	when:	“no	additional	data	being	found	whereby	[the…]	
researcher	 becomes	 empirically	 confident	 that	 a	 category	 is	 saturated”	 (Glaser	 and	
Straus	1967).	Although	 this	criterion	has	originally	been	developed	and	used	 in	 theory	
development	(Glaser	and	Straus	1967),	it	has	become	an	important	approach	by	which	
purposive	sample	sizes	are	determined	in	health	science	research	(Guest	et	al	2006).	So,	
although	a	definitive	sample	size	was	not	possible	 to	calculate	 initially,	 to	manage	 the	
logistical	 aspects	 of	 the	 research,	 approximately	 fifteen	 participants	 in	 each	 of	 the	
respondent	groups	were	anticipated.	The	actual	samples	have	shown	that	the	estimated	
number	 of	 interviews,	 with	 the	 exception	 of	 the	 physicians’	 group,	 was	 sufficient	 to	
achieve	data	saturation	for	detailed	analysis,	as	the	literature	suggests	that	up	to	twelve	
interviews	 are	 usually	 sufficient	 if	 the	 aim	 is	 to	 understand	 common	 perceptions	 and	
experiences	among	a	group	of	relatively	homogeneous	individuals	(Guest	et	al	2006).		
The	final	sample	and	associated	characteristics	of	the	participants	in	each	of	the	groups	
are	presented	in	Tables	6-10	below.	
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Table	6.	Sampling	rationale	for	interviewees	–	Elite	stakeholders	
	 N=12	
Representative	area	 Rationale	for	inclusion	
Ministry	of	Health	
(2	participants)	
To	 learn	 about	 how	 the	 policies	 regulating	 prescription	 and	
dispensing	 have	 been	 designed,	 envisaged	 to	 be	 implemented	
and	are	implemented;	
Health	Insurance	Fund	
(3	participants)	
To	 learn	 how	 Health	 Insurance	 Fund	 has	 transferred	 these	
policies	 into	 their	 practice	 and	 what	 are	 the	 implications	 from	
these	policy	changes	on	the	overall	pharmaceuticals	prescription	
and	on	the	prescription	reimbursements;	
Agency	for	Drugs	and	
Medical	Devices	
(2	participants)	
To	 learn	 how	 the	 Agency	 for	 Drugs	 and	 Medical	 Devices	 has	
transferred	 these	 policies	 into	 their	 practice	 and	 what	 are	 the	
implications	 from	 these	 policy	 changes	 on	 the	 overall	
pharmaceutical	market;	
Professional	
associations	and	
chambers	
(3	participants)	
	
To	 learn	 what	 is	 the	 professional	 standpoint	 of	 the	 medical	
community	 in	 regard	 to	 the	 medicine	 prescribing	 policies	 and	
how	it	affects	the	practices	and	attitudes	of	health	professionals;	
how	the	prescription	policies	overall	have	affected	the	work	and	
income	of	the	pharmacists,	if	there	are	complaints	or	other	forms	
of	dissatisfaction	from	the	changes.	Specific	focus	was	put	on	the:		
-	Macedonian	Medical	Association,	as	an	umbrella	organisation	of	
all	professional	associations;	and	
-	Association	of	private	doctors	in	primary	care.	
Academic	staff	
working	in	the	fields	
of	economics	and	
social	medicine	
(2	participants)	
To	learn	how	these	legislative	and	policy	changes	are	intended	to	
influence	 the	 overall	 prescription	 regulation,	 and	 what	 are	 the	
forecasts	of	their	long-term	effects	in	the	Macedonian	healthcare	
system;	to	obtain	academic	views	on	the	policies	with	regard	to	
international	and	European	Union	practices	in	the	field.	
	
	
Table	7.	Interviewees’	characteristics	–	Elites	(educational	background)	
Elite	stakeholders	 N=	12	
Gender	 Female	 6	
Male	 6	
Educational	
background	
Medical	doctor	 7	
Pharmacist	 4	
Economist	 1	
Position	 Policy	maker	 7	
Professional	association	
representative	
3	
Academia	representative	 2	
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Table	8.	Interviewees’	characteristics	–	Primary	care	physicians	
Physicians	in	primary	care	 N=	17	
Gender	 Female	 9	
Male	 8	
Geographical	
location	
Capital	 5	
Small	town	or	city	 10	
Rural	 2	
	
Table	9.	Interviewees’	characteristics	–	Pharmacists	
Pharmacists	in	primary	care	 N=	12	
Gender	 Female	 9	
Male	 3	
Geographical	
location	
Capital	 3	
Small	town	or	city	 8	
Rural	 1	
Status	 Owner	 2	
	 Employee	 10	
	
Table	10.	Interviewees’	characteristics	–	Patients	
Patients	 N=	14	
Gender	 Female	 6	
Male	 8	
Geographical	
location	
Capital	 5	
Small	town	or	city	 7	
Rural	 2	
	
4.3.3	Research	instruments	
Four	different	topic	guides	for	semi-structured	interviews	were	developed,	one	for	each	
of	 the	groups	of	 interest	 to	reflect	 the	different	experiences,	perspectives	and	relative	
knowledge	of	each.	While	all	guides	comprised	common	themes	to	inform	the	research	
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question,	they	differed	to	reflect	the	specific	position	and	role	of	each	of	the	groups.	The	
initial	 content	 of	 the	 topic	 guide	 was	 informed	 by	 the	 literature,	 identifying	 a	 broad	
agenda	of	 topics	 and	 themes	 to	 explore	 (Ritchie	 and	 Lewis	 2003,	 p.	 115).	 These	were	
then	 discussed	 with	 the	 supervisors,	 who	 provided	 critical	 review	 and	 substantial	
comments	that	helped	me	structure	the	guide	and	reformulate	questions.	A	key	aim	was	
to	 maintain	 ‘neutrality’	 in	 how	 questions	 were	 developed	 and	 to	 avoid	 leading	 the	
respondents	(Ritchie	and	Lewis	2003,	p.160).	Following	this,	I	undertook	pilot	interviews	
with	 one	 representative	 from	 each	 group,	 to	 ensure	 questions	 were	 not	 only	
understood,	but	also	comprehensive	so	that	they	permitted	sufficient	scope	and	depth	
of	data	 to	be	obtained	 (Ritchie	and	Lewis	2003,	p.	135).	Piloting	was	also	helpful	as	 it	
provided	 me	 with	 some	 experience	 of	 using	 the	 guides,	 mostly	 with	 regards	 to	
maintaining	neutrality	during	the	conversations,	which	could	have	been	jeopardized	as	a	
result	of	my	knowledge	and	 involvement	 in	 the	content	and	context	of	 the	country	of	
interest	 (Bryman	 2008,	 p.	 247).	 Following	 piloting,	minor	 changes	were	 introduced	 to	
the	 guides,	 so	 the	 data	 from	 the	 pilot	 interviews	 was	 used	 to	 inform	 the	 research	
questions,	as	 suggested	by	Ritchie	and	Lewis	 (2003,	p.	135).	The	 research	 instruments	
are	provided	in	Appendices	D	to	G.		
4.3.4	Incentives	for	participants	
Given	the	national	economic	and	societal	context	and	the	necessity	to	recruit	physicians	
and	pharmacists	who	are	part	of	the	private	sector,	it	became	apparent	that	there	might	
be	some	reluctance	to	participate	for	the	reasons	of	interviews	being	a	time-consuming	
exercise.	 It	was	as	a	 result	of	 these	assumptions	 that	 I	 decided	 to	offer	 some	 form	of	
remuneration	 to	 participants,	 as	 suggested	 by	 Seidman	 (2012	 p.73)	 to	 ensure	
uninterrupted	 time	 for	 getting	 an	 in-depth	 interview.	 The	 funds	 for	 this	 remuneration	
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were	to	be	secured	 from	the	organization	 in	which	 I	work	 in	 the	capacity	of	executive	
director	 –	 Centre	 for	 Regional	 Policy	 Research	 and	 Cooperation	 “Studiorum”,	 a	 non-
governmental	research	think-tank	that	does	research	on	a	daily	basis	and	is	familiar	with	
such	concepts	as	compensation	for	loss	of	time	or	earnings.	In	practice,	this	meant	that	
every	 invited	 and	 participating	 interviewee	 was	 offered	 a	 small	 monetary	 sum	 in	
exchange	for	the	value	of	the	time	they	were	asked	to	spend	in	the	interview.	However,	
in	 practice,	 almost	 all	 participants	 declined	 the	 offered	 remuneration,	 with	 the	
exception	 of	 four	 patient	 respondents.	 It	 could	 therefore,	 be	 concluded	 that	 the	
participants	agreed	 to	 the	 interview	and	 shared	 their	opinions,	 views	and	experiences	
without	expectation	of	any	direct	benefit.		
4.3.5	Interviewing	
This	 section	describes	 the	process	 of	 approaching	 and	 informing	 the	 respondents	 and	
the	interview	itself,	including	issues	related	to	the	location.		
Firstly,	prospective	participants	were	approached	by	telephone	or	in	person	with	a	brief	
explanation	of	the	study	inviting	them	to	participate.	Once	they	agreed	and	as	required	
by	the	research	ethics	standards,	prior	to	the	interview,	the	respondents	were	informed	
in	further	detail	of	the	purpose	of	the	study	and	its	outcome,	both	verbally	and	through	
a	study	information	sheet	(given	in	Appendix	B).	A	signed	consent	form	(sample	given	in	
Appendix	C)	was	a	requirement	from	all	respondents	for	participating	 in	the	interview.	
The	 respondent	was	 given	 all	 relevant	 information,	 the	 right	 to	 voluntarily	 participate	
and	 the	 right	 to	 withdraw	 at	 any	 given	 time	 without	 giving	 explanation	 about	 the	
reasons.	The	information	sheet	and	the	consent	form	were	provided	to	the	participants	
in	both	English	and	Macedonian	languages.	Participants	were	asked	to	sign	the	consent	
form	in	both	languages.	
108	
For	securing	anonymity,	 the	consent	form	contains	a	 line	where	the	coding	number	of	
the	 interview	was	written.	 The	 audio	 recordings,	 as	will	 be	 described	 later,	 contained	
only	 the	 coding	number	 and	 the	date	of	 the	 interview.	 Consent	 forms	 and	 audio	 files	
were	kept	separately	in	locked	cabinets.	
The	majority	of	interviews	lasted	between	40	minutes	and	an	hour,	but	a	small	number	
were	significantly	longer	in	duration.	These	included	two	physicians,	one	pharmacist	and	
two	 respondents	 in	 the	elite	 stakeholders’	 group.	Regarding	 time	 the	 interviews	were	
conducted,	 all	 respondents	 from	 physicians’	 and	 pharmacists’	 groups	 preferred	 to	 be	
interviewed	 outside	 of	 their	 working	 hours,	 most	 of	 them	 requesting	 a	 time	 period	
immediately	after	working	hours,	while	three	physicians	and	two	pharmacists	agreed	to	
meet	at	the	weekend	when	they	were	free	from	professional	duties.	In	the	elites	group,	
with	the	exception	of	three	persons,	all	respondents	insisted	the	interview	be	conducted	
during	 their	 office	 hours.	 In	 the	 group	 of	 patients,	 interviews	 were	 scheduled	 on	 a	
different	day	than	the	day	when	they	were	initially	recruited	from	the	physician’s	office	
or	 pharmacy.	 In	most	 cases	 –	 with	 exception	 to	 the	 retired	 persons	 –	 the	 interviews	
were	scheduled	after	their	own	working	hours.	
Respondents	were	encouraged	to	choose	a	location	they	preferred,	to	encourage	their	
engagement	 and	 participation	 in	 research	 (Mauthner	 1997,	 Gallagher	 2005)	 so	 they	
could	 speak	 freely,	 comfortably	 and	 in	 confidence.	 Most	 of	 the	 interviews	 with	
physicians	 and	 pharmacists	 took	 place	 at	 their	 office,	 or	 in	 the	 pharmacy	where	 they	
worked	(specifically,	in	the	dispensary,	so	to	be	uninterrupted	by	incoming	customers),	
and	 some	 were	 conducted	 at	 the	 common	 room	 at	 their	 workplace	 (usually	 the	 tea	
kitchen	 or	 similar	 place).	 Four	 interviews	 were	 conducted	 at	 the	 office	 where	 I	 work	
(three	with	 the	elites	 and	one	with	a	physician),	 as	 their	 preferred	option	of	 location,	
109	
since	they	found	it	convenient	or	considered	it	would	allow	for	uninterrupted	interview	
time.	For	 the	patients	 several	options	were	offered,	 including	 their	home,	cafeteria	or	
office	where	I	work.	With	the	exception	of	two,	who	chose	to	be	interviewed	at	a	quiet	
cafeteria,	all	patients	considered	their	home	to	be	most	appropriate	for	the	interview.		
The	 participants	 were	 also	 given	 the	 choice	 of	 whether	 to	 conduct	 the	 interview	 in	
either	 English	 or	Macedonian	 language,	 as	 interviews	 conducted	 in	 a	 native	 language	
may	 yield	much	 richer	data	 than	 if	 conducted	 in	 English	 as	 a	 second	 language	 (Wallin	
and	Ahlstrom	2006);	all	of	them	chose	their	native	language.	There	are	many	advantages	
to	conducting	interviews	in	native	language,	such	as	there	are	no	language	barriers	and	
it	 avoids	 the	use	of	 interpreters,	which	has	been	 shown	 to	 reduce	 validity	 (Kaae	et	 al	
2016).	
As	 the	 interview	 guide	 was	 exactly	 that	 –	 a	 guide	 that	 could	 provide	 structure	 for	
systematically	 covering	 the	 relevant	 issues,	 while	 allowing	 flexibility	 to	 pursue	 details	
salient	to	each	individual	respondent	(Ritchie	and	Lewis	2003,	p.115)	–	it	was	not	used	in	
a	rigid	manner	and	additional	questions	were	posed	in	response	to	particular	responses	
and	 some	 questions	 were	 occasionally	 omitted.	 However,	 throughout	 the	 interview,	
wherever	 possible,	 respondents	 were	 asked	 to	 reflect	 on	 their	 views	 of	 current	 or	
potential	 problems,	 and	were	 encouraged	 to	 discuss	 ideas	 for	 overcoming	 any	 of	 the	
obstacles	or	issues	they	found	to	be	relevant	and	important	in	their	view.	For	example,	
one	of	the	participants,	as	will	be	reviewed	in	the	later	chapters,	opened	a	discussion	on	
the	 ‘chosen	pharmacy’	 concept	 that	 at	 the	 time	of	 the	 interviews	was	a	policy	option	
considered	 by	 the	 government;	 another	 participant	 elaborated	 in	 extenso	 a	 policy	
alternative	 that	 was	 considered	 prior	 to	 introducing	 the	 budget	 ceilings,	 but	 was	 not	
adopted,	yet	it	was	important	to	understand	the	process	from	the	perspective	of	policy	
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formulation.	A	pharmacist	from	a	rural	settlement	picked	up	on	a	topic	that	was	in	the	
media	 during	 the	 period	 of	 the	 interviews,	 and	 related	 to	 the	 rural	 ‘pharmacies	 on	
wheels’,	which	was	 considered	as	 issue	of	 concern	 from	 the	pharmacists’	perspective.	
The	intention	was,	as	stated	earlier	in	this	chapter,	to	identify	what	the	respondents	in	
their	view	and	from	their	daily	practice	and	experience	considered	to	be	problematic,	if	
any,	 and	 to	 gain	 new	 perspectives	 on	 why	 they	 perceived	 these	 to	 be	 problematic,	
mostly	 in	 relation	 to	 their	 subsequently	declared	attitudes	and	behaviour	 in	 the	given	
circumstances.	Vignette	questions	were	used	several	times,	to	probe	with	respondents	
who	have	been	extremely	categorical	about	a	certain	topic,	however,	not	in	the	sense	of	
controlling	what	the	respondent	had	to	say	or	to	divert	their	opinion	on	the	issue,	but	
rather	to	test	if	the	categorical	attitude	was	indeed	intrinsic	or	was	used	as	a	theoretical	
answer	 to	 the	 question	 posed.	 Such	 hypothetical	 situations	 were	 asked	 for	 example	
regarding	 the	 prescribing	 of	medicine	 without	medical	 indication	 to	 a	 close	 friend	 or	
family	 member;	 dispensing	 medicine	 without	 prescription	 to	 a	 vulnerable	 patient	
coming	 into	 the	 pharmacy,	 or	 what	 would	 be	 the	 policy	 response	 if	 physicians	
prescribed	so	little	as	to	jeopardize	the	access	to	medicines	to	preserve	their	prescribing	
budget.	Prompting	as	a	technique	was	not	used.		
4.3.6	Reflecting	on	interviewing	and	data	collection	process		
As	 part	 of	 reflexive	 practice	 (Jupp	 2006),	 what	 is	 also	 termed	 ‘benign	 introspection’	
(Davies	2002,	p.7),	keeping	a	reflexive	journal	of	notes	has	been	considered	as	another	
source	of	 information,	as	the	researcher	needs	to	fully	recognize	the	role	of	reflexivity	
with	 acceptance	 so	 that	 in	 social	 research	 ‘the	 specificity	 and	 individuality	 of	  the	
observer	 are	 ever	 present	 and	must	 therefore	 be	 acknowledged,	 explored	 and	 put	 to	
creative	use’	 (Okely	1996,	p.28).	Reflexivity	encompasses	 the	continuous	evaluation	of	
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subjective	 responses	 and	 the	 research	 process	 itself	 and	 involves	 a	 shift	 in	
understanding	 data	 as	 something	 objective	 to	 the	 active	 construction	 of	 knowledge	
(Finlay	2002).		
Throughout	my	research	I	have	been	conscious	of	my	relationship	with	the	context	and	
some	 of	 the	 respondents	 and	 thus	 decided	 to	 keep	 a	 reflexive	 journal,	 including	
personal	observations	and	progress	during	the	course	of	the	qualitative	data	collection	
and	analysis	to	facilitate	reflection	on	each	aspect	of	the	research.	Through	this	process,	
I	 was	 able	 to	 identify	 ways	 in	 which	 my	 findings	 may	 have	 been	 shaped	 by	 the	 co-
construction	 of	 accounts	 and,	 where	 possible,	 I	 challenged	 myself	 as	 principal	
researcher	 in	 relation	 to	 these	 co-constructions.	 As	 the	 interviews	were	 conducted	 in	
the	 Macedonian	 language,	 the	 reflective	 journal	 was	 kept	 in	 the	 same	 language,	 for	
uninterrupted	reflexive	process.	As	mentioned	by	Davies	(2002,	p.8),	there	are	concerns	
of	 the	 interference	 from	 subjectivity	 of	 the	 interviewer’s	 observations,	 and	 these	 are	
acknowledged	throughout	the	thesis,	where	relevant.	
In	 line	 with	 the	 above,	 throughout	 the	 data	 collection,	 analysis	 and	 interpretation	
processes,	I	was	reflecting	a	lot	on	my	relationship	with	the	research	context	and	some	
of	the	respondents.	With	my	background	and	previous	experience,	 it	was	 inevitable	to	
anticipate	 that	 some	 of	 the	 respondents	who	were	 familiar	with	my	 previous	work	 –	
especially	 policy	makers	 –	would	 have	 pre-understanding	 of	my	 knowledge,	 and	 thus	
this	was	very	important	to	acknowledge	in	the	interviewing	process.	Thus,	I	decided	to	
undertake	piloting	of	research	instruments,	which	was	to	serve	a	dual	purpose:	to	clarify	
and	 further	 refine	 the	 questions,	 but	 as	 well	 to	 observe	 my	 interaction	 with	 the	
respondents	in	terms	of	keeping	neutrality	as	much	as	possible	when	asking	questions.	
Beyond	 the	 piloting	 phase,	 I	 kept	 this	 process	 of	 understanding	 the	 influence	 of	 my	
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knowledge	 and	 relationship	 with	 some	 respondents	 throughout	 the	 entire	 data	
collection,	 improving	 the	 approach	 to	 asking	 questions	 in	 each	 subsequent	 interview.	
The	issue	of	knowing	my	previous	work	was	not	significant	for	the	other	two	respondent	
groups	–	providers	and	patients.	However,	with	 these	groups	 I	 kept	 reflecting	on	how	
my	personal	pre-understandings	would	affect	the	interviews,	and	continued	to	observe	
ways	in	which	I	could	be	as	neutral	as	possible	when	asking	the	questions.		
With	all	of	the	above,	I	have	described	particular	instances	of	my	reflexive	practice	and	
sensitivity	 about	 how	my	 experiences	 and	 relationship	with	 the	 research	 context	 and	
previous	acquaintance	with	some	of	the	respondents	could	influence	the	data	collection	
and	 analysis.	 The	 next	 section	 describes	 the	 process	 of	 recording,	 transcribing	 and	
translation	of	data.	
4.3.7	Recording,	transcribing	and	translation	
	The	majority	 of	 interviews	were	 recorded	 using	 a	 digital	 audio	 recorder	 so	 that	 later	
transcription	 could	 be	 undertaken.	 The	 recordings	 were	 made	 on	 a	 digital	 recording	
device	(Dictaphone),	allowing	convenient	and	prompt	data	transfer	into	a	computer	that	
was	 used	 for	 listening	 to	 the	 recordings	 while	 transcribing.	 As	 the	 interviews	 were	
conducted	in	Macedonian	as	the	native	language	(Kaae	et	al	2016),	the	use	of	personal	
computer	dictation	software	was	not	considered,	as	no	technical	possibilities	were	yet	
developed	for	this	language	on	the	required	professional	level	at	the	time	of	conducting	
the	data	analysis.	Each	recorded	file	was	labelled	with	the	date	and	the	coding	number	
assigned	onto	the	consent	form,	as	a	reference	to	protect	the	anonymity	of	data.	After	
each	interview,	brief	notes	were	made	about	the	overall	impression	from	the	interview,	
mainly	regarding	how	much	the	respondent	felt	comfortable	with	the	questions,	if	there	
were	 significant	 interruptions	 and	 so	 forth.	 These,	 as	 described	 under	 a	 separate	
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section,	were	kept	in	a	reflective	journal.	One	physician	and	four	patients	preferred	not	
to	be	recorded	and	in	these	cases,	extensive	notes	were	taken	during	the	interview	and	
follow-up	notes	also	made	summarising	key	points	in	the	interview.	
I	 undertook	 transcription	 as	 soon	 as	 possible	 after	 each	 interview.	 This	 approach	was	
chosen	as	there	is	an	advantage	of	this	very	time-consuming	process	(Bryman	2008,	p.	
456),	 over	 the	 professional	 transcription	 service,	 as	 it	 allows	 for	 closer	 familiarisation	
with	the	data	and	identification	of	key	themes	at	a	very	early	stage,	which	contributed	
to	 identifying	emerging	 issues	 that	were	 incorporated	 into	 the	 subsequent	 interviews.	
Through	 this	 process,	 it	was	much	 easier	 for	me	 to	 become	 aware	 of	 similarities	 and	
differences	 between	 the	 accounts	 of	 different	 respondents,	 and	 to	 capture	 some	
nuances	that	could	be	noted	only	from	the	recording	and	not	from	the	written	account	
itself.	 For	 example,	 a	 long	 pause	 of	 hesitation,	 a	 tone	 of	 voice	 or	 specific	 sound	 of	
agreement	 or	 disapproval;	 these	 gave	 me	 valuable	 insights	 into	 the	 feelings	 of	 the	
participant	about	the	particular	issue	that	was	not	verbally	expressed.		
There	 are	 conflicting	 views	 in	 the	 literature	 about	 who	 should	 undertake	 translation.	
Some	 literature	 suggests	 that	 combining	 the	 role	 of	 researcher	 and	 translator	 may	
influence	the	objectivity	of	the	knowledge	claims	(Temple	2005).	In	contrast,	it	has	also	
been	 argued	 that	 a	 joint	 approach	provides	 the	possibility	 for	 checking	 the	 validity	 of	
interpretations	 (Young	 and	 Ackerman,	 2001),	 and	 offers	 the	 researcher	 significant	
opportunities	 for	 close	 attention	 to	 cross-cultural	 meanings	 and	 interpretations	 and	
potentially	 brings	 the	 researcher	 close	 to	 the	 problems	 of	 the	 equivalence	 of	 the	
meaning	within	 the	 research	 process	 (Temple	 and	 Young	 2004).	 The	 latter	 arguments	
coupled	with	my	familiarity	with	the	 local	 language,	and	also	my	understanding	of	 the	
subject	itself,	led	me	to	undertake	the	translation	process	myself.	The	use	of	third	party	
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translation	 might	 not	 have	 enabled	 this,	 and	 the	 associated	 requirement	 to	 provide	
contextual	 meaning	 in	 qualitative	 research	 (Esposito	 2001).	 To	 address	 the	 threat	 to	
validity	 posed	 in	 the	 literature	 by	 the	 subjective	 presentation	 of	 accounts	 from	 a	
researcher’s	 own	 social	 position	 (Temple	 2005)	 the	 technique	 of	 back	 translation	was	
used	 (Pham	 and	 Harris	 2001,	 Twinn	 1998).	 Back	 translation	 was	 used	 on	 the	 pilot	
interviews	and	involved	me	translating	the	full	Macedonian	language	transcripts	of	the	
pilot	 interview	 into	English	 language	firstly.	Then	these	English	translations	were	given	
to	a	professional	translator	for	back	translation	into	the	Macedonian	language.	The	final	
stage	 involved	 comparing	 the	 original	 Macedonian	 transcript	 with	 that	 produced	
through	 the	 back	 translation	 and	 checking	 for	 any	 differences.	 No	 significant	
discrepancies	were	found	in	the	use	of	specific	terminology	between	the	two	document	
types.	As	a	result,	 I	was	confident	that	the	analysis	of	transcripts	could	be	done	 in	the	
original	 language	 and	 that	 only	 the	 selected	 quotes	 relevant	 to	 the	 identified	 themes	
would	be	translated	and	used	in	the	data	interpretation	of	this	thesis.	
	
4.4. Data	analysis	
4.4.1	Description	of	thematic	analysis	
Analysis	of	the	data	in	this	research	was	undertaken	using	thematic	analysis	(Braun	and	
Clarke	2006).	This	approach	to	analysis	was	selected	as	it	represents	a	well	recognised,	
transparent,	and	methodical	approach	which	can	be	applied	to	this	research	topic	and	is	
compatible	with	 all	 qualitative	methods	 (Boyatzis	 1998).	 This	 type	 of	 analysis	 enables	
researchers	 to	 create	 the	 ‘big	 picture’	 about	 experiences	 and	 events	 as	 participants	
understand	them	or	act	upon	them	(Chambliss	and	Schutt	2010,	p.339).	
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Although	it	has	been	interpreted	differently,	thematic	analysis	 is	usually	understood	as	
‘a	method	for	identifying,	analysing	and	reporting	patterns	(themes)	within	data’	(Braun	
and	Clarke,	2006).	 The	most	 influential	 and	 thorough	approach	 to	 thematic	analysis	 is	
that	of	Braun	and	Clarke	(2006)	who	identify	six	phases	(as	illustrated	in	Table	11).	
Table	11.	The	six	phases	of	thematic	analysis		
Phase	of	analysis		 Description	of	the	analytic	process		
1.	Familiarizing	yourself	with	
the	data	
Transcribing	data	(if	necessary),	reading	and	re-reading	the	
data,	noting	down	initial	ideas.		
2.	Generating	initial	codes	
Coding	interesting	features	of	the	data	in	a	systematic	fashion	
across	the	entire	data	set,	collating	data	relevant	to	each	code.		
3.	Searching	for	themes	
Collating	codes	into	potential	themes,	gathering	all	data	
relevant	to	each	potential	theme.		
4.	Reviewing	themes	
Checking	if	the	themes	work	in	relation	to	the	coded	extracts	
(Level	1)	and	the	entire	data	set	(Level	2),	generating	a	
thematic	‘map’	of	the	analysis.		
5.	Defining	and	naming	
themes	
Ongoing	analysis	to	refine	the	specifics	of	each	theme,	and	the	
overall	story	the	analysis	tells,	generating	clear	definitions	and	
names	for	each	theme.		
6.	Producing	the	report	
The	final	opportunity	for	analysis.	Selection	of	vivid,	compelling	
extract	examples,	final	analysis	of	selected	extracts,	relating	
back	from	the	analysis	to	the	research	question	and	literature,	
producing	a	scholarly	report	of	the	analysis.		
(Reproduced	from	Braun	and	Clarke,	2006)	
The	sections	that	follow	offer	a	more	situated	account	of	the	stages	as	they	related	to	
this	 research,	 giving	 relevant	 examples	 and	 insights	 that	 contribute	 to	 a	 transparent	
approach	to	research.	
4.4.2	Data	familiarization	
The	first	step	in	data	analysis,	as	suggested	by	Braun	and	Clarke	(2006)	is	to	familiarize	
oneself	with	the	data.	This	 involved	reading	the	transcripts,	 listening	to	audio	files	and	
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being	immersed	in	each	respondent’s	account.	In	addition,	I	went	back	to	the	reflective	
journal	 and	 tried	 to	 understand	 if	 my	 own	 pre-understandings	 emerged	 during	 the	
interview	process,	 and	how	 they	might	have	affected	 the	 respondents.	Understanding	
that	my	personal	horizons	would	evolve	throughout	the	research,	I	undertook	this	step	
as	 the	 first	attempt	to	understand	the	topic	 from	a	broader	perspective.	 In	 this	sense,	
Gadamer	 (1996,	 p.360)	 helped	me	 through	 his	 emphasis	 on	 the	 essence	 of	 the	 right	
questions,	 further	 stating	 that	 there	 is	 no	 understanding	 without	 the	 activity	 of	
questioning.		
Reflecting	upon	potential	bases	of	interpretation	of	the	respondents’	accounts,	I	posed	
myself	 several	 additional	 questions,	 which	 aimed	 to	 provide	 a	 greater	 context	 to	 the	
fusing	of	horizons	between	the	texts	and	the	researcher:		
• Why	is	the	past	system	frequently	mentioned	and	what	is	the	significance	of	its	
influence	on	current	practices?	
• What	value	do	providers	and	patients	place	on	prescribing	and	dispensing?		
• What	value	do	elite	stakeholders	place	on	prescribing	and	dispensing?		
• How	are	decisions	made	by	providers	regarding	prescribing	and	dispensing?	
• Are	those	decisions	always	based	on	medical	indication	and	clinical	knowledge?	
• What	 is	 the	 influence	of	communication	between	the	providers	and	the	policy	
makers	on	implementation?		
• What	 is	 the	 influence	 of	 communication	 between	 providers	 and	 patients	 on	
prescribing	and	dispensing?	
	
I	 personally	 transcribed	 the	 interviews	 as	 soon	 as	 possible	 after	 conducting	 each	
interview,	 so	 as	 to	 maximise	 familiarity	 with	 the	 data.	 The	 transcribed	 and	 already	
anonymised	text	was	set	out	in	Microsoft	Word	as	plain	text	that	was	later	reorganized	
into	table	format	while	generating	initial	codes,	as	described	in	the	next	section.	
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4.4.3.	Generating	initial	codes	
In	qualitative	research,	collected	data	can	be	quite	large	even	if	collected	from	few	cases	
or	respondents	(Chambliss	and	Schutt	2010,	p.324).	It	is	therefore	necessary	to	employ	a	
data	 management	 process,	 so	 to	 enable	 analysis	 of	 its	 meaningful	 parts	 that	 could	
inform	 the	 research	 questions.	 I	 used	 coding,	 as	 this	 is	 the	 most	 often	 used	 data	
management	 method	 in	 qualitative	 research,	 as	 conceived	 by	 Glaser	 and	 Strauss	 in	
grounded	 theory	 (1967).	 Coding	 is	 a	 process	 in	which	 the	 data	 are	 broken	 down	 into	
their	component	parts	 that	are	 related	 to	a	similar	concept	or	 issue,	and	are	analysed	
based	 on	 their	 common	 characterisation	 (Braun	 and	 Clarke	 2006).	 Coding	 is	 thus	
essential	as	 it	 ‘provides	the	 link	between	data	and	the	conceptualization’	 (Bryman	and	
Burgess	2002,	p.	5).		
For	coding,	software	packages	have	been	developed,	such	as	NVivo	and	similar.	 I	have	
familiarized	 myself	 with	 NVivo	 in	 one	 of	 the	 courses	 taken	 as	 part	 of	 the	 graduate	
research	 requirements,	 but	 realized	 that	 it	 could	 not	 be	 used	 for	 the	 Macedonian	
language.	Thus,	 I	had	to	take	a	manual	rather	than	software-assisted	approach	to	data	
analysis,	in	line	with	Ritchie	and	Lewis’s	(2003)	suggestion	that	software	packages	such	
as	 these	should	not	be	a	 replacement	 for	 the	researcher	and/or	rigorous	analysis.	The	
next	step	of	data	analysis	involved	making	notes	of	initial	ideas,	interesting	features	and	
messages	from	respondents’	accounts.		
Since	 thematic	 analysis	 is	 a	 flexible	 method,	 the	 size	 of	 data	 chunks	 identified	 for	
analysis	was	variable.	In	some	cases,	I	 identified	a	broad	code	to	one	component	of	an	
interview	and	then	within	 it	 further	 identified	several	others.	As	 I	gradually	completed	
more	transcripts,	the	earlier	identified	codes	were	revisited	and	refined.	For	example,	I	
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might	 have	 read	 an	 excerpt	 from	 an	 account	 and	 interpreted	 it	 as	 an	 example	 of	 a	
specific	phenomenon,	when,	if	I	looked	at	it	within	the	context	of	the	account	and	data	
as	a	whole,	I	would	then	see	it	as	more	complex,	and	continued	to	analyse	into	further	
more	specific	codes.	The	process	of	initial	coding	is	illustrated	in	Table	12	below.	
Table	12.	An	example	of	analysis	conducted	on	a	section	of	transcript,	together	with	
the	resolved	interpretation	in	the	final	column	
Respondent	
	
Transcribed	text	 First	
analysis	
attempt	
Second	
analysis	
attempt	
Interpretation	
PCP4	 The	list	of	medicines	was	
satisfactory.	And	there	were	
no	limitations,	we	had	
freedom	of	prescribing.	Let’s	
say,	I	as	a	practitioner	believe	
that	certain	illness	should	be	
treated	with	certain	
medications	and	I	was	free	to	
prescribe	them.	Things	are	
different	today.	Nowadays,	I	
cannot	prescribe	certain	
medications	although	I	am	an	
experienced	pediatrician.	I	
face	limitations	and	I	am	
obliged	to	ask	for	the	opinion	
of	different	institution	from	a	
less-experienced	medical	
practitioner.	It	doesn’t	make	
any	sense	to	me.	
Emphasis	
put	on	
freedom	to	
prescribe	
and	
professional	
knowledge	
and	
experience	
valuation	in	
the	past	
system	
compared	
with	the	
current	
policy	
changes	
		
Previous	
system	had	
no	
limitations		
and		
Professional	
knowledge	
and	
experience	
were	more	
valued	in	the	
past	
There	is	
obvious	
attachment	
and	
association	
with	the	
previous	
system	
Professional	
autonomy	is	
affected	by	
policy	changes	
	
The	coding	is	necessary	for	categorizing	and	sorting	data	(Charmaz	1984,	p.111),	and	it	
precedes	 the	 identification	 of	 themes	 (Bryman	 2008,	 p.554),	 which	 are	 essentially	
recurring	motifs	 in	 the	 interviews	 used	 at	 later	 stages	 to	 analyse	 the	 data	 against.	 In	
following	 sections	 I	 describe	 the	 process	 of	 searching	 for	 themes,	 reviewing	 and	
subsequently	refining	them.	
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4.4.4.	Development	of	themes	
As	explained	in	the	previous	section,	with	initial	coding	I	extracted	the	data	chunks	from	
the	transcripts	and	divided	each	into	codes,	i.e.	units	of	meaning,	identifying	interesting	
features	and	choosing	codes	to	capture	the	meaning	in	the	accounts.		
The	 next	 step	 of	 development	 of	 themes	was	 performed	using	 a	manual	 approach	 of	
identifying	the	common	patterns	in	the	data	chunks	to	form	potential	themes	and	sub-
themes,	 searching	 for	 the	 presence	 or	 absence	 of	 illustrative	 data	 extracts	 relating	 to	
these	themes	from	each	participant	in	each	of	the	groups.	I	have	repeated	this	process	
several	times;	an	apparent	‘absence’	of	data	from	a	participant	that	was	highlighted	in	
other	participants’	accounts	triggered	a	review	of	their	transcript	to	ensure	the	related	
data	 had	 not	 been	 missed.	 A	 good	 example	 from	 my	 analysis	 relates	 to	 the	 theme	
‘Nostalgia	for	the	past’	which	although	not	initially	planned	in	the	interview	guides,	has	
strongly	 emerged	 in	 many	 accounts	 in	 all	 respondents’	 groups.	 Although	 interview	
guides	 included	 questions	 related	 to	 the	 past	 system,	 the	 strength	 of	 responses	 was	
such	that	I	felt	it	should	stand	as	a	theme	in	its	own	right.		
At	 the	 same	 time,	 I	 was	 conscious	 of	 the	 issue	 of	 ‘importance’	 of	 data	 that	 was	 not	
dominant	 in	 all	 accounts,	 and	 therefore	 paid	 additional	 attention	 to	 data	 that	 was	
raising	 interesting	 issues	but	was	only	present	 in	 some	accounts,	 considering	 these	as	
deviant	 or	 negative	 cases.	 From	my	 initial	 coding	 I	 started	 to	 get	 a	 sense	 for	 themes	
existing	 within	 the	 transcripts,	 and	 continued	 to	 reflect	 on	 the	 identified	 themes,	
reviewing	 and	 refining	 them	 into	 the	 finally	 defined	 themes	 and	 sub-themes.	 These	
steps	are	elaborated	in	the	next	section.		
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4.4.5.	Reviewing	and	refining	of	themes	
The	next	step	in	thematic	analysis	was	reviewing	and	refining	the	themes.	This	involved	
reading	 and	 interpreting	 texts	 as	 a	 whole,	 and	 repeated	 coming	 back	 to	 the	
supplementary	questions	developed	at	the	stage	of	familiarizing	myself	with	the	data	in	
a	 process	 of	 deepening	 my	 understanding.	 As	 I	 was	 getting	 more	 immersed	 in	 the	
transcripts	 and	 the	 extracted	 data,	 I	 continuously	 worked	 on	 refining	 the	 specifics	 of	
each	theme,	the	overall	story	of	the	analysis,	and	finally	generating	clear	descriptors	for	
the	themes.	
In	detail,	firstly	I	checked	the	themes	against	the	data	extracts	and	explored	whether	the	
themes	work	in	relationship	to	the	data.	Checking	if	the	themes	‘worked’	in	relation	to	
the	entire	dataset	was	undertaken	as	an	iterative	process	using	the	following	questions	
taken	from	Braun	and	Clarke	(2006)	to	guide	my	decisions:		
• Is	this	a	theme?			
• What	is	the	quality	of	the	theme	and	does	it	tell	us	something	useful	about	my	
dataset	and	research	questions?			
• Is	there	enough	meaningful	data	to	support	this	theme?			
The	 main	 themes	 and	 sub-themes	 were	 further	 refined	 through	 continuation	 of	 the	
iterative	 process,	 until	 I	 felt	 that	 optimal	 understanding	 of	 the	 transcripts	 had	 been	
achieved.	 As	 an	 outcome	 of	 this	 process,	 I	 identified	 three	 themes	 each	with	 several	
sub-themes,	elaborated	in	detail	in	the	next	chapter	on	findings.	
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4.4.6	Presenting	the	data	findings	and	write-up	
The	 final	 step	 of	 the	 thematic	 analysis,	 as	 suggested	 by	 Braun	 and	 Clarke	 (2006)	 is	
writing	up	the	findings	and	relating	them	back	to	the	research	aims	and	literature.	This	
section	describes	this	process	 in	further	detail	and	particularly	 in	relation	to	the	use	of	
quotations.	This	 involved	several	aspects	such	as	the	level	of	detail	 from	the	individual	
accounts	 to	 be	 presented	 and	 the	 presentation	 of	 deviant	 cases.	 It	 was	 considered	
important	 to	 present	 not	 only	 quotations	 supporting	 the	 main	 themes,	 but	 also	 to	
capture	 alternative	 and	 contrasting	 accounts,	 particularly	 from	 the	 perspective	 of	
deviant	cases	(Emigh	1997).	As	noted	by	Anderson	(2010):	
‘It	 is	 also	 important	 to	 present	 outlying	 or	 negative/deviant	 cases	 that	 did	
not	fit	with	the	central	interpretation.’	(Anderson	2010)	
	
However,	as	the	data	were	collected	in	a	language	different	from	the	one	in	which	this	
thesis	 is	 written,	 additional	 attention	 was	 dedicated	 to	 the	 process	 of	 translation,	 as	
already	elaborated	in	the	section	on	data	collection.		
In	 summary,	 to	 present	 the	 findings	 of	 the	 present	 research,	 predominantly	 verbatim	
fragments	 from	 personal	 interviewees’	 accounts	 were	 used,	 and	 where	 necessary,	
although	to	a	minimal	extent,	interpretations	of	interview	data	were	employed,	mainly	
in	 an	 attempt	 to	 avoid	 duplicated	 presentation	 of	 very	 similar	 accounts,	 which	
contribute	 to	arriving	at	 a	 given	 finding	or	 conclusion.	 In	 addition,	deviant	 cases	were	
treated	with	utmost	 sincerity	 and	openness,	 so	 to	avoid	 reducing	 the	data	 richness	 in	
the	convenience	of	fitting	the	themes	into	existing	theories.	
The	 entire	 process	 of	 data	 collection	 and	 analysis	 should	 be	 subjected	 to	 scrutiny	 of	
quality	and	credibility	issues,	which	are	elaborated	on	in	the	next	section.	
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4.5. Quality	and	credibility	of	this	research	
The	 positivist	 approach	 in	 research	 utilises	 concepts	 of	 validity	 and	 reliability.	 Validity	
refers	 to	 how	 well	 the	 research	 assesses	 what	 it	 is	 attempting	 to	 assess	 and	 if	
generalisation	of	the	results	could	be	inferred,	whereas	reliability	is	concerned	with	the	
degree	 to	 which	 the	 research	 process	 produces	 stable	 and	 consistent	 results	 (Bale	
2011).	 These	 definitions	 are	 not	 entirely	 applicable	 to	 the	 qualitative	 interpretative	
approach,	as	argued	by	Ritchie	and	Lewis	(2003)	due	to:		
“the	 very	 different	 epistemological	 basis	 of	 qualitative	 research,	 there	 are	
real	 concerns	 about	 whether	 the	 same	 concepts	 have	 any	 value	 in	
determining	 the	 quality	 or	 sustainability	 of	 qualitative	 evidence.”	 (Ritchie	
and	Lewis	2003	p.270)	
	
Although	the	need	for	achieving	rigour	in	qualitative	health	research	is	well	recognised,	
there	is	no	agreement	on	specific	criteria	for	demonstrating	the	robustness	of	evidence	
derived	 from	 qualitative	 inquiries	 into	 health	 practice	 issues	 (Bale	 2011).	 However,	
among	the	most	commonly	used	criteria	for	achieving	the	required	scientific	rigour	are	
quality	 and	 credibility	 of	 the	 research.	 In	 the	 next	 paragraphs	 I	 address	 these	 in	 the	
context	of	my	research.	
To	 evidence	 the	 quality	 of	 the	 research,	 I	 considered	 the	 categories	 of	 reflexivity	 and	
reliability.	Under	 the	 section	on	data	 collection,	 I	 have	 already	described	my	 reflexive	
practice	and	how	my	experiences	and	viewpoints	could	influence	the	data	collection	and	
analysis,	and	how	I	have	addressed	this	potential	influence	in	the	process.		
Assessment	of	 reliability	 of	 qualitative	 research	 is	 complicated	by	 a	 number	of	 issues,	
related	to	the	possibility	for	and	the	extent	to	which	the	current	study	can	be	replicated	
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in	terms	of	design	and	sampling.	The	possibility	that	others	may	be	able	to	replicate	the	
study	was	considered	from	the	perspective	taken	by	LeCompte	and	Goetz	(1982),	who	
argued	 that	 the	 impossibility	 to	 ‘freeze’	 the	 social	 setting	 has	 to	 be	 taken	 into	
consideration	when	considering	the	reliability	issues	with	qualitative	research.	As	such,	
the	 standpoints	 of	 Ritchie	 and	 Lewis	 (2003)	 and	 Mays	 and	 Pope	 (2000)	 mentioned	
earlier	 become	 the	 main	 arguments	 for	 reliability,	 bearing	 in	 mind	 that	 the	 process	
represents	 a	 mapping	 exercise	 of	 particular	 views,	 experiences	 and	 phenomena,	 and	
that	 search	 for	 ‘subtle	 realism’	 rather	 than	 ‘the	 truth’	 is	 pursued.	 In	 this	 sense,	 and	
relevant	 to	 this	 research,	 I	 applied	 a	 social	 constructivist	 approach,	 as	 explained	 by	
Finlay	(2002):		
“Meanings	 are	 to	 be	 seen	 to	 be	 negotiated	 between	 researcher	 and	
researched	within	a	particular	social	context	so	that	another	researcher	in	a	
different	relationship	will	unfold	a	different	story.“	(Finlay	2002	p.53)	
	
From	the	point	of	view	that	the	social	setting	cannot	be	 ‘frozen’	 (LeCompte	and	Goetz	
1982),	and	that	meanings	are	bound	to	a	‘particular	social	context’	(Finlay	2002),	I	have	
considered	 the	 credibility	 of	 the	 research	 as	 another	 technique	 to	 ensuring	 scientific	
rigour	of	my	work.	Evidence	to	this	end	is	presentations	and	papers	produced	during	the	
course	of	this	research.	As	presented	in	the	beginning	of	this	thesis,	I	have	written	and	
published	 several	 publications	 related	 to	 the	 broader	 topic	 of	 health	 policy,	 primary	
health	 care	 and	 policy	 changes	 in	 primary	 health	 care,	 which	 were	 written	 with	 or	
consulted	with	other	academics	in	the	field.	In	addition,	as	I	myself	have	conducted	the	
research	within	 this	 thesis,	 this	 raised	 the	concern	of	 lack	of	an	additional	perspective	
from	another	 researcher	 in	 terms	of	 sampling,	 data	 gathering	 or	 data	 analysis.	 In	 this	
sense,	 a	 general	 process	 of	 peer	 review	 (LeCompte	 and	 Goetz	 1982)	 was	 pursued	
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through	discussions	with	my	supervisors	in	relation	to	the	data,	interpretations	and	the	
overall	thesis,	as	described	under	relevant	sections	earlier	in	this	chapter.	
Through	the	above,	I	believe	that	I	have	paid	due	attention	to	the	issues	of	quality	and	
credibility	throughout	this	research	and	that	the	 identified	themes	and	sub-themes,	as	
well	as	the	discussion	and	conclusions	elaborated	in	the	following	chapters	are	a	result	
of	a	thorough	and	appropriate	approach	to	the	research	process.	
	
4.6. Research	ethics	and	confidentiality	
In	 the	course	of	 the	 research,	 some	of	 the	 issues	discussed	during	data	collection	and	
analysis	involved	disclosure	of	information	that	might	incriminate	the	respondents,	such	
as	non-compliance	of	PHC	physicians	with	 the	policy	 for	 limitation	of	prescriptions,	or	
non-compliance	 of	 pharmacists	 with	 the	 existing	 dispensing	 policies.	 From	 an	 ethical	
standpoint,	 during	 the	 interviews	 it	 was	 inferred	 that	 PHC	 physicians	 or	 pharmacists	
were	 not	 always	 adhering	 to	 the	 prescribing	 and	 dispensing	 policies	 or	 in	 other	ways	
performed	 practices	 that	 were	 not	 in	 full	 compliance	 with	 ethical	 principles.	 As	 the	
purpose	was	 to	 research	attitudes	and	practices,	 the	anonymity	and	protection	of	 the	
data	from	misuse	or	abuse	by	a	third	party	was	essential.	
As	in	any	other	research	involving	personal	and	corporate	data,	the	personal	accounts	of	
respondents	 or	 data	 collected	 and	 analysed	 in	 this	 study	 that	 may	 in	 any	 way	
incriminate	 involved	 parties	 have	 been	 processed	 according	 to	 the	 principles	 of	
protection	 of	 such	 data.	 As	 part	 of	 the	 research	 done	 under	 the	 regulations	 of	 the	
University	 of	 Sheffield,	 the	 study	 was	 subject	 to	 University	 of	 Sheffield	 Ethics	 and	
Research	 Governance	 conditions	 and	 approval
125	
respondents,	obtaining	 informed	consent	and	management	and	protection	of	personal	
data	gathered	 in	the	research	process.1	An	application	was	prepared	for	the	University	
of	 Sheffield	 Ethics	 and	 Research	 Governance	 Committee,	 containing	 all	 necessary	
information	 regarding	 the	 research,	 i.e.	 the	 project’s	 aim	 and	 objectives;	 the	 planned	
methodology	 and	 research	 approach;	 types	 of	 respondents	 and	 sampling	 strategy;	
means	 for	 ensuring	 confidentiality	 and	 anonymity;	 and	 use	 of	 a	 consent	 form.	 Ethics	
approval	was	obtained	in	May	2013	(Appendix	A).	The	application	was	accompanied	by	
an	information	sheet,	consent	form	and	interview	guides	for	each	participant	group.	The	
information	 sheet	 and	 consent	 form	 are	 given	 in	 Appendix	 B	 and	 Appendix	 C,	
respectively.	The	interview	guides	are	given	in	the	subsequent	appendices,	i.e.	for	elite	
stakeholders	(Appendix	D),	primary	care	providers	(Appendix	E),	pharmacists	(Appendix	
F)	and	patients	(Appendix	G).		
Further	 to	 this,	 as	 the	 primary	 data	 collection	 was	 done	 in	 Macedonia,	 the	 research	
proposal	was	 also	 submitted	 for	 review	 and	 approval	 to	 the	 Ethics	 Committee	 at	 the	
State	Medical	 Faculty	 at	University	 “Ss.	 Cyril	 and	Methodius”	 in	 Skopje,	 together	with	
the	obtained	Ethics	approval	 from	the	University	of	Sheffield.	This	Ethics	Committee	 is	
authorized	 by	 the	 Ministry	 of	 Health	 to	 give	 approval	 for	 all	 medical	 and	 bioethical	
research	done	on	the	territory	of	the	country.	The	Ethics	Committee	considered	that	the	
nature	 of	 the	 research,	 i.e.	 qualitative	 data	 collection,	 was	 not	 subject	 to	 ethical	
approval	in	the	country,	and	provided	a	written	notice	that	the	obtained	Ethics	approval	
from	the	University	of	Sheffield	is	sufficient	to	continue	the	research.		
																																								 																				
1	Details	of	rules	and	procedures	of	the	University	of	Sheffield	Ethics	and	research	Governance	are	available	
at:	http://www.sheffield.ac.uk/ris/other/gov-ethics/ethicspolicy/approval-procedure/routes;	and	regulatory	
requirements	for	research	data	management	are	available	at:	
https://www.sheffield.ac.uk/library/rdm/requirements	(accessed:	10	September	2017)	
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All	 research	 activities	 were	 conducted	 in	 line	 with	 relevant	 legal	 frameworks	 and	
guidance	related	to	personal	data	protection	acts	applicable	in	both	the	country	of	study	
(Law	 on	 Personal	 Data	 Protection,	 Official	 Gazette	 of	 the	 Republic	 of	Macedonia,	 no.	
7/05	and	103/08),	and	country	of	submission	of	the	study	(Data	Protection	Act	1998	(c	
29)).	Further	to	this,	the	study	was	conducted	and	framed	within	University	of	Sheffield	
Guidelines	on	anonymity,	confidentiality	and	data	protection,	as	stated	in	the	University	
of	Sheffield’s	Research	Ethics	Policy	Note	no.	4:	Principles	of	Anonymity,	Confidentiality,	
and	Data	Protection.2	
No	 personal	 data	 of	 respondents,	 such	 as	 date	 or	 place	 of	 birth,	 or	 personal	
identification	 number	 were	 collected;	 respondents’	 full	 names	 were	 stored	 securely:	
information	 that	 identifies	 them	 was	 not	 stored	 on	 a	 computer.	 All	 forms	 from	 the	
research,	 the	 interview	 recordings	 and	 transcripts	 were	 stored	 securely	 in	 a	 locked	
cabinet,	 separately	 so	as	 to	ensure	 that	no	 respondent	 could	be	 identified	by	persons	
other	than	myself.	All	participants	were	assigned	a	coding	number	that	was	used	in	this	
thesis	 in	 order	 to	 protect	 their	 identity.	 However,	 given	 their	 specific	 role,	 the	 elite	
stakeholders	were	asked	if	they	want	to	be	identified	in	the	study.	All	of	them	expressed	
a	wish	to	be	anonymous,	so	they	too	were	assigned	a	coding	number.	
As	the	rigid	scientific	rules	require,	written	consent	(Appendix	C)	was	obtained	from	all	
respondents	 who	 agreed	 to	 participate.	 Respondents	 received	 an	 information	 sheet	
(Appendix	 B),	 explaining	 their	 rights	 in	 relation	 to	 confidentiality	 and	 personal	 data	
safeguarding	policy.	The	protection	of	the	identity	of	participants	and	their	accounts	was	
																																								 																				
2	Research	Ethics	Policy	Note	no.	4:	Principles	of	Anonymity,	Confidentiality,	and	Data	Protection,	available	
at:	http://www.sheffield.ac.uk/ris/other/gov-ethics/ethicspolicy/policy-notes/confidentiality-anonymity-
data-protection	
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secured	 by	 providing	 a	 consent	 form	 signed	 by	 the	 participants	 with	 the	 following	
content:	
“Any	information	you	supply	will	be	kept	confidential.	However,	if	you	tell	me	
something	that	makes	me	think	you	are	in	danger	of	being	harmed,	I	will	tell	
you	so	and	advise	you	 to	seek	assistance	 from	appropriate	 institutions	and	
authorities”.	
	
Participants	 were	 made	 aware,	 in	 writing	 and	 in	 person	 that	 participation	 in	 the	
research	was	entirely	 voluntary,	 that	 they	 could	withdraw	at	any	 time	without	 stating	
the	reason	and	that	they	would	not	be	affected	in	any	way	by	withdrawal.	 
	
4.7. Dissemination	of	findings	
Although	 the	 main	 purpose	 of	 my	 research	 was	 to	 prepare	 and	 defend	 this	 thesis,	 I	
intend	 also	 to	 further	 elaborate	 and	 report	 the	 findings	 of	 the	 research	 to	 specific	
audiences.	 Among	 these	 is	 the	 academic	 community	 in	 Macedonia,	 in	 particular	 the	
teaching	and	research	staff	at	the	State	Medical	Faculty	at	the	University	“Ss.	Cyril	and	
Methodius”	 in	 Skopje	 and	 the	 University	 American	 College	 Skopje	 where	 I	 am	 also	
engaged	as	a	visiting	researcher.	As	my	intention	is	to	continue	working	in	this	field,	the	
expanded	research	will	continuously	be	presented	in	papers,	academic	conferences	and	
policy	meetings.	As	I	also	work	on	formulation	of	national	policies	in	Europe,	I	hope	that	
the	 knowledge	 acquired	 through	 this	 research	 will	 have	 applied	 value	 for	 prescribing	
and	 dispensing	 policies	 in	 my	 country	 and	 other	 transition	 countries	 with	 similar	
economic	and	societal	contexts.		
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4.8. Summary	of	chapter	
The	 primary	 aim	 of	 this	 chapter	 was	 to	 defend	 and	 describe	 the	 choice	 of	 the	 most	
appropriate	 research	methodology	 and	methods	 to	 answer	 the	 research	 questions	 of	
this	research.	A	further	aim	was	to	reflect	critically	upon	different	aspects	of	the	chosen	
method	 and	 overall	 research	 process.	 Qualitative	 semi-structured	 interviews	 were	
chosen,	 as	 they	would	 provide	 important	 insights	 into	 the	 perspectives,	 attitudes	 and	
practices	 of	 diverse	 stakeholders	 regarding	 the	 changes	 of	 policy	 environment.	 The	
stakeholders’	 groups	 identified	 and	 interviewed	 in	 this	 research	 were:	 physicians,	
pharmacists,	 patients	 and	 elite	 stakeholders.	 The	 researched	 changes	 in	 policy	
environment	 were	 the	 primary	 care	 reform	 and	 accompanying	 prescribing	 and	
dispensing	policy	changes,	and	their	impact	on	prescribing	and	dispensing	practices	and	
behaviours.	The	chapter	also	described	the	data	collection	process,	 including	sampling,	
research	instruments,	interview	process	and	reflexive	practice.	I	described	my	reflexive	
practice	and	elaborated	how	I	viewed	my	experiences	and	relationship	with	the	research	
context	 and	 how	 it	 might	 have	 influenced	 the	 data	 collection	 and	 analysis.	 I	 also	
described	 the	 methods	 of	 recording,	 transcribing	 and	 translation,	 which	 I	 considered	
particularly	important	given	the	use	of	language	different	from	the	one	in	which	I	have	
written	this	thesis.		
Further,	 the	 chapter	 explained	 the	 data	 analysis.	 The	 chosen	 analytical	 method	 was	
thematic	analysis,	and	I	followed	the	approach	proposed	by	Braun	and	Clarke	(2006),	as	
this	 appeared	most	 appropriate	 to	 analyse	 similar	 concepts	 from	 different	 sources	 of	
information	–	in	this	case	different	groups	of	respondents	who	represent	different	sides	
in	 the	 prescribing	 process.	 Towards	 the	 end	 of	 the	 chapter,	 I	 addressed	 the	 issues	 of	
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ensuring	scientific	rigour,	through	concepts	of	quality	and	credibility	of	this	research,	as	
well	as	the	process	for	observing	ethics	in	research.	
The	following	chapters	are	dedicated	to	presentation	of	the	collected	data	pertinent	to	
the	 research	 questions	 and	 its	 relevance	 to	 the	 wider	 body	 of	 knowledge	 from	 the	
perspective	of	 the	chosen	theoretical	 framework.	Beyond	the	data	presentation	 in	 the	
next	 chapter,	 the	 subsequent	 chapters	 are	 dedicated	 to	 discussion	 of	 findings,	 and	
linking	 them	 to	 the	 context	 and	 the	wider	 social	 theory,	 leading	 into	 conclusions	 and	
recommendations	intended	to	feed	future	policy	making	processes.	
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CHAPTER	5:	Findings	
5.1. Introduction	
	
5.1.1	Overview	of	chapter	 	
This	 chapter	 describes	 the	 identified	 themes	 and	 associated	 attitudes	 and	opinions	 of	
physicians,	pharmacists,	patients	and	elite	stakeholders	in	relation	to	the	various	policy	
changes	described	in	chapter	2.	The	aim	in	this	chapter	is	to	offer	descriptions	of	these	
identified	themes,	with	illustrative	extracts	from	interviews.	It	is	left	to	the	next	chapter,	
to	 consider	 these	 findings	 in	 relation	 to	 the	 literature	 described	 in	 chapter	 3	 and	 in	
particular	to	Habermas’	conception	of	system	and	 lifeworld.	Before	elaborating	on	the	
findings,	 it	 is	 important	 to	 offer	 a	 brief	 reminder	 of	 the	 rationale	 and	 context	 of	 the	
study,	 and	 also	 explain	 the	 approach	 taken	 to	 the	 presentation	 of	 collected	 data	 and	
emerging	themes.	
Since	its	independence,	Macedonia	embarked	on	large	economic	and	social	reforms	that	
affected	 the	 health	 system	 (Ivanovska	 and	 Ljuma	1999;	 Lazarevik	 et	 al	 2012).	 Prior	 to	
reforms,	 the	 system	 provided	 universal	 health	 coverage,	 free	 to	 all	 at	 every	 point	 of	
delivery,	 including	health	 services,	 rehabilitation	 treatment,	prescription	and	over-the-
counter	medicines.	A	lack	of	resources	imposed	a	need	for	rationalisation	and	increased	
efficiency	 of	 the	 use	 of	 such	 health	 services	 and	 medicines.	 Policy	 changes	 were	
introduced	 to	 reduce	 pharmaceutical	 expenditures	 through	 rationalisation	 to	 a	 list	 of	
essential	medicines,	and	existing	policies	were	reinforced	to	dispensing	of	prescription	
medicines	only	with	a	prescription	issued	by	a	physician.		
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The	adoption	of	new	and	the	reinforcement	of	existing	policies	were	anticipated	to	bring	
a	 new	 period	 of	 rules	 and	 discipline	 in	 prescribing	 and	 dispensing.	 However,	 as	
described	in	the	second	chapter,	both	pharmaceutical	costs	and	number	of	prescriptions	
have	continued	to	increase.	This	chapter	presents	a	range	of	accounts	relating	to	these	
changes,	 from	 very	 different	 stakeholder	 perspectives	 based,	 as	 will	 be	 shown,	 on	
differing	values,	beliefs	and	needs.	
5.1.2.	Approaches	to	data	presentation	 	
The	 complexity	 of	 policy	 changes	 of	 interest	 and	 the	 diversity	 of	 interviewed	 groups	
raised	the	issue	of	the	most	suitable	approach	to	presentation	of	collected	data.	One	of	
the	 approaches	 considered	was	 to	have	a	 straightforward	data	presentation,	 in	which	
the	 identified	 themes	 from	 each	 of	 the	 respondents’	 groups	 would	 be	 presented	 in	
separate	 sections.	 This	 approach	 would	 be	 beneficial	 in	 allowing	 for	 an	 in-depth	
consideration	of	the	understanding,	experiences	and	practices	of	each	of	the	groups	 in	
relation	to	all	analysed	policy	changes,	and	only	then	to	comparatively	interpret	them	in	
the	subsequent	chapters.	This	approach,	though,	while	seeming	more	appropriate	from	
the	 perspective	 of	 the	 different	 roles	 played	 by	 each	 group,	 was	 rejected	 as	 it	 was	
considered	a	threat	to	illustrating	the	relevance	of,	and	relationship	between,	emerging	
themes.	Trying	to	offer	differing	perspectives	so	overtly	as	a	structure	may	also	result	in	
the	danger	that	Mason	terms	‘mutivocality’,	and	it	is	important:	
	 “[…]	that	we	get	to	grips	with	different	and	often	diverging	perspectives	in	
our	arguments,	and	with	different	ways	of	expressing	 those	 […]	but	 I	 think	
we	should	be	cautious	 in	assuming	 that	we	can	absent	ourselves	and	 in	 so	
doing	create	a	genuinely	democratic	multivocality.”	(Mason	2002	p.185)	
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As	 such,	 organising	 the	 findings	 in	 terms	 of	 identified	 themes,	 illustrated	 using	
participant	quotations,	is	argued	to	be	most	beneficial.	Such	an	approach	was	chosen	as	
it	 best	 represented	 how	 analysis	 was	 undertaken	 but	 also	 as	 it	 would	 still	 allow	 the	
variety	of	opinions	and	views	of	the	interviewed	stakeholders	to	be	represented.	As	will	
be	shown,	 three	main	overarching	themes	were	 identified	but	within	these	many	sub-
themes	were	 also	 apparent	 and	 these	 are	 considered	 in	 turn.	 It	 should	 also	 be	noted	
that	 whilst	 these	 represent	 summary	 themes	 and	 sub-themes,	 they	 did	 not	 reflect	
consensus	 and	 it	 will	 be	 shown	where	 contrasting	 or	minority	 views	 and	 experiences	
were	also	identified.	
This	chapter	presents	only	 the	emerging	 themes	and	sub-themes	and	quotations	 from	
the	 interviews	with	participants;	 it	 is	 left	 to	 the	 following	chapter	 to	provide	a	 further	
development	 of	 the	 findings,	 in	 terms	 of	 how	 they	 are	 related	 to	 the	 theoretical	
framework	 –	 Habermas’	 system	 and	 lifeworld	 –	 and	 how	 themes	 relate	 to	 existing	
literature.		
	
5.1.3.	Summary	of	key	themes	
Interviews	revealed	differing	perspectives	between	stakeholder	groups.	Using	thematic	
analysis,	 key	 findings	were	clustered	 into	 three	key	 themes,	briefly	 summarized	 in	 the	
following	 paragraphs,	 and	 elaborated	 in	more	 details	 in	 the	 subsequent	 sections	 (see	
Table	13	below).	
	
Table	13.	Summary	of	key	themes	and	sub-themes	and	relationship	to	participants	
Theme Sub-theme Group Sub-theme Sub-theme 
	
	
	
	
	
Past 
and 
present 
policies 
	
	
	
Nostalgia 
for the past 
system 
	
Providers Autonomy in prescribing 
	
Clinical experience & patient need 
	
Elites 	 Better relationship 
With the system 
With the patients – more patient-centred 
system 
Some nostalgia for previous system but not sustainable 
Patients Availability of medicines Freedom to obtain medicines (no need to negotiate) 
	
Reflections 
on recent 
policies 
Providers Qualified acknowledgement of need for policies’ cost containment 
Elites Necessity for change – efficiency, cost limitation, inappropriate prescribing 
	
Patients Not aware of policies or what the changes are bringing 
	
	
	
	
	
Lack of providers’ 
involvement in policy 
	
	
	
	
	
Providers 
Exclusion from policy making 
Pressure to implement policies 
Lack of support in implementation, detachment from system 
Reduced autonomy in prescribing due to policies 
Inability to prescribe where clinically appropriate due to budget ceilings 
	
Elites 
	
Acknowledgement 
Lessened provider autonomy 
Poor enforcement of policies 
Lack of willingness to share responsibility for implementation 
	
	
	
	
	
	
	
	
	
	
	
Pressures in practice 
	
	
Providers 
	
	
Dis-empowerment 
Pressure from patients – cannot get 
medicines they previously could 
Non-prudent prescribing and dispensing under 
patient pressure 
Denial of irrational prescribing 
Perception of patients playing an unenforced 
system 
	
	
	
	
	
Elites 
	
	
Acknowledgement 
Increased power of patients qua rights 
Aware of prescribing under pressure and 
dispensing without prescription 
	
	
	
Expectation 
Perceived requirement for patient education on 
appropriate medications 
Perceived requirement for better physician 
knowledge of clinical guidelines 
Lack of willingness to share responsibility for 
policy enforcement 
	
	
Patients 
	
	
New Demands 
Reduced possibility for obtaining medicines 
(patients’ disempowerment) 
Negotiating medicine 
supply 
Response to system 
changes 
Justification 
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One	of	 the	 key	 identified	 themes	 related	 to	 the	 stakeholders’	 perceptions	of	 the	past	
and	present	policies.	The	narratives	of	providers	revealed	nostalgia	for	the	past	system,	
which	brought	comparisons	with	current	practice,	regarding	professional	autonomy	and	
appreciation	of	their	profession	in	the	society.	Similar	to	providers,	patients	also	felt	the	
past	 system	 to	 be	 more	 beneficial	 to	 their	 health	 needs,	 and	 the	 current	 one	 as	
disempowering	when	it	came	to	negotiating	the	necessity	to	obtain	medicines.	Many	of	
the	respondents	in	the	elite	stakeholders’	group	referred	to	the	benefits	in	the	past,	and	
conversely	 the	 lack	 of	 sustainability	 of	 such	 a	 system,	 justifying	 the	 need	 for	 policy	
changes.	
The	second	key	theme	that	emerged	from	analysis	of	the	data	related	to	pharmacist	and	
physician	providers’	 perceptions	 of	 a	 lack	 of	 their	 involvement	 in	 policy	making	 and	 a	
lack	of	support	for	them	in	implementing	new	policies.	The	providers	felt	detached	from	
the	system	for	policy	development	and	implementation,	which	for	both	physicians	and	
pharmacists	meant	 they	 had	 to	 find	 other	ways	 of	 dealing	with	 the	 arising	 problems,	
some	 of	 which	 were	 beyond	 their	 competences	 and	 authorisation.	 In	 a	 similar	 way,	
patients,	 whilst	 not	 appearing	 very	 familiar	 with	 specific	 policies	 or	 their	 aims,	 were	
explicit	about	their	own	disempowerment,	which	in	their	view	was	imposed	by	the	new	
policy	context.	While	elite	stakeholders	fully	 justified	the	necessity	for	policy	change	in	
terms	 of	 implementation,	 their	 opinions	 varied	 but	were	 generally	 in	 agreement	 that	
implementation	of	policies	was	 lacking.	 It	also	emerged	that	this	was	not	effective	and	
patients	were	 still	 able	 to	 obtain	medicines	without	 prescription,	 particularly	 cheaper	
ones.	In	their	views,	both	the	reasons	and	the	responsibility	for	lack	of	implementation	
laid	with	the	patients	and	providers.		
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The	 third	 identified	 theme,	 closely	 linked	 to	 the	 other	 two	 above,	was	 related	 to	 the	
pressures	 in	 practice,	 experienced	 by	 both	 providers	 and	 patients.	 Physicians	 and	
pharmacists	 perceived	 pressures	 from	 regulatory	 and	 governmental	 bodies	 to	 adopt	
policies;	 policies,	moreover,	 that	 they	 did	 not	 feel	 sufficiently	 involved	 in	when	 being	
developed.	They	also	perceived	or	anticipated	pressure	from	patients	 in	terms	of	their	
expectations	 and	 demands	 for	 medicines,	 with	 a	 related	 negative	 impact	 upon	 them	
maintaining	professional	autonomy.		
Patients	also	 felt	pressures	 related	 to	 the	new	policies,	 such	as	having	 to	negotiate	 to	
obtain	prescriptions	from	primary	care	physicians,	and	from	the	now	limited	opportunity	
to	 buy	 medicines	 without	 prescription.	 Accounts	 revealed	 that	 patients	 found	 their	
autonomy	and	options	for	self-medication	to	be	very	 important.	Most	of	them	did	not	
consider	 out-of-pocket	 payments	 for	medicines	 to	 be	 a	 problem	 as	much	 as	 was	 the	
limitation	of	 their	 right	 to	purchase	medicines	at	 their	own	discretion.	Their	 response,	
however,	to	this	new	medicine	supply	situation	was	a	pragmatic	one;	in	their	views,	the	
reduced	 access	 to	medicines	 offered	 justification	 for	 subterfuge	 of	 regular	 prescribing	
and	dispensing	procedures.		
Throughout	 all	 these	 accounts,	 it	 will	 be	 shown	 that	 there	 were	 diverse	 views	 and	
differing	opinions:	
- For	 physicians	 and	 pharmacists,	 this	 was	 manifest	 in	 being	 caught	 between	
patient	 demands	 and	 expectations	 and	 maintaining	 professional	 autonomy	
within	 a	 more	 constraining	 system	 in	 which	 they	 felt	 unsupported	 and	 un-
consulted	about.	
- For	elite	stakeholders,	this	was	articulated	as	 justification	for	policy	changes	to	
contain	 costs	 and	 to	 reduce	 inappropriate	 prescribing,	 and	 an	 admission	 that	
implementation	 was	 difficult	 for	 providers	 due	 to	 patient	 pressure	 and	 other	
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issues;	 yet,	 they	 shifted	 the	 responsibility	 for	 implementation	 onto	 both	
providers	and	patients,	suggesting	both	groups	needed	a	better	understanding	
of	the	policies	and	associated	drivers.	
- For	patients,	 in	 terms	of	 an	 awareness	of	 the	 consequences	of	 policy	 changes	
that	 appeared	 to	 restrict	 their	 access	 to	 prescribed	 medicines	 yet	 having	 the	
opportunity	 to	act	as	new	health	consumers	and	obtain	medicines	beyond	the	
traditional	pathway	of	a	physician.	
	
The	 following	 sections	 describe	 in	 depth	 the	 identified	 themes	 emerging	 from	 the	
interviews	with	different	stakeholder	groups.	It	relation	to	the	ordering	of	themes,	this	
adopts	 a	 temporal	 sequence,	 with	 the	 first	 to	 be	 presented	 relating	 to	 comparisons	
between	 past	 and	 present	 policy,	 followed	 by	 reflections	 on	 the	 implementation	 and	
finally	the	subsequent	implications	of	the	policy	changes.		
	
5.2. Reflections	on	past	and	present	policies	
	
This	 theme	 is	 constructed	 from	 two	 sub-themes:	 ‘nostalgia	 for	 the	 past	 system’	 and	
‘recent	 policies:	 necessity	 for	 change	 and	 qualified	 acceptance’.	 The	 first	 sub-theme	
focuses	 on	what	 I	 interpreted	 as	 comparisons	 between	 the	 past	 and	 present	 policies,	
and	what	effect	the	experience	from	the	past	had	on	the	perception	of	the	new	reality.	
The	first	sub-theme	‘nostalgia	for	the	past	system’	as	it	suggests,	is	concerned	with	the	
reflections	of	 participants	on	 the	past	 system	 in	 general,	 and	on	 the	 specific	 topics	 of	
professional	autonomy,	raised	by	providers	and	availability	of	medicines,	 raised	by	the	
patients.	The	second	sub-theme	‘reflections	on	recent	policies:	necessity	for	change	and	
qualified	 acceptance’	 focuses	 on	 what	 I	 interpreted	 as	 respondents’	 perceptions	 and	
acceptance	of	policy	changes.	
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5.2.1	Nostalgia	for	the	past	system	
5.2.1.1	Reflections	on	the	past	system	
In	 reflecting	 on	 their	 understanding	 of	 recent	 policy	 changes,	 all	 respondent	 groups	
made	explicit	reference	to	the	past	system	under	socialist	control	and,	most	tellingly,	its	
benefits.	 The	 discourse	 of	 nostalgia	 was	 strongly	 present	 despite	 the	 apparent	
understanding	 of	 the	 necessity	 for	 policy	 change.	 In	 most	 of	 the	 interviews,	 when	
discussion	 was	 initiated	 on	 the	 actual	 system	 and	 respondents’	 opinions	 on	 its	
characteristics,	 the	 current	 situation	 was	 referred	 to	 as	 a	 compound	 of	 changes,	 and	
significant	emphasis	was	placed	on	 the	comparison	with	 the	previous	 socialist	 system.	
Discussions	on	specific	policies	(described	in	earlier	chapters	as	PC1,	PC2	and	PC3)3	only	
came	 later	 in	 dialogues,	 upon	 explicit	 reference	 by	 the	 researcher.	 In	 the	 providers’	
group,	 accounts	 varied	 according	 to	 whether	 they	 had	 experience	 of	 working	 in	 the	
previous	system,	while	in	the	elite	stakeholders’	group,	variations	were	noted	according	
to	whether	they	had	experience	as	providers	in	primary	practice	in	the	past.		
In	 many	 of	 the	 physicians’	 accounts	 there	 appeared	 to	 be	 reminiscence	 and	 indeed	
nostalgia	 for	 the	 past	 system.	 It	mainly	 projected	 through	 the	 professional	 autonomy	
they	seem	to	have	enjoyed	with	prescribing.	Such	discourse	was	articulated	in	an	almost	
uncritical	view	on	the	circumstances	at	the	time	and	idealization	of	the	system,	in	which	
prescribing	was	the	discretionary	right	and	responsibility	of	doctors:		
“We	could	prescribe	anything	we	wanted.	There	were	no	policies…	So,	for	
any	 diagnosis	 the	 doctor	 could	 prescribe	 any	 medicine.	 I	 don’t	 know	 if	
somebody	 could	 have	 held	 him	 responsible	 for	 that…	 before	 1990,	what	
																																								 																				
3	The	mentioned	policy	changes	are:	PC1	-	prescribing	policy	with	limitation	on	number	of	prescriptions	per	
patient;	PC2	–	prescribing	ceiling	policy;	PC3	-	reinforcement	of	dispensing	policy	and	introduction	of	
dispensing	ceiling	policy.	
-	138	-	
can	I	say,	you	could	go	to	the	pharmacy	and	go	out	carrying	five	bags	of	
medicines	and	you	wouldn’t	spend	a	penny,	there	was	no	participation	fee	
or	anything…”	(PCP2)	
“…we	were	not	scrutinized,	but	we	knew	what	was	appropriate,	there	was	
no	doubt	about	it…”	(PCP12)	
	
What	 could	 be	 noted	 from	 the	 accounts	 was	 their	 perception	 of	 the	 professional	
freedom	they	experienced	in	the	past.	As	 illustrated	in	the	quote	above,	such	freedom	
was	 associated	 with	 a	 perceived	 limitless	 amount	 of	 treatment	 and	 medicines.	 The	
vocabulary	 physicians	 used	 suggested	 that	 this	 freedom	 and	 availability	 of	 care	 were	
some	 of	 the	 features	 that,	 in	 their	 opinion,	 were	 significantly	 reduced	 in	 the	 current	
system.	
Besides	professional	autonomy	and	availability	of	medicines,	elaborated	as	sub-themes	
in	 the	 following	 sub-sections,	 the	 dialogues	 on	 previous	 policies	 did	 not	 reveal	 other	
specific	 features	 of	 association	 to	 the	 past.	 Interestingly,	when	 asked	what	 the	 policy	
was	at	the	time,	the	majority	of	physicians	could	not	provide	a	simple	response,	as	they	
would	for	the	policy	changes	of	the	present	time.	Rather,	they	provided	elaborations	on	
the	outcomes	produced	by	the	past	policies.	They	were	certain	that	the	policy’s	aim	was	
care	for	patient	and	highest	standards	of	professional	practice	-	even	at	the	expense	of	
the	economy.	In	their	view,	the	system	was	responsible	for	providing	the	necessary	care	
at	whatever	cost;	at	the	core	of	healthcare	then	were	patients,	and	everything	else	was	
secondary.	 Within	 such	 a	 system,	 providers’	 sole	 role	 was	 to	 provide	 health	 services	
without	any	fiscal	responsibility,	and	thus	they	were	not	concerned	with	the	economics	
of	 care.	 In	 their	 opinion,	 this	 represented	 a	 good	 health	 system,	where	 everyone	 got	
what	they	needed	and	no	one	talked	about	budgets:		
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“…we	prescribed	antibiotics,	simply,	with	no	budget	limitations,	no	danger,	
I	 think	 that	 we	 used	 to	 have	 a	 very	 good	 health	 care	 system…it	 was	 a	
budget-free	 system…Before	everything	was	budgeted,	one	couldn’t	know	
where	exactly	the	money	came	from,	the	medications	were	produced	here,	
they	were	cheap,	the	factory	wasn’t	making	any	profit…”	(PCP13)	
	
The	elite	stakeholders,	more	notably	those	who	had	working	experience	in	primary	care	
in	 the	 past	 system,	 shared	 similar	 opinions	 on	 the	 previous	 system’s	 benefits	 where	
peoples’	 welfare	 was	 put	 before	 profit.	 For	 most	 of	 them,	 it	 was	 an	 exceptional	
achievement	 that	 medicines	 and	 even	 medical	 preparations	 without	 active	
pharmaceutical	components,	including	supplements	and	vitamins,	were	paid	for	through	
health	insurance.	One	of	them	described	it	as	an	ideal,	‘perfect’	system:	
“I'd	have	to	go	back	to	the	socialist	system,	when	all	registered	drugs	were	
put	on	the	positive	 list,	even	multivitamins,	 supplements….	Meaning	that	
the	 system	 was	 perfect,	 the	 state	 provided	 complete	 coverage	 of	 the	
drugs.”	(EI4)		
	
The	noted	access	to	medicines	without	any	limitations	was	confirmed	through	accounts	
of	 patients,	 who	 made	 similar	 recollections.	 Although	 patients	 constituted	 a	 mixed	
group,	many	of	them	had	experience	or	could	recall	prescribing	and	dispensing	practices	
of	the	previous	system.	Within	this	group	too,	there	were	reflections	on	the	fairness	and	
suitability	of	the	past,	although	not	as	elaborate	and	eloquent	as	those	of	physicians	and	
pharmacists.	
When	comparing	to	the	previous	system,	patients	mostly	reflected	on	the	free	access	of	
medicines	 and	 the	 ease	 of	 obtaining	 them.	 In	 their	 recollections,	 at	 the	 time,	 while	
medicines	 could	 only	 be	 obtained	 on	 prescription,	 getting	 the	 physician	 to	 prescribe,	
even	without	medical	 indication,	was	 not	 seen	 as	 an	 obstacle.	 As	 illustrated	with	 the	
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following	 quote,	 medicines	 -	 in	 this	 case	 antibiotics	 -	 were	 obtained	 without	medical	
indication,	yet	with	physician’s	agreement:	
“Our	children	were	small,	 so	we	always	had	antibiotics	with	us	when	we	
went	on	holidays.	Especially	if	you’re	abroad,	you	don’t	know	any	doctors,	
the	 language.	 In	 case	 the	 child	 got	 fever,	 you	 want	 to	 be	 prepared.	
Everyone	had	a	home	pharmacy;	now	you	can	have	it	too,	but	you	have	to	
pay	for	it.”	(Pat12)	
	
Most	of	the	patients	considered	access	to	free	medicines	as	an	 important	benefit.	 In	a	
wider	 sense,	 this	 was	 articulated	 as	 a	 good	 physician-patient	 relationship	 and	 their	
satisfaction	with	the	treatment	from	the	system.	One	of	the	patients,	however,	pointed	
to	the	fact	that	although	everything	was	free,	there	were	still	some	obstacles	to	access.	
As	illustrated	in	the	quote	below,	these	obstacles	were	not	associated	with	prescribing,	
but	 with	 dispensing,	 and	 more	 specifically	 with	 the	 availability	 of	 medicines	 at	
community	pharmacy	level:		
“Everything	 was	 on	 prescription	 and	 it	 was	 free…it	 was	 not	 always	
accessible,	pharmacies	were	getting	medicines	once	per	month,	but	if	you	
had	a	friend	they	would	stock	 it	for	you...	 It	was	not	so	hard,	now	I	think	
it’s	 more	 difficult	 to	 have	 your	 therapy…there	 are	 many	 more	 patients	
compared	to	then,	everybody	I	know	is	on	some	therapy…”	(Pat5)	
	
Some	 disagreement	 with	 the	 idealisation	 of	 the	 system	 also	 emerged	 among	 elites,	
questioning	whether	 such	 a	 situation	was	 realistic,	 in	 terms	of	 the	 actual	 provision	of	
services	and	medicines	to	patients:	
“Imagine	 how	 all	 the	 needs	 of	 everyone	were	 covered	 (smiling)…	 it	 [the	
previous	 socialist	 system]	 suffered	 from	 non-efficiency…	 [in	 the	 past]	 I	
think	 not	 everything	 was	 provided	 in	 real	 sense,	 people	 received	
prescriptions,	 but	 if	medicines	were	 not	 available	 at	 the	 pharmacy,	 that	
prescription	was	worthless…”	(EI7)	
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Broadly,	 this	 respondent	 showed	 concern	 about	 the	 discrepancy	 of	 providers’	 and	
patients’	perceptions	and	the	reality	of	medicine	supply.	In	other	words,	it	brought	into	
question	 the	 roots	 of	 nostalgic	 feelings	 which	 might	 have	 been	 based	 on	
(mis)perceptions	and	idealisation,	as	already	illustrated	with	earlier	quotes.	In	addition,	
this	quote	clearly	illustrates	elite	stakeholders’	view	on	inefficiency	of	resource	use	as	a	
concern	 of	 sustainability,	 raising	 the	 issue	 of	 necessity	 for	 change,	 addressed	 as	 the	
second	sub-theme	later	in	this	section,	after	elaboration	of	the	sub-theme	on	autonomy	
in	prescribing	and	availability	of	medicines	within	the	past	system.	
5.2.1.2	Autonomy	in	prescribing	and	obtaining	medicines	within	the	
past	system	
Within	 the	 reflections	 on	 past	 policies,	 participants	 mostly	 reminisced	 about	 aspects	
they	 considered	 to	 have	 been	 negatively	 affected	 by	 the	 changes,	 in	 particular	
pertaining	 to	 their	 professional	 role	 for	 providers,	 or	 personal	 benefits	 in	 medicine	
supply	 for	 patients.	 Providers,	 and	 to	 some	 extent	 elite	 stakeholders	 reflected	 that	
changes	brought	 reduced	autonomy	 in	prescribing.	 Interviews	with	patients	 resonated	
on	 the	 same	 theme,	 but	 were	 expressed	 through	 their	 perspective	 of	 reduced	
availability	 of	 medicines,	 due	 to	 reduced	 possibility	 to	 obtain	 prescriptions	 or	 be	
dispensed	 a	 medicine	 without	 a	 prescription.	 As	 described	 in	 the	 previous	 section,	
patients	 talked	 about	 their	 position	 to	 obtain	 medicines	 even	 without	 medical	
indication,	 which	 confirmed	 their	 negotiating	 power	 and	 autonomy	 to	 take	 medicine	
upon	their	own	decision,	once	 it	was	put	at	 their	disposal.	With	this	being	said,	 I	have	
interpreted	 these	 two	 as	 interlinked,	 given	 that	 the	 expressed	 concern	 of	 reduced	
availability	of	medicines,	in	a	way,	could	also	be	interpreted	as	reduced	autonomy	of	the	
patients	in	obtaining	medicines.		
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Both	physicians	and	pharmacists	in	primary	care	felt	a	level	of	threat	to	their	profession	
in	relation	to	the	curtailing	policy	changes.	This	was	articulated	both	in	relation	to	their	
professional	 autonomy	vis-à-vis	 the	 system	and	professional	 appreciation	 in	 the	wider	
society,	which	in	their	view,	were	both	related	to	the	policy	changes.	
Physicians’	 accounts	 revealed	 that	 for	 them	 the	most	 important	 feature	 lost	with	 the	
policy	changes	was	the	‘liberty’	of	making	decisions	in	prescribing:	
“Back	 then	 we	 had	 the	 liberty	 of	 prescribing.	 So	 we	 could	 prescribe	
medicine	with	no	limits	depending	on	the	knowledge	and	the	experience	of	
the	 general	 practitioner,	 on	 what	 he	 [sic]	 gained	 in	 the	 process	 of	
education.”	(PCP6)	
	
This	 so-called	 ‘liberty’	 was	 not	 necessarily	 considered	 by	 all	 of	 them	 as	 an	 ultimate	
freedom	–	although	the	wording	used	by	some	of	the	respondents	might	implicate	such	
perception.	 The	 above	 quote	 also	 illustrates	 physicians’	 opinion	 of	 their	 knowledge	
being	a	very	important	part	of	the	system.	Thus,	their	concern	could	rather	be	linked	to	
the	perceived	questioning	of	their	knowledge	and	professionalism:		
“I	am	a	physician	for	over	fifteen	years,	and	the	least	I	know	is	what	is	the	
best	therapy	for	the	patients…”	(PCP10)	
“…professional	integrity	and	ethics’	are	in	question…”	(PCP12)		
	
Elites,	too,	agreed	that	policy	changes	affected	the	autonomy	of	health	care	providers.	
In	 the	 views	 of	 most	 elite	 respondents,	 the	 autonomy	 of	 physicians	 was	 somewhat	
confined	to	the	limitations	on	prescribing.	This	reduced	their	ability	to	provide	the	most	
optimal	care,	described	by	one	respondent,	as	being	‘creative’	in	prescribing:	
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“When	 the	 doctors	 are	 prescribing,	 very	 often	 they	 are	 concerned	 with	
what	 is	 going	 to	 happen	 to	 them.	 The	 doctor	 has	 to	 be	 creative	 in	 the	
prescription	 of	 treatment,	 with	 untied	 hands	 …	 isn’t	 health	 the	 biggest	
national	treasure?”	(EI3)		
	
Defending	the	importance	of	autonomy	in	prescribing	was	found	mainly	in	the	accounts	
of	 the	elites	who	were	practising	medicine	before	moving	 into	 their	 current	positions.	
This	was	understandable,	 given	 the	 influence	past	experiences	and	memories	have	on	
personal	 attitudes	 and	 perceptions.	 Conversely,	 among	 elite	 stakeholders	 without	
experience	in	primary	care	practice,	discussions	had	a	more	neutral	tone.	There	was	an	
acknowledgement	of	reduced	autonomy,	but	they	had	a	different	view	on	what	it	meant	
and	why	it	was	important	to	providers:		
“They	 [physicians]	 would	 prefer	 having	more	 freedom	when	 it	 comes	 to	
their	 expertise,	 some	 of	 them	 even	 believe	 that	 there	 shouldn’t	 be	 any	
protocols,	that	they	have	studied	long	enough	to	know	it…”(EI8)	
	
The	 above	quote	 also	 illustrates	 another	 issue	 raised	by	most	 elites,	 pertaining	 to	 the	
existence	 of,	 and	 adherence	 to,	 evidence-based	 guidelines.	 For	 them,	 guidelines	were	
inevitable,	 despite	 the	 desired	 ‘freedom’	 and	 discretion	 in	 prescribing.	 Protocols,	 as	
much	 as	 exerting	 rigidity	 of	 one’s	 behaviour,	 were	 considered	 to	 provide	 certainty	 in	
decision-making.	In	their	accounts,	there	was	a	strongly	expressed	association	between	
autonomy	as	a	right	and	protocol	adherence	as	a	responsibility.	Along	these	lines,	when	
asked,	participants	did	not	 feel	 competent	 to	define	 the	boundaries	of	autonomy,	but	
were	certain	it	needed	to	be	confined	to	evidence-based	medicine,	and	conditioned	by	a	
systematic,	standardized	approach	in	advancing	knowledge	and	practice:		
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“The	physician	should	be	enabled	to	treat	the	patients	as	he	[sic]	sees	fit,	
by	 prescribing	 therapies	 that	 he	 [sic]	 thinks	 would	 give	 the	 best	
results…but,	 it	 [the	 system]	 should	 be	 upgraded	 with	 education	 of	 both	
patients	and	physicians…”	(EI6)	
	
In	 most	 elites’	 accounts	 when	 talking	 about	 providers,	 there	 was	 an	 explicit	
acknowledgement	 of	 a	 frustrating	 position	 regarding	 autonomy.	 But,	 the	 elites’	 group	
provided	other	reasons	for	reduced	autonomy,	which	in	their	view	was	not	intended	to	
undermine	primary	care	physicians’	knowledge	or	reputation.	Rather,	it	was	part	of	the	
cost-containment	 strategy,	 involving	 among	others,	 a	 recommendation	 for	 prescribing	
by	 a	 specialist	 for	 medicines	 usually	 prescribed	 at	 primary	 level.	 According	 to	 one	
respondent,	 this	 resulted	 in	 a	 very	 cumbersome	 mechanism	 of	 referring	 patients	
between	 levels	 of	 care	 for	 obtaining	 confirmation	 of	 therapy	 appropriateness	 –	
particularly	and	only	for	very	expensive	medicines:	
“I	understand	the	frustration,	sometimes	they	need	to	send	the	patient	to	
a	specialist	for	a	medicine	that	is	typical	for	primary	care,	because	the	law	
says	it	has	to	be	recommended	by	the	specialist…these	rules	are	imposed	
mainly	 for	medicines	 that	are	very	expensive…	 in	most	cases,	 the	price	 is	
the	 reason	 for	 imposing	 limitations.	 So	 there	 might	 not	 be	 a	 medical	
justification,	as	there	wasn’t	for	the	[…]	but	because	it	was	expensive,	you	
could	 read	on	 the	 package	 that	 it	must	 be	 recommended	by	 a	 specialist	
although	it	had	nothing	to	do	with	that,	the	medicine	is	typical	for	primary	
care,	 the	 same	was	 for	 […],	 it	was	 the	 same	 as	 it	was	 quite	 expensive…	
they	 have	 to	 ask	 permission,	 if	 you	wish,	 to	 prescribe	 something	 that	 is	
already	within	their	competences.”	(EI7)	
	
Physicians	felt	their	knowledge	and	experience	were	also	underappreciated	by	patients.	
They	 were	 particularly	 uncomfortable	 when	 they	 had	 to	 continue	 an	 already	 taken	
prescribing	decision	with	which	they	tended	to	disagree	professionally.	In	several	of	the	
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accounts,	providers	noted	cases	of	patient’s	decision	for	self-medication	or	requests	for	
medicines	for	which	patients	have	heard	from	another	person:		
“I	 don’t	 like	 when	 the	 patient	 already	 started	 using	 antibiotic	 ‘at	 own	
hand’ 4 	or	 when	 ‘colleague’	 who’s	 friend	 of	 the	 patient	 suggests	 the	
antibiotic	I	should	prescribe.”	(PCP17)	
	
Similar	to	physicians,	pharmacists	expressed	the	feeling	of	threat	to	their	profession,	but	
more	in	terms	of	its	appreciation	in	the	society,	and	particularly	by	patients.	For	many	of	
them,	 one	 of	 their	 crucial	 roles	was	making	 the	 final	 check	 on	 prescription	 regarding	
medicine	and	 its	dosage,	and	making	sure	that	patient	understood	 instructions	spoken	
and	 hand-written	 by	 them	 on	 the	 box.	 But	 they	 felt	 patients,	 sometimes	 questioning	
their	ability	to	understand	the	doctor’s	instructions,	undermined	this	role:	
“I	 dispensed	 the	 medicine	 based	 on	 the	 prescription,	 which	 said	 three	
times	one	pill	 per	day…and	he	 [patient]	 started	quarrelling	with	me	 that	
this	is	his	regular	therapy,	it	should	be	half	a	pill	per	day,	not	one;	he	said	
who	am	I	to	increase	the	dosage,	and	to	make	him	take	more…	I	think	he	
simply	didn’t	 remember	what	 the	doctor	 said,	and	he	blamed	 it	 on	me…	
we	get	that	every	day,	it	is	not	nice,	but	you	get	used	to	it…”	(Ph11)	
	
The	 level	 of	 details	 provided	 by	 this	 respondent	 to	 describe	 the	 event	 illustrate	 the	
apparent	discontent	of	providers	–	in	this	case,	pharmacists	–	with	the	patients’	attitude	
towards	their	profession,	manifested	as	distrust	in	their	knowledge	and	qualifications.		
Another	 pharmacist,	 expressed	 this	 discontent	 in	 even	 stronger	 language,	 clearly	
exhibiting	a	frustration	from	the	attitude	of	patients	who	came	in	without	prescriptions,	
sought	 medicines	 but	 would	 not	 listen	 to	 the	 professional	 advice	 provided.	 She	
																																								 																				
4	Idiom	describing	making	a	decision	based	on	own	judgment	and	responsibility,	not	supported	by	any	
formal	expertise	or	legal	mandate.	
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explained	that	her	feeling	in	such	moments	was	as	if	pharmacists	were	perceived	to	be	
simply	delivering	an	ordered	good,	like	a	‘grocer	in	a	grocery	store’	(Ph9):	
“I	am	not	a	grocer	in	a	grocery	store…it	is	the	kind	of	attitude	of	‘I	pay	for	
you	to	give	me	the	medicines	I	want’,	like	they’re	buying	pears	or	apples…	
‘give	me	2	capsules	of	Vibramycin’	is	not	right	when	I	tell	them	that	the	full	
therapy	is	five	days,	but	they	insist,	even	though	the	medicine	is	so	cheap,	
it	 is	not	about	the	money,	 I	think	it	 is	about	their	feeling	of	being	able	to	
get	what	they	want.”	(Ph9)	
	
Several	 of	 the	 elite	 stakeholders	 expressed	 similar	 views	 on	 lessened	 appreciation	 of	
pharmacists,	 considering	 it	 to	 be	 largely	 due	 to	 poor	 enforcement	 of	 the	 dispensing	
policy,	 which	 enables	 uncontrolled	 access	 to	 prescription	 medicines	 without	 a	 valid	
prescription:	
“Very	frequently	patients	are	buying	[on	their	own]	medicines...	Only	40%	
are	covered	by	the	state	and	for	60%	citizens	are	paying…most	of	the	time	
without	a	valid	prescription.”	(EI4)	
“It	is	a	rather	annoying	fact	that	patients	can	come	and	get	any	medicine	
they	ask	for.	First	thing	they	teach	at	pharmacy	school	is	that	every	drug	is	
a	 poison	 at	 the	 same	 time	 and	 has	 to	 be	 under	 control,	 under	 specific	
administration…it’s	 irritating…people	 don’t	 draw	 blood	 themselves,	 so	
they	 also	 shouldn’t	 buy	 or	 take	 medicines	 as	 they	 consider	 necessary.”	
(EI1)	
	
Although	 most	 of	 policy	 makers’	 accounts	 resonated	 in	 the	 tone	 of	 support	 and	
understanding	of	 the	 lessened	appreciation	and	profession’s	 standing	 in	 society,	 there	
were	those	who	disagreed.	One	of	them,	critical	of	his	own	profession,	considered	that	
decreased	cognizance	was	in	part	the	responsibility	of	the	providers	and	professionalism	
they	exhibited	and	practiced	at	their	workplace:	
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“I	expect	 the	pharmacist	 to	be	more	persistent	 in	explaining	to	the	client	
that	 taking	 medicines	 ‘at	 own	 hand’	 is	 not	 appropriate.	 He	 can	 offer	
alternatives,	 herbal	 preparations,	 teas,	 supplements;	 he	 should	 advise	 a	
visit	to	the	doctor	at	the	very	least.”	(EI5)		
	
This	 quote	 in	 a	 rather	 prescriptive	 tone,	 illustrates	 the	 standpoint	 of	 the	 majority	 of	
elites	regarding	the	health	providers’	 roles	 in	society,	but	also	their	 responsibilities.	As	
this	issue	strongly	emerged	and	was	discussed	at	length	with	all	respondent	groups,	it	is	
elaborated	 in	more	details	under	 the	 second	 theme,	as	part	of	 the	 sub-theme	dealing	
with	the	willingness	to	share	responsibility	for	implementation.	
Providers	held	views	about	their	own	roles	and	responsibilities	 in	society.	According	to	
them,	 decreased	 appreciation	 of	 the	 profession	 in	 the	 society,	 was	 undoubtedly	
associated	with	the	policy	changes	pertaining	to	prescribing	and	dispensing	but	also	with	
other	 circumstances,	 such	 as	 strengthening	 patients’	 rights.	 Under	 these	 new	
circumstances,	patients	were	perceived	to	exert	pressure	on	providers	in	the	process	of	
decision-making	 in	 prescribing.	 This	 raised	 the	 issue	 of	 pressure	 that	 pharmacists	 and	
physicians	felt	 from	actual	and	perceived	patients’	expectations,	which	as	an	emerging	
theme	is	elaborated	on	later	in	this	chapter.		
Before	 going	 into	 the	 elaboration	 of	 the	 other	 two	 themes	 touched	 upon	 in	 the	 two	
preceding	paragraphs,	 it	 is	 important	to	describe	the	reflections	of	respondents	on	the	
recent	policies	and	their	differing	perspectives	on	acceptance	of	policy	changes.		
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5.2.2	Reflections	on	recent	policies:	necessity	for	change	and	qualified	
acceptance	
Alongside	 the	 reminiscence	on	 the	past	elaborated	 in	previous	sections,	 reflections	on	
recent	policies	emerged	very	strongly	throughout	dialogues	with	all	respondent	groups.	
But,	as	mentioned	earlier,	when	referring	 to	 the	current	situation,	participants	did	not	
appear	 to	 differentiate	 between	 various	 recent	 policies	 and	 these	 appeared	 to	 be	
considered	 together;	 specific	 policy	 changes	 were	 only	 discussed	 when	 prompted	 in	
interviews.	As	noted	 in	earlier	chapters,	 interviews	specifically	sought	to	explore	views	
on	 limiting	 the	 number	 of	 prescriptions	 and	 prescribing	 budget	 ceilings,	 mandatory	
dispensing	 only	 with	 prescription	 and	 introduction	 of	 dispensing	 budget	 ceilings.	
Dialogues	were	 intended	 to	 investigate	 the	 understanding	 of	 current	 policies	 and	 the	
necessity	 for	 their	enforcement,	as	well	as	attitudes	 towards	 their	 implementation.	As	
will	 be	 elaborated	 upon	 further	 in	 this	 section,	 the	 findings	 showed	 diverse	 accounts	
around	acceptance	of	the	recent	policies	across	respondent	groups.	For	example,	policy	
makers	 were	 explicit	 about	 the	 necessity	 for	 change	 and	 drew	 upon	wider	 economic	
concerns,	 referring	 to	 issues	 such	 as	 ‘inefficiency’	 and	 ‘lack	 of	 resources’	 in	 their	
accounts.	Their	narratives	were	also	characterised	by	a	measured	and	considered	tone,	
with	objectivity	and	fairness	being	evident	in	their	accounts.	In	contrast,	the	accounts	of	
providers	 and	 patients	 were	 more	 emotional	 and	 rich	 with	 detailed	 descriptions	 of	
particular	events,	which	they	used	to	illustrate	the	effects	of	policy	changes.	They	were	
less	keen	to	discuss	the	necessity	for	change,	but	exhibited	their	qualified	acceptance	of	
policy	interventions.		
The	 majority	 of	 elite	 stakeholders	 were	 supportive	 of	 policy	 changes	 introduced	 in	
primary	care	in	Macedonia.	In	their	view,	the	changes	addressed	some	of	the	key	issues,	
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one	of	which	was	the	 inefficient	resource	use	present	across	the	entire	health	system.	
To	 illustrate	 the	 effects	 of	 these	 changes,	 one	 of	 the	 respondents	 proudly	 used	 the	
comparison	 with	 secondary	 and	 tertiary	 care,	 which	 in	 his	 view	 were	 far	 less-well	
organized	and	still	inefficient:		
“Let	me	tell	you,	if	something	good	has	happened	in	this	country,	the	best	
thing	is	the	primary	health	care.	It’s	the	most	organized	system…unlike	the	
secondary	 or	 the	 tertiary	 care,	 where	 we	 invested	 far	 more	 and	 the	
situation	is	still	not	as	good…”	(EI2)	
	
The	 efficiency	 of	 resource	 use,	 touched	 upon	 in	 the	 above	 quote	was	 pointed	 out	 by	
several	 of	 the	 respondents	 as	 one	 of	 the	 key	motivations	 for	 changes.	 In	 their	 view,	
there	was	a	need	to	introduce	efficiency	measures,	for	example	through	rationalization	
of	the	oversupply	of	medical	staff,	as	illustrated	by	one	participant:	
“There	was	oversupply	of	medical	staff	in	some	places...	For	example,	in	a	
town	 of	 10,000	we	 had	 17	 doctors…	 In	 the	 pharmacies	we	 had	 in	 some	
places	5	[pharmaceutical]	staff	in	one	shift…”	(EI7)	
	
To	improve	efficiency,	according	to	elite	stakeholders,	several	models	were	considered.	
While	 none	 of	 the	 respondents	 in	 this	 group	 discussed	 any	 of	 the	 other	 models	
specifically,	in	general	they	were	in	agreement	that	the	model	of	privatisation	of	primary	
care	chosen	in	Macedonia	was	appropriate	for	the	purpose.	There	was	also	a	common	
inference	 that	 change	 of	 the	 existing	 fixed	 salary	 system	 was	 inevitable,	 to	 reduce	
inefficiency	and	unfair	treatment	between	physicians,	as	illustrated	in	the	quote	below:	
“The	 reform	 in	 the	 primary	 care	 was	 inevitable…overemployment	 and	
demotivation	 were	 the	 deciding	 factors.	 There	 were	 doctors	 who	 did	
nothing	but	drinking	coffee	and	chatting	and	got	the	same	salary	as	those	
who	were	examining	forty	to	fifty	patients	a	day.”	(EI8)	
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Improving	 efficiency	 was	 linked	 to	 the	 lack	 of	 resources,	 which	 also	 emerged	 in	 the	
accounts.	As	already	elaborated	above,	many	of	the	elites	acknowledged	various	types	
of	benefits	of	the	old	system,	but	when	elaborating	further	also	raised	concerns	about	
the	 unsustainability	 of	 that	 system.	 One	 of	 the	 extensively	 discussed	 topics	 from	 this	
point	 of	 view	 involved	 pharmaceutical	 expenditure,	 which,	 as	 elaborated	 before,	
included	 both	 prescription	 and	 over-the-counter	 medicines	 and	 was	 used	 on	 a	 first-
come-first-served	basis.	In	the	view	of	the	elite	stakeholders,	changes	and	restrictions	of	
spending	on	medicines	were	inevitable,	and	as	one	participant	noted:		
	 “[…]	 the	needs	and	the	requests	of	 the	health	system	and	the	patients	are	one	
	 thing,	and	what	the	state	can	afford	is	a	different	thing…”(EI4).		
Whilst	the	concept	of	equity	was	not	explicitly	mentioned	or	discussed,	the	above	quote	
illustrates	the	implicit	view	amongst	at	least	some	elites	that	a	fair	and	just	distribution	
of	the	limited	health	resources	was	important.	
Patient	participants	did	not	appear	to	be	as	well-informed	on	the	changes	and	reasons	
for	the	new	policies,	as	the	other	two	groups,	and	their	views	were	very	much	bound	to	
personal	 experiences	 with	 the	 system,	 and	 in	 some	 cases	 –	 second-hand	 knowledge	
acquired	 through	 personal	 conversations	 with	 someone	 engaged	 as	 a	 provider.	 Only	
three	patients	recognized	the	inefficient	resource	use,	exemplified	through	widespread	
stockpiling	of	medicines	at	home:		
“It’s	nice	to	have	all	at	hand,	but	that’s	not	right…	Many	people,	me	too,	
were	having	boxes	of	medicines	at	home,	most	of	it	for	‘God	forbid’	cases	
and	then	thrown	them	away	when	expired.	I	used	to	do	the	same,	but	now	
I	see	that	 it	makes	no	sense	when	you	can	go	to	your	doctor	and	get	the	
prescription	when	you	need	it.”	(Pat8)	
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“My	 sister	 in	 law	 is	 a	 pharmacist,	 and	 she’s	 saying	 that	 earlier	 people	
would	 leave	 [the	pharmacy]	with	whole	bags	of	drugs,	especially	around	
holidays.	And	then,	some	complained	there	were	not	enough	medicines	in	
pharmacies;	 well,	 the	 medicines	 were	 available	 only	 they	 were	 in	 the	
wrong	place…”	(Pat4)	
	
Although	disclosed	 through	personal	examples	and	without	 touching	upon	 the	 system	
perspective,	 the	 above	 quotes	 suggest	 justification	 for	 the	 enactment	 of	 the	 policies,	
from	 the	 perspective	 of	 the	 non-sustainability	 of	 earlier	 practices.	 Thus,	 through	
recognising	 the	 importance	 of	 efficient	 resource	 use,	 these	 three	 patients	 implicitly	
acknowledged	the	necessity	for	policy	change.	Furthermore,	one	of	them	illustrated	this	
using	 the	Macedonian	 idiom	of	 ‘stretching	 your	 legs	 as	 long	as	 your	 carpet	 is’5	(Pat4),	
referring	to	its	common	meaning	that	one	can	only	spend	as	much	as	they	have	and	any	
other	practice	represents	a	route	into	debts	and	poor	reputation.	The	above	quotes	also	
suggest	that	some	patients	were	aware	of,	and	knowledgeable	about,	the	circumstances	
and	 arising	 changes,	 from	 their	 personal	 involvement	 with	 the	 system	 or	 from	
conversations	 with	 a	 person	 who	 had	 experience	 as	 a	 provider.	 However,	 and	 as	
elaborated	in	following	paragraphs,	this	was	not	a	widespread	understanding.	
Such	 justification	 did	 not	 come	 forward	 so	 clearly	 in	 the	 other	 patients’	 accounts,	
although	there	was	a	sense	of	reluctant	acceptance	of	the	changes.	Despite	the	lack	of	
understanding	of	the	policies’	aims	and	functioning,	patients	nonetheless	were	aware	of	
the	 consequences	 of	 policy	 changes.	 The	 following	 quote	 is	 illustrative	 of	 the	 level	 of	
awareness	 about	 more	 recent	 policy	 changes	 that	 characterised	 the	 majority	 of	
interviewed	patients’	accounts:	
																																								 																				
5	Idiom	with	a	meaning	of	getting	only	as	much	as	you	can	afford.	
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“It	was	the	way	it	was,	now	it’s	different…To	me,	the	most	important	thing	
is	 to	 get	 the	 therapy	 I	 need,	 and	 I	 go	 to	 the	 doctor,	 she	 gives	 me	
prescriptions…when	 I	go	 to	 the	pharmacy,	 for	 some	medicines	 they	 say	 I	
have	 to	 pay	 participation	 [co-payment]	 and	 for	 some	 there	 is	 no	
participation.	If	they	say	I	have	to	pay,	I	pay…I	don’t	really	know	how	they	
decide	which	one	goes	with	participation	[i.e.	co-payment]	and	which	one	
without.”	(Pat11)	
	
Of	note	in	the	final	sentence	of	this	quote	and	typifying	many	patients’	experiences,	was	
a	lack	of	understanding	as	to	specific	details	about	recent	policy	and	with	the	exception	
of	 the	 three	 informed	 patients	 discussed	 earlier,	 ignorance	 of	 recent	 policy	 was	 also	
bound	up	in	a	perception	of	patients	having	no	options:		
“Your	 question	 is	 ridiculous	 to	 me,	 sounds	 like	 we	 have	 some	 other	
choice…we	are	 patients,	we	 have	 no	 other	 alternative	 but	 to	 do	 as	 they	
have	 decided;	 if	 I	 don’t	 like	 the	 procedures,	 I	 can	 always	 buy	 the	 drugs	
privately,	but	why	spend	money	when	I	can	follow	the	procedure	and	get	it	
for	a	lot	less?”	(Pat	10)	
	
Although	according	to	this	participant,	the	implementation	had	little	to	do	with	patients’	
choice,	as	will	be	described	later	in	the	chapter,	there	were	choices	that	patients	made,	
especially	when	 it	came	to	negotiating	medicine	supply	and	practicing	self-medication.	
Their	 views	 on	 the	 impact	 of	 policies	 on	 their	 behaviour	 and	practices	 are	 elaborated	
under	the	third	theme	of	pressures	in	practice.	
Thus,	 I	 have	 to	 note	 that,	 specific	 policies	 were	 not	 deliberated	 at	 length	 with	 the	
patients’	group,	given	their	lack	of	knowledge	on	policies’	rationale	and	aim.	Rather,	the	
discussions	 were	 directed	 towards	 opinions	 on	 the	 effects	 of	 policy	 implementation,	
which	is	elaborated	under	the	second	theme,	later	in	this	chapter.		
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Among	 physicians	 there	 was	 some	 understanding	 of	 the	 necessity	 for	 change,	 and	
qualified	 acceptance	 of	 the	 new	 circumstances.	 Very	 few	 of	 them	 expressed	 their	
understanding	 in	a	positive	tone,	such	as	the	one	who	used	the	analogy	of	a	domestic	
budget:		
“Budgets	are	limited	thing,	it	is	not	a	bottomless	well,	and	we	all	live	in	the	
real	world…it’s	like	the	budget	you	have	at	home…”	(PCP3)	
	
When	 asked	 about	 privatisation,	 in	 a	 number	 of	 accounts	 there	 was	 a	 sense	 that	
physicians	were	not	quite	aware	why	 the	policy	change	had	been	 introduced.	Most	of	
them	already	felt	used	to	being	private	providers	and	recalled	the	transition	from	public	
to	 private	 itself	 to	 have	 not	 been	 particularly	 difficult;	 they	 continued	 to	 perceive	
themselves	as	part	of	the	public	health	service	provision,	with	one	participant	(PCP	10)	
commenting	that	they	felt	they	belonged	to	the	‘most	important	and	indispensable	part	
of	 the	 healthcare	 system’.	 It	 was	 apparent,	 however,	 that	 many	 still	 questioned	 the	
necessity	of	this	transformation	overall.	However,	the	prevailing	opinion	was	somewhat	
dismissive	of	the	policy	change;	to	them,	privatisation	disrupted	the	continuity	of	care,	
and	links	to	other	levels	in	the	health	system,	as	illustrated	in	the	following	quote:	
“They	 shouldn’t	 have	 privatized	 the	 primary	 care,	 we	 were	 ‘one’	 in	 the	
health	 centres	 and	 working	 together	 with	 the	 hospitals,	 maternities,	
community	nurses…now	we	are	separate	worlds…”	(PCP11)	
	
Only	 one	 participating	 physician	 referred	 to	 the	 impact	 of	 policy	 change	 on	 the	
efficiency	of	 resource	use	and	service	provision,	and	even	this	participant	appeared	to	
have	gained	insights	from	rather	superficial	information	acquired	from	the	bulletins	and	
reports	read	out	of	personal	interest:	
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“It	 was	 introduced	 so	 as	 to	 limit	 the	 spending	 on	medicines.	 In	 general,	
practitioners	 prescribe	 medicines	 a	 lot,	 with	 their	 cap	 and	 fist6,	 and	 I	
believe	 that	 this	 ministerial	 policy	 directly	 aims	 to	 limit	 that	 practice...”	
(PCP4)	
	
Physicians	 continued	 to	 see	 privatisation	 as	 insufficiently	 thought-through	 policy	 with	
lots	 of	 problems	 arising	 in	 its	 implementation.	 Their	 shared	 experiences	 hugely	
contributed	to	their	views	that	the	previous	system	was	far	fairer	to	both	patients	and	
providers.	 There	 was	 apparent	 justification	 of	 the	 policy	 changes,	 although	 mostly	
hypothetical,	 further	 contrasted	 with	 statements	 of	 reluctant	 acceptance.	 The	 arising	
dilemma	 as	 to	 whether	 the	 changes	 were	 a	 necessary,	 logical	 and	 inevitable	 step	 in	
reforming	 the	 health	 system	 was	 mainly	 informed	 by	 individual	 examples	 of	 daily	
practice,	and	those	are	elaborated	under	the	second	theme	dealing	with	the	aspects	of	
policy	implementation,	in	the	later	parts	of	this	chapter.	
Pharmacists	were	also	not	too	familiar	with	the	overall	aims	of	any	of	the	policies	they	
have	 been	 asked	 about.	 For	 them,	 privatisation	 was	 not	 a	 significant	 issue	 and	 they	
readily	 accepted	 being	 part	 of	 the	 private	 sector.	 They	 were	 to	 a	 lesser	 extent	
questioning	 the	 necessity	 for	 change	 compared	 to	 physicians.	 One	 of	 the	 underlying	
reasons	 might	 be	 that	 liberalisation	 of	 the	 health	 market	 started	 with	 private	
community	 pharmacy	 practice,	 as	 early	 as	 the	 beginning	 of	 the	 1990s,	 whereas	 the	
privatisation	of	primary	care	came	over	a	decade	later.	Several	of	the	respondents	who	
shared	 their	 opinion	 about	 the	 necessity	 for	 change	 considered	 it	 to	 be	 for	 ‘money	
saving’	(Ph7)	and	monitoring	the	use	of	medicines:	
																																								 																				
6	Cap	and	fist	is	a	local	Macedonian	idiom	which	approximates	to	giving	in	abundance	
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“I	 think	 it	 was	 for	 the	 medicine	 usage,	 who	 was	 taking	 what	 and	 how	
much…in	 the	 previous	 system	 we	 had	 no	 control;	 of	 course	 we	 had	
prescriptions,	 but	 no	 one	 was	 controlling	 who	 was	 taking	 how	much	 of	
what…”	(Ph2)	
	
However,	 far	 more	 important	 concerns	 for	 pharmacists	 were	 the	 other	 two	 policies	
considered	in	this	research,	namely	the	dispensing	ceiling	policy	(referred	to	as	quotas)	
and	the	enforcement	of	the	dispensing	policy,	which	are	elaborated	later	in	this	section.		
Although	 physicians	 and	 pharmacists	 shared	 their	 views	 on	 the	 overall	 policy	
circumstances	and	necessity	for	change,	they	were	more	interested	in	talking	about	the	
current	 system	 through	 recounting	 involvement	 with	 particular	 policies.	 They	 were	
generally	 very	 opinionated	 about	 the	 budget	 ceilings	 or	 limits	 to	 prescribing	 and	
dispensing,	 and	 they	 did	 not	 talk	 about	 privatisation	 specifically,	 as	 for	most	 of	 them	
these	policies	were	seen	as	part	of	the	privatisation	process.	However,	while	most	of	the	
providers	justified	policy	changes,	it	was	apparent	that	such	justification	was	accepted	in	
theory	 qua	 policy	 change	 but	 in	 practice,	 views	 differed	 somewhat	 and	 were	 more	
equivocal.	 Their	 accounts,	 reflecting	 quite	 an	 opposite	 opinion,	 were	 rich	 of	 detailed	
narrations	of	specific	events	shared	as	experience	with	implementation	of	these	policies.		
With	 regards	 to	 specific	 policies	 of	 interest	 to	 this	 research,	 understanding	 and	
justification	 was	 amply	 offered	 by	 policy	 makers	 for	 the	 introduction	 of	 limitation	 to	
prescribing.	 The	 major	 thread	 of	 arguments	 was	 namely	 around	 the	 expenditure	 on	
medicines:	
“Limiting	the	prescribing	was	a	very	necessary	step,	with	the	country	being	
in	 transition	 and	 economically	 very	 weak…As	 you	 know,	 everything	 was	
covered	before	and	that	created	huge	costs,	enormous	debts	of	the	health	
system…We	separated	from	Yugoslavia	and	some	of	the	companies	were	
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in	 Slovenia,	 Croatia,	we	were	 not	 part	 of	 the	 same	 country	 anymore,	 so	
those	debts	became	real	liabilities…”	(EI1)	
	
This	 respondent	 provided	 explanation	 for	 the	 necessity	 to	 introduce	 limitations	 to	
prescribing,	referring	back	to	the	old	system	in	which	everything	was	covered.	Namely,	
what	this	respondent	is	explaining	is	the	historical	background	of	rising	debts,	generated	
through	 unlimited	 medicine	 supply,	 despite	 the	 political	 and	 economic	 changes	 that	
happened	in	the	country.	During	the	times	of	Socialist	Federative	Republic	of	Yugoslavia,	
there	was	one	health	market	with	state-owned	factories	for	producing	and	distributing	
medicines	to	state-owned	health	facilities.	After	separation	from	Yugoslavia,	Macedonia	
was	 still	 providing	 its	 supplies	 from	 some	 of	 these	 factories,	 which	were	 now	 part	 of	
other	countries,	and	which	 imposed	market	rules	for	medicine	supply.	Thus,	under	the	
new	 political	 circumstances,	 debts	 within	 the	 health	 system	 very	 quickly	 became	
executable	liabilities,	demanding	restrictions	in	medicine	supply.	
Further	to	improving	efficiency,	the	policy	for	limitation	of	number	of	prescriptions	was	
justified	 as	 a	 measure	 for	 standardization	 of	 care	 at	 primary	 level.	 It	 was	 widely	
acknowledged	 that	 unlimited	 medicine	 supply	 was	 encouraging	 overprescribing,	 and	
several	 of	 the	 respondents	 talked	 about	 this	 as	 particularly	 apparent	 in	 prescribing	 of	
antibiotics.	 One	 of	 the	 respondents	 pointed	 to	 research	 conducted	 in	 the	 early	 years	
after	 independence	 (Spasovski	 1996,	 PhD	 dissertation),	which	 showed	 that	 antibiotics	
were	prescribed	widely,	to	100%	of	patients	who	came	in	with	any	symptom	that	could	
be	mistaken	for	bacterial	infection,	including	sore	throat,	running	or	congested	nose:	
“…every	 patient	 who	 had	 some	 sort	 of	 infection	 was	 treated	 with	
antibiotics…	 so	 antibiotics	 were	 prescribed	 100%...	 It	 was	 striking	 that	
antibiotics	 were	 generously	 prescribed	 for	 respiratory	 infections,	
exclusively	upper	respiratory	ones,	and	the	results	were	catastrophic.	One	
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could	 see	 that	 even	 children	 at	 the	 age	 of	 6	 were	 prescribed	 with	
aminoglycosides…”	(EI9)	
	
Thus,	 the	 policy	 of	 limitation	 on	 prescribing,	 in	 the	 policy	 makers’	 view	 had	 dual	
intended	 outcome:	 to	 ensure	 pharmaceutical	 costs	 containment	 and	 prudent	
prescribing.	For	several	of	 them	the	policy,	however,	was	not	producing	 the	economic	
saving	 anticipated,	 and	 for	 some	 initially	 it	 was	 not	 intended	 to.	 One	 participant	
described	 it	 as	 ‘the	 first	 aid’	 policy	 on	 dealing	 with	 overprescribing;	 the	 policy	 was	
intended	to	introduce	prescribing	discipline	with	primary	care	physicians:		
“We	expected	some	effects,	but	not	drastic…	And	there	was	some	lowering	
of	 the	expenditures.	 The	 intention	was	 for	 physicians	 to	understand	 that	
there	is	a	limit,	and	to	make	them	adhere	to	it.	This,	as	first	aid	policy	was	
to	 limit	 the	 number	 of	 prescriptions	 per	 patient	 without	 any	 value	
attached	to	it.	So,	the	physicians	could	write	any	medicine	from	10	to	1000	
denars	and	it	would	still	count	as	one	prescription…We	had	no	experience	
where	to	put	the	thresholds…”	(EI12)	
	
Many	of	 the	 elite	 stakeholders	 shared	 the	 same	 view	about	 the	 first	 policy	 change	of	
limiting	 the	 number	 of	 prescriptions.	 Another	 policy	 maker	 respondent	 explained	 in	
further	 detail,	 as	 illustrated	 through	 the	 quote	 below,	 how	 limiting	 the	 number	 of	
prescriptions	 would	 potentially	 contribute	 to	 increased	 pharmaceutical	 expenditure,	
since	the	prescriptions	were	not	accounted	for	their	monetary	value:	
“Let’s	say,	a	package	of	diazepam	costs	30	denars,	so	the	doctors	asks	the	
patient	 to	go	and	buy	 this	medicine,	 the	patient	 still	needs	 to	pay,	 if	not	
30,	 then	20,	 so	 that	 these	kinds	of	medicines	wouldn’t	be	counted	 in	 the	
total	 number	 of	 prescriptions.	 The	 doctor	 doesn’t	 want	 the	 cheap	
medicines	to	be	counted	in	the	end	so	that	he	could	prescribe	to	any	of	his	
patients	 or	 relatives	 a	 medicine	 that	 costs,	 let’s	 say,	 3000	 denars…	 It’s	
because	 the	 medicine	 that	 costs	 30	 and	 the	 other	 one	 that	 costs	 3000	
denars	were	counted	in	the	same	way.”	(EI1)	
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This	 participant	 was	 arguing	 for	 justification	 of	 subsequent	 budget	 ceiling	 policies	 for	
prescribing	and	dispensing.	Many	of	 the	elites	had	only	general	understanding	of	how	
these	 policies	 were	 functioning	 in	 practice,	 and	 were	 interpreting	 them	 as	 an	
advancement	 of	 the	 efficiency-improving	 agenda.	 The	 majority	 of	 them	 considered	
budget	ceilings	policy	to	be	a	better	solution	than	the	previous	limitation	of	number	of	
prescriptions,	 aimed	 at	 a	 real	 containment	 of	 pharmaceutical	 expenditure	 at	 primary	
level:	
“…Budget	 ceilings	on	medicines	had	 to	be	 introduced,	a	prescription	 is	 a	
monetary	 instrument	 and	 has	 to	 have	 a	 price	 tag	 to	 it.	 Over	 time,	 we	
found	doctors	that	prescribed	only	several	very	expensive	medicines	all	the	
time,	and	that	was	symptomatic…”	(EI1)	
“…based	on	the	experience	with	the	limits	[on	number	of	prescriptions]	we	
were	 able	 to	 define	 the	 [budget]	 ceilings…we	 are	 able	 to	 provide	 more	
[medicines]	with	the	money	we	have.”	(EI12)	
	
As	 elaborated	 earlier,	 providers	 did	 not	 consider	 budget	 ceilings	 to	 be	 an	 appropriate	
measure	for	regulating	their	relationship	with	the	system.	In	fact,	the	majority	of	them	
considered	 this	 to	 be	 a	 measure	 of	 unnecessary	 control,	 again	 reinforcing	 that	 it	
undermines	their	professional	knowledge	and	ethics	in	prescribing	the	most	appropriate	
therapy:	
“I	don’t	 think	 there	should	be	a	budget	because	we	are	aware	enough…I	
don’t	 think	 there	 should	 be	 a	 Fund,	 or	 a	 budget	 or	 anything.	 Nobody	 is	
that	foolish,	patients	aren’t	either,	nobody	would	take	a	medication	just	to	
have	it;	so	people	really	consume	those	medications.”	(PCP3)	
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5.2.3	Summary	of	policy	perceptions	
The	data	presented	above	 illustrates	 the	diversity	of	 views	 regarding	past	and	current	
policies,	and	acceptance	of	policy	changes.		
Across	 the	 accounts	 of	 all	 respondent	 groups,	 there	 was	 an	 explicit	 positive	 sense	 of	
attachment	 to	 the	 policies	 of	 the	 past.	 In	 the	 narratives,	 the	 nostalgic	 notion	 was	
dominantly	linked	to	autonomy	in	prescribing	and	dispensing	(for	providers)	and	access	
to	medicines	(for	patients).	For	providers,	the	old	‘perfect’	and	‘budget-free’	system	was	
perceived	 as	 posing	 ‘no	 danger’	 to	 the	 professional	 delivery	 of	 services.	 Stories	 from	
their	 experiences	 were	 used	 to	 provide	 arguments	 that	 the	 previous	 system	 was	 far	
fairer	for	both	providers	and	patients,	although	there	were	some	contrasting	views	of	its	
unsustainability.	 Elites	 also	 perceived	 the	 previous	 system	 as	 fairer,	 but,	 were	 more	
objective	in	their	understanding	that	it	was	unsustainable.	For	patients,	the	past	system	
was	better	as	it	represented	easy	and	unlimited	access	to	medicines.		
On	 the	 current	 policies,	 respondent	 groups	 also	 had	 different	 opinions.	 These	 ranged	
from	 justifying	 the	 inevitability	 of	 changes	 by	 the	 policy	 makers’	 group	 to	 qualified	
acceptance	 by	 the	 providers	 and	 patients.	 Policy	 makers	 advocated	 the	 necessity	 for	
change,	 offering	 sustained	 and	 forthright	 arguments	 of	 justification	 that	 related	 to	
improving	efficiency	of	resource	use	and	rational	prescribing	based	on	protocols.	Among	
providers,	 there	 was	 general	 lack	 of	 understanding	 of	 policy	 changes	 overall;	 the	
accounts	 were	 deprived	 of	 serious	 contemplation	 on	 the	 aims	 of	 these	 policies	 at	
conceptual	 level.	 The	 most	 apparent	 was	 the	 dilemma	 as	 to	 whether	 the	 changes	 -	
privatisation	in	particular	-	were	a	necessary,	logical	or	inevitable	step	in	reforming	the	
health	 system,	 which	 culminated	 in	 a	 reluctant	 acceptance	 of	 the	 policy	 changes.	
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Overall,	discussions	with	regards	to	current	policies	were	driven	by	examples	of	practice	
and	difficulties	in	implementation	and	their	consequences	that	will	be	considered	in	the	
following	 sections	 of	 this	 chapter.	 Patients	 were	 aware	 that	 health	 reforms	 were	
happening,	 but	 most	 of	 them	 were	 not	 aware	 of	 specific	 policy	 changes.	
Understandably,	 their	 views	 were	 mostly	 informed	 by	 their	 own	 experiences,	 which	
reflected	issues	of	implementation,	and	patients	lacked	understanding	of	specific	policy	
changes.	 A	minority	 of	 patients	were	 somewhat	more	 knowledgeable	 of	 the	 on-going	
processes,	 mainly	 as	 a	 result	 of	 their	 own	 experience	 of	 working	 in	 the	 system	 or	
knowing	 a	 provider.	 They,	 too,	 provided	 justification	 for	 policy	 changes,	 with	
argumentation	mainly	on	resource	use	and	availability	of	medicines.		
The	above	sections	described	the	wider	understanding	of	the	policy	context	in	which	the	
present	 research	 is	 investigating	 the	 attitudes	 and	 practices	 of	 the	 primary	 care	
physicians	 and	 pharmacists	 regarding	 prescribing	 and	 dispensing.	 In	 the	 following	
sections,	 the	 other	 two	 main	 identified	 themes	 relating	 to	 implementation	 problems	
and	pressures	in	practice	will	be	presented.	
	
5.3. Policy	implementation	problems:	lack	of	involvement	and	
support		
	
This	section	explores	the	second	identified	key	theme,	which	related	more	specifically	to	
the	 implementation	of	policy	 changes,	particularly	 from	 the	perspective	of	pharmacist	
and	 physician	 providers.	 Furthermore,	 this	 theme	 was	 broadly	 negative	 and	 revealed	
perceptions	 amongst	 providers	 of	 a	 lack	 of	 being	 sufficiently	 included	 in	 any	 of	 the	
processes	related	to	their	line	of	work.	Notably,	they	expressed	a	lack	of	involvement	in	
policy	making,	 revealing	 the	 feeling	of	not	being	consulted	sufficiently	about	decisions	
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made	in	primary	care.	They	also	expressed	dissatisfaction	with	the	support	provided	by	
institutions	in	the	implementation	of	imposed	policies,	and	a	feeling	of	being	detached	
from	 the	 overall	 process.	 Elite	 stakeholders’	 accounts	mirrored	 to	 some	 extent	 these	
perceptions	 of	 providers,	 but	 in	 contrast	 there	 was	 more	 concern	 about	 policy	
implementation	deficiencies	overall	and	a	perceived	failure	to	observe	the	full	potential	
of	 policies.	 However,	 they	 were	 unwilling	 to	 share	 the	 responsibility	 for	 the	 lack	 of	
implementation,	which	they	considered	to	be	mostly	within	the	domain	of	the	other	two	
groups	 –	 patients	 and	 providers.	 They	 believed	 that	 improving	 health	 literacy	 for	
patients	 and	 education	 for	 providers	 could	 potentially	 be	 part	 of	 the	 solution.	On	 the	
same	 issue,	 providers	 also	 did	 not	 quite	 readily	 accept	 the	 responsibility;	 they	
considered	policy	makers	to	be	in	a	position	to	improve	implementation,	through	fixing	
the	 identified	 flaws	 for	 implementation.	Physicians	and	pharmacists	were	also	 seeking	
accountability	 from	the	others	 in	 the	provider	group	(physicians	 from	pharmacists	and	
vice	 versa).	 Their	perception	of	 responsibility	was	always	described	at	 individual	 level,	
narrowing	 it	down	to	sporadic	and	distant	cases	of	 lack	of	adherence	to	policies.	Also,	
they	 were	 calling	 upon	 the	 interrelatedness	 of	 prescribing	 and	 dispensing	 but	 never	
considered	 a	 shared	 responsibility	 as	 a	 possibility	 for	 improved	 implementation.	 In	
addition,	 providers	 sought	 responsibility	 from	 patients,	 bringing	 to	 the	 attention	
experienced	and	perceived	pressures,	which	are	elaborated	under	the	third	theme	later	
in	 this	 chapter.	 But,	 before	 arriving	 at	 the	 theme	 of	 pressures	 in	 practice,	 in	
continuation,	 I	 elaborate	 the	 findings	 from	 the	 second	 theme	 of	 issues	 with	
implementation,	 divided	 into	 three	 sub-themes:	 lack	 of	 involvement	 in	 policy	making,	
lack	 of	 support	 to	 implementation,	 and	 willingness	 to	 share	 responsibility	 for	 lack	 of	
implementation.	
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5.3.1	Lack	of	involvement	in	policy	making		
An	 identified	 sub-theme	 concerned	 providers’	 perceived	 lack	 of	 involvement	 in	 the	
policy	development	process.	In	their	accounts	they	emphasised	their	feeling	of	exclusion	
from	 the	 processes	 that	 directly	 affected	 their	 daily	 work.	 Physicians	 were	 more	
emotional	 about	 having	 a	 chance	 to	 participate	 in	 the	 policy	 making,	 whereas	
pharmacists,	were	not	 as	 concerned	with	 their	 involvement	 in	 consultation	processes.	
Several	 physicians	 admitted	 there	 might	 be	 some	 processes	 -	 consultations	 through	
their	professional	association	body	for	example	-	but	most	were	not	aware	of	when	and	
how	these	processes	had	happened,	and	doubted	if	they	actually	existed.	Several	of	the	
physicians	expressed	a	very	sceptical	view,	with	one	participant	believing	 that	most	of	
the	policies	had	been	‘invented’	by	someone	‘who	was	never	a	practicing	doctor’	(PCP5).	
Overall,	there	was	a	perceived	lack	of	communication,	which	exacerbated	the	sense	of	a	
lack	of	involvement	and	a	didactic	approach:	
	“I	 don’t	 think	 anyone	was	 ever	 invited	 to	 tell	 our	 problems…maybe	 the	
associations…we	 are	 only	 invited	 when	 they	 [Ministry	 and	 HIF]	 want	 to	
inform	 us	 of	 the	 new	 rules.	 Sometimes	 not	 even	 that,	 they	 simply	 send	
them	in	an	e-mail	as	instructions.”	(PCP7)		
	
Providers	believed	that	policies	should	not	be	developed	without	their	participation,	and	
were	 persuaded	 that	 officials	 and	 policy	 makers	 without	 practicing	 experience	
particularly	in	primary	care	could	not	develop	appropriate	policies:	
“I	don’t	think	anyone	working	in	the	Ministry	and	not	in	the	primary	health	
care	 should	 create	 a	 policy;	 one	 should	 have	 experience	 in	 the	 field.”	
(PCP6)	
“…we	are	forced	to	sign	the	contract	because	if	you	don’t,	you’d	be	out	of	
work,	 nobody	 asks	 if	 you	 want	 to	 sign	 it	 or	 not,	 all	 they	 [the	 Health	
Insurance	Fund]	do	 is	give	us	 the	papers,	we	don’t	 even	 read	 them,	why	
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should	we,	even	if	we	read	and	don’t	agree	with	everything,	we	still	have	
to	sign	them.	Otherwise,	I’d	be	out	of	work,	and	what	patient	would	come	
to	my	private	practice?	So	I	accept	everything.”	(PCP3)	
	
Although	wanting	 to	 be	 part	 of	 the	 process,	 providers	were	 not	 very	 articulate	 about	
how	this	involvement	could	be	achieved.	Only	two	providers,	however,	expressed	their	
ideas	on	how	they	could	be	involved,	mentioning	online	consultation	and	surveys:		
“Well,	 maybe	 before	 sending	 out	 a	 plan	 of	 activities	 or	 measures,	 they	
could	include	us	by	making	surveys	on	whether	we	agree	on	some	issue	or	
not….”	(PCP6)	
	
Among	 pharmacists,	 there	 were	 also	 several	 who	 did	 not	 feel	 they	 were	 consulted	
enough.	One	respondent	shared	an	example	of	an	initiative	among	small	pharmacies	to	
become	a	relevant	voice	at	the	negotiating	table,	which	in	her	view,	as	depicted	in	the	
first	 quote	 below	 (Ph6),	 was	 not	 adequately	 recognised.	 Instead,	 as	 illustrated	 in	 the	
second	quote,	they	felt	that	they	simply	had	to	deliver	on	the	decisions,	without	being	
asked	‘if	they	can	do	it’	(Ph4):	
“Large	pharmacy	chains	like	[…]	and	[…]	are	very	strong,	I	don’t	have	such	
position…We	[small	pharmacies]	got	organized	in	the	Joint	Pharmacies	of	
Macedonia,	 there	were	benefits	 for	 joint	procurement,	having	one	voice,	
but	 still	 the	 HIF	 does	 how	 they	 think,	 we	 didn’t	 get	 to	 change	 much…”	
(Ph6)	
“We	 get	 letters	 or	 e-mails	 with	 decisions,	 what,	 how	 to	 do…there	 is	 no	
question	 in	 those	mails	 if	we	 can	 do	 it…I	 don’t	 even	want	 to	 send	 reply	
back	with	a	question,	as	they	will	see	who	is	sending	and	maybe	they	will	
send	me	an	inspection…”	(Ph4)	
	
Lack	of	involvement	in	the	policy	making	was	expressed	also	as	not	being	consulted	on	
the	list	of	treatments	made	available	to	patients.	As	noted	in	the	earlier	sections,	some	
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of	the	medicines	typically	prescribed	at	primary	level	were	raised	at	higher	level	of	care	
and	 could	 be	 prescribed	 only	 upon	 specialist	 recommendation.	 The	 purpose	 of	 such	
decisions	 was	 argued	 by	 policy	 makers	 to	 relate	 to	 controlling	 consumption	 of	 very	
expensive	medicines	 (as	 exemplified	 in	 the	quote	by	 EI7	 earlier	 (page	144),	 under	 the	
sub-theme	of	autonomy),	but	was	interpreted	by	physicians	as	a	lack	of	involvement,	as	
they	were	not	consulted	on	such	decision.		
“We	 are	 limited	 as	 [primary	 health]	 doctors	 to	 treat	 the	 patients	 in	
accordance	with	 the	knowledge	we	have	acquired...if	 I	 know	a	patient	 is	
well	 off,	 I	might	 suggest	 to	 buy	 the	medicine	 out-of-pocket,	 if	 it’s	 better	
than	the	one	on	the	insurance”	(PCP7)	
“I	 want	 to	 be	 treated	 as	 a	 professional.	 I	 am	 not	 here	 to	 take	 anything	
from	them,	I’m	here	to	do	my	job,	and	I	deserve	to	be	part	[of	creation	of	
policies].”	(PCP16)	
	
As	reflected	in	this	quote,	and	articulated	by	other	physicians	as	well,	after	privatisation,	
there	 was	 a	 notion	 of	 divide	 -	 a	 sense	 of	 them	 and	 us	 -	 which	 was	 interpreted	 as	
widening	 with	 the	 introduction	 of	 the	 subsequent	 policy	 changes.	 As	 a	 prevailing	
perception	among	 the	providers,	 this	detachment	 from	 the	 system	was	 considered	an	
important	 finding	and	 interpreted	under	a	separate	sub-theme	and	 is	described	 in	 the	
next	section.	
Based	on	their	expressed	perception	of	lack	of	 involvement	in	policy	making,	providers	
were	asked	to	reflect	on	possible	 ideas	they	might	have	shared	 if	 they	were	 invited	to	
participate	in	policy	creation	processes.	From	these	discussions	and	across	other	parts	of	
interviews,	 it	 was	 apparent	 that	 providers	 found	 it	 difficult	 to	 identify	 specific	
suggestions.	So,	although	having	strong	feelings	of	being	unrightfully	distanced	from	the	
processes,	 providers	 did	 not	 appear	 to	 have	 specific	 proposals	 relating	 to	 their	
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involvement.	 There	 was,	 however,	 a	 belief	 among	most	 of	 the	 providers	 –	 especially	
physicians	–	that,	if	given	the	chance	to	exert	influence,	they	would	either	revert	to	the	
previous	 system	or	waive	 some	of	 the	 restrictions	and	administrative	burden	 imposed	
with	the	changes.	The	first	of	these	propositions	is	consistent	with	the	views	expressed	
in	section	5.2.1.	The	second	suggested	more	of	a	concern	around	possible	bureaucracy	
and	 process	 and	 did	 not	 appear	 to	 be	 related	 to	 the	 main	 concern	 about	 a	 lack	 of	
involvement	 for	 providers.	 However,	 one	 respondent	 did	 express	 a	 view	 as	 to	 how	
policies	should	be	changed	to	improve	providers’	position:	
“…as	 there	 is	 a	 budget	 ceiling	 setting	 the	 limit	we	 cannot	 exceed,	 there	
should	 be	 a	 lower	 limit	 [threshold]	 that	we	mustn’t	 go	 below	 as	well.	 If	
somebody	doesn’t	spend	the	estimated	amount	of	money,	he	[sic]	should	
be	rewarded.	There	should	be	rewards	as	there	are	sanctions.”	(PCP3)	
	
It	was	also	interesting	to	observe	that	elites,	in	particular	policy	makers	did	not	consider	
it	problematic	that	providers	were	only	informed	about	policy	decisions	that	they	were	
asked	 to	 conform	 to.	 In	policy	makers’	 accounts,	providers	were	mostly	mentioned	as	
part	 of	 the	 implementation	 process,	 and	 policymaking	 was	 seen	 as	 the	 work	 of	
government	 institutions	 including	 themselves	 or	 institutions	 they	 represented.	 In	 this	
way,	 they	 appeared	 to	 implicitly	 delineate	 the	 responsibilities:	 policy	 makers	 –	 for	
policymaking,	and	providers	–	for	 implementation.	Overall,	the	 issue	of	 involvement	of	
diverse	 stakeholders	 in	 the	policy	making	process	was	 covered	 rather	 vaguely	 in	 their	
accounts.	 Policy	 makers	 were	 unanimous	 in	 acknowledging	 the	 necessity	 for	
involvement,	 but	 this	 appeared	 to	 be	manifest	more	 in	 a	 symbolic	 rather	 than	 actual	
way;	 only	 a	 few	 policy	 makers	 advocated	 or	 actually	 gave	 examples	 of	 provider	
involvement	in	policy	development,	mostly	through	providers’	associations.		
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Apart	from	the	involvement	in	policy-making,	participation	of	providers	in	development	
of	clinical	protocols	and	evidence-based	guidelines	was	mentioned.	Providers’	opinions	
were	diversified	and	at	one	extreme	were	those	who	had	no	opinion	on	who	should	be	
involved	in	writing	such	protocols.	In	contrast,	others	considered	their	non-involvement	
to	be	a	problematic	limit	to	them	expressing	their	professional	knowledge	and	potential	
for	providing	best	care	to	patients.	In	line	with	the	latter,	one	policy	maker	respondent	
raised	the	issue,	confirming	lack	of	providers’	involvement,	despite	her	view	that	it	was	
critical	to	ensuring	ownership	and	adherence	to	such	standardized	procedures:	
“This	is	exactly	what	I	was	talking	about	earlier.	Before	it	[the	guideline]	is	
accepted	and	finalized	by	the	[Health	Insurance]	Fund	and	the	Ministry	[of	
Health]	 as	a	public	 document,	 to	make	 the	draft	 available	 for	 discussion	
and	review	to	the	doctors	in	their	Association	or	on	their	web	site,	so	they	
can	provide	their	input	and	express	their	thoughts	about	the	guideline.	In	
that	case	the	guidelines	will	be	more	acceptable	for	all	of	them.”	(EI6)	
	
Other	 policy	 makers	 also	 considered	 evidence-based	 guidelines	 to	 be	 essential	 for	
containing	 costs	 and	 providing	 better	 quality	 of	 care,	 but	 as	 mentioned	 earlier,	 they	
have	 not	 made	 clear	 connection	 between	 guidelines	 development	 and	 providers’	
involvement.	 Rather,	 in	 the	 view	 of	 the	 majority,	 this	 was	 the	 role	 of	 academia	 in	
collaboration	with	the	Ministry	of	Health	and	Health	Insurance	Fund.		
The	issue	of	 involvement	of	providers	 in	policy	making	has	not	been	explored	with	the	
patient	 group,	 for	 obvious	 reasons	 and	 the	earlier	 discussed	 lack	of	 knowledge	within	
this	group	on	policies	and	policy	processes	in	which	they	were	developed.		
In	summary,	there	was	an	expressed	dissatisfaction	by	providers	with	their	involvement	
in	policymaking,	but	a	limited	knowledge	or	idea	as	to	how	policies	should	be	changed	if	
participation	 in	 the	processes	was	granted.	Policy	makers	 shared	 these	views	 to	 some	
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extent,	ultimately	providing	a	mixed	message	in	arguing	that	provider	involvement	was	
important,	 but	 that	 delineation	 of	 responsibilities	 between	 policy	 making	 and	
implementation	 was	 also	 necessary.	 Crucially,	 it	 was	 apparent	 that	 elite	 stakeholders	
viewed	 providers	 as	 part	 of	 the	 latter	 in	 practice.	 The	 next	 section	 explores	 crucial	
consequences	 related	 to	 implementation	 for	 providers,	 manifest	 as	 a	 lack	 of	 support	
and	a	perception	of	detachment.	
5.3.2	Providers’	lack	of	support	and	detachment	
In	 addition	 to	 the	 lack	 of	 involvement	 in	 policy	 making,	 in	 their	 accounts,	 providers	
expressed	dissatisfaction	about	 the	support	 they	had	obtained	 from	 institutions	 in	 the	
implementation	 of	 the	 imposed	 policies.	 This	 emerged	 in	 relation	 to	 newly	 imposed	
administrative	 work	 and	 lack	 of	 guidance	 with	 regards	 to	 problems	 arising	 in	
implementation.	 It	 also	 led	 to	 increased	 curative	 actions	 (such	 as	 inspections)	 at	 the	
expense	of	preventive	ones	(such	as	advice)	by	the	relevant	institutions.		
The	providers’	complaints	on	the	lack	of	support	from	the	system	were,	among	others,	
related	to	the	additional	administrative	work	imposed.	As	mentioned	earlier,	one	of	the	
changes	 physicians	 would	 make	 if	 they	 could	 exert	 influence	 was	 reducing	 the	
administrative	 burden.	 This	 lack	 of	 support	 from	 the	 system	 in	 relation	 to	
implementation	 emerged	 from	 many	 provider	 accounts	 and	 was	 associated	 with	 the	
view	that	privatisation	had	also	imposed	additional	administrative	work,	which	was	not	
their	 responsibility	 before,	 since	 they	 were	 part	 of	 large	 health	 centres	 that	 had	
dedicated	 administrative	 units.	With	 the	 subsequent	 policy	 changes,	 (i.e.	 limitation	 of	
prescriptions	 and	 budget	 ceilings	 described	 earlier),	 the	 administrative	 workload	
increased,	 comprising	 of	 record	 filling	 and	 frequent	 reporting	 to	 the	Health	 Insurance	
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Fund.	In	their	view,	this	clerical	work	impacted	negatively	on	the	main	work	of	treating	
patients	as	the	following	three	quotes	variously	illustrate:	
“We	 are	 literally	 buried	 in	 admin	 stuff…paper	 forms,	 electronic	 forms,	
reports	 to	 the	 Fund,	 reports	 to	 the	Ministry…and	with	only	one	nurse…	 I	
also	have	patients	to	see,	so,	we	often	stay	[with	the	nurse]	afterhours	to	
fill	them	[records	and	reports]”	(PCP12)	
“Lot	of	administration…we’ve	even	become	accountants…I	am	alone	with	
the	 nurse,	 and	 the	 capitation	 is	 not	 enough	 to	 hire	 an	 assistant;	 I	 give	
some	extra	money	to	the	nurse	to	stay	overtime,	and	myself,	I	do	it	within	
my	salary.”	(PCP15)	
“Let’s	 say	 that	 according	 to	 the	 Fund,	 we	 should	 give	 each	 patient	 15	
minutes,	that	that	would	be	the	length	of	the	examination	in	the	primary	
health	care,	five	minutes	consultation,	and	you	spend	the	rest	of	the	time	
writing	 everything	 down,	 checking	 if	 it	 all	 corresponds	 with	 the	 health	
book,	with	that	in	the	computer,	in	the	chart…”	(PCP6)	
	
Physicians	did	not	 seem	to	have	willingly	accepted	 the	amount	of	administrative	work	
imposed,	as	 in	 their	accounts	 they	did	not	express	any	added	value	 from	the	 files	and	
reports	they	were	preparing	and	submitting.	They	understood	the	epidemiological	need	
for	 data	 collection,	 but	 nonetheless	 felt	 dissatisfaction	 from	 the	 lack	 of	 feedback	
provided	 to	 them.	 Only	 one	 of	 the	 physician	 respondents	 was	 aware	 that	 the	 Health	
Insurance	Fund	was	providing	feedback	through	publishing	reports	online:	
“…that	information	can	be	found	on	the	Fund’s	website,	you	can	learn	how	
many	 antibiotics	 we	 have	 spent,	 how	 many,	 to	 be	 more	 precise,	
antidepressants,	how	many	antihypertensives,	and	so	on,	so	they	provide	
a	report	that	we	have	access	to.	The	information	is	also	divided	by	cities.”	
(PCP8)		
	
Regardless	 of	 the	 feelings	 of	 providers,	 this	 quote	 confirmed	 the	 existence	 of	
transparency	 on	 the	 part	 of	 institutions,	 at	 least	 with	 regards	 to	 information	 sharing,	
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and	 at	 the	 same	 time	 it	 raised	 the	 issue	 of	 providers’	 wish	 to	 be	 informed,	
understanding	 the	 policies	 and	 having	 meaningful	 participation	 in	 policy	 making,	 as	
discussed	earlier.		
Another	 important	 manifestation	 of	 the	 isolation	 felt	 by	 providers	 was	 the	 lack	 of	
support	 from	 the	 responsible	 authorities	 in	 dealing	 with	 arising	 issues	 during	 policy	
implementation.	 In	their	view,	the	problems	that	occurred	should	be	a	concern	of	and	
dealt	with	by	the	institutions	and	not	made	‘their	own	business’	(Ph3).	Examples	shared	
referred	 mainly	 to	 obtaining	 support	 for	 administrative	 issues,	 as	 these	 two	 quotes	
illustrate:	
“If	you	know	someone	there	 [at	 the	HIF]	you	can	call	and	ask.	 If	you	call	
regular	numbers	you’re	always	transferred	or	asked	for	your	mail	to	send	
you	the	same	unclear	information	you	already	got…”	(PCP9)	
“Clerks	[at	the	Fund]	can	be	nice,	but	they	are	not	very	helpful,	they	simply	
don’t	get	 it	 [the	problem],	they	 look	 into	the	 law,	or	some	bylaw	and	tell	
you	what	you	already	know.	 I	 say,	 ‘I	know	that,	but	 this	 is	different’	and	
they	 simply	 smile	 or	 nod.	 They	 are	 not	 interested	 what	 is	 the	 problem.	
There	 are	 exceptions,	 for	 sure,	 but	 I	 have	 no	 such	 experience,	
unfortunately.”	(PCP12)	
	
In	contrast	to	the	majority	of	provider	respondents	sharing	the	feeling	of	lack	of	support,	
several	 respondents	 expressed	 satisfaction	 from	 their	 relationship,	 with	 Health	
Insurance	 Fund	 (HIF).	 In	 their	 opinions,	 HIF	 was	 responsive	 to	 questions	 and	 arising	
issues,	however,	still	with	limited	scope:	
“If	I	send	e-mail	to	the	[Health	Insurance]	Fund,	they	respond	very	quickly,	
especially	on	[issues	of]	reporting	or	e-software…they	always	refer	to	their	
website;	all	instructions	are	put	there”	(PCP8)	
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Elites	 held	 similar	 views	 with	 physicians	 in	 some	 aspects	 regarding	 policy	
implementation.	As	portrayed	in	the	following	quote,	elites	spoke	highly	of	policies,	but	
they	were	willing	to	admit	that	suitable	implementation	was	not	always	in	place:	
“We	are	good	at	creating	policies	and	writing	laws,	we	have	a	very	good	
legal	and	policy	base,	but	it	usually	stays	on	paper…”	(EI6)	
	
Elites	had	diverse	views	on	providers’	practices.	Whilst	the	majority	disapproved	of	non-
compliance	 with	 the	 policies,	 some	 of	 them	 appeared	 to	 be	 sympathetic	 towards	
providers’	 perspectives,	which	as	previously	noted,	may	have	been	 related	 to	 the	 fact	
that	some	of	the	policy	makers	were	having	provider	experience	previously.	Illustrating	
this,	 several	 elites	 argued	 that	 there	 had	 been	 unrealistic	 setting	 of	 budget	 ceilings,	
especially	for	the	pharmacies:	
“No	matter	how	many	prescriptions	are	brought	in,	they	should	be	issued.	
Actually,	 the	 [Health	 Insurance]	 Fund	 issues	prescriptions	and	 I	 don't	 see	
why	the	pharmacy	should	have	a	limited	budget	when	the	doctors	already	
have	 set	 ceilings	with	 the	 Fund,	 right?	All	 prescriptions	 from	 the	doctors	
have	to	be	dispensed	by	the	pharmacies.	With	the	 limited	budgets	this	 is	
not	 possible...it’s	 dishonest,	 you	 issue	 a	 prescription	 under	 the	 insurance	
for	a	medicine	that	can’t	get	covered”	(EI4)	
	
This	 view	 was	 also	 shared	 by	 pharmacists,	 who	 felt	 that	 one	 of	 the	 difficulties	 of	
implementation	 was	 the	 low	 threshold	 of	 the	 dispensing	 ceilings	 policy.	 This	 was	
dramatically	 described	 by	 one	 pharmacist	 in	 terms	 of	 the	 need	 to	 then	 try	 and	
communicate	this	to	patients:	
“We	 had	 a	 lot	 of	 trouble	 at	 first	 to	 explain	 that	 they	 cannot	 get	 their	
medicine,	 that	 they	 have	 to	 come	 earlier	 in	 the	month...it	was	 like	 ‘first	
come	first	served’…sometimes	we	posted	announcements	on	the	window	
that	the	medicines	are	finished	for	that	month…”	(Ph2)	
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However,	there	were	also	opposing	opinions	on	the	levels	of	prescribing.	In	the	view	of	
some	 policy	 makers,	 both	 overprescribing	 and	 overdispensing	 still	 represented	 a	
significant	problem,	which	required	further	improvement:	
“In	the	beginning	we	had	higher	ceilings	than	we	would	have	expected	to	
be	prescribed,	and	we	noticed	that	our	doctors	are	spending	always	close	
to	 the	 upper	 limit;	we	 lowered	 them	 and	 they	were	 again	 on	 the	 upper	
limit.	 To	me	 that	means	 that	 still	 there	 is	 overprescribing,	 and	 probably	
more	room	for	corrections	of	the	budgets.”	(EI12)	
	
Related	to	this,	physicians’	accounts	involved	admissions	relating	to	overprescribing,	as	
a	 result	of	previous	practices	and	perseverance	of	 some	patients,	exemplified	 through	
the	quote	below:	
“Some	pensioners	were	very	used	to	making	stashes	of	therapy	for	several	
months…It	was	not	easy	to	persuade	them	to	get	a	prescription	only	for	a	
month…some	were	persistent	saying	it	is	difficult	to	come	every	month…”	
(PCP5)	
	
This	 quote	 raises	 the	 issue	 of	 provider-patient	 relationship,	 and	 in	 particular	 the	
pressures	providers	experience	or	perceive	 from	patients	and	 represented	a	 recurrent	
theme	in	many	provider	accounts	that	is	described	in	more	detail	later	in	this	chapter.	
Discussions	on	policy	implementation	elicited	another	important	finding.	Both	physician	
and	pharmacist	providers,	openly	and	vigorously	expressed	their	feeling	of	detachment	
from	 the	 system.	 Physicians	 felt	 that	 prior	 to	 the	 policy	 changes,	 within	 the	 health	
system	they	worked	in	coordination	with	other	levels	of	care,	whereas	under	the	more	
recent	policy	circumstances	they	considered	themselves	to	be	distanced,	especially	as	a	
result	of	the	privatisation,	as	illustrated	by	the	following	quote:	
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“They	 shouldn’t	 have	 privatized	 the	 primary	 care,	 we	 were	 ‘one’	 in	 the	
health	 centres	 and	 working	 together	 with	 the	 hospitals,	 maternities,	
community	nurses…now	we	are	separate	worlds…”	(PCP11)	
	
Echoing	 this	 theme,	 another	 physician	 expanded	 on	 the	 consequences	 of	 the	 policy	
changes	in	terms	of	being	much	less	connected	to	others:	
“We	got	alienated	from	each	other,	from	the	colleagues,	from	the	[Health	
Insurance]	 Fund…in	 the	 beginning	 at	 least	we	would	 go	 there	 to	 submit	
the	reports,	now	we	don’t	need	to	go	there	in	person	any	more,	and	I	don’t	
know	anybody	there	anymore.”	(PCP16)	
“Providers	are	part	of	the	system,	we	are	not	enemies…”	(PCP11)	
	
The	 participant	 in	 the	 first	 quote	 above	 further	 illustrated	 how	 these	 changes	 to	
‘separate	worlds’	(PCP11)	affected	the	vertical	links	between	the	primary	and	the	other	
levels	of	care	–	as	in	the	following	example	with	preventive	services,	which	in	her	view	
should	have	been	re-established,	to	enable	their	full	potential	as	professionals:	
“When	 I	worked	 at	 the	 health	 centre,	 if	 I	 had	 a	 child	 coming	 often	with	
respiratory	 problems,	 I	 would	 send	 the	 community	 nurse	 to	 check	 their	
home	conditions,	maybe	the	kid	lives	in	a	damp	place,	or	they	don’t	clean	
the	dust;	she	would	advise	them	to	air	the	room	and	so	forth.	Now,	I	can’t	
do	that,	I	have	no	authority	to	send	the	nurse.	All	I	can	do	is	ask	the	family,	
or	visit	myself	or,	if	the	nurse	is	a	good	friend	she	will	go	for	me…”	(PCP11)	
	
These	quotes	captured	a	sense	of	separation	and	difference	and	were	a	recurrent	theme	
in	 provider	 accounts.	 This	 perception	of	 being	 isolated	was	 not	 only	 felt	 to	 be	 due	 to	
changes	 that	 had	 removed	 previous	 aspects	 of	 health	 care	 delivery	 but	 also	 due	 to	 a	
perception	that	health	professionals	were	actively	being	treated	as	if	they	were	not	part	
of	the	system;	there	was	an	emerging	feeling	of	being	under	unnecessarily	strict	scrutiny	
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and	an	associated	dislike	 for	such	treatment.	 In	varying	accounts,	 it	was	apparent	that	
health	 care	professionals	 believed	 there	was	 intentionality	 to	 this	 consequence	of	 the	
policy	changes,	and	an	associated	level	of	disquiet	from	participants:		
“…They	[Ministry	and	HIF]	cannot	simply	treat	us	as	if	we	are	other	people	
than	we	were	before…they	take	now	that	we	are	private	and	that	we	work	
for	profit,	and	that	we	are	different,	changed;	we	are	the	same	old	folks,	
that	 treated	 patients	 the	 same	 way	 we	 were	 before,	 just	 now	 we	 have	
more	controls	and	inspections	snooping	around…”	(PCP4)	
	
This	 participant	 highlights	 another	 dimension	 of	 this	 feeling	 –	 namely,	 this	 quote	
insinuates	something	that	was	in	other	accounts	more	openly	outspoken:	that	they	have	
been	 subordinated	 to	 authorities	 and	 scrutinized	 in	 a	 rather	 negative	 way	 -	 with	
numerous	controls	and	inspections,	which	instead	of	being	advisory	in	the	first	instance	
like	the	legislation	recommends,	in	most	cases	ended	up	with	penalty	for	the	physician	
or	the	pharmacy:	
“Inspection	came,	they	do	come	a	lot…yes,	sometimes	they	inform	you	and	
sometimes	you	don’t	know	they	are	coming…when	you	see	the	inspector,	
you	 know	 already	 you	 will	 be	 fined,	 500,	 1000	 euros,	 depends…usually	
you’re	fined,	not	advised	or	warned,	like	they	are	doing	in	the	public	health	
[settings]”.	(PCP9)	
“It	didn't	really	happen	to	me,	but	a	colleague	of	mine	told	me	that	when	
the	 inspector	 couldn’t	 find	anything	he	 simply	 fined	her	 for	not	having	a	
proper	 display	 of	 the	 nameplate	 [at	 the	 practice].	 How	 insane	 is	 that…”	
(PCP4)	
	
One	example	was	given	of	a	penalty	being	imposed	for	a	clerical	error	on	a	prescription,	
which	 the	 participant	 pharmacist	 considered	 to	 be	 completely	 unwarranted	 and	
disproportionate.	 The	 participant	 felt	 that	 this	 undermined	 the	 relationship	 between	
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providers	 and	 government	 and	 argued	 that	 such	 relationships	 were	 important	 but	
needed	to	be	based	on	good	will,	trust	and	confidence.		
In	 some	 other	 accounts,	 the	 dislike	 of	 the	 treatment	 was	 articulated	 as	 unreturned	
commitment	 in	 the	 relationship	 –	 in	 which	 physicians	 feel	 they	 have	 invested	
disproportionately	more	 than	what	 they	got	 in	 return.	 Some	health	 care	professionals	
have	given	extreme	examples	of	their	attempts	to	cope	with	the	challenges	of	the	daily	
work	that	they	have	not	signed	up	for.	And,	yet	in	their	view	the	system	perceives	them	
as	just	another	number:	
“My	 replacement	 colleague	 broke	 her	 leg	 and	 I	 had	 to	 receive	 all	 her	
patients	 for	 over	 a	 year,	 and	 I	was	using	my	 stamp	and	 I	went	 over	 the	
ceilings	 every	 trimester…I	got	penalized	 for	 not	 staying	within	 the	 limits,	
but,	what	could	I	do…	Who,	you	mean	the	Fund?	They	are	not	interested,	
for	them	we	are	only	numbers…”	(PCP9)	
	
This	quite	clearly	illustrated	how	the	physicians’	feeling	of	being	left	alone	materialized	
in	 non-protection	 for	 unforeseen	 circumstances,	 for	which	 they	 had	 nowhere	 to	 turn.	
Similar,	although	hypothetical,	examples	were	given	for	maternity	leave:	
“You	simply	do	not	have	the	luxury	to	get	sick…if	I	go	on	a	maternity	leave,	
or	longer	sick	leave,	there	is	no	coverage	for	my	patients.	I	am	lucky	that	
we	 are	 two	 at	 the	 practice,	 so	 we	 can	 manage,	 but	 for	 those	 that	 are	
alone,	I	don’t	know	how	they	deal…how	could	we	manage?	We	would	use	
each	other’s	stamps,	we	have	agreement	on	that”	(PCP13)	
	
From	the	quotes	above,	and	other	examples	physicians	clearly	depict	their	perception	of	
the	 response	 from	 the	 Health	 Insurance	 Fund	 per	 se,	 as	 turning	 a	 deaf	 ear	 for	 their	
claims	or	problems.	Another	 less	dramatic	case	was	penalisation	for	not	staying	within	
the	limits,	which	triggered	the	issue	of	using	only	the	stick	without	the	carrot:	
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“I	got	fined	last	year	for	going	over	the	limit	with	the	prescriptions,	but	it	
was	such	a	year,	many	of	my	patients	were	sick,	the	air	pollution	was	very	
high…I	was	never	rewarded	for	staying	within	the	budget”	(PCP16).	
“If	 we	 spend	 under	 the	 ceiling,	 nothing	 happens	 (he	 smiles).	 On	 the	
contrary,	we	face	sanctions.”(PCP9)	
	
The	 pharmacists	 felt	 detachment	 in	 a	 similar	 way,	 but	 obviously	 in	 the	 context	 of	
medicine	dispensing.	 For	 them,	 the	quotas	on	medicines	 that	 can	be	dispensed	under	
the	health	insurance	were	the	key	stumbling	block	in	their	relationship	with	the	system.	
Their	examples	illustrated	circumstances	in	which	they	were	surpassing	the	quota	for	a	
certain	 medicine	 that	 was	 requested	 from	 them	 by	 a	 patient.	 They	 felt	 they	 had	 no	
proper	 interaction	 with	 the	 responsible	 organisations	 to	 solve	 the	 issue	 through	 the	
formal	channels:	
“We	asked,	but	they	[HIF]	say	that	quotas	are	enough,	but	there	are	times	
when	 we	 have	 no	 quota	medicines	 in	 stock…we	 don’t	 want	 to	 turn	 the	
patient	 down,	 so	 what	 I	 do	 is	 I	 go	 to	 the	 neighbouring	 pharmacy	 to	
‘borrow’	(showing	quotation	sign)	from	their	quota	if	they	have	left.	Then	I	
return	it	the	next	month…yes,	I	do	the	same	for	them…”	(Ph3).	
	
As	 explained	 above,	 they	 resorted	 to	 finding	 their	 own	 ways	 of	 solving	 such	 issues,	
within	or	outside	the	legal	frameworks.	Although	not	captured	in	the	quote,	the	shrug	of	
shoulders	of	the	pharmacist	made	it	clear	that	such	behaviour	was	unlawful	and	could	
be	 subject	 to	 penalty.	 However,	 she	 believes	 that	 providing	 medicines	 to	 a	 patient	
should	be	the	highest	priority	–	as	a	dedication	to	the	profession.		
On	the	same	 issue,	policy	makers	had	an	opposing	opinion.	 In	 their	accounts,	 some	of	
them	provided	examples	of	irregularities	to	illustrate	how	pharmacists	used	the	policy’s	
loopholes	in	their	practice:	
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	“It	is	not	forbidden	to	get	prescription	medicine	with	a	private	prescription	
so	long	as	it	has	a	valid	stamp,	but	you	pay	for	it	privately	[out-of-pocket].	
In	 some	 pharmacies	 inspectors	 found	 empty	 pink	 [private]	 prescriptions	
under	 the	 counter,	 stamped	 and	 ready	 to	 be	 used	 to	 cover	 for	 such	
privately	bought	medicines.”	(EI12)	
“The	current	system	enables	us	to	oversee	all	activities	at	primary	level;	in	
pharmacies	 though,	we	 can	 only	 see	 the	medicines	 from	 the	 quota,	 and	
not	 the	 other	 supplies	 they	 would	 have.	 But	 you	 can	 expect	 that	 if	 the	
quota	 is	 finished	 by	 the	 10th	 of	 the	 month,	 the	 rest	 is	 sold	
privately…whether	 all	 dispensed	 medicines	 are	 issued	 with	 a	 valid	
prescription	can	only	be	detected	by	inspection	on	the	spot.”	(EI4)	
	
Another	 example	 was	 shared	 by	 one	 of	 the	 pharmacist	 respondents,	 regarding	 the	
disregard	of	the	system	for	the	investments	–	both	material	and	professional	–	made	by	
the	providers.	Namely,	with	privatisation,	providers	were	expected	to	 invest	 their	own	
resources	 for	 opening	 a	 practice	 or	 pharmacy.	 At	 first,	 licensing	 of	 practices	 and	
pharmacies	 was	 done	 in	 a	 non-systematic	 manner,	 with	 all	 applications	 that	 fulfilled	
general	 technical	 conditions	 were	 approved.	 As	 the	 market	 reached	 saturation,	
institutions,	 namely	 HIF,	 submitted	 to	 rationalisation	 of	 contracts,	 but	 without	
consideration	 of	 the	 already	 invested	 resources.	 One	 respondent	 was	 agitatedly	
explaining	the	frustration	from	the	situation	she	was	put	 in,	where	despite	discussions	
and	negotiations	with	the	HIF	to	continue	the	contract	 for	a	village	pharmacy,	without	
prior	 notice	 the	 HIF	 has	 not	 signed	 an	 extension,	 explaining	 that	 village	 didn’t	 have	
enough	patients	and	the	nearby	town	was	close:		
“They	didn't	explain	anything,	 they	 simply	discontinued	 the	collaboration	
when	 the	 contract	 expired…no	 prior	 notice,	 no	 nothing.	 I	 went	 several	
times	to	ask,	but	got	no	answer,	just	that	I	can	file	a	claim,	that’s	it…	there	
is	no	other	pharmacy	in	the	village,	the	nearest	one	is	in	the	town	some	20	
kilometres	away.	I	had	really	invested	a	lot,	and	it’s	not	a	car	or	a	TV	[i.e.	
movable	item]	to	move	it	to	a	different	place…”	(Ph6)		
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As	noted	above,	policy	implementation	and	its	appropriateness	were	also	discussed	with	
policy	makers,	as	they	were	seen	as	particularly	knowledgeable	through	their	position	to	
overview,	monitor	and	control	the	implementation.	Additional	issues	of	concern	related	
to	 implementation	 for	 them	 were	 the	 continuing	 trends	 of	 overprescribing	 and	 non-
compliance	with	the	dispensing	policy.		
The	issue	with	overprescribing,	according	to	the	policy	makers	is	still	a	serious	concern	
not	 only	 from	 a	 fiscal	 perspective,	 but	more	 so	 for	 its	 public	 health	 consequences.	 In	
their	view,	 it	had	its	highest	 levels	during	the	policy	of	 limited	number	of	prescriptions	
per	patient,	for	which	reason	the	fiscal	discipline	measures	of	prescribing	ceilings	were	
introduced:	
“Doctors	 were	 prescribing	 generously,	 because	 the	 policy	 was	 that	 for	
each	patient	 two	prescriptions	were	counted,	without	any	earmarking	or	
amount.	There	was	a	case	of	one	doctor	who	prescribed	200	scatulas	to	a	
single	patient	 in	one	month…it	was	suspicious	so	we	sent	 the	 inspection;	
he	 was	 fined	 but	 we	 never	 found	 out	 what	 actually	 happened…	 He	
could’ve	 sold	 those	 medicines	 or	 provided	 them	 to	 uninsured	 persons	
under	the	name	of	a	registered	patient.”	(EI4)	
	
From	 the	 patients’	 accounts,	 the	 issues	 evidently	 of	most	 concern	were	 the	 access	 to	
medicines	 and	 the	 impact	new	policies	had	on	obtaining	 them;	 further	 and	 related	 to	
the	 above,	 an	 important	 theme	 identified	 from	 their	 accounts	 was	 on	 the	 self-
medication	and	providing	 justification	 for	 it.	They	openly	admitted	non-adherence	and	
using	 loopholes	when	possible,	which	 they	 interpreted	 as	 a	 response	 to	 the	 curtailing	
policy	 changes.	 Patients	 thought	 that	 information	 asymmetry	 is	 used	 for	 the	 interests	
and	material	 gains	of	 the	providers,	but	also	used	 it	 as	an	argument	 in	 justifying	 their	
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self-medication	 practices;	 to	 them,	 self-medication	 and	 circumventing	 procedures	 for	
legal	medicine	 supply	were	a	consequence	of	 the	policy	changes.	As	 this	 finding	came	
strongly	 in	 patients’	 accounts	 and	 was	 linked	 to	 the	 pressures	 felt	 by	 providers,	 it	 is	
elaborated	under	the	separate	theme	of	pressures	in	practice,	later	in	this	chapter.		
Through	all	 of	 the	 above,	 the	 appropriateness	of	 policy	 implementation	was	 implicitly	
linked	 to	 responsibility	 for	 policy	 implementation,	 analysed	 below	 as	 a	 separate	 sub-
theme.	
5.3.3	Unwillingness	to	share	responsibility		
The	experiences	and	opinions	described	above	suggested	that	among	respondents	there	
was	 a	 pronounced	 belief	 that	 policy	 implementation	 was	 lacking	 in	 certain	 aspects.	
Policy	makers	considered	overprescribing	and	non-adherence	to	dispensing	policy	to	be	
the	 most	 critical	 issues;	 for	 providers,	 lack	 of	 implementation	 was	 linked	 to	 lack	 of	
support	 from	the	system	and	pressures	 from	patients	–	the	 latter	described	under	the	
third	theme	further	in	this	chapter.	Patients	on	the	other	hand,	considered	failure	of	the	
policies	 to	 be	 mainly	 related	 to	 reduced	 access	 to	 medicines,	 and	 increased	 need	 to	
negotiate	 their	 medicines’	 supply.	 These	 findings	 triggered	 discussions	 regarding	
responsibility	for	implementation.		
Policy	makers	were	very	 forthright	 in	 their	opinions	about	 the	 responsibility	 for	policy	
implementation;	in	their	view	the	system	was	doing	as	much	as	it	could,	with	the	limited	
resources	 for	control	and	 inspection	being	available,	and	 it	was	felt	 that	governmental	
efforts	related	to	implementation	were	sufficient.	Their	accounts	very	clearly	placed	the	
responsibility	with	providers	and	patients,	and	the	policy	makers’	role	was	perceived	to	
involve	 ensuring	 policies	 were	 in	 place	 rather	 than	 implementing	 them.	 Specific	
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examples	were	given	on	the	dispensing	policy	enforcement,	which	as	described	earlier	
was	considered	by	policy	makers	as	one	of	the	remaining	implementation	issues:	
“These	[dispensing	with	prescription	only]	policies	are	not	new;	they	have	
been	endorsed	long	time	ago.	The	medicine	that	has	an	R	on	it,	even	if	it’s	
an	ointment,	mustn’t	be	dispensed	by	a	pharmacist	[without	prescription].	
But	they	do	it	regularly,	the	authorities	didn’t	fine	them	nor	did	they	think	
of	doing	anything	like	that.	This	was	the	practice	up	until	2009	when	they	
decided	that	each	medicine	must	be	prescribed	[so	to	be	dispensed].”	(EI3)	
	
This	 quote	 illustrates	 the	 opinion	 of	 policy	 makers	 that	 responsibility	 lay	 with	
pharmacists	but	also	 implicitly	with	patients	 too,	 since	 the	unlawful	 act	 committed	by	
pharmacists	was	 initiated	by	demand	 from	 the	patients.	Also	of	particular	note	 in	 this	
quote	was	reference	to	‘prescribing	and	dispensing	by	a	pharmacist’	and	whilst	there	is	
no	 legal	 authority	 given	 to	 pharmacists	 to	 prescribe	 medicines	 in	 Macedonia,	 in	 the	
accounts	 of	 several	 policy	 makers	 this	 practice	 was	 described.	 Namely,	 upon	
enforcement	 of	 the	 dispensing	 policy	 in	 2009,	 the	 pressure	 to	 dispense	 without	
prescription	 was	 still	 felt	 to	 be	 considerable	 –	 both	 from	 patients	 to	 obtain	 their	
medicines,	 as	well	 as	 from	owners	of	pharmacies	 interested	 in	maximizing	 their	 sales.	
According	to	elites,	subterfuge	was	used	to	create	a	procedure	that	deviated	from	the	
dispensing	policy,	in	which	pharmacies	kept	blank	non-reimbursable	prescriptions	under	
their	desk	and	filled	them	when	a	patient	without	a	prescription	came	in:	
“They	 [prescriptions]	 could	 be	 from	 the	 [Health	 Insurance]	 Fund,	 empty	
like	this	one	[showing	a	prescription],	the	only	difference	is	that	there	isn’t	
anything	 in	 the	 upper	 corner,	 no	 name	 and	 surname,	 so	 they	 aren’t	
counted	by	the	Fund	in	the	quota…A	doctor	would,	let’s	say,	leave	a	bunch	
of	stamped	prescriptions,	and	they	[pharmacists]	would	write	the	medicine	
down,	the	pharmacist	would	write	it	himself.”	(EI1)	
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This	sought	to	make	the	subsequent	dispensing	legal,	but	also	involved	obvious	illegality	
in	the	actual	writing	of	the	prescription.	Furthermore,	elites	argued	that	such	practices	
encouraged	 self-medication	 through	 unprofessional	means.	 Hence,	many	 of	 the	 elites	
not	only	considered	providers	responsible	for	the	lack	of	implementation,	but	they	also	
viewed	them	to	be	primarily	responsible	for	the	diminished	appreciation	of	the	medical	
profession,	elaborated	in	more	details	under	section	5.2.1.2.		
It	 was	 not	 just	 in	 elite	 interviews	 that	 unprofessional	 practice	 emerged;	 some	 of	 the	
pharmacist	respondents	described	similar	examples	of	dispensing	without	prescription.	
However,	their	interpretation	of	such	practices	was	very	different,	placing	responsibility	
with	policy	makers,	who	it	was	argued,	have	allowed	variable	implementation	in	primary	
care,	 and	also	were	not	 checking	on	and	 recognising	 such	practices.	According	 to	one	
pharmacist,	 although	 such	 ambiguous	 enforcement	 was	 perceived	 to	 be	 common	
knowledge,	it	was	regarded	as	a:	
“[…]	 public	 secret	 that	 there	 are	 pharmacies	 issuing	 medicines	 without	
prescription.	 I	 know	 which	 those	 are;	 I	 don’t	 want	 to	 mention	
names…patients	 use	 it	 as	 an	 argument	 when	 they	 come	 without	
prescription.	I	tell	them	to	go	there	if	they	can	get	it	elsewhere”	(Ph9)	
	
	The	pharmacist	believed	that	there	were	few	or	no	repercussions	for	those	who	did	not	
adhere	 to	 prudent	 policy	 implementation,	 and	 were	 alleged	 to	 be	 abused	 by	 those	
‘having	connections’	(Ph9).	
It	was	not	 just	pharmacists	but	physicians	who	also	engaged	 in	non-standard	practices	
that	did	not	follow	the	new	policy:	
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“If	I	know	a	patient	is	well	off,	I	might	suggest	to	buy	the	medicine	out-of-
pocket,	if	it’s	better	than	the	one	on	insurance…I	issue	the	prescription,	but	
it	is	not	counted	in	my	medicines’	budget.”	(PCP7)	
	
As	 illustrated	 in	 the	above	quote,	most	providers	perceived	their	own	behaviour	to	be	
justified,	 and	distanced	 themselves	 from	any	 responsibility	or	blame	 in	 relation	 to	 the	
perceived	 problems	 of	 policy	 implementation.	 Rather,	 their	 opinions	 cast	 aspersions	
towards	 other	 groups	 –	 namely	 policy	 makers	 or	 patients.	 According	 to	 them,	 their	
responsibility	was	minimized	with	the	increased	regulation	that	marginalised	them	and	
their	 professional	 autonomy	 to	 make	 independent	 decisions	 about	 prescribing	 and	
dispensing	 medicines.	 Among	 physicians,	 there	 was	 an	 apparent	 distancing	 from	
responsibility	that	emerged	in	their	accounts,	illustrated	through	the	quotes	below:		
“Doctors	 cannot	 be	 responsible	 if	 there	 are	 not	 enough	 medicines…I	
sometimes	go	over	the	 limits,	but	cannot	do	 it	 too	much	and	too	often,	 I	
get	 less	money,	which	 is	 not	 patients’	 business	 but	 I	 have	 to	 care	 about	
it…’don’t	kill	the	messenger’,	you	know…I	am	only	doing	as	told,	and	they	
[patients]	can	go	claim	it	above	[to	the	authorities]…”	(PCP17)	
“…you	do	your	 job	and	 it	 is	not	our	fault	that	there	are	patients	who	got	
used	 to	 consuming	 certain	 quantity	 of	 medications;	 the	 fault	 is	 with	
completely	other	factor.”	(PCP1)	
“When	 they	were	writing	 them	 [laws	and	bylaws]	 they	hopefully	 had	an	
idea	how	they	would	work	in	practice.	I	don’t	know	if	they	are	happy	with	
this,	but	you	know	what	hurts	most?	If	I	don't	pass	the	ceiling	I	risk	losing	
patients,	and	if	I	go	above,	I	lose	the	capitation.	It’s	like	the	snake	and	the	
donkey	choice7	(laughs).	I’m	like	‘from	all	sides	Gorgi	surrounded’8”	(PCP6)	
	
Again,	 similar	 narratives	 emerged	 between	 the	 two	 provider	 groups,	 and	 pharmacists	
also	felt	that	they	were	not	responsible	and	levelled	concerns	of	policy	makers:	
																																								 																				
7	Idiom	referring	to	having	to	choose	between	one	of	two	poor	options.	
8	Further	Macedonian	idiom	that	implies	having	no	options.	
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“Officials	 [i.e.	policy	makers]	 should	be	 responsible,	 they	probably	had	 in	
mind	 how	 to	 execute	 them	 when	 they	 were	 writing...And	 it’s	 their	
responsibility	to	enforce,	to	inspect,	all…if	I	get	a	valid	prescription,	I	don’t	
think	I	have	any	responsibility	but	to	dispense	it.	I	cannot	tell	doctors	that	
antibiotics	are	not	for	viral	infections,	let’s	say,	they	learnt	it	in	the	medical	
school”	(Ph10)	
	
The	above	quotes	suggest	that	as	well	as	policy	makers,	providers	also	consider	patients	
to	 bear	 a	 large	 share	 of	 the	 responsibility,	 based	 on	 perceptions	 of	 their	 demands	 in	
relation	to	medicines,	as	the	following	quotes	explicate:	
“…I	mean	 self-treatment	 is	 the	problem.	You	 come	 to	 the	pharmacy	and	
you	take	antibiotics,	you	take	tuberculostatic,	antiviral	medicine...”	(Ph3)	
“The	 other	 day,	 a	 patient	 came	 to	 ask	 for	 diazepam,	 he	 was	 obviously	
disturbed;	he	 said	his	daughter	had	an	accident	at	 school,	 but,	 he	didn’t	
seem	to	me	like	he	had	a	daughter	of	school	age.	I	tried	to	explain	when	to	
use,	when	not	to	use,	but	I	think	he	knew	already,	he	seemed	like	a	user…”	
(Ph8)	
	
The	 accountability	 of	 patients	was	 also	 referred	 to	 by	 policy	makers,	who	 considered	
patients’	behaviour	of	seeking	ways	to	perpetuate	self-medication	practices:	
“I	personally	think	that	the	doctors	prescribe	drugs	rationally,	 there	 is	no	
dilemma.	The	patients	spend	irrationally	when	they	decide	to	buy	drugs	on	
their	own.”	(EI5)	
“Unless	 we	 raise	 people’s	 awareness	 that	 they	 cannot	 simply	 go	 to	 the	
pharmacy	 and	buy	medicines	 as	 if	 they	were	 in	 a	 grocery	 store,	 nothing	
will	change.”	(EI1)	
	
However,	of	note	was	that	a	minority	of	providers	admitted	that	some	responsibility	was	
with	providers	as	already	illustrated	in	a	quote	of	one	pharmacist	who	admitted	to	the	
practice	of	other	colleagues	‘issuing	medicines	without	prescription’	(Ph9).	This	reflected	
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a	 minority	 view,	 however,	 and	 most	 provider	 participants	 believed	 that	 the	
responsibility	of	providers	rested	with	the	other	provider.	Physicians	readily	transferred	
the	obligation	for	improving	implementation	to	pharmacists:	
“Pharmacists	 shouldn’t	 dispense	 without	 prescription.	 If	 I	 didn’t	 think	 it	
was	necessary,	why	should	they	think	otherwise?	It	is	for	their	benefit	only,	
not	for	the	patient’s…”	(PCP10)	
	
Pharmacists	too,	considered	that	physicians	could	improve	their	practices	to	contribute	
to	better	implementation:	
“Sometimes	 patients	 do	 ask	 for	 antibiotics	 without	 prescription	 but	 I	
always	 suggest	 them	 to	 first	 consult	 a	 physician…I’m	 not	 competent	 for	
establishing	diagnosis	which	is	why	I	advise	them	[patients]	to	go	and	see	
a	physician.	I	do	the	same	myself.”	(Ph5)	
	
Patients’	 narratives	 disclosed	 interesting	 views	 on	 responsibility	 for	 implementation.	
They	were	mainly	concerned	with	the	satisfaction	of	providing	for	their	real	or	perceived	
needs	 for	 medicines.	 Most	 patients	 were	 vaguely	 interested	 in	 the	 overall	 policy	
implementation	or	 responsibility	but	 admitted	 to	having	managed	 to	establish	 regular	
practices	of	obtaining	medicines	–	 sometimes	outside	 legal	procedures.	 Several	of	 the	
respondents,	acknowledged	that	dispensing	without	a	prescription	was	not	appropriate	
practice,	but	this	was	accepted	as	a	necessity	due	to	a	lack	of	other	opportunities:	
“…if	you	can’t	afford	to	buy	medicines	privately,	you	have	to	find	a	way…”	
(Pat2)	
	
Although	 patients	 were	 aware	 that	 they	 are	 not	 always	 adhering	 to	 the	 regular	
practices,	 they	 did	 not	 consider	 themselves	 directly	 responsible	 for	 lack	 of	 policy	
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implementation.	 On	 the	 contrary,	 they	 used	 their	 feeling	 of	 subordination	 as	 a	 good	
ground	for	justifying	their	practices	and	established	routines,	explained	at	length	in	the	
third	theme	of	pressures	in	practice.	
5.3.4	Summary	of	theme	findings	
In	 summary,	 the	 views	 of	 policy	 makers	 on	 the	 policy	 changes	 reflected	 a	 forthright	
justification	for	the	necessity	of	changes,	although	it	was	admitted	that	implementation	
had	not	been	complete	and	therefore	a	success.	Their	understanding	of	the	sometimes	
unfavourable	 position	 of	 providers	 suggested	 a	 good	 degree	 of	 insight	 although,	
ultimately,	they	placed	the	responsibility	for	the	lack	of	successful	implementation	with	
providers	and	not	themselves.	While	distancing	themselves	from	responsibility	for	policy	
implementation,	 they	 also	 found	 patients	 to	 be	 responsible	 for	 implementation	
problems,	 through	perpetuating	practices	of	 self-medication	and	 requesting	medicines	
without	prescription.		
Patients’	standpoint	depicted	a	feeling	of	 lack	of	care	and	focus	on	their	problems	and	
concerns	 when	 it	 came	 to	 medicines	 –	 quite	 contrary	 to	 the	 perceptions	 of	 policy	
makers	(as	the	later	part	of	this	chapter	will	show)	and	providers	about	the	supremacy	
of	 the	 patient,	 safeguarded	 by	 the	 system.	 To	 respond	 to	 this	 situation,	 they	 had	
managed	to	develop	their	own	ways	of	handling	the	new	situation	of	limited	access	and	
need	 to	negotiate	medical	 supply.	They	disclosed	a	 set	of	 justifying	arguments	 for	 the	
non-adherence	 and	 subterfuge	 of	 the	 regular	 prescribing	 and	 dispensing	 procedures,	
and	did	not	accept	any	responsibility	for	that.		
Providers	 considered	 the	 lack	 of	 implementation	 to	 be	 associated	 with	 additional	
administrative	workload	imposed	in	their	work,	as	well	as	with	lack	of	support	from	the	
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system.	This	brought	about	the	feeling	of	isolation	and	detachment	from	the	system.	In	
their	view,	lack	of	implementation	was	vaguely	associated	with	themselves,	and	mostly	
with	 the	 providers	 outside	 of	 their	 own	 group.	 Still	 they	 placed	 the	 greatest	 share	 of	
responsibility	with	policy	makers	and	patients.		
Overall,	 it	 was	 apparent	 from	 all	 groups	 that	 there	 was	 lack	 of	 willingness	 to	 accept	
responsibility	 for	 the	 failure	 of	 implementation.	 All	 groups,	 with	 exception	 of	 several	
respondents,	 considered	 the	 responsibility	 to	 be	 with	 others,	 despite	 some	 of	 the	
examples	 clearly	 pointing	 to	 shared	 responsibility	 for	 actions	 of	 all	 stakeholders	 and	
finally	resulting	 in	policy	failure	of	overprescribing,	subterfuge	of	dispensing	policy	and	
encouraging	self-medication.		
	
5.4. Pressures	in	practice	
	
This	 section	 presents	 the	 final	 group	 of	 findings,	 which	 are	 related	 to	 another	
perspective	of	 implementation,	namely	the	diverse	pressures	experienced	by	providers	
and	patients	in	relation	to	medicine	supply.	Presenting	them	as	a	separate	overarching	
theme	relating	 to	pressures	 in	practice	was	 justified	given	how	 important	 these	 issues	
were	for	the	two	groups.	It	also	emerged,	although	to	a	lesser	extent,	in	the	interviews	
with	elite	stakeholders	who	also	recognised	it	was	of	importance.	This	third	main	theme	
is	 further	 divided	 into	 two	 sub-themes	 that	 are	 framed	 around	 the	 different	 insights	
from	 providers	 and	 patients:	 one	 related	 to	 providers’	 perceived	 pressures	 from	 the	
system	and	 from	patients,	and	 the	second	related	 to	patients’	perceived	pressures	 for	
negotiating	medicine	supply.	
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5.4.1	Providers’	professional	disempowerment	
Many	 providers’	 accounts	 revealed	 a	 key	 emerging	 theme	 related	 to	 pressures	 felt	 in	
their	daily	work.	One	of	the	pressures	pertained	to	the	system,	and	was	largely	linked	to	
the	 previously	 elaborated	 sub-theme	 of	 a	 lack	 of	 support	 in	 implementation	 and	
detachment	 from	 the	 system.	 In	 addition,	 though,	 providers	 described	 a	 perceived	
pressure	 from	 patients	 in	 relation	 to	 medicine	 supply,	 describing	 it	 as	 a	 lack	 of	
understanding	 and	 empathy	 from	 patients	 about	 the	 circumstances	 imposed	 on	 the	
providers.	 In	a	broader	sense,	providers’	 feelings	could	be	summarized	as	 loneliness	 in	
handling	 the	 situation,	 in	 which	 they	 had	 to	 respond	 to	 requirements	 and	 deliver	 on	
demands	of	both	sides	they	interacted	with	–	the	system	and	the	patients.	Or,	as	already	
illustrated	 in	 the	 previous	 section,	 they	 described	 their	 situation	 as	 unfavourable	 of	
being	‘from	all	sides	Gorgi	surrounded’9	(PCP6).	With	this	and	similar	quotes,	it	appeared	
that	providers	considered	pressures	from	the	system	and	patients	to	be	interlinked	–	in	
their	 view,	 the	 system	 was	 encouraging	 patients’	 empowerment,	 while	 not	 equally	
supporting	 providers,	 as	 part	 of	 the	 system.	 As	 the	 following	 quote	 illustrates,	 this	
notion	came	 from	the	endorsement	of	patients’	 rights,	at	 the	expense	of	 the	 rights	of	
providers:	
“Everyone	 talks	 about	 those	 patients’	 rights,	 nobody	 says	 a	 thing	 about	
the	 doctors’	 rights,	 we	 haven’t	 read	 those	 anywhere,	 it	 hasn’t	 been	
promoted	yet…patients	should	know	that	we,	too,	have	rights…”	(PCP6)	
	
This	 quote	 captures	 providers’	 perception	 of	 increased	 pressure	 from	 patients,	 but	 it	
also	 suggests	 an	 implicit	 pressure	 from	 the	 system,	 by	 not	 taking	 actions	 to	 protect	
																																								 																				
9	Further	Macedonian	idiom	that	implies	having	no	options.	
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providers’	rights	and	interests.	These	perceptions	were	articulated	in	different	examples	
linked	 to	 all	 analysed	 policy	 changes.	 Namely,	 as	 described	 in	 the	 quote	 below,	 the	
enforcement	of	prescribing	ceiling	policy	also	brought	two	types	of	pressure	–	one	from	
the	system	to	change	providers’	prescribing	behaviour,	and	the	other	one	from	patients,	
whose	behaviour	providers	were	expected	to	influence,	regarding	medicine	demand:		
“Patients	are	not	interested	if	I	have	no	budget	to	prescribe,	they	feel	they	
have	 the	 right	 to	 their	 medicines,	 they	 have	 paid	 for	 their	 health	
insurance…”	(PCP3)	
“Some	pensioners	were	very	used	to	making	stashes	of	therapy	for	several	
months,	 because	 during	 the	 transition	 years,	 there	 were	 periods	 of	
deficiency	 of	 medicines.	 It	 was	 not	 easy	 to	 persuade	 them	 to	 get	 a	
prescription	only	for	a	month…some	were	persistent	saying	it	is	difficult	to	
come	in	every	month…”	(PCP5)	
	
In	 their	 view,	 physicians’	 position	 was	 pressurised	 from	 the	 current	 policies	 but	 also	
from	past	 conduct.	 The	 second	quote	 above	 exemplifies	 these	pressures,	 arising	 from	
their	dual	role	of	acting	on	behalf	of	the	system	in	safeguarding	 it,	and	being	patients’	
agents	in	delivering	good	quality	care	and	professional	advice.		
Pharmacists	 felt	 similarly	 regarding	 pressures	 from	 the	 system	 and	 patients.	 In	 their	
view,	 the	 system	 did	 not	 appropriately	 communicate	 the	 new	 circumstances	 of	
dispensing	ceiling	policy	 to	 the	wider	public,	 causing	misperception	and	distrust	 in	 the	
profession:	
“We	 had	 a	 lot	 of	 trouble	 at	 first	 to	 explain	 that	 they	 cannot	 get	 their	
medicine,	 that	 they	 have	 to	 come	 earlier	 in	 the	month...it	 was	 like	 ‘first	
come	first	served’…sometimes	we	posted	announcements	on	the	window	
that	the	medicines	are	finished	for	that	month…”	(Ph2)	
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Related	 to	 this,	 the	 following	 short	 quote,	 illustrates	 pharmacists’	 perception	 of	
patients’	negativity	and	suspicion	related	to	the	new	policies	and	specifically	quotas:	
	“I	know	that	some	people	think	we	are	hiding	the	quota	so	to	be	able	to	
sell	them	the	medicines…”	(Ph8)	
	
Providers	 expressed	 their	 reluctance	 to	 prescribe	 under	 pressure,	 but	 also	 admitted	 a	
sense	of	defeat,	describing	it	as	‘indulging’	patients	in	their	requests:		
“It	is	difficult	to	explain	to	a	patient,	when	you	can	see	it	in	their	eyes,	they	
would	not	go	away	without	antibiotic…I	would	otherwise	not	indulge,	but	I	
decide	 to	 give	 those	 the	 antibiotic…I	 think	 it	 would	 do	 no	 good,	 but	 I	
prescribe	anyway”	(PCP14)	
“I	tell	young	mothers	that	antibiotics	are	not	always	needed,	but	 it	 is	our	
mentality,	 an	 advice	 from	 other	 mothers,	 they	 even	 suggest	 what	 to	
prescribe…I	 really	 don’t	 like	 when	 the	 sentence	 starts	 with:	 ‘a	 friend	 of	
mine	told	me…’	I	have	a	desire	to	say	‘go	to	your	friend’...”	(PCP10)	
	
While	being	descriptive	of	the	pressures	felt	from	patients,	this	last	quote	also	illustrates	
the	 undermining	 of	 professional	 autonomy	 by	 providers	 themselves.	 When	 asked,	
providers	 justified	 such	behaviour	 again	 through	 the	 lack	of	 support	 from	 the	 system,	
describing	it	through	examples	of	 loose	policy	implementation	allowing	patients	to	still	
pursue	their	desired	goal:	
“Our	 people	 get	 easily	 petty	 and	 they	 could	 say	 ‘OK,	 I	 don’t	 need	 that	
prescription	from	you,	I’ll	get	it	from	another	physician’...	So	you	prescribe,	
what	can	you	do…”	(PCP14)	
	
In	 the	pharmacists’	accounts,	 this	 submission	 to	pressure	was	also	articulated	 through	
variable	 implementation	 and	 ambiguous	 enforcement	 of	 policy	 regulating	 dispensing	
only	with	prescription.	Many	of	the	pharmacist	respondents	articulated	the	pressure	in	
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terms	 of	 it	 being	 the	 persistence	 of	 patients	 obtaining	 medicines	 for	 their	 own	 self-
medication	plan.	In	addition,	concerns	emerged	in	relation	to	how	to	respond	to	patient	
pressures	 when	 they	 ask	 that	 rules	 be	 not	 observed.	 Some	 of	 the	 pharmacist	
respondents	 tried	 to	 justify	 the	 dispensing	 without	 prescription,	 through	 specific	
situation,	which	not	necessarily	could	be	associated	with	the	discussed	policy	changes:		
“Sometimes	a	patient	comes	without	a	prescription,	but	we	live	in	a	small	
town,	 everybody	 knows	 everybody.	 I	 ask	 him	 who	 is	 his	 doctor	 and	
dispense	the	medicine.	Later	I	call	the	doctor	to	ask	for	a	prescription	and	I	
go	fetch	it	later,	so	that	I	have	the	dispensed	medicine	covered.”	(Ph7).	
	
Such	 accounts	 reflected	 a	 duality	 and	 this	 pharmacist	 appeared	 to	 convey	 two	
interpretations	 of	 such	 occurrences:	 firstly,	 that	 they	 reflected	 pressure	 and	 this	
diminished	 the	professional	 autonomy	of	providers,	but	 secondly	and	more	positively,	
that	 this	 was	 perceived	 as	 an	 attempt	 to	 assist	 and	 serve	 the	 patient	 in	 need.	 The	
majority	of	pharmacists	held	the	opinion	that	uneven	implementation	of	policies	was	a	
far	 more	 important	 factor	 enabling	 patients	 to	 exert	 pressures	 to	 obtain	 medicines	
without	prescription:		
“…if	 I	 didn’t	 [give	 patient	 the	 medicine	 without	 prescription],	 he’d	 have	
gone	to	the	pharmacy	next	door,	we	are	three	in	a	row	if	you	look	out	the	
window…”	(Ph8)	
	
The	above	quotes	from	both	the	pharmacist	and	the	physician	respondent	PCP14	earlier	
(page	188),	suggest	importantly	that	to	providers,	simply	keeping	the	patient	as	client	to	
the	 pharmacy	 or	 as	 registered	 patient	 in	 the	 physician’s	 roster	 (and	 the	 associated	
capitation)	was	sometimes	more	important	than	professional	knowledge	and	integrity.		
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It	was	not	only	in	provider	accounts	that	such	pressures	were	perceived,	and	as	shown	
in	 the	 following	 quote,	 it	 also	 emerged	 in	 the	 accounts	 of	 elite	 stakeholders.	 It	 was	
apparent	 that	 they	 also	 understood	 and	 predicted	 some	 pressure	 and	 perceived	
expectations	 from	patients,	which	possibly	 affected	providers’	 attitudes	 and	practices,	
motivated	by	maintaining	a	good	physician-patient	relationship:	
“…they	prescribe,	because	they	are	expected	to	prescribe…	it	would	make	
them	 look	 foolish	 if	 they	 don’t,	 the	 patient	 would	 go	 to	 see	 the	
neighbour[ing	doctor]	if	he	must…”	(EI10)	
	
Elites	 also	 agreed	with	 providers	 that	 patients	were	 excessively	 demanding	medicines	
and	 that	 such	 behaviour	 was	 one	 of	 the	 most	 challenging	 aspects	 of	 the	 policy	
implementation.	Elites’	accounts	revealed	that	the	greatest	influence	on	prescribing	and	
dispensing	was	that	exerted	by	patients,	and	that	this	could	be	traced	back	to	the	past	
when	medicines	were	 fully	 accessible.	 This	 legacy	was,	 in	 their	 view,	 additionally	 and	
unintentionally	reinforced	by	the	recent	policies	on	patient	empowerment:	
“Those	I	call	the	‘informed	patients’	(laughs).	They	read	off	the	internet	or	
talk	 to	 friends	 and	 neighbours,	 and	 they	 all	 know	 what	 is	 wrong	 with	
them,	then	also	know	the	best	therapy…	or	they	would	not	like	the	therapy	
that	 the	specialist	prescribed,	before	 they	even	took	 it,	because	 it	wasn’t	
what	 they’d	expected,	 so	 they	ask	 for	 referral	 to	go	 to	another	one…and	
this	 is	 all	 covered	 with	 the	 insurance,	 the	 first	 opinion,	 the	 second	
opinion…We	introduced	this	 in	2008	 in	the	 law	on	protection	of	patients’	
rights	 but	 the	 intention	 was	 not	 to	 enable	 abuse,	 rather	 to	 give	 wider	
access…”	(EI10)	
	
In	 their	 view,	 such	 practices	 continued	 to	 exist,	 in	 a	 form	 of	 overprescribing	 and	
dispensing	without	prescription,	both	of	which	were	viewed	as	unethical:	
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	“The	 electronic	 system	 has	 a	 real	 time	 information	 on	 the	 so-called	
patient	 pathways;	 that	means	where	 and	 at	what	 time	 the	 patients	 are	
with	their	papers…We	see	a	 lot	of	antibiotics	there…individually	 I	am	not	
convinced	that	all	those	prescriptions	were	really	necessary.”	(EI13)	
	
One	of	the	elites	stakeholders	described	patients’	exerted	pressure	as	one	supported	by	
the	 ‘aura’	 of	 supremacy	 of	 the	 patient,	 which	 was	 also	 reflected	 in	 their	 behaviour	
towards	the	system	and	responsible	institutions	for	handling	the	claims,	as	illustrated	in	
the	next	quote:		
“There	 is	 this	 aura	 that	 the	 system	 exists	 for	 the	 patients	 …in	 their	
understanding	 there	 shouldn’t	 be	 any	 hesitation	 to	 giving	 them	 the	 best	
available	 treatment,	 be	 it	 diagnostics,	 treatments,	 medicines,	 medical	
aids…We	 get	 complaints	 from	 patients	 which	 are	 not	 always	 grounded,	
and	when	we	reject	them	they	go	to	the	second	instance	[higher	authority	
level]...”	(EI1)	
	
As	 noted	 above,	 elites	 considered	 such	 behaviour	 and	 a	 feeling	 of	 supremacy	 to	 be	
reinforced	 by	 the	 recently	 endorsed	 policies	 that	 promoted	 patient	 empowerment.	
Among	 other	 impacts,	 according	 to	 them,	 these	 policies	 enabled	 a	 high	 degree	 of	
freedom	of	the	patient	to	make	choices	that	could	be	single-handedly	decided	upon,	but	
had	implications	for	physician’s	practice	and	even	income:	
“Patients	 can	 change	 their	 physician	 as	 many	 times	 as	 they	 want,	 and	
there	were	lot	of	requests	at	first,	so	we	limited	it	to	two	times	per	year…in	
the	beginning,	 it	was	 required	 to	state	 the	 reason	 for	changing,	now	not	
any	 more...	 They	 don’t	 even	 have	 to	 inform	 the	 doctor	 that	 they	 have	
chosen	a	different	one,	all	there	is	to	do	is	to	go	to	the	new	one	and	sign	
in,	 the	 system	 automatically	 removes	 them	 from	 the	 doctor’s	 listing,	 no	
questions	asked…the	capitation	will	be	deducted	for	the	removed	patient.”	
(EI13)	
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This	 view	 was	 consistent	 with	 the	 providers’	 concerns	 about	 the	 diminution	 of	 their	
autonomy	and	 respect	 for	 their	profession,	discussed	earlier	 in	 this	 chapter.	However,	
policy	 makers	 perceived	 this	 reduction	 in	 autonomy	 and	 respect	 to	 also	 come	 from	
providers	 themselves,	 and	 believed	 that	 more	 should	 be	 invested	 in	 the	 continuous	
professional	 development	 and	 communication	 skills	 of	 providers	 in	 primary	 care.	 For	
policy	 makers,	 the	 role	 of	 education	 and	 continuing	 professional	 development	 was	
argued	to	be	key;	in	their	view,	the	physicians	had	sufficient	clinical	knowledge,	but	they	
lacked	awareness	of	clinical	guidelines.	 In	addition,	many	of	 them	felt	 that	 introducing	
training	 on	 communication	with	 patients	would	 be	 beneficial,	 for	 both	 physicians	 and	
pharmacists,	which	was	in	a	way	confirmed	by	the	providers	themselves:		
“Many	 trainings	 we	 had	 [on	 rational	 prescribing]	 with	 foreign	
consultants…	we	used	to	ask	doctors	what	would	they	prescribe	given	the	
diagnosis.	We	would	give	them	the	example,	I’d	ask,	this	was	the	medicine	
prescribed	 in	 one	 country,	 what	would	 you	 have	 prescribed?	…they	 said	
that	 it	 was	 easier	 to	 answer	 theoretical	 questions	 or	 to	 raise	 the	 color-
coded	 card	 [with	 correct	 answers],	 rather	 than	 telling	 to	 the	 patient…”	
(EI9)	
	
In	summary,	this	section	has	presented	a	varied	and	complex	account	of	the	experiences	
and	views	of	physicians	and	pharmacists	in	primary	care	in	Macedonia	in	relation	to	one	
particular	 aspect	 of	 implementation,	 articulated	 as	 pressures	 in	 practice.	 It	 has	 been	
shown	 that	 they	 appear	 to	 be	 in	 a	 difficult	 position	 due	 to	 dual	 pressures	 –	 upwards	
from	patients’	pressure	and	expectations	and	downwards	from	new	policy	frameworks.	
These,	 in	 their	 view,	 are	 exacerbated	 by	 a	 perceived	 lack	 of	 support	 or	 guidance	 in	
relation	 to	 policy	 changes,	 elaborated	 in	 the	 previous	 sections.	 Similar	 accounts	were	
provided	 by	 policy	 makers,	 though	 their	 views	 also	 included	 proposed	 solutions	 for	
reducing	 these	 pressures	 through	 continued	 professional	 development	 and	 providing	
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training	 for	 communication	 with	 patients.	 The	 next	 section	 goes	 on	 to	 explore	 the	
experiences	and	views	of	patients,	with	 regards	 to	 their	perceived	pressures	 from	 the	
new	policy	circumstances.	
5.4.2	Patients’	negotiation	of	medicine	supply	
The	second	sub-theme	related	to	pressures	in	practice	following	policy	change	involves	
patients’	 felt	 pressures	 under	 the	 new	 policy	 circumstances.	 As	 elaborated	 earlier,	
patients	related	closely	to	the	past	system,	and	shared	experiences	of	several	negative	
consequences	related	to	policy	changes.	In	the	new	policy	setting	of	limited	prescribing	
and	dispensing,	patients	no	longer	had	unlimited	access	to	medicines	and	supplements,	
and	 in	 their	 view	 perceived	 themselves	 to	 be	 pressured	 into	 engaging	 in	 negotiation	
over	medicine	supply.	As	will	become	clear,	this	was	manifest	in	terms	of	pressure	being	
exercised	by	patients	over	physicians	 in	relation	to	prescribing	decisions,	and	also	over	
pharmacists	in	relation	to	dispensing	medicines	without	prescription.		
Although	a	range	of	patients	and	ages	were	purposively	sampled	in	this	study,	many	of	
the	respondents	had	experience	of,	and	could	recollect,	the	prescribing	and	dispensing	
practices	 in	 the	previous	system.	Although	 there	was	explicit	acknowledgement	of	 the	
necessity	of	 limitations	and	cost	 containment	 (as	noted	 in	 section	5.2.2	Reflections	on	
recent	 policies:	 necessity	 for	 change	 and	 qualified	 acceptance),	 patients	 were	 critical	
when	 considering	 the	 personal	 impact	 of	 such	 policy	 changes.	 Their	 understanding	
appeared	 to	be	 informed	by	 their	own	personal	needs	 in	 relation	 to	medicines.	 There	
was	 a	 sense	 that	 for	many,	 they	 did	 not	 represent	 a	 burden	 to	 the	 system,	 and	 as	 a	
result	 there	 was	 a	 certain	 entitlement	 or	 expectation	 in	 relation	 to	 medicines	 and	
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therapies.	This	was	justified	in	terms	of	the	view	that	they	had	contributed	sufficiently	to	
health	insurance	through	fringe	benefits,	as	one	patient	argued:		
“…I	worked	for	35	years,	was	strong	as	a	horse,	never	got	sick,	so	I	think	I	
am	entitled	to	the	healthcare	to	enable	me	to	enjoy	my	retirement	for	as	
long	as	 I	would	be	around…I	take	a	very	common	therapy	for	high	blood	
pressure,	 I	 also	 take	 prevention	 for	 blood	 clotting…	 those	 are	 all	 regular	
stuff,	half	of	the	nation	is	taking	them,	I	think	they	are	not	as	expensive	as	
cancer	treatment	for	example…”	(Pat12)	
	
In	their	view,	access	to	medicines	should	be	guaranteed,	and	they	found	it	rather	novel	
that	in	some	instances	they	needed	to	negotiate	or	argue	with	physicians	or	pharmacists	
to	obtain	the	medical	therapy.	Of	note	was	that	most	of	the	examples	given	were	about	
anti-microbial	treatment,	usually	in	smaller	children.	As	the	following	quote	illustrates:		
“Several	times	the	paediatrician	suggested	we	try	without	antibiotics,	but	I	
know	 my	 child,	 she	 is	 very	 weak	 on	 her	 throat,	 and	 if	 we	 don’t	 react	
quickly	it	goes	straight	down	to	the	lungs…I	tried	once	and	it	didn’t	work,	
we	 ended	 up	 with	 pneumonia	 in	 Kozle	 [lung	 disease	 hospital	 for	
children]…I	 know	 my	 child	 and	 if	 I	 think	 antibiotics	 are	 needed,	 they	
usually	 are…I	 am	 not	 in	 favour	 of	medications,	 but	 when	 it’s	 needed,	 it	
can’t	be	helped…”	(Pat9)	
	
To	many	of	the	interviewed	patients	this	need	to	negotiate	for	medicines	represented	a	
new	dimension	 of	 their	 relationship	with	 the	 system,	 and	 this	was	 not	 just	 related	 to	
examples	 like	 the	 one	 above	 about	 controversial	 antibiotic	 prescribing,	 but	 also	
medicines	 for	well-recognised	 long-term	conditions.	For	 those	who	were	on	 long-term	
therapies,	the	main	issue	raised	was	the	very	real	possibility	of	not	being	able	to	obtain	
necessary	 therapies	 for	 longer	 periods	 in	 advance.	 One	 patient	 felt	 it	 was	 a	 futile	
exercise	 that	 was	 not	 only	 an	 inefficient	 use	 of	 time,	 but	 was	 also	 undermining	 the	
expertise	by	a	specialist:	
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“I’m	a	heart	patient	for	20	years;	I	know	all	medicines,	I’ve	taken	them	all;	
I	 can	 even	 tell	 you	 which	 companies’	 have	 better	 effect…	 enalapril,	 for	
example,	from	[…]	company	is	not	effective,	at	 least	not	for	me,	so	I	stay	
with	[…]	company…I	go	to	the	cardiologist	once	a	year,	so	I	tell	my	doctor,	
if	 the	 cardiologist	 thinks	 that	 I	 can	 go	 with	 the	 therapy	 that	 long,	 why	
can’t	I	get	the	prescriptions	at	once?”	(Pat12)	
	
What	then	emerges	from	the	perspective	of	patients,	is	a	threat	to	their	previous	ability	
to	obtain	any	medicine	through	prescribing,	and	a	current	process	whereby	physicians	
appeared	to	be	restricting	patients’	access	to	certain	medicines.	Although,	as	noted,	not	
framed	in	an	explicit	understanding	or	awareness	of	the	three	key	policies	themselves,	
patients	 nonetheless	were	 aware	 of	 the	 changes	 and	 the	 negative	 consequences	 and	
need	to	negotiate	more.		
Two	 other	 patients,	 referring	 to	 the	 impact	 that	 new	 policies’	 limited	 access	 to	
medicines	 had	 on	 their	 routines,	 considered	 alternative	 solutions	 to	 obtaining	 the	
required	medicines:	
“I	have	a	holiday	apartment	in	Ohrid	and	I	go	there	for	three-four	months	
during	 summer…so,	 I	 ask	 the	 doctor	 to	 give	 me	 the	 medicines	 for	 the	
whole	period	but	it	is	not	possible…up	to	three	months,	yes	but	after	that	I	
have	to	come	back	to	Skopje	to	get	the	prescription,	because	I	can’t	get	it	
from	 a	 doctor	 in	 Ohrid…sometimes	 I	 decide	 to	 buy	 privately	 as	 it	 is	 less	
bothering	 to	 pay	 than	 to	 go	 back	 in	 the	 heat	 just	 for	 the	
prescription…sometimes,	 I	 ask	 someone	 to	 go	 to	 my	 doctor	 for	 the	
prescription	 and	 then	 anyone	 traveling	 to	 Ohrid	 will	 bring	 it	 for	 me…”	
(Pat1)	
“My	daughter	lives	in	Serbia,	and	I	spend	the	winter	with	her	to	help	with	
the	children…but	it	is	most	difficult	with	the	medicines,	they	have	different	
ones	and	also	I	don’t	have	insurance	there.	So,	when	I	have	to	make	larger	
stock,	 and	 it’s	 not	 easy…some	 of	 the	 medicines	 are	 the	 same	 as	 my	
husband’s,	 so	 I	 take	prescriptions	 some	on	my	name	and	 some	on	his	 to	
get	enough	of	the	medicines	I	need.	I	leave	with	him	some,	and	he	can	get	
additional	packs	while	 I’m	away…he	does	the	same	to	get	the	medicines,	
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some	on	my	name	and	some	on	his…if	you	can’t	afford	to	buy	medicines	
privately,	you	have	to	find	a	way…”	(Pat2)	
	
In	the	second	quote	above,	the	patient	is	describing	a	rather	complex	scheme	of	trying	
to	circumvent	current	policies	in	order	to	be	able	to	continue	the	established	practice	of	
providing	 sufficient	 medicine	 supply	 that	 was	 possible	 in	 the	 past.	 For	 the	 described	
situation	not	covered	by	the	policies,	the	patient	needs	a	medicine	supply	for	a	period	
longer	than	the	allowed	maximum,	so	she	combined	prescriptions	with	another	patient	-	
in	this	case	her	partner	-	to	make	an	advance	supply	in	another	name,	that	will	later	be	
covered	by	the	prescriptions	in	her	name	for	the	supply	of	the	other	patient.		
These	quotes	 illustrate	 two	of	 the	non-standard	alternative	 routes	 to	medicine	 supply	
faced	by	patients	within	the	current	prescribing	and	dispensing	policies,	 to	either	 fund	
the	supply	of	medicines	themselves	privately,	or	to	use	subterfuge	to	obtain	supplies.	
For	some	of	the	patients	the	wearying	nature	of	such	negotiated	supplies	 led	to	active	
attempts	to	exercise	a	choice	over	prescriber,	and	so	to	search	for	another	doctor	who	
was	willing	to	acquiesce	to	patients’	requests:	
“I	 have	 a	 very	 stressful	 job,	 I	was	 telling	my	 previous	 doctor	 that	 I	 have	
trembles	 all	 day	 long	 if	 I	 don’t	 take	 Helex	 [anxiolytic],	 and	 that	 I	 don’t	
sleep	well,	and	I	tried	all	alternatives	he	offered,	melatonin,	valerian,	but	
with	no	effect.	He	also	said	physical	activity,	but	I’m	too	tired	when	I	come	
home…	He	said	Helex	is	addictive,	but	I	was	only	taking	one	in	the	morning	
and	one	in	the	evening,	sometimes	skipped…He	prescribed	once	or	twice,	
then	said	I	should	consult	a	neurologist.	I	decided	to	change	the	doctor…”	
(Pat14)	
	
Negotiating	 for	medicines	was	 described	 as	well	 at	 the	 dispensing	 level.	 A	 few	 of	 the	
patients	described	situations	when	they	could	not	obtain	the	medicine	despite	having	a	
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valid	prescription,	often	as	a	result	of	the	unavailability	of	the	required	medicine	at	the	
pharmacy,	due	to	the	exhausted	quotas	for	the	month:	
“At	 the	 pharmacy	 they	 would	 sometimes	 have	 only	 two	 of	 the	 four	
prescriptions	I	need,	so	I	have	to	go	to	another	pharmacy….it	is	frustrating	
to	do	it	every	month…I	made	arrangement	with	our	local	pharmacy	that	I	
leave	 the	 prescriptions	 with	 them	 and	 they	 call	 me	 in	 when	 medicines	
come…”	(Pat6)	
	
The	 negotiating	 at	 the	 pharmacy	 level	 also	 happened	 when	 there	 were	 no	 genuine	
medical	 reasons.	 This	 patient	 had	 already	made	 the	 decision	 to	 obtain	 the	medicines	
and	found	a	way	to	effect	her	decision	despite	the	circumstances:	
“Here	 in	 the	village	we	have	no	doctor,	 there	was	one	but	he	 closed	 the	
office…now	we	only	have	a	dentist…	When	I	need	antibiotic	I	have	to	go	to	
the	town,	and	then	get	 it	 from	the	pharmacy	here,	but	usually	 I	can’t	go	
when	I’m	sick,	I’ll	get	even	sicker…so	I	ask	the	pharmacist	for	the	medicine	
and	I	bring	the	prescription	later…”	(Pat14)	
	
Further	 to	 this,	 in	 the	 patient	 group,	 such	 necessity	 to	 negotiate	medicine	 supply	 has	
evolved	 into	 justification	 of	 ‘means’	 towards	 the	 end	 goal	 of	 providing	 necessary	 or	
desired	 therapy	 for	 their	 treatment	 and	 resulting	 sometimes	 in	 subterfuge	 of	 regular	
mechanisms	 and	 unethical	 practices.	 The	 above	 quotes	 exemplify	 patients’	 practices	
already	described	by	providers	and	confirmed	by	elites	who	also	shared	these	views:	
“There	are	cases	when	the	patient	has	already	bought	and	consumed	the	
antibiotic	 …	 For	 example,	 the	 patient	 has	 bought	 himself	 Vibramycin	
[branded	 form	of	 tetracycline	antibiotic]	 because	 the	dose	 is	 one	pill	 per	
day,	it	costs	40-50	denars	[less	than	one	GB	pound],	five	pills,	he	will	take	
them	 and	 will	 then	 come	 to	 me	 and	 I	 have	 no	 other	 choice	 than	 to	
prescribe	the	same…”	(PCP14)	
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As	 considered	 above,	 patients	 admitted	 to	 actively	 pressuring	 providers	 and	
encouraging	 non-compliance	 with	 regular	 prescribing	 and	 dispensing	 procedures.	 For	
them,	 this	 new	 reality	was	 a	 justification	of	 their	 practices	 -	 previous	 and	 current	 -	 of	
obtaining	 medicines	 on	 their	 own,	 especially	 if	 they	 anticipated	 the	 physician	 would	
consider	their	choice	of	medicines	not	to	be	necessary.	They	have	very	openly	spoken	of	
inclining	 towards	a	decision	of	 taking	medicines	without	prior	health	care	professional	
consultation.	 Examples	 were	 given	 mainly	 for	 antimicrobials	 and	 anxiolytics,	 mostly	
among	younger	respondents	but	the	elder	alike;	some	referred	to	previous	experience	
with	the	same	medical	condition:	
“When	I	have	a	sore	throat	I	know	that	I	can’t	solve	it	without	antibiotics.	I	
usually	take	Vibramycin	[a	branded	form	of	tetracycline	antibiotic],	it	helps	
me	 every	 time,	 and	 it’s	 very	 affordable.	 I	 always	 have	 a	 dose	 at	 home,	
‘cause	 it’s	 best	 to	 take	 immediately	when	 you	 feel	 the	 scratching	 in	 the	
throat”	(Pat7)	
“I	don’t	mind	paying	for	the	medicines,	and	I	do…it	is	quicker	and	easier	to	
go	 to	 a	 pharmacy	 and	 get	 what	 you	 need…some	 of	 the	 prescription	
medicines	 should	 be	 without	 prescription	 [over-the-counter]	 if	 you	 ask	
me…for	 example,	 my	 husband	 has	 a	 sleeping	 problem	 and	 he	 takes	
diazepam	from	time	to	time.	For	that,	I	don’t	think	it’s	so	necessary	to	go	
to	a	doctor…	I	think	should	not	be	on	prescription,	it	seems	like	a	matter	of	
marketing…”	(Pat3)	
	
Further,	these	and	other	respondents	are	seemingly	speaking	of	availability	of	medicines	
as	a	matter	of	material	possibility	to	obtain	them;	the	above	examples	reveal	disregard	
for	 the	 necessity	 of	 medical	 consultation,	 and	 provide	 another	 explanation	 for	 their	
straightforward	 justification	 of	 self-medication	 practices.	 But,	 at	 the	 same	 time	 these	
excerpts	 also	 disclose	 that	 medicines	 can	 be	 obtained	 without	 prescription,	 i.e.	 that	
there	 are	 pharmacies	 enabling	 this	 practice.	 Here	 too,	 patients	 have	 inclined	 to	
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developing	 a	 new	 skill	 for	 identifying	 such	 pharmacies	 where	 obtaining	 desired	
medicines	was	not	problematic:	
“…needed	 antibiotic	 for	 my	 girlfriend,	 she	 was	 burning	 with	 fever	 and	
Paracetamol	[branded	form	of	acetaminophen]	didn’t	help…	The	lady	said	
she	cannot	give	me	any	drug	without	prescription,	no	matter	what…I	had	
to	go	to	the	next	and	the	next,	and	I	bought	 it…I	was	scolded	(laughing),	
but	I	got	it…”	(Pat13)	
	“Some	pharmacists	are	very	tough,	they	wouldn’t	give	anything	without	a	
prescription,	 they	 tell	 you	 that	 such	 are	 the	 rules,	 and	 there	 are	 strict	
inspections…they	are	nice	and	apologize	but	will	not	give	in…There	are	few	
that	I	know	which	sell	you	the	same	medicines	without	a	prescription,	and	
for	 them	 there	 are	 no	 inspections...	 even,	 they	 will	 give	 you	 an	 advice	
which	is	better	than	the	other…”	(Pat10)	
	
These	two	quotes	illustrate	the	justification,	triggering	the	compensatory	mechanisms	of	
finding	 their	 own	ways	 of	 dealing	 with	 the	 arising	 issues	 while	 at	 the	 same	 time	 not	
feeling	 the	 responsibility	 when	 those	 are	 outside	 of	 the	 normative,	 legal	 or	 ethical	
frames.		
For	 one	 patient	 the	 request	 for	 a	 medicine	 without	 prescription	 was	 justified	 if	
supported	by	the	provider,	and,	as	in	this	quote,	this	could	be	for	a	variety	of	medicines	
including	those	with	abuse	potential:	
“My	wife’s	mother	was	in	terminal	stage	of	cancer	and	she	[the	wife]	was	
very	anxious,	very	nervous,	I	became	anxious	too,	I	didn’t	know	what	to	do	
…I	went	to	a	pharmacy	and	asked	for	diazepam	or	something	similar…they	
didn’t	have	diazepam	and	[the	pharmacist]	offered	me	helix	[sic],	Helex	[a	
branded	 form	 of	 alprazolam,	 an	 anxiolytic]	 …	 explained	 the	 dosage…”	
(Pat11)		
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Elites’	 accounts	 confirmed	 the	 above	 practice	 of	 circumventing	 primary	 care	 for	
obtaining	 a	 prescription,	 and	 going	 directly	 to	 a	 pharmacy	 with	 self-medication	
intentions,	exemplified	through	the	following	quote:	
“Still	 today	 patients	 don’t	 go	 to	 the	 doctor,	 they	 go	 straight	 to	 the	
pharmacy;	if	there	are	any	family	ties	they	would	get	the	medicine	without	
any	 problem…those	 who	 want	 to	 get	 the	 medicines	 through	 the	 Fund	
regularly	take	prescriptions,	but	there	is	one	part	[of	the	population]	that	
doesn’t	bother,	obviously	because	they	can	afford	it.”	(EI2)	
	
The	 above	 quote	 also	 conveys	 the	 finding	 that	 despite	 policy	 changes	 restricting	
unregulated	medicine	 supply,	 obtaining	 a	 prescription	medicine	 was	 still	 viewed	 as	 a	
matter	of	financial	affordability	even	by	elite	stakeholders.		
5.4.3	Summary	of	pressures	in	practice	
The	theme	of	pressures	in	practice	revealed	providers’	felt	pressures	from	both	system	
and	 patients,	 and	 patients’	 felt	 pressures	 for	 obtaining	 medicines	 they	 deemed	
necessary.	
In	providers’	accounts	there	was	an	obvious	tension	between	the	necessity	to	respond	
to	system’s	requirements	and	deliver	on	patients’	demands.	The	system’s	pressure	was	
mainly	 articulated	 as	 an	 increased	 pressure	 to	 adhere	 to	 the	 new	 rules	 under	 the	
conditions	 of	 perceived	 lack	 of	 involvement	 in	 policymaking	 and	 lack	 of	 support	 for	
implementation.	The	pressure	from	patients	was	articulated	as	both	felt	and	perceived,	
forcing	providers	 to	 unwanted	practices	 of	 prescribing	without	medical	 indication	 and	
illegal	dispensing	without	prescription.	Although	reluctant	to	abide,	providers	admitted	
to	 accepting	 such	 demands	 under	 pressure,	 which	 contributed	 to	 their	 feeling	 of	
isolation	and	detachment	from	the	system.		
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What	emerged	 in	patients’	accounts	was	a	new	found	need	to	seek	out	and	negotiate	
medicine	 supply	 both	 at	 prescriber	 level,	 but	 also	 through	 less	 regulated	 pharmacy	
supplies.	A	tension	was	shown	to	emerge	in	patients’	identity,	where	they	appeared	to	
be	somewhat	empowered	health	consumers,	yet	still	treated	paternalistically.	Providers	
had	 opposing	 views,	 as	 they	 found	 patients	 to	 be	 unjustifiably	 empowered	 and	more	
supported	by	the	system	then	themselves	as	 its	part.	Elites	agreed	with	providers	that	
patients’	behaviour	 significantly	 influences	decisions	 in	prescribing	and	dispensing,	but	
were	negligent	of	the	fact	that	failed	policy	implementation	was	one	of	the	key	factors	
enabling	such	influence.		
	
5.5. Summary	of	chapter	
	
This	chapter	has	provided	detailed	descriptions	of	the	emerging	themes	resulting	from	
the	 in-depth	 analysis	 of	 the	 interviews	 revealing	 several	 key	 findings	 related	 to	 the	
effects	of	policy	changes	on	the	prescribing	and	dispensing	practices	in	primary	care	in	
Macedonia.		
All	groups	expressed	a	positivity	and	attachment	to	the	previous	system,	manifest	as	a	
positive	 nostalgia.	 This	 nostalgia	was	 articulated	 by	 providers	 from	 the	 perspective	 of	
professional	autonomy	and	belonging	to	the	system,	and	by	patients	as	less	problematic	
and	 unlimited	 medicine	 supply	 in	 the	 past.	 Elite	 stakeholders	 also	 talked	 about	 the	
benefits	of	 the	previous	policies,	 and	agreed	 that	professional	autonomy	was	 reduced	
with	 the	 new	 policies,	 but	 also	 understood	 the	 lack	 of	 sustainability	 of	 that	 system,	
justifying	the	necessity	for	change	for	improvement	of	efficiency	of	resource	use.		
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With	 regards	 to	 the	 policy	 implementation,	 all	 groups	 similarly	 believed	 that	 this	was	
lacking,	however	each	group	argued	this	was	so	 for	different	reasons.	For	providers,	 it	
was	 a	 consequence	 of	 the	 lack	 of	 their	 involvement	 in	 policy-making,	 ambiguity	 of	
enforcement	and	 lack	of	 support	 from	 the	 system.	While	providers	 largely	questioned	
the	 policy	 changes	 and	 patients	 were	 ambiguous,	 the	 views	 of	 the	 elites	 generally	
described	the	policy	changes	as	being	necessary,	although	they	also	made	comparisons	
to	 the	previous	system,	which	was	perceived	more	positively	as	being	 fairer	and	more	
oriented	towards	patients,	though	not	sustainable	in	terms	of	cost	efficiency.	
The	patients	on	the	other	hand,	were	much	less	aware	of	the	details	and	drivers	of	the	
policy	 changes,	 beyond	 their	 experience	 in	 visiting	 a	 primary	 care	 physician	 or	 a	
pharmacist.	When	compared	to	the	past	system,	they	too,	felt	the	previous	system	was	
much	more	oriented	to	address	their	needs,	and	were	not	quite	ready	to	justify	the	cuts	
on	prescribing	and	dispensing	under	the	health	insurance;	with	the	exception	of	some,	
who	had	 knowledge	on	 policies	 through	 a	 person	working	 in	 primary	 care.	 The	 policy	
makers	held	a	more	 forthright	view	that	resultant	problems	associated	with	 the	policy	
changes	 were	 attributable	 to	 the	 other	 groups.	 They	 identified	 perceived	 problems	
amongst	 providers	 and	 patients	 related	 to	 a	 lack	 of	 professional	 development	 for	 the	
former	and	a	lack	of	health	literacy	amongst	the	latter.		
Primary	 care	 physicians	 and	 pharmacists	 felt	 detached	 from	 the	 system,	 expressing	
themselves	 as	 being	 left	 alone	 to	 cope	 with	 policy	 implementation.	 In	 line	 with	 the	
feeling	of	detachment,	another	important	issue	was	the	lack	of	guidance	and	support	for	
the	policy	implementation;	to	the	physicians	and	pharmacists	this	meant	that	they	had	
to	 find	 other	 ways	 of	 dealing	 with	 the	 arising	 problems,	 beyond	 the	 framework	 for	
which	they	have	been	engaged.		
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In	addition	to	this,	providers	felt	disempowered	and	their	autonomy	threatened.	In	their	
view,	 this	 resulted	 in	 a	 deteriorated	 appreciation	 for	 their	 profession	 across	 society,	
which	also	had	negative	ethical	 implications.	 This	was	manifest	 in	 terms	of	 continuing	
the	 practices	 of	 overprescribing	 and	 supplying	 medicines	 without	 prescriptions.	 The	
elites	stakeholders	broadly	shared	a	similar	standpoint	to	that	of	providers	with	respect	
to	the	above,	but	were	more	cautious	in	justifying	these	practices.	On	the	contrary,	they	
distanced	themselves	 from	responsibility	and	considered	 improving	 implementation	 to	
be	in	the	domain	of	providers	and	patients.	
Another	important	theme	arising	from	the	interviews	involved	pressures	in	practice.	As	
already	noted,	the	analysis	of	interviews	revealed	differing	perspectives,	with	providers	
feeling	 pressure	 from	 both	 regulatory	 and	 governmental	 bodies	 to	 adopt	 the	 policy	
changes	 but	 also	 from	 patients	 in	 relation	 to	 their	 expectations	 and	 demands	 for	
medicines.	Their	repetitive	and	ample	examples	of	being	pressured	depicted	changes	in	
their	 relationship	 with	 patients;	 they	 feel	 subordinated	 -	 to	 the	 system,	 through	
privatisation	and	to	the	patients	through	the	perceived	patients’	supremacy	as	a	result	
of	their	empowerment	with	the	patients’	rights	policies.	While	policy	makers	tended	to	
generally	 agree	with	 providers	 on	 the	 issue	of	 patient	 pressure,	 patients’	 felt	 strongly	
that	 the	 situation	 was	 quite	 the	 opposite.	 They	 described	 being	 in	 an	 unfavourable	
position	 in	 their	 interaction	 with	 the	 system,	 making	 the	 case	 for	 their	 access	 to	
medicines,	negotiating	medicine	supply	and	justifying	self-medication.	
Patients	 also	 did	 not	 consider	 their	 relationship	 with	 the	 physicians	 to	 have	 changed	
dramatically,	but	expressed	a	 feeling	of	disempowerment	when	 it	came	to	negotiating	
what	 they	 argued	 were	 necessary	 medicines.	 Their	 attitudes,	 in	 fact,	 appeared	 to	
depend	 much	 on	 their	 ability	 to	 pay	 for	 the	 medicines	 out-of-pocket,	 and	 patients	
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openly	 stated	 that	 they	 would	 circumvent	 going	 to	 the	 physician	 and	 getting	 the	
prescription,	 if	they	could	find	a	pharmacist	that	would	dispense	the	medicine	without	
it.	Some	extreme	and	negative	opinions	were	identified	in	this	respect,	captured	in	one	
respondent’s	 view	 that	 all	 recent	prescribing	 and	dispensing	 rules	 and	policies	were	 a	
‘matter	of	marketing’.	
The	next	chapter	focuses	on	the	interpretation	of	the	findings	presented	in	this	chapter,	
along	 with	 further	 reflection	 on	 the	 emerging	 themes	 in	 the	 context	 of	 relevant	
literature	and	also	Habermas’	theory	of	communicative	action.	
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CHAPTER	6:	Discussion	
	
6.1. Introduction	
	
6.1.1	Overview	of	chapter	 	
Social	 science	 approaches	 not	 only	 provide	 a	 means	 of	 describing	 particular	 socially	
occurring	 phenomena	 but	 also	 offer	 a	 way	 of	 seeing	 them	 that	 might	 not	 be	
immediately	apparent	(Cooper	2006).	As	evident	from	the	previous	chapter,	the	themes	
identified	 from	 the	 individual	 respondent’s	 accounts	 reflect	 the	 lived	 experiences	 of	
individuals	 in	different	roles	and	often	at	a	micro-social	 level,	but	always	 in	relation	to	
the	macro-level	framing	of	different	policy	initiatives.	To	this	end,	the	identified	themes	
were	analysed	from	the	perspective	of	their	common	underlying	concepts	while	looking	
into	 patterns	 of	 behaviour	 through	 individuals’	 attitudes	 and	 practices,	 expressed	
through	their	accounts.		
The	 key	 task	 in	 this	 chapter	 is	 to	 provide	 additional	 context	 and	 reflection	 on	 these	
emerging	themes,	and	crucially	to	relate	them	not	only	to	the	extant	literature	but	also	
to	 relevant	 theoretical	 concepts.	 Thus,	 beyond	 the	 attention	 to	 the	excerpts	 from	 the	
respondents’	 individual	 accounts,	 provided	 in	 the	 previous	 chapter,	 the	 interpretation	
and	contextualisation	of	these	findings	in	the	present	time	and	more	importantly	in	the	
theoretical	 framework	 chosen	 for	 this	 research	 is	 of	 equal	 importance	 and	 as	 such	 is	
elaborated	in	this	chapter.	
The	chapter	will	reflect	the	findings	 in	the	context	of	the	Habermasian	social	theory	of	
the	system	and	the	lifeworld,	and	its	notions	of	‘selective	rationalization’	consequent	on	
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the	 growth	 and	 dominance	 of	 the	 capitalist	 economy	 and	 state	 bureaucracy	 (Brand,	
1990),	 and	 ‘lifeworld	 colonization’	 consequent	 on	 increasing	 systematisation	 of	
particular	areas	of	the	lifeworld,	 leading	to	deviation	from	or	stagnation	of	the	original	
purpose	of	the	lifeworld	and	its	communicative	action	(Barry	et	al	2001).	Both	selective	
rationalisation	 and	 lifeworld	 colonisation	 have	 direct	 relevance	 to	 understanding	 the	
prescribing	 and	 dispensing	 practices	 as	 part	 of	 the	 provider–patient	 interaction	
(Scambler	 2001,	 p.21),	 and	 of	 decision-making	 in	 health	 care	 in	 general.	 Used	 as	 a	
framework	 for	 critical	 analysis	 of	 prescribing	 and	 dispensing	 which	 are	 of	 particular	
interest,	Habermas’	theory	provides	the	grounds	for	understanding	the	behaviours	and	
therefore	practices	on	the	part	of	both	providers	and	patients,	who	are	arguably	inclined	
to	resistance	of	their	respective	life-world	colonisation.	
6.1.2	Observations	
Before	 discussing	 the	 findings	 reported	 in	 the	 previous	 chapter,	 it	 is	 useful	 to	 share	
some	 observations	 from	 the	 data	 collection	 and	 analysis	 processes.	 One	 of	 the	most	
discernible	 is	 that	 the	 clearest	 voices	 in	 this	 study	 were	 those	 of	 the	 primary	 care	
providers.	 Such	 an	 observation	 is	 very	 natural	 since,	 compared	 to	 other	 stakeholders,	
and	 the	 interviewed	 groups	 in	 particular,	 they	 have	 to	 manage	multiple	 interactions,	
processes	 and	 agents	 in	 their	 roles,	 described	 by	 Jones	 (2001)	 as	 being	 ‘ambivalent’	
between	 decision	 making	 and	 mediation.	 In	 this	 sense,	 their	 engagement	 in	 the	
interactions	with	both	the	system	and	the	 lifeworld	need	to	be	understood	as	political	
rather	 than	 technical	 (Jones	 2001)	 and	 this	 perspective	 will	 be	 used	 to	 frame	 the	
discussion	that	follows.	
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The	second	important	observation	from	the	interviews	was	that	primary	care	providers	
did	not	 appear	 to	be	 comfortable	offering	 criticism	of	 the	 system	and	policy	 changes;	
there	 was	 an	 observable	 reservation	 together	 with	 disclaimers	 suggesting	 that	 their	
experience	might	 be	 only	 that	 of	 a	minority.	 As	 the	 interviews	were	 progressing,	 the	
unfolding	 stories	 of	 their	 own	and	of	 their	 colleagues’	 experiences	made	 them	 realise	
that	in	fact	they	were	not	satisfied,	but	on	the	contrary	–	they	felt	isolated	and	distanced	
from	the	system	on	one	side	and	pressurized	from	patients	on	the	other.	However,	they	
quietly	 acknowledged	 an	 acceptance	 of	 policy	 changes,	 yet	were	 not	 ready	 to	 accept	
responsibility	 for	 failure	 of	 implementation,	 but	 rather	 considered	 themselves	 to	 be	
subject	to	pressures	in	practice	resulting	from	the	policy	changes.	
The	third	key	observation	from	the	data	collection	was	related	to	ethical	issues	arising	in	
policy	 implementation.	 It	 was	 evident	 that	 all	 of	 the	 interviewed	 groups	 clearly	
understood	 the	 unethical	 nature	 of	 some	 of	 their	 practices;	 however,	 these	 practices	
were	in	most	cases	spoken	of	in	the	third	person,	or	as	if	they	were	happening	to	others.	
Most	 apparent	 were	 the	 examples	 in	 the	 providers’	 accounts,	 describing	 with	
condemnation	the	cases	of	prescribing	without	medical	indication	or	dispensing	without	
valid	 prescription.	 This	 partial	 disapproval	 could	 be	 understood	 as	 a	 search	 for	
justification	for	possibly	their	own	practices	that	were	not	openly	articulated,	but	at	the	
same	time	as	a	reflection	of	the	apprehension	regarding	possible	sanctions	against	such	
practices.	 As	 noted	 in	 earlier	 chapters,	 this	 was	 an	 issue	 identified	 by	 Van	 der	 Geest	
(1982)	 in	 relation	 to	 the	 supply	of	medicines	 to	 the	public	 from	 inappropriate	or	non-
regular	activities.	 In	either	case,	 it	 illustrates	an	understanding	amongst	providers	 that	
some	 acts	 were	 recognised	 as	 being	 unethical	 but	 arguably	 an	 inevitable	 means	 by	
which	to	deal	with	the	ambivalent	role	earlier	described.	
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6.2. The	significance	of	findings	in	this	research	
	
The	following	section	focuses	on	the	significance	of	study	findings	and	their	meaning	in	
relation	to	the	wider	literature.	It	begins	by	elaborating	on	the	comparisons	made	by	the	
respondents	with	 regards	 to	 the	 previous	 system	 and	 the	 current	 policy	 context.	 This	
study	 is	 argued	 to	 have	 offered	 a	 greater	 understanding	 of	 how	 new	 policies	 have	
influenced	and	changed	prescribing	and	dispensing	 in	Macedonia	from	the	perspective	
of	 different	 stakeholder	 groups,	 namely:	 primary	 care	 physicians	 and	 pharmacists,	
patients	 and	 elite	 stakeholders.	 Analysis	 revealed	 three	 main	 themes	 that	 are	 briefly	
summarized	 in	 the	 next	 paragraphs	 and	 discussed	 in	 more	 detail	 in	 the	 context	 of	
existing	literature	later	in	this	chapter.	
In	 brief,	 analysis	 revealed	 considerable	 attachment	 to	 the	 previous	 system.	 This	 was	
manifest	 as	 nostalgia	 and	 it	 will	 be	 shown	 that	 this	 is	 a	 recognised	 phenomenon	 in	
transition	countries,	in	general	and	in	the	health	sector	(Bartlett	et	al	2012;	Kamat	2008;	
McDonald,	 Waring	 and	 Harrison	 2006).	 Nostalgia	 may	 offer	 a	 way	 for	 individuals	 to	
adapt	 to	 change	 and	 define	 their	 identity	 and	 given	 the	 impact	 of	 policy	 change	 for	
providers	and	patients	in	particular.	
The	 findings	 also	 suggest	 a	 significant	 difference	 in	 the	 respective	 understanding	 of	
policy	 changes	 from	 the	 perspective	 of	 providers	 and	 elite	 stakeholders	 and	 most	
notably	 policy	makers	 themselves.	 Part	 of	 the	 explanation	 for	 this	mismatch	 could	 be	
based	on	the	roles	of	each	respondent	group;	however,	it	could	also	be	interpreted	as	a	
result	of	the	lack	of	communication	and	providers’	involvement	in	policy	making,	which	
was	also	clearly	noted	by	this	respondent	group.	The	findings	from	this	research	suggest	
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that	 the	 attitudes	 and	 practices	 of	 primary	 care	 providers	 and	 patients	 may	 be	
significant	factors	influencing	the	implementation	of	prescribing	and	dispensing	policies.	
However,	findings	have	also	suggested	that	the	uneven	policy	enforcement,	especially	in	
terms	of	dispensing	without	prescription	plays	a	key	role	in	policy	outcomes.		
In	 this	 sense,	 the	 findings	 offer	 a	 more	 comprehensive	 understanding	 of	 the	 policy	
implementation	gaps	 and	how	 the	 responsibility	 for	overcoming	 these	 is	 perceived	by	
the	different	stakeholders.	Namely,	the	providers	perceived	these	gaps	in	terms	of	a	lack	
of	support	and	guidance	from	the	system,	which	contrasted	with	the	accounts	of	elites,	
who	delineated	their	role	to	be	only	that	of	policy	making.	The	findings	also	suggested	
providers’	 and	 elites’	 perceived	 lack	 of	 understanding	 from	 patients,	 regarding	 the	
necessity	to	 implement	the	stringent	rules	 in	prescribing	and	dispensing	by	the	former	
and	 lack	 of	 health	 literacy	 by	 the	 latter.	 As	 will	 be	 shown	 later	 in	 this	 chapter,	 such	
tensions	have	been	described	in	the	literature,	using	Habermas’	social	theory	to	explain	
them	(Mishler	1984;	Britten	2001).		
A	 further	key	finding	–	providers’	dual	pressure	from	the	system	and	patients	 -	will	be	
shown	 to	 be	 similar	 to	 that	 previously	 identified	 in	 other	 research	 but	 in	 some	 cases	
contrasting.	 A	 final	 theme	 to	 be	 considered	 further	 and	 related	 to	 the	 literature	
concerned	the	effects	of	policy	changes	on	both	the	system	and	the	lifeworld.	This	will	
be	done	by	focusing	on	providers	and	patients	and	their	respective	roles	and	positions	in	
relation	to	the	system	and	the	lifeworld.		
6.2.1	Reflections	on	past	and	recent	policies:	nostalgia	for	the	past	
As	elaborated	 in	the	previous	chapter,	many	of	 the	participants’	accounts	appeared	to	
involve	a	reminiscence	and	indeed	nostalgia	for	the	previous	socialist	system.	Although	
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participants	(other	than	policy	makers)	did	not	exhibit	comprehensive	understanding	of	
the	 discussed	 policies,	 either	 previously	 or	 at	 the	 time	 of	 interviews,	 most	 of	 them	
articulated	 a	 preference	 for	 the	 previous	 system,	 viewed	 as	 more	 oriented	 towards	
patients,	even	at	the	expense	of	the	economy.	There	was	an	apparent	inclination	of	the	
state	in	becoming	a	coordinating	economic	entity	consisting	of	interdependent	inclusive	
associations	 rather	 than	 a	 mechanism	 of	 class	 and	 political	 control	 (Engels	 1880).	
Bartlett	 et	 al	 (2012)	 described	 that	 health	 systems	 in	 centrally	 planned	 economies,	 at	
least	 formally,	provided	universal	service	and	equal	access.	Such	a	perception	 in	terms	
of	 social	 theory	 can	 be	 interpreted	 as	 the	 lifeworld	 dominating	 the	 system	 with	 its	
existence	 and	 experience	 (Habermas	 1984).	 It	 can	 be	 also	 argued	 that	 the	 ‘voice	 of	
lifeworld’,	 pertaining	 to	 contextual	 understanding	 of	 health	 subsumed	 the	 ‘voice	 of	
medicine’,	 constructed	 of	 technical	 knowledge	 and	 instrumental	 efficiency	 (Mishler	
1984).		
Although	 it	 has	 be	 argued	 that	 the	 past	 communist	 system	was	 typified	 by	 excessive	
state	 involvement	 (Rechel	 2008;	 Bartlet	 et	 al	 2012),	 such	 involvement	 was	 oriented	
towards	maintaining	communicative	action	with	the	lifeworld	and	supporting	exchange	
towards	mutual	 understanding	 between	members	 of	 society	 (Braaten	 1991,	 p.12).	 As	
the	 findings	of	 this	 study	 indicate,	 it	 can	be	 argued	 that	 participants	 identify	with	 the	
lifeworld	rather	than	with	the	system,	despite	some	of	them	–	namely	policy	makers	and	
providers	–	representing	the	latter.	The	examples	given	by	the	respondents	reveal	that	
the	past	system	was	colonized	by	the	lifeworld,	to	the	extent	of	neglecting	its	basic	aims	
of	rationalisation,	efficiency	and	even	control.	And	while	the	past	system	as	part	of	the	
socialist	paradigm	can	be	considered	a	suitable	foundation	for	the	Habermasian	concept	
of	 ‘regulatory	 ideals’,	 understood	 as	 the	 social	 forms	 to	 which	 society	 can	 aspire	
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(Habermas	 1989,	 p.115),	 at	 the	 same	 time	 rationalization	 of	 the	 lifeworld	 turns	 back	
destructively	 upon	 the	 lifeworld	 itself	 (Habermas	 1989,	 p.186).	 This	 in	 a	 way	 was	
validated	 by	 the	 policy	 maker	 group	 who	 articulated	 that	 changes	 were	 not	 merely	
necessary	 but	 inevitable,	 as	 a	 result	 of	 the	 perceived	 and	 experienced	 lack	 of	
sustainability	of	the	system.		
Notwithstanding	 policy	 makers’	 realisation	 of	 the	 inevitability	 of	 change,	 they,	 along	
with	providers	and	patients,	 expressed	nostalgia	 for	 the	past	 system.	One	explanation	
for	 such	 attachment	 to	 the	past	may	be	 that,	 in	 the	 comparisons	of	 the	past	 and	 the	
current	system,	the	disadvantage	of	the	current	is	the	lack	of	knowledge	and	experience	
with	the	past	system	in	the	current	time.	As	noted	by	Garro	and	Mattingly	(2000):	
‘as	persons	talk	about	their	experiences,	past	events	are	reconstructed	in	a	
manner	congruent	with	current	understanding;	the	present	is	explained	with	
reference	 to	 the	 reconstructed	 past;	 and	 both	 are	 used	 to	 generate	
expectations	about	the	future.’	(Garro	and	Mattingly	2000,	p.72)	
	
In	other	words,	 the	two	are	compared	 in	different	 time	and	circumstances,	 raising	the	
emotions	of	nostalgia,	 subsequently	 leading	 to	 idealisation	of	what	 is	no	 longer	 there.	
Conversely,	 the	 involvement	 in	 the	current	 system	 is	 real,	 and	 therefore	 very	 strongly	
experienced	 as	 limited	 possibilities	 for	 communicative	 action	 in	 which	 the	 lifeworld	
attenuates	 through	 what	 Scambler	 (2001,	 p.13)	 terms	 hyper-rationalized	 social	
participation.	 Participants	 become	 part	 of	 interactions	 strongly	 confined	 to	 legal	
exchange	and	immediate	returns,	at	the	expense	of	thinking	and	mutual	understanding	
(Crook	et	al	1992,	p.28).	And	thus,	the	distinction	between	the	two	compared	realities	
(past	and	current)	becomes	sharper,	causing	the	participants	–	both	part	of	the	system	
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and	of	the	 lifeworld	–	to	strive	towards,	and	even	act	 in	 line	with,	the	premises	of	the	
past	system.		
In	 contrast	 to	 the	perception	of	 the	past,	 the	emerging	 reality	under	 the	new	policies	
was	an	experience	of	lifeworld	colonisation,	which	becomes:	
	‘[…]	 increasingly	 state	 administered	 (“juridified”)	 with	 attenuated	
possibilities		 for	 communicative	 action	 as	 a	 result	 of	 the	
commercialization	and		 rationalization	 in	 terms	 of	 immediate	 returns.’	
(Scambler	2001,	p.13)		
	
In	 the	 views	 of	 the	 respondents,	 this	 was	 particularly	 expressed	 as	 a	 perceived	 over-
imposition	 of	 the	 system	 forcing	 the	 participants	 to	 engage	 in	 their	 interaction	 ‘as	
parties	 to	 contracts	 rather	 than	 as	 thinking	 and	 acting	 subjects’	 (Crook	 et	 al.,	 1992,	
p.28).	
The	 notion	 of	 nostalgia	 in	 transition	 countries	 was	 also	 described	 by	 other	 authors.	
Todorova	 and	 Gille	 (2010)	 have	 published	 a	 volume	 of	 essays	 on	 post-communist	
nostalgia	 and	 its	 unexpected	 proliferation	 across	 the	 entire	 societal	 milieu,	 including	
health,	welfare,	and	even	music	and	arts	(McCracken	2015).	Rechel	(2008)	described	this	
as	 a	 form	of	path	dependency	and	a	 continued	 influence	of	 the	 legacy	of	 the	past	on	
contemporary	 policy	 decisions.	 And	 indeed,	 as	 shown	 throughout	 this	 thesis,	 the	past	
played	 a	 significant	 role	 in	 the	 policy	 processes,	 from	 their	 development	 to	
implementation	and	follow	up.	This	was	evident	mainly	in	the	opinions	of	providers	and	
patients	who	describe	the	conditions	of	the	past	system	almost	uncritically,	despite	the	
evidence	 from	 the	 wider	 literature	 of	 the	 socialist-time	 health	 systems	 describing	
suffering	 from	 lack	 of	 patient	 rights,	 low	 quality	 of	 care,	 and	 little	 technological	
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improvement	 (Kornai	 and	 Eggleston	 2001).	 The	 effect	 of	 this	 nostalgic	 longing	 was	
described	by	Boyer	(2010),	as	the:	
‘…very	real	propensity	of	Eastern	Europe	to	govern	and	direct	its	own	future	
is	 powerfully	 suppressed	 within	 a	 discourse	 environment	 where	 Eastern	
European	 citizens’	 estrangement	 from	 the	 external	 steering	 of	 their	 social	
transformation	 is	 labelled	 (also	 autolabeled)	 nostalgic,	 where	
“modernizing”	Eastern	European	elites	persistently	apologize	for	their	fellow	
Eastern	European	citizens...’	(Boyer	2010,	p.26)	
	
In	 health	 care	 writing	 and	 research,	 the	 concept	 of	 nostalgia	 has	 been	 utilised	 and	
identified	from	both	 lay	(Kamat	2008)	and	health	practitioner	perspectives	(McDonald,	
Waring	 and	 Harrison	 2006)	 and	 has	 been	 argued	 to	 emerge	 particularly	 in	 times	 of	
profound	 change	 and	 transition	 (Bissell	 2005)	 and	 is	 therefore	 arguably	 a	 not	
unexpected	theme.	Although	not	explicitly	articulated	as	such	 in	 interviews,	the	use	of	
nostalgia	 may	 represent	 a	 narrative	 device	 that	 helps	 secure	 a	 sense	 of	 identity	 for	
participants.	As	such,	it	is	important	not	to	consider	nostalgia	simply	as	being	bound	up	
in	 the	 past,	 but	 as	 a	 current	 and	 powerful	 psychological	 means	 of	 coping	 with	 and	
adapting	to	change	for	 individuals	 (McDonald,	Waring	and	Harrison	2006).	Gille	 (2010)	
suggested	that	this	nostalgia	in	post-socialist	societies	is:	
	‘not	 “mere”	 nostalgia,	 but	 neither	 is	 it	 false	 consciousness	—	 rather,	 it	 is	
social	 critique,	however	 confused,	hidden,	 subtle,	 or	 cautious.’	 (Gille	2010,	
p.283)	
		
The	 findings	 also	 suggest	 that	 such	 reminiscence	 can	 play	 a	 significant	 role	 in	 the	
acceptance	and	success	of	policies.	The	discourse	of	nostalgia,	the	‘longing	for	the	past’	
(Kumat	2008)	was	strongly	present	despite	incremental	policy	change	attempts	over	an	
extended	period	of	time,	as	was	the	case	in	Macedonia.	And,	as	Garro	(2001)	suggests,	
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such	discourse	of	‘personal	past	has	to	be	understood	as	cultural	past’	and	be	taken	into	
consideration	 in	 the	 processes	 of	 policy	 and	 decision-making	 for	 the	 present	 and	 the	
future.	As	also	evident	from	the	findings,	personal	experiences	of	providers	and	patients	
drawing	on	their	personal	past	and	present	can	be	interpreted	as	collective	experiences	
that	 have	 influenced	 prescribing	 and	 dispensing	 at	 an	 individual	 level,	 as	 well	 as	 the	
policy	 implementation	on	a	macro	 level.	Drawing	on	 the	 former,	 the	 following	 section	
discusses	 influences	of	 these	experiences	on	perceptions	on	 recent	policies,	beginning	
with	reflections	on	professional	autonomy.		
6.2.2	Reflections	on	professional	autonomy	
Another	 important	 theme	discerning	 from	this	 research	 is	 the	providers’	perception	of	
reduced	professional	autonomy.	Physicians	articulated	this	as	pressure	from	patients	to	
prescribe	even	when	considered	clinically	 inappropriate,	and	 from	the	system	through	
the	 imposition	 of	 budget	 ceilings.	 For	 pharmacists,	 professional	 autonomy	 was	
jeopardized	 through	 uneven	 implementation	 of	 dispensing	 policies,	 which	 allowed	
patients	to	obtain	medicines	without	prescription.	For	both	groups,	this	resulted	also	in	
a	perceived	reduction	 in	respect	for	their	respective	professions	from	wider	society.	 In	
their	views,	the	policies	were	a	trigger	for	reconsidering	prescribing	practices,	but	more	
so	from	financial	and	administrative	perspectives	rather	than	from	the	point	of	view	of	
professional	appropriateness	of	decision-making	in	prescribing.	Some	authors	suggested	
that	 financial	 (dis)incentives	 can	 influence	 decision-making	more	 in	 terms	 of	 changing	
the	quality	but	not	the	quantity	of	prescribed	medicines	(Mossialos	et	al	2004),	such	as	
prescribing	 branded	 rather	 than	 generic	 medicines,	 or	 prescribing	medicines	 that	 are	
not	on	 the	positive-drug	 lists.	 The	 literature	 in	 this	 area	 is	 conflicting,	however,	 and	 it	
has	 been	 suggested	 that	 physicians	 can	 influence	 patient	 demand,	 both	 in	 terms	 of	
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quantity	and	quality	(Rochaix	1993).	However,	the	findings	of	this	study	suggest	that	the	
physicians	 were	 not	 confident	 in	 their	 ability	 to	 influence	 the	 demand,	 as	 a	 result	 of	
their	reduced	professional	autonomy.	
The	concept	of	professional	autonomy	has	been	of	 interest	 to	medical	 sociologists	 for	
several	 decades	 (Freidson	 1970)	 and	 although	 it	 has	 focused	 more	 on	 medical	
dominance,	other	professions	such	as	pharmacy	have	also	been	explored	(Cooper	et	al	
2012).	 Elston	 (1991)	 distinguishes	 clinical	 (or	 technical)	 autonomy	 as	 the	 right	 of	 the	
physicians	 to	 set	 their	 own	 standards	 and	 devise	 clinical	 performance.	 It	 is	 in	 some	
cases,	 brought	 into	 relation	with	 clinical	 freedom	 (Davis	 1997),	 to	which,	 as	described	
later	in	the	chapter,	the	respondents	also	relate.	Further	to	this,	literature	suggests	that	
prescribing	 exemplifies	 clinical	 autonomy	 (Davis	 1997),	 predominantly	 as	 it	 represents	
one	 of	 the	 core	 activities	 of	 physicians	 that	 differentiate	 them	 from	 other	 health	
professionals	 (Britten	 2001).	 For	 physicians	 in	 British	 general	 practice	 it	 has	 been	
asserted	 that	 ‘prescribing	 is	a	battleground	on	which	 the	 cause	of	 clinical	autonomy	 is	
defended’	(Britten	2001).	
Scambler	 and	 Britten	 (2001)	 continue	 the	 discussion	 of	 Haug	 (1975)	 to	 describe	 this	
reduced	 professional	 autonomy	 as	 a	 ‘proletarianisation’	 and	 ‘de-professionalization'	
processes	 in	which	 physicians	 are	 drawn	 into	 a	 factory-like	 system	of	 production	 that	
imposes	 a	 loss	 of	 both	 autonomy	 and	 skills	 that	 also	 affect	 the	 physician-patient	
relationship.	This,	 in	 conjunction	with	 further	 rationalisation	of	 the	medical	profession	
and	 increased	 lay	knowledge	on	health	have	undermined	 the	 cultural	 authority	of	 the	
medical	profession	(Scambler	and	Britten	2001);	the	more	informed	and	critical	patients	
are	becoming,	the	more	assertive	they	are	in	decision-making	related	to	their	health	or	
disease.	 The	providers	 in	 this	 study	 felt	 such	assertiveness	as	 increased	pressure	 from	
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patients,	who	were	supported	by	the	system	–	with	these	and	other	policies,	such	as	the	
option	 to	 change	 their	 provider	without	 any	 formal	 explanation	 –	 to	 act	 as	 agents	 of	
social	control	of	health	professionals’	work	and	decision-making	(Zola,	1972).	Providers	
perceived	this	as	a	shift	of	power,	in	which	their	position	of	knowledge	supremacy	and	
monopoly	was	marginalized,	both	at	the	level	of	decision-making	for	individual	patients,	
as	well	as	on	a	more	systemic	 level	of	policy	and	decision-making.	This	marginalisation	
and	 the	 lack	 of	 support	 from	 the	 system	 in	 policy	 implementation,	 articulated	 rather	
strongly	among	the	providers,	is	discussed	in	the	next	sections.	
6.2.3	Involvement	in	policy	making	
In	addition	to	the	themes	of	nostalgia	and	professional	autonomy,	the	third	key	theme	
discerned	 from	 the	 interviews	 concerned	 provider	 and	 patient	 relationships	 to	 policy.	
This	 arose	both	 in	 terms	of	 policymaking	 and	 also	 implementation	 and	was	perceived	
negatively	by	participants.	 In	 this	 section,	 it	will	 be	 argued	 that	 such	 findings	 contrast	
with	existing	literature	and	theory	but	that	there	may	be	opportunities	to	involve	such	
groups	more	actively	in	the	future.		
One	 of	 the	 experiences	 of	 the	 physicians	 and	 pharmacists	 arising	 from	 the	 policy	
changes	was	their	involvement	–	or	rather	non-involvement	–	in	the	policy	and	decision-
making	 processes.	 Findings	 suggest	 that	 the	 practice	 of	 involving	 providers	 in	 policy	
making	 is	 not	 yet	 in	 place,	 with	 the	 exception	 of	 a	 few	 formal	 representatives	 of	
professional	 associations.	 However,	 in	 the	 views	 of	 the	 respondents,	 such	
representation	 is	 not	 sufficient,	 as	 this	 institutionalized	 form	 of	 ‘problem-solving	
discourses	 on	 questions	 of	 general	 interest’	 axiomatically	 has	 only	 limited	 scope	 of	
action	 (Habermas	 1996,	 p.372).	 They	 perceived	 their	 ideal	 involvement,	 in	 line	 with	
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Habermas’	 suggestions,	 as	 one	 enabled	 by	 a	 public	 sphere	 characterized	 by	 open	
political	 discussion,	 informed	 by	 inputs	 of	 expert	 knowledge	 (Habermas	 1996,	 p.169).	
Their	narratives	of	marginalisation	and	segregation	from	the	processes	of	policy	making	
and	power	to	make	decisions	were	pointed	at	the	system,	which	in	their	view	failed	to	
ensure	 their	 participation	 in	 the	 process.	 In	 the	 wider	 literature,	 examples	 of	 non-
involvement	have	been	described	mainly	for	the	nursing	profession	(Richter	et	al	2012;	
Arabi	 et	 al	 2014),	 and	 explore	 the	 possibilities	 for	 transforming	 nurses’	 roles	 and	
participation	 in	 health	 policy	 making,	 based	 on	 their	 professional	 experience	 and	
effective	communication	(Institute	of	Medicine	2011).	
The	literature	suggests	that	involvement	in	the	policy	making	process	of	those	who	play	
a	 part	 in	 implementation	 increases	 the	 possibility	 for	 interaction,	 familiarisation	 and	
ultimately	 adherence	 in	 the	 process	 of	 policy	 implementation	 (Kingdon	 2003,	 p.	 160;	
Dunn	2004,	p.64;	Abood	2007).	Thus,	along	these	lines,	and	in	contrast	to	the	findings	of	
this	 study	 of	 non-involvement	 of	 physicians	 and	 pharmacists	 at	 primary	 care	 level	 in	
Macedonia,	 the	 wider	 literature	 suggests	 that	 providers,	 through	 their	 professional	
bodies	 or	 at	 organizational	 level,	 have	been	 very	much	 and	 actively	 involved	 in	 policy	
and	 decision	making	 (Garpenby	 1989;	Griesler	 2012;	 Yariv	 2015).	 Indeed,	 as	 noted	 by	
Buse,	Mays	 and	Walt	 (2012)	 and	 drawing	 on	 the	 influential	 work	 of	 Alford	 (1975)	 in	
relation	to	structural	interests,	not	inconsiderable	influence	is	exerted	by:	
	‘professional	 monopolists	 –	 the	 doctors	 and	 to	 a	 lesser	 extent	 the	 other	
health		 professionals	whose	 dominant	 interests	 are	 served	 by	 the	 existing	
economic,	social	and	political	structure	of	government	and	health	systems.’	
(Buse,	Mays	and	Walt	2012.	p.113)	
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As	noted,	it	was	not	only	providers	but	patients,	too,	who	perceived	themselves	not	to	
have	been	involved	in	policy	formation	or	having	the	possibility	of	doing	so.	Recognition	
of	 the	role	of	 individuals	or	 the	public	as	key	agents	 in	health	policymaking	have	been	
well	 documented	 (Buse,	 Mays	 and	 Walt	 2012)	 and	 is	 associated	 with	 wider	 debates	
about	the	democratisation	of	policy	making.	There	is	a	considerable	literature	describing	
recent	 trends	of	democratisation	of	policymaking	processes	 through	examples	 such	as	
patient	advocacy	groups	and	patient	and	public	involvement	(Smith	et	al	2003,	p.303).	A	
further	aspect	of	Habermas’	theory	of	communicative	rationality	–	discourse	ethics	-	has	
been	 invoked	 in	 this	 area,	 drawing	 on	 his	 arguments	 that	 open	 dialogue	 enabling	 the	
public	opinion	 to	be	heard	can	 lead	 to	more	democratic	decision-making	 (Godin	et	al,	
2007;	 Habermas,	 1987).	 The	 main	 rationale	 for	 and	 value	 of	 such	 involvement	 is	
captured	 by	 Farrell	 (2004,	 p.41)	 as	 one	 of	 exploring	 the	 differences,	 in	 particular,	
between	professional	and	lay	perspectives	on	health	needs	and	demands.	The	findings	
of	this	study	in	relation	to	patients,	and	particularly	their	negative	experiences	and	views	
about	 the	 system,	 raise	 questions	 as	 to	 the	 degree	 to	 which	 they	 could	 have	 been	
included	in	the	policy	process.	Habermas’	vision	of	a	more	open	society	offers	one	way	
of	 achieving	 this.	 However,	 enduring	 barriers	 and	 power	 imbalances	 (Buse,	Mays	 and	
Walt	(2012)	may	threaten	such	aims.	Britten	(2008,	p.	84-85)	questioned	how	the	public	
obtains	 information,	providing	arguments	 that	much	of	 the	policy	process	 is	 conveyed	
behind	closed	doors.	She	argues	that	system	imperatives	need	to	be	challenged	by	the	
lifeworld	 perspectives,	 including	 by	 means	 of	 greater	 patient	 involvement	 through	
organized	forms	of	self-help	groups	and	voluntary	organisations	(Britten	2008,	p.181),	or	
even	 through	a	 system	 for	 individual	 reporting	of	experienced	adverse	effects	 (Britten	
2008,	 p.84).	 This	 is	 particularly	 relevant	 to	 Macedonia,	 where,	 as	 findings	 have	
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suggested,	involvement	of	patients	–	and	health	professionals	–	in	policymaking	is	still	a	
declarative	 category.	 Illustrative	 of	 this	 is	 that	 in	 the	 Governing	 Board	 of	 the	 Health	
Insurance	Fund	the	one	mandatory	seat	 for	patients’	 representative	 is	always	given	 to	
one	organization,	despite	there	being	over	5000	registered	civil	society	organisations	in	
the	 country	 (MCIC	 2017).	 Thus,	 increasing	 patients’	 involvement	 in	 the	 policymaking	
process	 is	 advocated,	 especially	 in	 light	of	 the	 findings	 suggesting	 their	 influence	over	
prescribing	and	dispensing	and	their	self-medication	practices.	As	elaborated	in	the	final	
chapter,	 this	 could	 be	 either	 through	 approaches	 suggested	 by	 Britten	 (2008),	 or	
through	other	forms	appropriate	to	the	researched	context.	
6.2.4	Lack	of	support	in	policy	implementation	and	detachment	
Findings	 have	 also	 revealed	 a	 providers’	 perceived	 lack	 of	 support	 in	 policy	
implementation,	articulated	as	a	 feeling	of	detachment	 from	the	system.	According	 to	
them,	 policy	 changes	 resulted	 in	 a	 separation	 of	 primary	 care	 from	 the	 rest	 of	 the	
system;	although	their	 role	continued	to	be	serving	patients	within	 the	public	domain,	
their	removal	from	the	public	to	the	private	sector	imposed	a	sense	of	estrangement,	a	
notion	of	 ‘them	and	us’.	 In	 the	wider	 literature,	 this	 notion,	 described	 as	 professional	
isolation,	was	 researched	 for	 physicians,	 nurses	 (Magola,	Willis	 and	 Schafheutle	 2017)	
and	community	pharmacists	(Cooper,	Bissell	and	Wingfield	2009).	Professional	isolation	
was	argued	 to	stem	from	different	 factors,	 such	as	heavy	workload,	 limited	 resources,	
and	high	expectations	from	patients	(Szfran	2017),	 leading	to	 increased	stress	and	fear	
from	professional	errors	(Linzer	et	al	2005;	Lee,	Stewart	and	Brown	2008).	Cooper	et	al	
(2009)	have	also	noted	that	it	might	be	inimical	to	Habermas’	communicative	action,	as	
it	negatively	 influences	the	provider-patient	relationship	 (Cooper,	Bissell	and	Wingfield	
2009).		
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From	the	findings,	it	can	be	argued	that	the	occurrence	of	a	‘them	and	us’	notion	was	a	
result	of	privatisation	and	other	policy	 changes,	but	 could	also	be	associated	with	 the	
reminiscences	of	the	past,	elaborated	earlier.	Namely,	for	providers	the	previous	system	
supported	 communicative	 action	 through	 the	 ‘no	 limitation’	 on	 prescribing	 and	
dispensing	policies	and	alleged	universality	of	access	to	medicines.	It	provided	for	social	
interaction	 in	which	 reaching	mutual	 understanding	was	 facilitated,	 at	 the	 expense	 of	
material	success	and	efficiency,	which	are	the	prime	aims	of	the	system’s	 instrumental	
rationality	 (Scambler	 2001).	 Thus,	 introducing	 limitations	 on	 medicines	 through	
prescribing	 or	 dispensing	 –	 a	 manifestation	 of	 system’s	 natural	 inclination	 towards	
instrumental	 rationality	 –	 was	 perceived	 by	 providers	 as	 reduced	 support	 in	
implementation	and	detachment.		
It	 can	be	argued	 that	 through	 the	 feelings	of	detachment,	providers	became	aware	of	
their	dual	role	–	being	an	agent	for	the	system	in	achieving	strategic	action,	oriented	at	
success	and	efficiency,	while	at	 the	 same	 time	playing	a	part	 in	 communicative	action	
towards	reaching	understanding	with	patients	for	their	wellbeing	(Scambler	and	Britten	
2001).	The	detachment	and	professional	 isolation	were	 interpreted	as	superimposition	
of	the	system	over	the	lifeworld.	This	unaccepted	lifeworld	colonisation	also	raised	the	
issue	of	providers’	identification	with	their	role	of	system’s	agency,	as	arguably	this	role	
was	performed	by	the	system	in	the	past.	
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6.2.5	Perceived	reasons	for	inadequate	policy	implementation	and	
accepting	responsibility	
A	 key	 finding	 from	 all	 respondent	 groups	 was	 the	 perceived	 lack	 of	 successful	 policy	
implementation.	This	was	also	shown	with	prescribing	trends	over	time	in	Chapter	Two,	
suggesting	that	policy	 interventions	have	not	 led	to	the	intended	or	desired	outcomes.	
There	is	a	significant	body	of	literature	on	policy	implementation	which	recognises	that	
policies	 do	 fail	 often	 for	 a	 variety	 of	 often	 context-specific	 reasons	 (Fotaki	 2010;	
McConnel	 2015;	 Barreto	 2011),	 including	 economic	 (Friedman	 1982;	 Snower	 1993;	 Le	
Grand	2006),	political	(Coleman	1990)	and	social	(McConnel	2015)	or	not	achieve	what	
was	intended,	and:	
“[…]	it	is	common	to	observe	a	‘gap’	between	what	was	planned	and	what	
occurred	as	a	result	of	a	policy.”	(Buse,	Mays	and	Walt	2012,	p.121)	
	
In	 this	 research,	 understandably,	 each	 group	 perceived	 the	 lack	 of	 policy	
implementation	 from	 their	 respective	 position	 and	 roles.	 For	 providers,	 their	 lack	 of	
involvement	 in	 policy	 formulation	 was	 a	 very	 serious	 concern,	 and	 in	 line	 with	 the	
literature,	which	also	suggests	that	stakeholder	involvement	is	as	an	essential	part	of	the	
policy	process	and	is	intended	to	produce	particular	outcomes	from	its	implementation	
(McConnell	 2015).	 Policy	 implementation,	 as	 the	 step	 following	 policy	 formulation	 is	
considered	a	 ‘process	of	carrying	out	a	basic	policy	decision’	 (Sabatier	and	Mazmanian	
1983,	p.	143),	which	is	actualised,	applied	and	utilized	in	the	world	of	practice	(Ali	2006;	
Bhola	2004).	And,	thus,	providers	tended	to	value	the	importance	of	their	role	in	policy	
development,	 given	 their	 subsequent	 key	 role	 in	 implementation.	 Fotaki	 (2010)	
considered	that	the	fact	that	policies	are	often	designed	as	‘social	fantasies’	of	the	elites,	
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and	 lack	 of	 involvement	 of	 multiple	 stakeholders,	 is	 a	 major	 reason	 for	 under-
achievements	in	policy	implementation.	
The	 under-achievement	 of	 policy	 implementation	 was	 perceived	 by	 patients	 through	
their	reduced	access	to	medicines,	which	is	discussed	in	more	detail	in	later	sections.	For	
policy	makers,	lack	of	implementation	was	considered	to	be	linked	to	lack	of	providers’	
adherence	 to	 clinical	 guidelines	 and	 patients’	 health	 illiteracy.	 Elite	 stakeholders	
suggested	 ideas	 for	 addressing	 policy	 implementation	 through	 measures	 directed	 at	
patients,	 in	 improving	 their	 health	 literacy,	 and	 providers,	 in	 additional	 training	 in	
current	 clinical	 guidelines	 and	 improving	 their	 communication	 skills	 for	 negotiating	
prescribing	decisions	with	patients.	These	are	elaborated	further	later	in	the	chapter.	
The	recognition	of	policy	failure	highlights	the	need	to	identify	and	understand	the	root	
causes	or	independent	influences	that	have	led	to	such	failure	(Walsh	2006;	McConnell	
2015;	 Howlett	 2012).	 Changes	 of	 policies	 follow	 the	 initial	 failure	 when	 alternative	
policies	are	viable	and	feasible	to	implement,	as	well	as	when	the	reasons	for	the	failure	
itself	have	been	understood	(Walsh	2006).	In	this	sense,	this	section	will	now	attempt	to	
provide	explanations	 for	policy	 failure,	 through	 the	perceived	 responsibility	 for	proper	
policy	implementation	and	the	potential	ethical	issues	that	might	have	interfered	in	the	
process.	
As	 already	 described	 in	 the	 previous	 chapter,	 all	 groups	 interviewed	 in	 this	 research	
provided	 their	 views	 about	 where	 the	 responsibility	 lay	 for	 lack	 of	 policy	
implementation.	 Due	 to	 their	 different	 roles	 and	 positions,	 all	 groups	 had	 different	
understanding	and	acceptance	of	 responsibility.	 In	 summary,	 for	providers,	 the	 largest	
share	 of	 responsibility	 lay	 with	 the	 government	 and	 responsible	 authorities;	 this	 was	
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justified	by	noting	their	lack	of	involvement	in	policy	making.	To	some	extent,	however,	
the	 providers	 also	 considered	 some	 responsibility	 to	 rest	 with	 patients,	 and	 with	
professionals	other	than	themselves.	Patients	were	more	interested	in	denouncing	their	
own	responsibility	than	with	assigning	it	to	the	other	groups.	The	policy	makers,	too,	in	
general	 distanced	 themselves	 from	 either	 direct	 or	 indirect	 responsibility	 for	 policy	
implementation,	 arguing	 for	 their	 role	 as	 being	 one	 of	 policy	 setting	 not	 policy	
implementation	–	a	stance	that	has	been	described	in	the	literature	as	distancing	of	the	
theorists	by	rejection	of	realism	(Llewellyn	1996).		
While	many	factors	are	taken	into	consideration	in	policymaking,	there	is	little	certainty	
into	 whether	 the	 chosen	 policy	 options	 would	 actually	 produce	 any	 of	 the	 desired	
effects	 (Dunn	 2004,	 p.24).	When	 a	 policy	 is	 successful,	 there	 is	 little	 to	 be	 said	 about	
responsibility,	as	many	would	claim	their	involvement,	contribution	or	ownership	for	the	
success,	and	probably	rightfully	so,	as	policy	 implementation	 indeed	depends	on	many	
stakeholders	 and	 their	 interests	 for	 such	 success	 (Howlett	 2012;	 McConnel	 2015).	
However,	 it	 is	 far	more	complex	and	sensitive,	 sometimes	even	painful,	 to	discuss	 the	
issue	 of	 responsibility	 in	 the	 case	 of	 policy	 failure,	 or	 the	 lack	 of	 successful	
implementation,	as	 responsibility	 for	 failure	may	be	 linked	to	material	and	even	moral	
consequences	 (Clark	 and	 Wildavsky	 1990).	 It	 would	 be	 easier	 to	 discuss	 this	 issue	 if	
responsibility	 solely	 relates	 to	 defined	 policy	 implementation	 protocols.	 It	 becomes	
more	 complex	 when	 responsibility	 is	 associated	 with	 discretionary	 right,	 such	 as	
‘autonomy’	for	example,	 in	which	providers	assume	a	higher	level	of	responsibility	due	
to	 their	 professional	 knowledge	 (Scambler	 and	 Britten	 2001).	 Further	 complexity	 is	
added	 in	 the	 context	 of	 health,	 where	 policy	 implementation	 relates	 to	 partially	
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subjective	 judgements	 about	 a	 patient’s	 current	 health	 and	 whether	 prescribing	 or	
dispensing	is	clinically	indicated.	
In	 prescribing	 and	 dispensing,	 several	 key	 milestones	 are	 important	 for	 defining	 the	
responsibility	 of	 the	decision.	As	 explained	earlier,	multiple	 stakeholders	 are	 involved,	
and	 the	 transfer	of	 responsibility	goes	 from	one	 to	another,	or	 involves	 several	at	 the	
same	 time.	 Delineation	 of	 responsibility	 can	 be	 subdivided	 as	 follows:	 the	 act	 of	
prescribing	 as	 a	 responsibility	 lies	 with	 the	 prescriber,	 although	 it	 is	 influenced	 by	 a	
range	of	factors	that	were	reviewed	earlier;	the	act	of	dispensing,	on	the	other	hand	is	
with	 the	 pharmacist,	 and	 is	 again	 influenced	 by	 a	 number	 of	 factors	 that	 have	 been	
discussed.	The	patient’s	 involvement	occurs	 throughout	 the	process,	bringing	a	shared	
responsibility	with	the	other	actors.	In	this	context,	it	is	difficult	to	grasp	the	normative	
and	 ethical	 aspects	 of	 the	 responsibility	 for	 policy	 implementation.	 As	 Britten	 argued	
(2001)	in	her	paper	on	prescribing	and	clinical	autonomy,	the	responsibility	can	be	spilt	
from	one	to	another	step	on	the	ladder	(Britten	2001),	where	the	patient	usually	bears	
the	final	consequences.		
6.2.6	Non-prudent	dispensing	and	illegal	medicine	supply	
Data	in	this	study	has	suggested	that	 illegal	practices	in	terms	of	medicine	supply	have	
occurred	following	policy	change.	All	respondent	groups	pointed	to	the	lack	of	effective	
implementation	 and	 associated	 enforcement	 of	 the	 policy	 on	mandatory	 prescription	
dispensing.	Policy	makers	attributed	this	to	a	lack	of	responsibility	amongst	pharmacists	
and	patients.	Whyte,	Van	der	Geest	and	Hardon	(2002)	summarized	these	practices	at	
community	 level,	 pointing	 to	 a	 phenomenon	 of	 ‘pharmacists	 as	 doctors’	 wherein	
pharmacists	provided	a	 range	of	medicines	without	 the	need	 for	patients	 to	 consult	 a	
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physician.	Van	der	Geest	(1982)	argued	that	there	are	economic	and	commercial	drivers,	
which	can	influence	pharmacists	to	make	such	supplies	(Van	der	Geest	1982	p.211).	This	
was	 to	 some	 extent	 confirmed	 with	 the	 findings	 of	 this	 research,	 with	 pharmacists	
articulating	the	new	policy	circumstances	and	introducing	budgetary	limitations	to	play	a	
role	 in	 making	 illegal	 dispensing	 decisions.	 But	 they	 also	 recognized	 the	
inappropriateness	 of	 this	 practice	 and	 its	 effects	 on	 undermining	 of	 their	 profession.	
They	 justified	 the	practice	as	being	a	productive	 tension	between	 the	 regulatory	 roles	
that	they	play,	and	patient-focused	care.		
The	findings	also	suggested	that	patients	play	a	significant	role	in	illegal	medicine	supply.	
Self-medication	 practices	 were	 found	 regularly	 across	 the	 accounts	 justified	 by	 the	
perceived	reduced	possibility	for	obtaining	medicines	and	imposed	need	for	negotiating	
medicine	 supply.	 Such	 practices	 of	 obtaining	 medicines	 from	 pharmacies	 without	
prescription	 have	 been	 described	 in	 the	 literature	 as	 a	 global	 phenomenon,	 including	
Europe	(Orero	et	al	1997;	Gonzalez	Nunez	et	al	1998;	Contopoulos-Ioannidis	et	al	2001;	
Mitsi	et	al	2005;	Stratchounski	et	al	2003;	Borg	and	Scicluna	2002),	and	Eastern	Europe	
specifically	(Grigoryan	et	al	2006;	Versporten	et	al	2014).	Most	of	these	studies	point	to	
the	lack	of	enforcement	of	policies	as	the	main	enabler	of	practices	involving	the	supply	
of	 medicines	 without	 medical	 consultation.	 Some	 of	 them,	 however,	 suggested	 that	
pharmacists’	perception	of	their	underestimated	role	in	constructing	health	could	be	the	
driver	for	taking	additional	professional	roles	(Caamano	et	al	2005).	
This	study	offers	a	similar	explanation	and,	as	already	described,	there	was	an	identified	
lack	of	policy	enforcement.	In	addition	findings	in	this	study	suggested	that	pharmacists	
recognized	under-appreciation	of	 their	professional	 role,	 implying	that	such	might	also	
be	the	underlying	reason	for	pursuing	illegal	medicine	supply	practices.	Another	aspect	
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that	 should	 be	 taken	 into	 consideration	 is	 pharmacists’	 felt	 pressures	 from	 patients.	
Borg	 and	 Scicluna	 (2002)	 found	 that	 in	Malta,	 pressures	over	pharmacists	 to	dispense	
without	 prescription	 were	 higher	 than	 pressures	 on	 physicians	 to	 prescribe	 without	
medical	indication	(Bord	and	Scicluna	2002).	All	of	these	policy	implementation	aspects	
were	also	found	in	this	research	to	have	been	neglected	by	the	system,	felt	by	providers	
also	as	pressures	from	the	system	and	these	are	discussed	in	the	next	section.	
6.2.7	Providers’	perceived	pressures	in	practice	from	the	system		
Providers’	perceived	system	pressures	were	mainly	articulated	as	an	increased	pressure	
to	 adhere	 to	 the	 new	 rules	 under	 the	 conditions	 of	 perceived	 lack	 of	 involvement	 in	
policymaking	 and	 lack	 of	 support	 for	 implementation.	 There	 was	 an	 obvious	 tension	
between	the	necessity	to	respond	to	the	system’s	requirements	and	deliver	on	patients’	
demands.	Further	adding	to	this	tension	was	providers’	perceived	lack	of	support	from	
the	 system	 in	 acting	 upon	 reducing	 the	 levels	 of	 medicine	 supply	 patients	 were	
accustomed	to.	 In	 this	 fine	balancing	act,	providers	 felt	professional	disempowerment,	
associating	it	with	reduced	clinical	autonomy	in	prescribing,	re-enforcing	Britten’s	(2001)	
notion	of	prescribing,	also	mentioned	earlier	as	a	 ‘battleground	on	which	 the	cause	of	
clinical	autonomy	is	defended’.		
Explanation	 of	 professional	 disempowerment	 could	 be	 offered	 using	 Mishler’s	
operational	 concepts	 of	 ‘voice	 of	 medicine’,	 representing	 technical,	 decontextualized	
scientific	 assumptions	 of	 medicine,	 and	 ‘voice	 of	 lifeworld’,	 pertaining	 to	 contextual	
understanding	of	health	 issues	 (Leanza	et	al	2013),	professional	disempowerment	was	
associated	mainly	with	the	system’s	requirement	for	providers	to	represent	the	‘voice	of	
medicine’	 in	 exercising	 rationalization	 and	 lifeworld	 colonization	 (Habermas	 1984),	
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whereas	 in	 providers’	 view	 the	 system	 itself	 was	 inclined	 to	 support	 the	 ‘voice	 of	 a	
lifeworld’	 –	 articulated	 through	 intensive	 promotion	 of	 patients’	 rights	 and	 imposing	
huge	 penalties	 on	 providers.	 Although	 reluctant	 to	 abide,	 providers	 accepted	 such	
perceived	 distortion	 of	 roles,	 which	 contributed	 to	 their	 feeling	 of	 isolation	 and	
detachment	from	the	system,	discussed	in	earlier	section	in	this	chapter.		
6.2.8	Providers’	perceived	pressures	in	practice	from	patients		
The	 findings	 suggest	 that	 primary	 care	providers	 experience	dual	 pressures	 from	both	
the	 system	 and	 patients.	 The	 pressure	 and	 expectations	 from	 patients	 were	 not	
necessarily	 related	 only	 to	 policy	 changes,	 although	 the	 findings	 suggest	 that	 the	
changed	policy	context	exacerbated	these,	making	the	providers’	position	more	difficult	
in	 addressing	 them.	 There	 is	 ample	 literature	 on	 pressures	 and	 expectations	 from	
patients	 during	 prescribing;	 these	 pressures	 are	 cited	 as	 a	 barrier	 to	 evidence-based	
medicine	and	a	perceived	cause	of	 irrational	prescribing	 (Butler	et	al	1998:	Young	and	
Ward	 2001;	 Lewis	 and	 Tully	 2009).	 Lewis	 and	 Tully	 (2011)	 consider	 several	 causes	 of	
increased	 pressures	 and	 expectations	 from	 patients;	 in	 particular,	 patients’	 right	 to	
involvement	in	decisions	about	their	care	and	a	general	rise	in	consumerism,	which	‘may	
have	 inadvertently	 facilitated	 a	 rise	 in	 public	 expectations	 of	 health	 care	 and,	 hence,	
patient	demand’	(Lewis	and	Tully	2011).	The	findings	of	my	research	are	linked	to	extant	
literature,	 in	particular	studies	confirming	patients’	expectations	and	their	 influence	on	
prescribing	 (Cox	 et	 al	 2007;	 Britten	 and	 Ukoumunne	 1997;	 MacFarlane	 et	 al	 1997;	
Cockburn	 and	 Pit	 1997),	 and	 physicians	 ceding	 to	 patients’	 expectations	 (Little	 et	 al	
2004;	 Kumar,	 Little	 and	 Britten	 2003);	 both	 of	 which	 have	 been	 associated	 with	
unnecessary	 prescribing	 and	 overtreatment	 (Stevenson	 et	 al	 2000).	 The	 literature	
suggests	that	patients	come	to	the	physician	with	certain	expectations,	and	the	patients’	
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influence	on	prescribing	is	far	more	evident	when	patients	want	the	prescription,	rather	
than	when	they	don’t	(Britten	2008,	p.	134).	Patients’	expectations	in	themselves	play	a	
role	(Kravitz	et	al	1996),	but	so	too	does	the	awareness	or	perception	of	the	physician	
about	those	expectations	(Rao	et	al	2000;	Butler	et	al	1998).		
Scambler	and	Britten	(2001)	used	the	‘de-professionalization’	thesis,	which	is	focused	on	
changes	 in	 physician-patient	 relationships,	 arguing	 that	 the	 increase	 in	 lay	 knowledge	
and	reduced	trust	 in	 the	professions	 led	to	rejection	of	 the	paternalistic	approach	and	
acceptance	 of	 consumerist	 behaviour	 in	 health	 care	 (Roter	 and	 Hall	 1992).	 Habermas	
speaks	 of	 ‘grammar	 of	 forms	 of	 life’	 (1981,	 p.33,	 36)	 in	 the	 sense	 of	 changing	
relationships	of	 knowledge	and	power	between	ordinary	 citizens	or	patients	and	 their	
professionals,	 as	 a	 result	 of	 the	 increasing	 inclination	of	 professionals	 towards	politics	
and	power,	and	reduced	trust	of	patients	in	their	expert	judgements.	
In	this	sense	the	influence	of	increased	lay	knowledge	and	reduced	trust	in	professional	
knowledge	 should	 not	 be	 underestimated	 (Scambler	 and	 Britten	 2001;	 Curry	 1996),	
given	 that	 they	 play	 a	 part	 –	 through	 the	 patient	 –	 in	 individual	 decision	making	 and	
negotiation	 for	 medicine	 supply,	 manifest	 as	 improper	 policy	 implementation	 at	 a	
system	level.		
In	 addition,	 findings	 suggested	 providers’	 decision-making	 to	 be	 challenged	 by	
empowered	 patients	 and	 their	 intention	 to	 actively	 participate	 in	 prescribing	 or	
dispensing	decisions.	This	was	also	found	in	primary	care	settings	 in	Canada	(O’Connor	
et	 al	 2003)	 and	 Australia	 (Davey	 et	 al	 2002).	 In	Macedonia,	 such	 empowerment	 was	
negatively	associated	with	professional	autonomy,	discussed	earlier	in	this	chapter.		
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It	 could	be	argued	 that	patient	empowerment	also	 comes	 from	 increased	 information	
access	 through	 the	 Internet	 and	 further	 rationalisation	 of	 medical	 knowledge	 and	
practice	 (Scambler	 and	 Britten	 2001).	 Thus,	 the	 communicative	 action	 between	
providers	and	patients	 is	becoming	more	complex	and	requires	additional	skills	(Cox	et	
al	 2007;	 Britten	 2008).	 Elite	 stakeholders’	 accounts	 suggested	 the	 need	 for	 providers’	
improved	 skills	 in	 patient	 communication	 for	 conveying	 messages	 of	 professional	
knowledge	 in	 lay	 language	 terms.	 Improvement	 of	 providers’	 proficiency	 in	
communicating	with	patients	regarding	prescribing	decisions	might	be	understood	as	an	
attempt	to	regain	the	battle	over	professional	autonomy	(Bond	et	al	2012;	Elwyn	et	al	
2003;	Weller	2012;	Stenner	et	al	2011).	
6.2.9	Patients’	perceived	pressures:	Negotiating	medicine	supply	
The	findings	suggested	that	patients	also	felt	pressurised	by	the	new	reality.	Like	other	
participants,	 patients	 too	 felt	 nostalgia	 for	 the	 past,	 but	 appeared	 to	 have	 developed	
strategies	 for	 managing	 the	 current	 situation,	 which	 for	 them	 was	 characterised	 by	
limited	access	to	medicines,	and	therefore	the	necessity	 to	negotiate	medicine	supply.	
As	apparent	from	their	accounts,	they	have	used	loose	policy	implementation	as	a	basis	
for	 establishing	 and	 maintaining	 such	 practices,	 including	 obtaining	 multiple	
prescriptions	 and	 prescriptions	 on	 another	 patient’s	 name	 and	 self-medication.	 Thus,	
despite	 the	 lack	 of	 patients’	 knowledge	 of	 the	 overall	 policies	 and	 their	 expressed	
dissatisfaction	 with	 the	 consequences	 of	 the	 reforms,	 it	 can	 be	 argued	 that	 they	
acquired	skills	 to	negotiate	for	their	medical	supply,	 through	pressure	on	physicians	or	
pharmacists.	Through	this	process,	they	developed	a	set	of	justifying	arguments	for	their	
non-adherence	 and	 subterfuge	 of	 regular	 prescribing	 and	 dispensing	 procedures.	 As	
noted	earlier,	 for	patients,	evocations	of	nostalgia	may	also	 reflect	 identity	claims	and	
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also	attempts	 to	manage	 the	 scale	of	 such	 changes	 for	 individuals’	 lives;	 changes	 that	
may	 have	 led	 to	 new	 found	 responsibilities	 to	 obtain	 medicines	 that	 require	
considerable	understanding	and	insight	 into	supply	sources.	 In	current	 literature,	there	
are	 studies	 resonating	 with	 this	 finding	 (Ford	 et	 al	 2003;	 Gattellari	 et	 al	 2001).	 The	
perceived	 necessity	 for	 over-involvement	 in	 prescribing	 decision	 making	 or	 self-
medication	might	be	due	to	a	documented	physician	underestimation	of	patients’	desire	
to	 participate	 (Cox	 et	 al	 2007)	 or	 patients’	 dissatisfaction	 from	 not	 achieving	 their	
desired	 role	 in	 decision	making	when	 consulting	with	 physicians	 (Ford	 et	 al	 2003).	 To	
overcome	 such	 challenges,	 Mishler	 (1984)	 suggested	 that:	 ‘achieving	 humane	 care	 is	
dependent	 upon	 empowering	 patients’	 (Mishler,	 1984,	 p.193),	 which	 could	 be	 done	
through	 increasing	their	 involvement	and	active	participation	 in	decision-making	about	
their	own	health	(Mishler	1984;	Scambler	and	Britten	2001).		
The	 following	 section	 discusses	 the	 influences	 of	 prescribing	 and	 dispensing	 policy	
changes	through	the	Habermas’	perspective,	bearing	in	mind	the	relationships	between	
and	identity	of	the	different	participant	groups.	
	
6.3. Medicine	supply	policy	changes	-	a	Habermasian	perspective	
	
This	 thesis	 has	 provided	 a	 range	 of	 empirical	 insights	 into	 prescribing	 and	 dispensing	
policy	change	in	Macedonia	and	has	at	several	points	made	reference	to	the	relevance	
of	 Habermas’	 various	 theories.	 In	 this	 section,	 a	 more	 sustained	 attempt	 is	 made	 to	
expand	 on	 such	 theory	 in	 the	 context	 of	 the	 findings	 with	 the	 aim	 of	 indicating	 how	
many	 aspects	 of	 the	 identified	 themes	 can	 be	 viewed	 though	 Habermasian	 concepts.	
More	 specifically,	 and	 given	 the	 inherent	 normativity	 in	 Habermas’	 work,	 it	 will	 be	
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argued	 that	 important	 aspects	 of	 his	 ideal	 construction	 of	 society	 and	 associated	
mechanisms	 offer	 insights	 into	 how	medicine	 supply	 in	Macedonia	 could	 not	 only	 be	
conceptualised	but	improved.	
6.3.1	Considering	participant	groups	through	a	Habermasian	perspective	
Linked	to	the	preceding	sections	has	been	consideration	of	the	respective	power	(or	lack	
of	power)	of	different	groups	–	whether	this	is	providers	who	are	excluded	from	policy	
change,	 or	 patients	 who	 are	 now	 empowered	 health	 consumers	 who	 must	 seek	 out	
sources	 of	medicines	 in	 contrast	 to	 previous	 systems.	 Although	 not	 anticipated	 in	 the	
design	 of	 this	 study,	 involving	 these	 different	 participant	 groups	 in	 interviews	 may	
perpetuate	 or	 reinforce	 the	 separate	 nature	 of	 their	 status	 and	 involvement	 in	
prescribing	and	supply	of	medicines.	With	the	exception	of	patients’	perceived	pressure	
upon	prescribing	for	doctors,	it	is	possible	to	view	these	as	quite	separate	groups	but	in	
the	 literature	closer	connections	have	been	 identified.	For	Britten	(2008),	 for	example,	
physicians	may	be	capable	of	supporting	patients	using	a	Habermasian	perspective	and	
simultaneously	be	also	able	 to	 side	with	 the	 ‘state’	 and	gain	mutual	power	 from	such	
links.	As	 a	 result,	 the	different	 groups	may	operate	with	 additional	 links	 and	 resulting	
power	dynamics:	
“Even	 in	 private	 systems	 of	 heath	 care,	 there	 are	 common	 interests	
between	 the	 state	 and	 health	 professionals	 if	 only	 in	 terms	 of	 state	
legitimization	 of	 professionals’	 claims	 and	 the	 social	 management	 of	 ill	
health	by	 legitimating	work	absence	 for	example.	 […]	They	may	also	 see	
their	role	in	part	as	patient	advocates	and	therefore	representative	of	the	
lifeworld	 in	 the	public	 sphere.	However,	 these	 claims	 to	 act	 on	behalf	 of	
patients	may	also	serve	professional	interests.”	Britten	(2008	p.180)	
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A	 further	 concern	 related	 to	 this	 and	 not	 captured	 in	 Britten’s	 quote	 above10	is	 that	
health	care	professionals	are	also	individuals	and	it	is	arguably	incorrect	to	view	them	as	
being	only	representative	of	the	system.	This	 is	an	 important	concern	and	through	the	
data	presented	in	this	study,	it	has	hopefully	become	apparent	that	health	professionals	
at	the	micro-level	experience	difficult	and	personal	situations	and	threats	to	their	work	
and	 identities.	 The	 significance	 of	 this	 need	 to	 distinguish	 between	 individual	 health	
professional	experience	and	the	health	profession	is	captured	by	Greenhalgh	and	Heath	
(2010),	in	their	use	of	a	Habermasian	perspective	when	trying	to	understand	therapeutic	
relationships:	
“The	‘micro’	of	interpersonal	relationships	link	with	the	‘macro’	of	society	
and	 state.	 In	 other	 words,	 any	 particular	 GP–patient	 encounter	 is	 a	
product	of	the	roles	of	‘GP’	and	‘patient’	in	wider	society,	and	is	influenced	
by	wider	political	and	economic	forces.”	Greenhalgh	and	Heath	(2010,	p.1)	
	
In	 this	 sense,	Waitzkin	 (1991,	p.	83-92)	makes	an	 important	 contribution,	arguing	 that	
therapeutic	 relationships	 between	 doctors	 and	 patients	 can	 only	 be	 comprehensively	
understood	if	they	are	considered	within	the	broader	social	contexts	and	structures,	so	
as	 to	 understand	 whether	 they	 are	 based	 on	 communicative	 action	 oriented	 at	
understanding	or	on	strategic	action	oriented	at	success	(Habermas	1984,	p.289).	
A	 final	 point	 in	 relation	 to	 this	 positionality	 of	 the	 participant	 groups	 concerns	 the	
inclusion	 of	 a	 range	 of	 elite	 stakeholders	 (policy	 makers)	 and	 as	 noted	 earlier,	 it	 is	
important	not	to	over-state	some	of	their	claims	about	providers	or	patients	but	instead	
to	reflect	more	on	why	they	hold	such	views.	The	choice	of	elites	reflected	a	desire	to	
include	perspectives	from	several	different	areas	–	industry,	government,	and	academia	
																																								 																				
10	See	Scambler	and	Britten	2001	for	a	more	detailed	discussion	in	terms	of	the	doctor-patient	relationship	
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–	and	as	 such	 these	must	not	be	viewed	as	being	either	more	objective	or	necessarily	
more	informed.	
6.3.2	System	and	lifeworld	perspectives		
As	already	discussed	 in	previous	 sections,	 it	 can	be	argued	 that	Habermas’	 theoretical	
construction	of	the	relationship	between	system	and	lifeworld	‘justifies	the	exploration	
of	rationalities	in	everyday	life’	(Williams	and	Popay	2001,	p.41).	As	such,	it	can	then	be	
used	 as	 a	 theoretical	 concept	 to	 understanding	 prescribing	 and	 dispensing	within	 the	
already	explained	medicine	supply	policy	changes.	In	this	respect,	several	key	issues	are	
considered	as	part	of	the	exploration	of	such	rationalities	with	regards	to	the	findings	of	
this	thesis:	the	 influence	of	policies	on	the	 interactions	between	the	providers	and	the	
system,	provider-patient	relationship,	and	changes	of	attitudes	and	thereof	practices	as	
a	result	of	the	imposed	policy	changes	and	constructed	realities.	
As	already	established	in	the	findings,	there	is	evident	influence	of	the	policy	changes	on	
the	 interactions	between	 the	providers	 and	 system	on	one	hand	and	 the	 lifeworld	on	
the	other.	Within	these	complex	interactions,	the	providers	are	acting	as	a	mediator	in	
the	 dialogue	 between	 the	 lifeworld,	 represented	 by	 the	 communicative	 reason	 of	
language	and	culture,	and	the	system,	represented	by	instrumental	reason	of	power	and	
resources	(Habermas	1987).	
The	 system’s	 perspective	 on	 the	 policy	 changes	 has	 been	 one	 of	 necessity;	 increased	
efficiency	 of	 resource	 use	 is	 central	 to	 the	 rationality	 process,	 and	 has	 been	 pursued	
through	 further	 formalisation	 of	 relationships,	 in	 particular	 the	 juridification	 of	
prescribing	 and	 dispensing.	 The	 findings	 suggest	 that	 there	 is	 an	 intention	 towards	
further	 structuring	 and	 imposition	 of	 the	 system	 over	 the	 lifeworld.	 As	 described	 by	
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Britten	 (2008,	 p.19),	 the	 ‘colonisation	 of	 the	 lifeworld’	 (Habermas	 1987)	 occurs	when	
system	imperatives	begin	to	dominate	and	disrupt	the	 lifeworld,	gradually	 imposing	 its	
systematisation.	Cuff	et	al	(2006)	view	this	as	a	process	of	reshaping	of	the	lifeworld	in	
systems’	terms.	The	system	is	more	inclined	to	the	strategic	rather	than	communicative	
action,	pursuing	what	can	be	called	an	ulterior	motive	 for	achievement	of	 its	set	goals	
using	the	necessary	means.		
The	 lifeworld	 perspective	 of	 the	 policy	 changes	 has	 been	 one	 of	 reduced	 space	 for	
communicative	 action	 and	 exchanges	 for	 mutual	 understanding.	 The	 new	 policy	
environment	 was	 considered	 as	 one	 distancing	 the	 providers	 from	 the	 patients,	 by	
setting	barriers	to	their	mutual	understanding.	The	curtailing	policies	have	disabled	the	
‘ideal	 speech’	 described	 by	 Habermas	 (1987),	 which	 implies	 the	 non-existence	 of	 any	
coercion	on	communicative	action	except	the	power	of	the	better	argument.	Although	
already	 established	 in	 the	 literature	 that	 such	 a	 situation	 is	 not	 entirely	 achievable	 in	
practice	 (Barnes	 et	 al	 2006;	 Hodge	 2005),	 the	 reminiscence	 about	 the	 interactions	 of	
providers	 and	patients	 in	 the	past	 suggested	 their	 belief	 in	 the	 existence	of	 the	 ‘ideal	
speech’	situation,	in	which	both	providers	and	patients	had	their	perspective	on	how	the	
mutual	understanding	was	achieved.		
Providers’	 belief	 that	 their	 relationship	 with	 patients	 had	 not	 changed	 arguably	
suggested	some	degree	of	attachment	to	the	lifeworld.	This	 is	perhaps	understandably	
so,	 as	 the	 findings	 also	 suggested	 their	 distanced	 relationship	 with	 the	 system,	 with	
which	 they	 are	 legally	 and	 normatively	more	 bound	 compared	 to	 patients.	While	 this	
situation	of	occupying	a	middle	ground	between	the	patients	and	the	system	is	evident	
from	 the	 setup	 of	 the	 health	 systems	 in	 general,	 the	 feeling	 of	 ‘middleness’	 of	 the	
physicians	also	appears	strongly	as	conclusion	from	the	literature	(Scambler	and	Britten	
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2001;	 Higgs	 and	 Jones	 2001;	 Scambler	 2001).	 The	 detachment	 from	 the	 system	
identified	in	this	study	might	also	be	considered	as	contributor	to	enhanced	proximity	to	
the	lifeworld.		
The	 above	 highlights	 the	 debate	 around	 the	 plausibility	 of	 the	 patients	 feeling	
themselves	 to	 be	 informed	 enough	 to	 participate	 in	 decision-making	 (Cox	 et	 al	 2007;	
Britten	2008).	The	literature	in	this	area	suggests	that	in	recent	years	the	trend	of	simply	
following	the	instructions	of	the	physician	who	is	regarded	as	the	one	that	knows	what	
is	 in	 the	 best	 interest	 of	 the	 patient	 (Emanuel	 and	 Emanuel	 1992;	 Street	 2001),	 is	
replaced	by	a	partnership	producing	communicative	action	between	the	physician	and	
an	empowered	well-informed	patient	 in	 reaching	understanding	on	defining	what	 that	
best	interest	is	and	how	it	can	be	optimally	achieved	(Wald	et	al	2007;	Street	et	al	2003).	
But,	 as	 discussed	 earlier,	 although	 trends	 of	 decision-making	 ‘democracy’	 are	 slowly	
becoming	a	reality	for	part	of	the	population,	still	the	paternalistic	relationship	remains	
widely	practiced	across	the	Macedonian	healthcare	system.	
In	 summary	 this	 section	 has	 suggested	 that	 the	 findings	 of	 this	 study	 reflect	 similar	
situations	 in	 other	 countries	 and	 health	 systems	 and	 moreover	 that	 a	 Habermasian	
perspective	can	similarly	be	considered	of	value	in	framing	the	various	themes.	Several	
issues	 related	 to	 the	 literature	 give	 suggestions	 as	 to	 how	 things	may	be	 improved	 in	
Macedonia	 in	the	future	and	are	considered	 later	 in	this	chapter.	Before	doing	so,	 it	 is	
necessary	 to	 reflect	 on	 the	 overall	 process	 and	 consider	 reflexively	 and	 transparently	
strengths	and	limitations	to	this	study.	
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6.4. Methodological	challenges	and	limitations	of	the	study	
	
6.4.1	Methodological	challenges		
Throughout	 this	 research	 I	 have	 encountered	 a	 number	 of	methodological	 challenges	
that	 have	 taught	 me	 that	 a	 pragmatic	 approach	 in	 doing	 research	 is	 very	 important,	
while	maintaining	scientific	rigour	and	objectivity.	In	this	section	I	briefly	consider	some	
of	these,	as	they	might	provide	additional	clarity	regarding	the	methodological	choices	
made	during	the	research,	which	inevitably	brought	some	limitations	to	the	study,	also	
discussed	in	this	section.	
The	 first	 challenge	 that	 I	 encountered	 was	 regarding	 the	 access	 to	 certain	 forms	 of	
proposed	 data.	 As	 explained	 in	 the	 methodology	 chapter,	 the	 initial	 proposal	 was	 to	
conduct	a	mixed-methods	study,	in	which	the	findings	from	the	quantitative	data	about	
trends	 in	 levels	 of	 medicines	 prescribed	 and	 dispended	 would	 complement	 the	
qualitative	 part	 so	 as	 to	 be	 able	 to	 specifically	 understand	 and	 research	 in	 depth	 the	
most	important	factors	influencing	prescribing	and	dispensing	in	the	country	of	interest.	
However,	 due	 to	 a	number	of	 factors,	 such	as	unavailability	of	 reliable	or	 comparable	
data	for	the	study	period,	as	well	as	 lack	of	resources	to	retrieve	the	data	from	the	20	
years	of	paper	archives,	this	initial	approach	was	reconsidered	and	a	decision	was	made	
to	 focus	 on	 a	 qualitative	 study,	 in	 which	 the	 factors	 of	 influence	 would	 be	 first	
researched	 theoretically	 and	 empirically	 from	 the	 existing	 literature,	 and	 the	 findings	
would	inform	the	interview	guides	for	the	research.	However,	to	illustrate	the	situation	
in	the	researched	context,	I	have	provided	a	summary	of	the	available,	but	incomplete,	
data	 on	 prescribing.	 These	 data,	 described	 in	 Chapter	 two,	 not	 only	 confirmed	 the	
hypothesis	set	for	the	quantitative	analysis	-	that	despite	policy	changes	the	prescribing	
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levels	 remained	 unchanged	 or	 showed	 a	 growing	 trend	 -	 but	 also	 raised	 questions,	
which	I	hope	to	be	able	to	inform	through	other	research	activities	in	the	future.	
The	second	methodological	challenge	was	the	language	barrier.	While	it	 is	much	easier	
to	do	quantitative	research	in	different	contexts	due	to	the	universality	of	the	language	
of	numbers,	in	qualitative	research	it	is	from	the	subtleness	of	the	communication	of	the	
language	that	sometimes	the	most	important	findings	emerge.	In	this	sense,	while	with	
the	 full	 support	 from	my	 supervisors,	 it	 has	 been	 unavoidable	 that	 I	would	 have	 sole	
responsibility	for	the	analysis	and	interpretation	of	the	qualitative	data.	Understanding	
that	the	finesses	are	important,	and	that	the	‘devil	is	in	the	detail’,	I	have	considered,	as	
explained	 in	 the	 methodology	 chapter,	 all	 possible	 strategies	 to	 avoid	 as	 much	 as	
possible	the	influence	I	might	have	on	the	data	 interpretation	and	translation,	through	
my	personal	beliefs	and	attitudes,	my	knowledge	and	experience.	
Another	 methodological	 challenge	 that	 I	 faced	 related	 to	 my	 knowledge	 of	 and	
experience	in	the	country	of	interest.	Professional	and	personal	contexts	affect	the	way	
research	 is	undertaken.	 In	the	 literature,	a	researcher	with	familiarity	with	the	context	
and	 people	 being	 researched	 is	 defined	 as	 an	 insider-researcher,	 and	 due	 to	 their	
specific	 knowledge	 and	 position,	 this	 issue	 requires	 due	 attention.	 The	 insider	 is	
‘someone	whose	biography	(gender,	race,	class,	sexual	orientation	and	so	on)	gives	her	
[sic]	a	 lived	familiarity	with	the	group	being	researched’	(Griffith,	1998,	p.	361),	and	as	
such	has	 a	 unique	position	 to	 study	 a	 particular	 issue	 in	 depth,	 from	a	 perspective	 of	
different	 knowledge,	 and	 easier	 access	 to	 people	 and	 information	 that	 can	 further	
enhance	 that	 knowledge	 (Costley	 2010,	 p.7).	 And,	 as	 a	 researcher	 works	 with	 the	
participants	 and	 data	 to	 create	 an	 interpretation	 of	 their	 reality,	 an	 insider	 position	
could	be	viewed	as	potentially	enhancing,	as	an	 insider’s	knowledge	could	be	valuably	
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used	 to	obtain	 richer	data.	With	 this	 in	mind,	 I	 considered	 the	benefits	of	 the	 insider-
researcher	 position	 and	 the	 insights	 it	 offered	 were	 ultimately	 an	 advantage	 for	 this	
research.	However,	on	the	other	hand,	the	insider’s	knowledge	could	also	influence	the	
research	 in	 a	 negative	way,	 if	 the	 researcher’s	 pre-understandings	 guide	 or	 dominate	
the	research	process	(Finlay	2003).	Since	insider	knowledge	could	be	both	a	benefit	and	
a	threat,	as	principal	researcher	I	felt	that	I	needed	to	consider	my	position	throughout	
the	 entire	 research	 process.	Whilst	 being	 ‘insider-researcher’	 has	 possible	 benefits	 in	
terms	 of	 access	 to	 participants	 and	 rapport,	 it	 can	 lead	 to	 difficulties.	 Making	
assumptions	and	 treating	 some	 topics	as	 tacit	was	possible	and	may	have	 led	 to	 their	
under-representation	and	also	influenced	how	some	participants	interacted	and	offered	
accounts.	 In	 this	 respect,	 keeping	 the	 reflexive	 journal	 and	 immediate	 transcribing	 of	
interviews	 helped	 me	 a	 lot,	 since	 I	 had	 a	 chance	 to	 observe	 these	 interactions	 and	
reconsider	 the	 approach	 if	 I	 felt	 that	 the	 insider	 influence	 was	 interrupting	 the	
interactive	 process	 with	 the	 respondents.	 Throughout	 this	 process,	 and	 as	 described	
earlier,	 Gadamer	 (1996,	 p.360)	 was	 a	 useful	 resource	 through	 his	 emphasis	 on	 the	
essence	of	 the	continuing	activity	of	questioning	and	 reflecting	on	both	questions	and	
responses.		
6.4.2	Limitations	of	this	study	
Scientific	 rigour	 also	 requires	 to	 recognise	 and	 give	 due	 consideration	 to	 limitations	
associated	with	the	research	process.	This	section	deliberates	on	the	limitations	of	this	
study.	
One	 limitation	 relates	 to	 the	 time	 period	 over	 which	 this	 study	 was	 undertaken	 and	
particularly	the	data	collection.	The	policy	changes	at	the	centre	of	this	study	occurred	
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during	 2005	 and	 2011	 and	 interviews	 were	 conducted	 between	 2014-2015	 and	 this	
reflects	 two	possible	 limitations:	 one	 is	 that	 the	 interviews	may	have	been	 shaped	by	
some	degree	of	recall	bias	and	the	other	is	that	the	views	and	experiences	captured	may	
not	reflect	those	current	at	the	time	of	writing	this	thesis.	
Another	limitation	to	this	study	was	the	sampling.	While	the	use	of	purposive	sampling	
was	considered	an	appropriate	widely	used	sampling	strategy	in	qualitative	research,	it	
has	to	be	pointed	out	that	it	has	its	disadvantages,	in	particular	related	to	ever	present	
concern	of	possibly	not	reaching	some	participants	who	may	not	want	their	potentially	
negative	practice	to	be	made	known.		
A	further	limitation	of	this	study	was	related	to	validation	of	the	findings.	As	elaborated	
in	earlier	chapters,	quantitative	data	was	difficult	 to	obtain	and	thus	a	mixed	methods	
study	could	not	be	conducted.	In	addition,	the	observation	method	was	also	considered	
at	 the	 initial	 stage,	 but	 due	 to	 legal	 limitations	 of	 privacy	 protection	 of	 patients,	 such	
method	was	rejected.	As	a	result,	triangulation	of	findings	was	not	possible	to	perform,	
and	 this	 study	 relies	 on	 self-report	 and	 researcher’s	 analysis	 and	 interpretations	 of	
collected	 data.	 All	 of	 the	 above	 limitations	 open	 space	 for	 further	 and	 improved	
research	in	this	field,	to	which	the	next	section	is	dedicated.	
	
6.5. Future	research	questions	
	
In	 this	 thesis	 I	 have	 explored	 the	 effects	 of	 recent	 policy	 changes	 on	 attitudes	 and	
practices	related	to	prescribing	and	dispensing	in	transition	countries,	through	analysing	
the	specific	context	of	Macedonia.	This	research	was	based	on	qualitative	interviews	and	
interpretation	 of	 the	 findings	 using	 existing	 social	 theories,	 and	 in	 particular	 the	
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Habermas’	 social	 theory	 of	 system	 and	 lifeworld.	 In	 the	 process	 I	 have	 arrived	 at	 the	
findings	presented	above,	which	gave	rise	to	further	research	questions.	The	purpose	of	
this	 section	 is	 to	 summarise	 possible	 research	 questions	 around	 prescribing	 and	
dispensing	policies	and	practices	in	transition	countries.	
Future	research	based	on	the	findings	from	this	study	are	argued	to	be	possible	 in	the	
following	methodological	and	topic	related	domains:		
1. Expanding	use	of	qualitative	 research	 in	healthcare	 for	understanding	 societal,	
cultural	 and	 other	 factors	 influencing	 decision-making,	 and	 prescribing	 and	
dispensing	 practices	 and	 behaviours	 in	 the	 transition	 countries,	 and	 in	
particular:	
a. Understanding	 the	 cultural	 influences	 of	 the	 past	 system	 and	 its	 effects	 on	
present	policy	development	and	implementation;	
b. Exploring	 the	 current	 power	 dynamics	 in	 policy	making,	 in	 particular	 involving	
suppliers,	providers	and	service	users;	
c. Exploring	 the	 current	 and	 potential	 patient	 participation	 modalities	 for	
democratisation	of	health	policy	and	decision	making;		
d. Exploring	 the	 influences	of	 the	 supply	 side,	 in	particular	of	 the	pharmaceutical	
industry,	on	decision-making	in	prescribing	and	dispensing;	
e. Exploring	 the	 practices	 and	 attitudes	 in	 prescribing	 and	 dispensing	 at	 other	
levels	of	care,	especially	hospitals	and	other	in-patient	facilities	and	researching	
how	policy	changes	in	other	levels	of	care	have	affected	prescribing	practices.	
2. Extending	 quantitative	 research	 in	 order	 to	 better	 estimate	 actual	 levels	 of	
medicine	consumption,	and	in	particular:		
a. Exploring	medicine	 consumption	at	primary	 care	 level,	with	 a	 focus	on	out-of-
pocket	 medical	 supply,	 to	 assess	 the	 influence	 these	 policies	 have	 on	 the	
economic	and	social	welfare	of	patients;	and	
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b. Exploring	 non-prescription	 dispensing,	 to	 identify	 pockets	 of	 non-prescription	
dispensing	 that	will	 inform	 the	 policy	making	 process	 for	 addressing	 potential	
policy	gaps.	
	
Expanding	on	point	1	above,	the	body	of	knowledge	related	to	the	health	consequences	
of	political	and	economic	transition	in	post-socialist	societies	is	growing	in	recent	years	
(Perlman	and	Balabanova	2011;	McKee	and	Nolte	2004;	Aleshkina	et	al	2011;	Jakab	and	
Kutzin	 2009;	 Versporten	 et	 al	 2014).	 As	 the	 literature	 review	 indicated,	 qualitative	
methodology	 is	 not	 widely	 used	 to	 explore	 societal	 phenomena	 in	 post-socialist	
economies.	This	may	be	related	to	the	priority	of	analysing	the	impact	of	changes	on	the	
economic	 indicators	 traditionally	 used	 to	 measure	 the	 success	 of	 a	 democracy	 or	
welfare	 state	 (Choe	2011).	 Following	 the	present	 study,	 I	 suggest	 that	 future	 research	
might	make	greater	use	of	qualitative	methods,	as	they	might	provide	additional	insights	
and	 more	 in	 depth	 understanding	 of	 why	 and	 how	 certain	 changes	 are	 perceived,	
accepted	 and	 implemented	 in	 practice.	 There	 are,	 however,	 challenges	 to	 qualitative	
research;	domestic	researchers	especially	still	do	not	fully	recognise	its	ability	to	address	
a	 wider	 range	 of	 questions	 through	 collection	 of	 richer	 and	 more	 authentic	 data	
(O’Cathain	et	al	2007;	Foss	and	Ellefsen	2002);	while	for	other	researchers	the	language	
barrier	may	be	 considered	a	problem.	However,	 as	with	 this	 thesis,	 these	perceptions	
are	changing	(Kaae	et	al	2016),	and	in	the	future	it	 is	expected	that	more	focus	will	be	
placed	 on	 qualitative	 research	 in	 these	 countries,	 which	 could	 potentially	 reveal	 new	
knowledge	 on	 the	 perceptions,	 values	 and	 the	 meaning	 of	 health	 in	 transitional	
contexts.	And,	as	Scambler	(2001)	encourages:	
“One	general	ramification	of	the	preceding	discussion	for	‘future	research’	
is	perhaps	worth	reiterating.	The	positivist	methods	still	adopted	by	many	
medical	 sociologists	 tackling	 health	 inequalities,	 especially	 but	 not	
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exclusively	in	the	quantitative	vein,	have	unsurprisingly	had	a	limited	yield.	
What	 is	 required	 in	 their	 place,	 it	 has	 been	 contended,	 is	 a	 critical	 and	
post-positivist	 mix	 of	 theoretical,	 conceptual	 and	 methodological	
innovations.”	(Scambler	2001,	p.110)	
	
6.6. Summary	of	chapter	
	
As	stated	earlier,	there	are	many	stakeholders	involved	in	the	process	of	prescribing	and	
dispensing	 -	 government,	 prescribing	 physicians,	 dispensing	 pharmacists,	 patients	 and	
the	 pharmaceutical	 and	 insurance	 industries.	 Yet,	 the	 link	 between	 them	 is	 the	
prescribing	physicians	and	dispensing	pharmacists,	who	are	also	the	key	decision	makers	
on	 the	 demand-side	 of	 the	 pharmaceutical	 market.	 Thus,	 it	 is	 very	 important	 that	
physicians	approach	prescribing	as	the:	
“appropriate	 choice	of	medicine	not	only	 from	 the	perspective	of	 the	physician	
but	 also	 that	 of	 the	 patient,	 while	 at	 the	 same	 time	 aiming	 to	 maximize	
	effectiveness	minimize	risk	and	minimize	cost.”	(Barber	1995)	
	
The	focus	of	this	research	has	been	on	the	effects	of	policy	changes	on	prescribing	and	
dispensing	practices	in	primary	health	care	in	the	specific	context	of	a	transition	country	
that	is	very	applicable	to	similar	contexts.		
Prescribing	policy	changes	in	Macedonia	were	perceived	negatively	overall	compared	to	
the	previous	system,	and	many	identified	themes	reflected	those	found	in	other	health	
systems,	such	as	patient	pressure,	 threats	 to	autonomy	and	a	 lack	of	 involvement	and	
consultation	 in	 the	 policy	 making	 process,	 as	 well	 as	 lack	 of	 support	 in	 policy	
implementation	 from	 the	 system	 to	 primary	 care	 physicians	 and	 pharmacists.	 A	 key	
aspect	of	this	study	appeared	to	be	the	threat	posed	by	increasing	regulation	which	both	
-	243	-	
marginalised	professionals	and	patients	in	relation	to	consultation	and	involvement	and	
threatened	 their	 autonomy	 and	 capacity	 to	 make	 independent	 decisions	 about	
prescribing	 and	obtaining	medicines.	Habermas'	 concepts	of	 system	and	 lifeworld	 and	
particularly	the	encroachment	of	the	former	on	the	 latter	are	argued	to	be	relevant	 in	
framing	 the	 themes	 in	 this	 study.	 The	 introduction	 of	 increasing	 waves	 of	 policy	
represent	juridification,	and	professionals’	perception	of	being	isolated	and	un-involved	
and	 unsupported	 reflect	 disruption	 of	 important	 forms	 of	 communicative	 acts	 and	
justice.	Using	 a	Habermasian	 perspective,	 it	 is	 apparent	 that	 the	 policy	 change	within	
Macedonia	is	but	one	example	of	many	such	threats	to	individuals'	lifeworlds.	This	study	
and	 these	associated	 theoretical	 insights	 suggest	 the	need	 to	 improve	 communication	
between	different	stakeholders	and	to	ensure	that	policy	change	is	undertaken	in	a	way	
that	is	sensitive	to,	and	not	a	threat	to	individuals'	autonomy	-	in	professional	practices	
such	as	prescribing	and	dispensing,	and	public	aims	of	obtaining	appropriate	medicines.	
	 	
-	244	-	
	
CHAPTER	7:	Conclusions	and	recommendations		
	
7.1. Conclusions	
	
The	 market-driven	 policy	 changes	 that	 were	 introduced	 in	 Macedonia	 in	 relation	 to	
regulating	 prescribing	 and	 dispensing	 are	 associated	 with	 various	 negative	
consequences	 from	 the	 perspective	 of	 a	 range	 of	 stakeholders.	 For	 primary	 care	
providers	 these	 changes	 meant	 detachment	 from	 the	 system,	 reduced	 professional	
autonomy	and	diminished	appreciation	of	their	profession	in	the	wider	society.	The	new	
policy	environment	 created	dual	pressures	on	 them	–	 from	patients	wishing	 to	obtain	
medicines,	and	from	the	system	through	the	regulatory	and	legal	mechanisms.	Providers	
also	articulated	lack	of	guidance	and	support	for	policy	implementation;	their	feeling	of	
detachment	from	the	system	is	amplified	by	lack	of	involvement	in	policy	making,	and	by	
government	 support	 for	 patients’	 empowerment	 through	 unlimited	 right	 to	 choice	 of	
provider.	 While	 the	 elite	 stakeholders	 tend	 to	 generally	 agree	 with	 the	 healthcare	
professionals	 on	 the	 issue	 of	 patient	 pressure,	 the	 patients’	 group	 described	 their	
position	 as	unfavourable	 and	marginalized,	making	 the	 case	 for	 unregulated	 access	 to	
medicines,	negotiating	medicine	supply	and	justifying	self-medication.	
However,	 providers	 and	 policy	 makers	 tend	 to	 agree	 on	 the	 persistence	 of	 irrational	
prescribing	and	inappropriate	dispensing	but	on	a	more	theoretical	level;	most	providers	
consider	it	 inappropriate	to	prescribe	without	clinical	 indication	or	to	dispense	without	
prescription,	however,	 they	admit	adherence	to	such	practice	upon	patients’	pressure.	
This	 implies	 that	not	only	providers	but	also	other	 interviewed	groups,	as	described	 in	
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the	findings,	placed	the	major	responsibility	for	the	lack	of	policy	implementation	with	a	
group	other	than	their	own.		
Patients	were	not	concerned	with	irrational	prescribing,	but	for	them	the	main	concern	
was	 the	access	 to	medicines,	and	negotiating	medicine	 supply.	Their	attitudes,	 in	 fact,	
depended	a	lot	on	their	ability	to	pay	for	the	medicines	out-of-pocket,	with	many	openly	
stating	 that	 they	would	circumvent	going	 to	 the	doctor	and	getting	 the	prescription,	 if	
they	could	find	a	pharmacist	that	would	dispense	the	medicine	without	it.		
With	 regards	 to	 policy	 implementation,	 all	 groups	 similarly	 believed	 that	 this	 was	
lacking,	 however	 due	 to	 different	 reasons.	 Providers	 considered	 it	 a	 consequence	 of	
non-involvement,	 ambiguity	of	 enforcement	and	 lack	of	 support	 from	 the	 system;	 the	
elites	 held	 a	more	 forthright	 view	 that	 resultant	 problems	 associated	 with	 the	 policy	
changes	 were	 attributable	 to	 the	 other	 groups.	 For	 the	 patients	 the	 lack	 of	
implementation	was	not	 considered	as	 such,	but	was	 rather	used	as	a	 justification	 for	
circumventing	the	regular	procedures	of	prescribing	and	dispensing.	
While	providers	largely	questioned	the	policy	changes	and	patients	were	ambiguous,	the	
views	 of	 the	 policy	makers	 generally	 described	 policy	 changes	 as	 being	 necessary.	 All	
groups	made	comparisons	to	the	previous	system,	which	was	perceived	more	positively	
as	being	fairer	and	patient-centred,	but	not	sustainable.	To	this	end,	it	can	be	concluded	
that	 future	 policy	 requires	 consultation	 and	 communication	 to	 ensure	 different	
individuals	are	not	isolated,	threatened	or	denied	medicines.	
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7.2. Current	policy	insights	
	
This	research	is	argued	to	be	timely,	given	the	evolving	policy	context	and	the	focus	on	
primary	 care	 reform	 in	 Macedonia.	 During	 the	 research,	 the	 number	 of	 interviews	
conducted	with	key	policy	makers	might	have	had	a	small	–	if	any	–	influence	on	some	of	
the	additional	policy	changes	that	were	proposed	and	adopted	thereafter.	Nonetheless,	
either	as	policy	reactivity	or	due	to	other	factors,	in	the	past	year	the	Health	Insurance	
Fund	proposed	and	 the	Government	adopted	 several	measures	aimed	at	 reducing	 the	
pressures	on	providers,	including	(HIF	2015):		
- Reduced	fines	for	providers,	especially	for	clerical	errors	in	issuing	prescriptions	and	
dispensing	medicines;	
- Introduced	mechanisms	for	covering	the	patients	of	a	provider	on	longer-term	sick	
leave	without	affecting	budget	ceilings	of	the	designated	replacement	physician;	
- Expressed	will	for	revising	levels	of	preventive	goals	in	the	coming	period.	
These	 changes	 are	 likely	 to	 increase	 the	 confidence	 of	 providers	 in	 their	 relationship	
with	 the	 system,	 which	 might	 further	 promote	 their	 increased	 participation	 in	
policymaking	 and	 adherence	 to	 policy	 implementation.	 Furthermore,	 the	 professional	
associations	 of	 primary	 care	 providers	 have	 initiated	 wider	 outreach	 and	 increasing	
visibility	activities	aimed	at	their	members,	especially	in	relation	to	their	interactions	and	
negotiations	with	the	Health	Insurance	Fund.	
It	 is	 therefore	 important	 to	 reiterate	 that	 policies	 need	 to	 be	 developed	 with	
involvement	of	those	directly	responsible	for	their	 implementation,	and	that	strategies	
should	 be	 put	 in	 place	 to	 communicate	with	 the	 providers	 and	 support	 them	 in	 their	
gatekeeping	 role	 at	 primary	 care	 level	 so	 they	 can	 be	 a	 successful	 part	 of	 an	 ever-
evolving	healthcare	system.	
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7.3. Policy	recommendations		
	
This	 section	 describes	 how	 the	 findings	 of	 this	 study	may	 inform	 the	 design	 of	 future	
policies	 in	 prescribing	 and	 dispensing,	 as	 well	 as	 the	wider	 agenda	 setting	 and	 policy	
process	in	Macedonia,	and	in	similar	political	and	societal	contexts.	It	will	explore	in	turn	
five	 key	 areas,	 relating	 to:	 increasing	 the	 involvement	 of	 provider	 and	 patient	
stakeholders	 in	 policymaking	 and	 implementation,	 increasing	 awareness	 of	 policy	
change	 through	 enhanced	 information,	 providing	 training	 for	 providers,	 and	 raising	
public	awareness	and	understanding	in	health-related	matters	more	generally	(see	Table	
14	for	summary).	
Table	14.	Summary	of	key	recommendations	
Agent	targeted		 Broad	Recommendation	 Specific	Actions	
Patients	and	
Providers	
Increase	involvement	in	
policy	making	process		
Through	recognition	by	government	of	the	value	
they	can	add	to	policy	process.	
Importance	of	working	towards	communicative	
action	and	removing	power	imbalance.	
Ensure	previous	feedback	about	practice	
experience	is	considered	in	the	process.	
Providers	 Increase	information	
about	policy	change	
Ensure	proper	communication	of	policy	changes.	
Enable	assistance	for	practical	questions	from	
providers	on	implementation	of	these.	
Providers	and	
Patients	
Increase	involvement	in	
future	policy	
implementation	
Ensure	advisory	and	consultative	support	upon	
introduction	of	policy	changes.	
Encourage	feedback	about	practice	experiences,	
and	make	it	available	(in	anonymised	form)	for	
other	providers.		
Actively	involve	agents	in	the	implementation	
process.	
Providers	 Training	on	guidelines	
and	communication	
Introduce	requirement	for	mandatory	continuous	
medical	education	training	to	be	linked	to	specific	
guidelines	with	peer-to-peer	experience	exchange.	
Introduce	communication	with	patients’	module	in	
senior	years	of	health	science	curricula	at	
undergraduate	and	specialisation	levels.		
Patients	 Increase	awareness	of	
prescribing	and	
dispensing	policy	and	
law	
Continue	and	fortify	awareness-raising	efforts	for	
health	literacy	using	examples	and	key	messages	
from	practice	experience.	
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7.3.1	Involvement	of	stakeholders	in	policymaking	
There	are	three	key	policy	implications	that	can	be	identified	through	the	findings	of	this	
thesis.	The	first	and	most	obvious	one	is	the	wider	consideration	of	all	stakeholders	and	
their	 interests	 in	 the	 process	 of	 policymaking	 and	 decision-making.	 As	 suggested	 in	
Habermas’	 theory	 on	 communicative	 rationality,	 democratisation	 of	 decision-making	
means	 providing	 open	 dialogue	 that	 enables	 stakeholders	 to	 have	 their	 voice	 at	 the	
decision-making	 table.	 In	 this	 case,	 it	 means	 involving	 patients	 but	 also	 health	
professionals	through	organized	forms	of	professional	associations	and	via	other	means,	
as	their	 involvement	might	provide	the	practice	 ‘street-level’	perspective	on	the	 issues	
that	 are	 otherwise	 invisible	 to	 the	 desk	 policy	maker.	 Government	 recognition	 of	 the	
value	these	stakeholders	can	add	to	the	policy	process	is	essential,	given	the	importance	
of	working	towards	communicative	action	and	removing	power	imbalances.	At	the	same	
time,	 failure	 to	 take	 into	 consideration	 the	 interests	 of	 all	 involved	 is	 very	 likely	 to	
produce	 resistance	 to	 policy	 implementation,	 subterfuge	 of	 procedures	 and	 use	 of	
loopholes	 to	 address	 the	 problems	 in	 implementation.	 In	 addition,	 ensuring	
consideration	 of	 previous	 feedback	 about	 practice	 experience	 in	 the	 process	 can	 also	
add	 value	 to	 learning	 from	 the	 implementation	 gaps,	 also	 raised	 as	 a	 concern	 in	 this	
research.	 As	 illustrated	 in	 further	 paragraphs,	 such	 involvement	 might	 already	 be	
underway	as	part	of	the	communications	and	discussions	undertaken	with	policy	makers	
during	the	course	of	this	research.		
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7.3.2	Provision	of	information	on	policy	changes	
Secondly,	this	research	has	drawn	upon	the	importance	of	articulation	and	exchange	of	
information	 related	 to	 policies	 if	 proper	 and	 successful	 implementation	 is	 desired.	
Following	 on	 from	 the	 importance	 of	 stakeholder	 involvement,	 a	 pivotal	 factor	 is	 the	
proper	 and	 timely	 exchange	of	 information	 and	 communication	on	 the	 envisaged	 and	
introduced	changes.	The	sense	of	detachment	perceived	by	the	providers	and	the	self-
perceived	 disadvantaged	 position	 of	 patients	 can	 be	 largely	 attributed	 to	 a	 lack	 of	
information	 and	 understanding.	 While	 no	 policy	 can	 be	 ensured	 full	 implementation	
solely	 on	 the	 grounds	 of	 equality	 of	 information,	 proper	 articulation	 of	 its	 goals,	
mechanisms	and	 intended	outcomes	 is	a	certain	way	 to	contribute	 to	 it.	 In	 this	 sense,	
some	 of	 the	 recommendations	 include	 ensuring	 establishment	 of	 regular	 and	 proper	
communication	channels	for	sharing	information	on	policy	changes,	but	also	for	assisting	
with	 practical	 questions	 providers	 might	 have	 for	 implementation.	 These	 channels	
would	certainly	include	professional	associations’	updates	and	events,	but	for	expanding	
outreach,	 it	 is	 essential	 to	 consider	 other	 forms	 offered	 by	 new	 technologies,	 such	 as	
Internet	and	social	media.		
7.3.3	Involvement	in	policy	implementation	
Pertinent	to	the	findings	on	policy	implementation,	and	in	particular	the	lack	of	support	
perceived	by	providers,	 future	policies	could	benefit	 from	encouraging	 feedback	about	
practice	 experiences	 from	 both	 providers	 and	 patients.	 This	 feedback	would	 not	 only	
inform	 policy	 making,	 but	 also	 practical	 aspects	 which	 might	 stand	 in	 the	 way	 of	
successful	 policy	 implementation,	 as	 they	 were	 neglected	 in	 the	 desktop	 policy	
development	 process.	 Such	 feedback	 could	 also	 assist	 other	 providers,	 and	 thus	 it	 is	
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important	that	an	appropriate	anonymised	form	of	it	is	made	publicly	available.	Also,	as	
one	 of	 the	 key	 aspects	 of	 lack	 of	 support	 in	 policy	 implementation	 was	 the	 newly	
imposed	administrative	burden	and	arising	penalties	for	clerical	errors,	it	is	advisable	to	
consider	introduction	of	advisory	and	consultative	support	to	providers,	as	a	prior	step	
to	penalisation.	These	consultations	by	peers	or	public	officials	could	be	also	used	as	a	
vehicle	to	sharing	information	on	policy	changes	and	for	educational	purposes	on	clinical	
guidelines.		
7.3.4	Guidelines	and	communication	training	for	providers	
While	 admitting	 the	 problems	 with	 policy	 implementation,	 for	 which	 they	 did	 not	
consider	themselves	responsible,	the	policy	makers	provided	ideas	for	its	improvement	
through	actions	 targeting	providers	and	patients.	 Some	of	 the	key	 issues	 in	 their	 view	
were	 improvement	of	health	 literacy	of	patients	(elaborated	 in	more	detail	 in	the	next	
sub-section),	 along	 with	 further	 rationalisation	 and	 formalisation	 measures	 for	
providers,	through	reinforcement	of	existing,	and	adoption	of	new,	clinical	guidelines	for	
prescribing	 in	 primary	 care.	 In	 addition,	 they	 consider	 the	 improvement	 of	
communication	 and	negotiation	 skills	 of	 providers	 in	 their	 interaction	with	patients	 to	
significantly	 contribute	 to	 better	 policy	 implementation	 regarding	 prescribing	 and	
dispensing.	 Mishler	 (1984)	 argued	 that	 if	 providers	 listened	 more	 and	 translated	
technical	 language	 into	 the	 voice	 of	 the	 lifeworld,	 they	would	 become	more	 effective	
practitioners.	It	is	thus	imperative	to	consider	ways	of	improving	communication	skills	of	
providers	 throughout	 the	 educational	 process,	 starting	 from	undergraduate	 level,	 and	
also	 during	 specialisation.	 This	 could	 be	 effectively	 done	 through	 introduction	 of	 a	
specific	module	on	communication	with	patients	 in	 the	 final	 years	of	education,	when	
students	 have	 required	medical	 expertise	 and	 could	more	 practically	 understand	 and	
-	251	-	
incorporate	 this	 knowledge	 into	 their	 future	 practice.	 In	 addition,	 practical	 aspects	 of	
clinical	guidance	application	should	be	introduced	as	mandatory	components	of	current	
continued	medical	education	system.	In	this	sense,	peer-to-peer	experience	exchange	is	
underutilized	but	could	be	a	valuable	asset	to	improving	guidance	adherence.		
7.3.5	Patients’	literacy	and	awareness	raising	campaigns	
Despite	articulation	of	prudent	prescribing	and	dispensing,	accounts	from	providers	and	
policy	makers	suggested	a	continuing	practice	of	irrational	prescribing.	Whilst	this	study	
did	not	set	out	to	verify	or	measure	such	practices,	the	emergence	of	these	contrasting	
accounts	does	suggest	 some	concern.	This	 research	also	underlined	 the	 importance	of	
the	patient	in	prescribing	and	dispensing.		
Policy	 proposals	 for	 addressing	 irrational	 prescribing	 from	 the	 demand-side	 mention	
parallel	 interventions	 of	 individual	 and	 collective	 health	 literacy	 improvement	 of	 the	
population.	 These	 include	 patients’	 education	 by	 providers	 –	 either	 physician	 or	
pharmacist	 -	 during	 their	 consultation,	 and	 public	 campaigns.	 This	 section	 provides	
elaboration	on	the	latter,	as	the	former	was	addressed	as	part	of	the	previous	section	on	
communication	skills	for	providers.		
Extensive	 efforts	 were	 made	 at	 national	 level	 and	 globally	 to	 address	 irrational	
prescribing	 (Goossens	 et	 al	 2006;	 Earnshaw	 et	 al	 2014).	 On	 the	 demand	 side,	 these	
efforts	 were	 directed	 at	 improving	 health	 literacy	 and	 information	 access	 through	
awareness	 raising	 campaigns	 (Goossens	 et	 al	 2006).	 In	 Macedonia,	 public	 awareness	
raising	campaigns	 for	 rational	antibiotic	use	have	been	systematically	organized	 in	 the	
country	 since	 2008,	 with	 endorsement	 of	 the	 European	 Antibiotic	 Awareness	 Day	
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(EAAD)	by	the	European	Centre	for	Disease	Prevention	and	Control	(ECDC)	(Earnshaw	et	
al	2014)	and	more	recently	with	the	World	Antibiotic	Awareness	Week	(WAAW).		
Building	 on	 the	 above	 experience,	 further	 efforts	 should	 be	 made	 in	 continuing	 and	
fortifying	 awareness	 raising	 efforts	 for	 prudent	 antibiotic	 use	 among	 patients.	 In	
addition,	the	messages	conveyed	to	the	public	should	be	related	to	practice	experience	
and	qualitative	research	on	underlying	reasons	for	 irrational	prescribing.	The	results	of	
this	research	could	build	upon	and	inform	future	public	campaigns.	
	
7.4. Final	reflections	
Post-communist	 policy	 changes	 have	 been	 shown	 to	 exert	 considerable	 and	 often	
unintended	 consequences	 upon	 key	 stakeholders	 in	 Macedonia,	 resulting	 in	 negative	
experiences	 and	 inappropriate	 practices.	 These	 may	 be	 arguably	 linked	 to	 problems	
relating	 to	 stakeholders	 not	 being	 involved	 in	 policymaking	 and	 implementation,	
inadequate	 communication	 of	 policy	 changes	 and	 insufficient	 providers’	 skills	 for	
communication	with	patients.	In	addition,	such	negativity	might	be	linked	to	experiences	
from	 the	 past,	 which	 future	 policy	 formation	 should	 consider.	 Recognition	 of	 these	
problems	 as	 identified	 in	 this	 research	 suggest	 important	 areas	 in	 which	 to	 consider	
change	and	involve	physicians,	pharmacists	and	patients	much	more,	and	offer	respect	
and	protection	of	their	threatened	lifeworlds.	
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Appendix	B:	INFO	SHEET	FOR	PARTICIPANTS	
	
Research	Project	Title:	
Effects	of	prescription	policy	changes	on	the	practices	and	attitudes	towards	
prescribing	in	the	primary	healthcare	in	Macedonia	
	
Researching	institutions:		
School	of	Health	and	Related	Research	(ScHARR),	The	University	of	Sheffield,	UK	
Centre	for	Regional	Policy	Research	and	Cooperation	‘Studiorum’,	Macedonia	
Researcher:	NEDA	MILEVSKA-KOSTOVA	
	
	
Dear	Participant,	
	
Thank	you	for	accepting	to	read	the	materials	provided.	
	
You	are	invited	to	take	part	 in	this	research	study,	closely	related	to	your	everyday	life	
and	work.	Before	 you	decide	whether	 to	 take	part	 in	 this	 research,	 it	 is	 important	 for	
you	to	understand	why	the	research	is	being	done	and	what	it	will	 involve.	Please	take	
time	to	read	the	following	information	carefully,	and	do	not	hesitate	to	ask	should	you	
find	anything	to	be	unclear	or	if	you	want	to	have	more	information.		
Giving	 of	 this	 information	 to	 you	 is	 by	 no	 means	 obliging	 you	 to	 participate	 -	 if	 you	
decide	 to	 take	 part	 you	 will	 be	 asked	 to	 sign	 the	 attached	 Consent	 form,	 which	 you	
should	also	read	carefully	before	signing.		
	
Background	on	the	research	
The	aim	of	this	study	is	to	investigate	what	are	the	effects	of	the	policy	changes	affecting	
the	regulation	of	prescription	medicines	and	incentives	available	to	healthcare	providers	
and	pharmacists	on	providers’	experience	and	perception	of	the	policy	changes.	
The	research	will	consist	of	qualitative	data	gathering	and	analysis	–	performed	through	
semi-structured	 interviews	with	different	stakeholder	groups,	 including	key	 informants	
(policy	and	decision	makers,	experts	and	academia,	professional	associations	and	private	
sector),	health	providers	 (general	practitioners	and	pharmacists	 involved	 in	prescribing	
and	dispensing	of	medicines)	and	patients.		
	
Why	have	you	been	chosen?	
A	number	of	persons	were	 invited	 in	 four	different	groups	 to	participate	 in	 this	 study,	
based	on	their	experiences	and/or	expertise.		
You	have	been	invited	as	part	of	the	group	of	key	informants,	constituted	of	policy	and	
decision	makers,	experts	and	academia,	professional	associations	and	private	sector.	
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What	are	you	expected	to	do?	The	procedure	
Your	involvement	is	expected	as	key	informant	to	the	group	of	policy	and	decision	
makers,	experts	and	academia,	professional	associations	and	private	sector.	
After	consenting	to	participate	 (by	signing	the	consent	 form),	you	will	be	asked	by	the	
researcher	a	number	of	open	questions,	that	allow	you	to	talk	about	issues	for	as	long	as	
you	want	and	 to	express	yourself	 fully	and	 to	 the	best	of	your	knowledge.	Please	also	
consider	that	there	are	no	right	or	wrong	answers,	and	that	actually	your	knowledge	and	
experience	in	the	field	is	of	great	value	for	the	study.	
The	interview	will	take	no	longer	than	40-60	minutes	of	your	time.	For	this	however,	a	
suitable	 location	 is	 a	 prerequisite,	 and	 it	 can	 be	 chosen	 by	 you	 –	 it	 can	 be	 your	
office/working	 space,	 a	 space	 within	 the	 research	 institution	 mentioned	 above.	 If	
neither	of	these	is	suitable,	a	mutually	acceptable	venue	can	be	selected.	
The	interview	will	be	voice-recorded	unless	you	request	that	it	not	be.		
The	recorded	interview	will	then	be	anonymously	transcribed	into	written	form	to	allow	
for	 better	 and	more	 accurate	 interpretation	 by	 the	 researcher.	 You	 can,	 if	 you	 wish,	
receive	the	full	transcript	of	the	interview	taken	with	you.		
After	that,	all	interviews	will	be	analysed	and	used	in	the	research	study	that	forms	part	
of	a	doctoral	thesis	of	the	researcher	named	above.		
	
Deciding	whether	to	take	part	or	not	
Accepting	 to	 read	 this	 Information	 Sheet	 is	 in	 no	way	 obliging	 you	 to	 take	 part	 -	 it	 is	
entirely	up	to	you	to	decide	whether	or	not	to	take	part.	If	you	do	decide	to	take	part,	
you	will	be	asked	to	sign	a	Participant	Consent	Form,	attached	herewith.		
As	 this	 is	academic	 research,	 there	are	no	envisaged	risks	 to	 taking	part.	The	methods	
and	the	subject	chosen	for	this	research	have	been	approved	by	the	Ethics	Committee	of	
the	 University	 of	 Sheffield,	 UK	 and	 the	 Ethics	 Committee	 of	 the	 University	 of	 Skopje,	
Macedonia.	
However,	 if	 you	 decide	 to	 take	 part	 you	 are	 still	 free	 to	 withdraw	 at	 any	 time	 and	
without	giving	a	reason	for	such	decision.	
	
Confidentiality	and	privacy	
All	 information	 that	 is	 collected	 about	 you	 and	 from	 you	 during	 the	 course	 of	 the	
research	will	be	kept	 in	secure	database	and	with	strict	confidentiality.	 If	you	explicitly	
require,	any	information,	which	will	be	used	for	the	research	study,	will	be	anonymous,	
meaning	that	all	personal	information	will	be	removed	accordingly.	
The	audio	recordings	of	your	interview	during	this	research	will	be	used	only	for	analysis	
and	for	illustration	in	conference	presentations	and	lectures.	No	other	use	will	be	made	
of	 them	 without	 your	 written	 permission,	 and	 no	 one	 outside	 the	 research	 will	 be	
allowed	access	to	the	original	recordings.	
	
Research	outcome:	What	will	the	research	results	be	used	for?	
The	results	of	this	study	will	be	used	primarily	as	part	of	a	PhD	thesis	that	will	be	written	
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up	and	submitted	by	the	researcher	named	above.	You	are	welcome	to	read	and	access	
the	thesis	once	it	has	been	defended	and	published.	
	
Contact	for	Further	Information	
If	 you	 require	 clarification,	 further	 information	 or	 want	 to	 discuss	 any	 aspect	 of	 this	
research,	please	do	not	hesitate	to	contact	the	researcher,	NEDA	MILEVSKA-KOSTOVA:	
(mobile:	+389	71	225	446,	e-mail:	N.Milevska@sheffield.ac.uk)	
	
Thank	you.		
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Appendix	C:	CONSENT	FORM		
	
Participant	Consent	Form	
	
	
Title	of	Research	Project:		
Effects	of	prescription	policy	changes	on	the	practices	and	attitudes	towards	prescribing	in	the	
primary	healthcare	in	Macedonia	
	
Name	of	Researcher:	NEDA	MILEVSKA	KOSTOVA	
	
Participant	Identification	Number	for	this	project:	 																																								Please	initial	box	
	
1. I	confirm	that	I	have	read	and	understand	the	Information	sheet		
dated	________________	explaining	the	above	research	project	
and	I	have	had	the	opportunity	to	ask	questions	about	the	project.	
	
2. I	understand	that	my	participation	is	voluntary	and	that	I	am	free	to	withdraw	
at	any	time	without	giving	any	reason	and	without	there	being	any	negative	
consequences.	In	addition,	should	I	not	wish	to	answer	any	particular	
question	or	questions,	I	am	free	to	decline.	Insert	contact	number	here	of	
lead	researcher/member	of	research	team	(as	appropriate).	
	
3. I	understand	that	my	responses,	if	I	wish	so	will	be	kept	strictly	confidential.	
I	give	permission	for	members	of	the	research	team	to	have	access	to	my	
anonymised	responses.	I	understand	that	my	name	will	not	be	linked	with	
the	research	materials,	and	I	will	not	be	identified	or	identifiable	in	the	
report	or	reports	that	result	from	the	research,	if	I	express	such	wish.		
	
4.				I	agree	for	the	data	collected	from	me	to	be	used	in	future	research		
	
5. I	agree	to	take	part	in	the	above	research	project.	
	
	
________________________	 ________________			____________________	
Name	of	Participant	 Date	 Signature	
(or	legal	representative)	
	
	
_NEDA	MILEVSKA	KOSTOVA________	 ________________			____________________	
	Lead	Researcher	 Date	 Signature	
To	be	signed	and	dated	in	presence	of	the	participant	
	
Copies:	2	
	
Once	this	has	been	signed	by	all	parties	the	participant	should	receive	a	copy	of	the	signed	and	
dated	 participant	 consent	 form,	 the	 letter/pre-written	 script/information	 sheet	 and	 any	 other	
written	 information	provided	 to	 the	participants.	A	 copy	of	 the	 signed	and	dated	 consent	 form	
should	 be	 placed	 in	 the	 project’s	main	 record	 (e.g.	 a	 site	 file),	which	must	 be	 kept	 in	 a	 secure	
location.		
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Appendix	D:	INTERVIEW	SCHEDULE	QUESTIONS	FOR	ELITES	
	
Elites:	Policy/decision	makers,	experts/academia,	professional	associations/	private	
sector	
	
	
[Introductory	questions]		
1. Have	 you	 been	 (and	 how	 long)	 involved	with	 the	 PHC	 reforms	 in	Macedonia?	
How?	
2. Have	you	been	involved	with	the	prescribing	policies	in	Macedonia?	How?	
3. Who	is	responsible	for	preparation	and	execution	of	prescribing	policies?	Who	
should	be	involved?	
4. Have/Do	 you	 participate/d	 in	 the	 preparation	 or	 execution	 of	 prescribing	
policies?	
5. In	your	opinion,	what	are	the	main	goals	of	the	prescribing	policies?		
a. Are	these	goals	addressed?		
b. Are	these	goals	met?	If	not,	why?	
6. What	are	the	most	important	achievements	of	the	prescribing	policies?	
	
[Policy	of	2005/7:	limitation	on	number	of	prescriptions]	
7. In	 2005/7,	 with	 the	 transformation	 (privatization)	 of	 the	 primary	 healthcare	
(PHC),	 the	prescribing	policy	has	changed	to	 involve	 limitations	on	the	number	
of	 prescriptions	 per	 patient,	 replacing	 the	 pre-2005	 policy	 (of	 no-limited	
prescribing).		
a. What	is	your	opinion	on	its	design	and	effectiveness?		
b. Is	this	policy	better/worse	than	the	one	before	2005	(no	limitations,	no	
privatization)?	For	whom	and	in	what	way?	
c. Do	 you	 think	 this	 policy	 contributed	 to	 rational	 prescribing	 (of	 PHC	
goals)?	
d. Was	the	policy	incentivising/dis-incentivising	for	PHC	doctors	and	how?	
e. Had	 this	 policy	 any	 influence	 on	 the	 freedom/levels	 of	 prescribing	 for	
PHC	doctors?	In	what	way?	
f. How	do	you	think	this	policy	affected	the	access	to	medicines?	
		
[Policy	of	2009:	budget	ceiling	for	prescribing]	
8. In	 2009,	 the	 prescribing	 policy	 in	 primary	 care	 was	 redefined	 using	 budget	
ceilings	 for	PHC	doctors.	How	 is	 this	policy	 compared	 to	 the	policy	of	2005/7?	
Compared	to	the	pre-2005	policy?	
a. Do	you	think	it	is	well	designed	and	fair?	If	not,	why?	To	whom	it	is	not	
fair?	
b. Who	is	responsible	for	this?	
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c. Do	 you	 think	 this	 policy	 contributes	 to	 rational	 prescribing	 (of	 PHC	
goals)?	
d. Is	the	policy	incentivising/dis-incentivising	for	PHC	doctors	and	how?	
e. Has	 this	 policy	 any	 influence	 on	 the	 freedom/levels	 of	 prescribing	 for	
PHC	doctors?	In	what	way?	
f. How	do	you	think	this	policy	affected	the	access	to	medicines?	
9. Of	all	policies	(pre-2005,	2005/7	and	2009),	which	gave	best	results	in:		
a. Rational	prescribing?	
b. Access	to	medicines?	
c. Better	off	and	worse	off?	Who	and	why?	
	
[Overall:	Policies	on	prescribing]		
10. Are	prescribing	policies	are	(fully	or	partially)	implemented?		
a. If	not,	what	parts	are	not	implemented	and	why?		
b. How	can	this	be	overcome?	
c. If	not,	who	is	responsible	for	lack	of	implementation?		
d. How	can	this	be	overcome?	
	
[General:	Policies	on	dispensing]	
11. Although	 rather	 stringent	 policies	 exist	 on	 the	 dispensing	 of	 prescription	
medicines,	 those	 are	not	well	 implemented.	 In	 your	 opinion	 (and	experience),	
where	the	main	problem	lays?	(enforcement,	incentives,	etc.)	
a. Who	is	responsible	for	such	low	enforcement?	
b. How	can	this	be	overcome?	
c. How	is	the	low	enforcement	reflected	on	the	rational	prescribing?	
d. What	can	be	done	to	reduce	the	non-prescription	dispensing?	
	
[EXTRAS]	
12. If	 you	 were	 a	 PHC	 provider,	 what	 would	 you	 say/do	 about	 the	 prescribing	
policies?	Would	you	think	the	policies	are:	fair,	incentivising,	backward?	
13. If	you	were	a	pharmacist,	what	would	you	say/do	about	the	dispensing	policies?	
14. If	you	were	the	patient,	what	would	you	say/do	about	the	prescribing	policies?	
15. Any	other	comments	or	opinions?	
	 	
Thank	you.	
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Appendix	E:	INTERVIEW	SCHEDULE	QUESTIONS	FOR	PHYSICIANS	
	
	
[Introductory	questions]		
16. How	long	have	you	been	working	in	the	PHC?	
17. Who	is	responsible	for	preparation	and	execution	of	prescribing	policies?	Who	
should	be	involved?	
18. Have/Do	you	participate/d	in	the	preparation	of	prescribing	policies?	
19. In	your	opinion,	what	are	the	main	goals	of	the	prescribing	policies?		
a. Are	these	goals	addressed?		
b. Are	these	goals	met?	If	not,	why?	
20. What	are	the	most	important	achievements	of	the	prescribing	policies?	
	
[Policy	of	2005/7:	limitation	on	number	of	prescriptions]	
21. In	 2005/7,	 with	 the	 transformation	 (privatization)	 of	 the	 primary	 healthcare	
(PHC),	 the	prescribing	policy	has	changed	to	 involve	 limitations	on	the	number	
of	 prescriptions	 per	 patient,	 replacing	 the	 pre-2005	 policy	 (of	 no-limited	
prescribing).		
a. What	is	your	opinion	on	its	design	and	effectiveness?		
b. Is	this	policy	better/worse	than	the	one	before	2005	(no	limitations,	no	
privatization)?	For	whom	and	in	what	way?	
c. Do	 you	 think	 this	 policy	 contributed	 to	 rational	 prescribing	 (of	 PHC	
goals)?	
d. Was	the	policy	incentivising/dis-incentivising	for	PHC	doctors	and	how?	
e. Had	 this	 policy	 any	 influence	 on	 the	 freedom/levels	 of	 prescribing	 for	
PHC	doctors?	In	what	way?	
f. How	do	you	think	this	policy	affected	the	access	to	medicines?	
		
[Policy	of	2009:	budget	ceiling	for	prescribing]	
22. In	 2009,	 the	 prescribing	 policy	 in	 primary	 care	 was	 redefined	 using	 budget	
ceilings	 for	PHC	doctors.	How	 is	 this	policy	 compared	 to	 the	policy	of	2005/7?	
Compared	to	the	pre-2005	policy?	
a. Do	you	think	it	is	well	designed	and	fair?	If	not,	why?	To	whom	it	is	not	
fair?	
b. Who	is	responsible	for	this?	
c. Do	 you	 think	 this	 policy	 contributes	 to	 rational	 prescribing	 (of	 PHC	
goals)?	
d. Is	the	policy	incentivising/dis-incentivising	for	PHC	doctors	and	how?	
e. Has	 this	 policy	 any	 influence	 on	 the	 freedom/levels	 of	 prescribing	 for	
PHC	doctors?	In	what	way?	
f. How	do	you	think	this	policy	affected	the	access	to	medicines?	
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[Overall:	Comparing	policies]	
23. If	you	compare	all	policies	(pre-2005,	2005/7	and	2009):		
a. Do	 you	 have	 more/less	 patient	 visits	 now	 (after	 2009)	 than	 before	 (pre-
2009)?	Pre-2005?	
b. Do	you	have	more/less	prescriptions	(in	absolute	terms)	now	than	before?	
c. Do	you	think	the	HIF	spending	on	medicines	is	higher/lower	now	(post-2009)	
than	with	the	prescription-limit	policy	(2005/7)?	Why	do	you	think	so?	
	
[Overall:	Policies	on	prescribing]		
24. Are	prescribing	policies	are	(fully	or	partially)	implemented?		
a. If	not,	what	parts	are	not	implemented	and	why?		
b. How	can	this	be	overcome?	
c. If	not,	who	is	responsible	for	lack	of	implementation?		
d. How	can	this	be	overcome?	
	
[General:	Policies	on	dispensing]	
25. Although	 rather	 stringent	 policies	 exist	 on	 the	 dispensing	 of	 prescription	
medicines,	 those	 are	not	well	 implemented.	 In	 your	 opinion	 (and	experience),	
where	the	main	problem	lays?	(enforcement,	incentives,	etc.)	
a. Who	is	responsible	for	such	low	enforcement?	
b. How	can	this	be	overcome?	
c. How	is	the	low	enforcement	reflected	on	the	rational	prescribing?	
d. What	can	be	done	to	reduce	the	non-prescription	dispensing?	
e. Do	 you	 think	 a	 patient	 should	 be	 allowed	 to	 obtain	medicine	without	
prescription?	If	not,	why?	
f. Do	you	think	it	is	appropriate	that	a	patient	can	get	a	medicine	without	
prescription?	If	not,	why?	How	do	you	feel	about	this	situation?	
g. Do	you	think	it	is	your	responsibility	to	prevent	patients	from	obtaining	
medicines	without	prescription?	If	not,	whose	responsibility	it	is?	
	
[EXTRAS]	
26. If	you	were	the	patient,	what	would	you	say/do	about	the	prescribing	policies?	
27. Any	other	comments	or	opinions?	
Thank	you.	
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Appendix	F:	INTERVIEW	SCHEDULE	QUESTIONS	FOR	PHARMACISTS	
	
[Introductory	questions]		
1. How	long	have	you	been	working	in	a	pharmacy?	
2. Who	is	responsible	for	preparation	and	execution	of	prescribing	policies?	Who	
should	be	involved?	
3. Have/Do	you	participate/d	in	the	preparation	of	prescribing	policies?	
4. In	your	opinion,	what	are	the	main	goals	of	the	prescribing	policies?		
a. Are	these	goals	addressed?		
b. Are	these	goals	met?	If	not,	why?	
5. What	are	the	most	important	achievements	of	the	prescribing	policies?	
6. In	your	opinion,	what	are	the	main	goals	of	the	dispensing	policies?		
a. Are	these	goals	addressed?		
b. Are	these	goals	met?	If	not,	why?	
7. What	are	the	most	important	achievements	of	the	dispensing	policies?	
	
[Policy	of	2005/7:	limitation	on	number	of	prescriptions]	
8. In	 2005/7,	 with	 the	 transformation	 (privatization)	 of	 the	 primary	 healthcare	
(PHC),	 the	prescribing	policy	has	changed	to	 involve	 limitations	on	the	number	
of	 prescriptions	 per	 patient,	 replacing	 the	 pre-2005	 policy	 (of	 no-limited	
prescribing).		
a. Do	 you	 think	 this	 policy	 contributed	 to	 rational	 prescribing	 (of	 PHC	
goals)?	
b. Had	 this	 policy	 any	 influence	 on	 the	 freedom/levels	 of	 prescribing	 for	
PHC	doctors?	In	what	way?	
c. How	do	you	think	this	policy	affected	the	access	to	medicines?	
		
[Policy	of	2009:	budget	ceiling	for	prescribing]	
9. In	 2009,	 the	 prescribing	 policy	 in	 primary	 care	 was	 redefined	 using	 budget	
ceilings	 for	PHC	doctors.	How	 is	 this	policy	 compared	 to	 the	policy	of	2005/7?	
Compared	to	the	pre-2005	policy?	
a. Do	 you	 think	 this	 policy	 contributes	 to	 rational	 prescribing	 (of	 PHC	
goals)?	
b. Has	 this	 policy	 any	 influence	 on	 the	 freedom/levels	 of	 prescribing	 for	
PHC	doctors?	In	what	way?	
c. How	do	you	think	this	policy	affected	the	access	to	medicines?	
	
[Overall:	Comparing	policies]	
10. If	you	compare	all	policies	(pre-2005,	2005/7	and	2009):		
a. Do	you	believe	 that	 the	change	 to	2009	policy	 for	prescribing	affected	
the	levels	of	private	purchased	medicines	by	patients?	
b. Do	you	have	more/less	patients	asking	medicines	without	prescriptions	
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now	than	before?	
c. Do	you	think	the	HIF	spending	on	medicines	is	higher/lower	now	(post-
2009)	than?	Why	do	you	think	so?	
d. Do	 you	 think	 that	 patients	 now	 spend	 more/less	 on	 prescription	
medicines	than	before?	
	
[Overall:	Policies	on	prescribing]		
11. Are	prescribing	policies	are	(fully	or	partially)	implemented?		
a. If	not,	what	is	not	implemented	and	why?	How	can	this	be	overcome?	
b. If	not,	who	is	responsible?	How	can	this	be	overcome?	
	
[General:	Policies	on	dispensing]	
12. Although	 rather	 stringent	 policies	 exist	 on	 the	 dispensing	 of	 prescription	
medicines,	 those	 are	not	well	 implemented.	 In	 your	 opinion	 (and	experience),	
where	the	main	problem	lays?	(enforcement,	incentives,	etc.)	
a. Who	is	responsible	for	such	low	enforcement?	
b. How	can	this	be	overcome?	
c. How	is	the	low	enforcement	reflected	on	the	rational	prescribing?	
d. What	can	be	done	to	reduce	the	non-prescription	dispensing?	
e. Do	 you	 think	 a	 patient	 should	 be	 allowed	 to	 obtain	medicine	without	
prescription?	If	not,	why?	
f. Do	you	think	it	is	appropriate	that	a	patient	can	get	a	medicine	without	
prescription?	If	not,	why?	How	do	you	feel	about	this	situation?	
g. Do	you	think	it	is	your	responsibility	to	prevent	patients	from	obtaining	
medicines	without	prescription?	If	not,	whose	responsibility	it	is?	
13. Have	you	ever	dispensed	a	prescription-only	medicine	without	prescription?	Do	
you	think	it	was	right?		
14. How	do	you	feel	about	medicine	dispensing	without	prescription?	Do	you	think	
that	it	is	related	to	the	current	setup	in	the	prescribing	policy?	Was	it	different	in	
the	past?	How?	
15. Do	you	think	that	dispensing-on-prescription	policy	should	be	strictly	enforced?	
What	effect	would	that	have	on	the	pharmacies?	On	the	patients?		
16. If	dispensing-on-prescription	policy	is	fully	enforced,	how	do	you	think	that	will	
affect	 your	 business	 (e.g.	 relationship	 with	 pharmaceutical	 companies	 would	
change,	less	patients	would	use	your	services,	etc.)?	
	
[EXTRAS]	
17. If	you	were	the	patient,	what	would	you	say/do	about	the	prescribing	policies?	
18. Any	other	comments	or	opinions?	
Thank	you.	
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Appendix	G:	INTERVIEW	SCHEDULE	QUESTIONS	FOR	PATIENTS	
	
[Introductory	questions]		
1. Are	you	taking	any	long-term	therapy?	For	how	long?	
2. Who	is	responsible	for	preparation	and	execution	of	prescribing	policies?	Who	
should	be	involved?	
3. Have/Do	you	participate/d	in	the	preparation	of	prescribing	policies?	
4. In	your	opinion,	what	are	the	main	goals	of	rules	for	medicine	prescribing?		
5. In	your	opinion,	what	are	the	main	goals	of	rules	for	medicine	dispensing?		
6. Do	 you	 agree	 that	 a	 doctor	 and	 pharmacist	 should	 make	 a	 decision	 on	 your	
therapy?	
	
[Policy	of	2005/7:	privatization	of	PHC	–	limitation	of	prescriptions]	
In	 2005/7,	 with	 the	 transformation	 (privatization)	 of	 the	 primary	 healthcare	
(PHC),	the	prescribing	policy	has	changed,	replacing	the	pre-2005	policy	(of	no-
limited	prescribing).		
7. If	you	remember,	how	did	you	feel	about	the	change	in	PHC?	Did	you	have	any	
problems	with	your	therapy?	If	yes,	was	it	related	to:	
a. Obtaining	prescription	from	PHC?	How?	
b. Obtaining	medicine	at	pharmacy?	How?	Or	both?	
		
[Policy	of	2009:	budget	ceiling	for	prescribing]	
In	 2009,	 the	 prescribing	 policy	 in	 PHC	was	 redefined	 using	 budget	 ceilings	 for	
PHC	doctors.		
8. Did	 you	 have	 experience	 of	 changes	 in	 attitude	 or	 practice	 of	 your	 doctor	
related	to	your	prescription	medicines?		
a. If	yes,	in	what	way?	
9. Did	 you	 have	 experience	 of	 changes	 in	 attitude	 or	 practice	 of	 the	 pharmacist	
related	to	your	prescription	medicines?	
a. If	yes,	in	what	way?	
	
[Overall:	Comparing	policies]	
If	you	compare	your	experience	with	medicines	over	the	past	decade,	from	2004	
until	today	(if	applicable):		
10. Access	to	your	medicines	at	your	PHC	doctor:	
a. Have	you	experienced	any	changes	in	access	to	your	doctor?	
b. To	his/her	readiness	to	prescribe	the	medicines	to	you?	
c. If	yes,	in	what	way	has	this	changed?	
11. Access	to	medicines	at	the	pharmacy:	
a. Have	 you	 experienced	 any	 changes	 in	 access	 to	 medicines	 at	 the	
pharmacy?	
b. Have	you	experienced	any	changes	to	obtaining	HIF-covered	medicines?	
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c. If	yes,	in	what	way	has	this	changed?	
d. Do	you	think	that	the	levels	of	your	spending	on	prescription	medicines	
have	changed	compared	to	before?	If	yes,	in	what	way?	
e. Have	you	ever	asked	prescription	medicine	without	prescription?	Why?	
Do	you	think	it	was	right?	
f. Have	you	ever	got	a	prescription	medicine	without	prescription?	Why?	
Do	you	think	it	was	right?	
	
[Overall:	Policies	on	prescribing]		
12. Do	 you	 think	 it	 is	 right	 that	 a	 patient	 should	 always	 get	 a	 prescription	 for	 a	
prescription	medicine?	If	not,	why?	How	can	this	be	overcome?	
	
[General:	Policies	on	dispensing]	
13. Do	you	think	 it	 is	right	that	a	patient	should	always	present	a	prescription	to	a	
pharmacist	to	obtain	a	prescription	medicine?	If	not,	why?		
a. Do	 you	 think	 a	 patient	 should	 be	 allowed	 to	 obtain	medicine	without	
prescription?	If	yes,	why?	If	not,	why?	
b. Do	you	think	it	is	appropriate	that	a	patient	can	get	a	medicine	without	
prescription?	If	yes,	why?	If	not,	why?	
14. If	dispensing-on-prescription	policy	is	fully	enforced,	how	do	you	think	that	will	
affect	your	health	and	access	to	medicines?	(not	be	able	to	get	all	medicines,	no	
freedom	of	choice,	etc.)	
	
[EXTRAS]	
15. Any	other	comments	or	opinions?	
Thank	you.	
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